date generated: 2020-12-06
Mitch performs unidimensional and multidimensional gene set enrichment analysis. The concept behind this dates to work by Cox and Mann (https://doi.org/10.1186/1471-2105-13-S16-S12). This implementation is suited to R based workflows of multi-omics datasets. This software was developed by Antony Kaspi and Mark Ziemann. Learn more about Mitch at the website: https://github.com/markziemann/Mitch
Here is the first few lines of the input profile.
## x
## -1266.6248017
## 5_8S_rRNA -15.7561510
## A1BG -1.6154621
## A1CF 0.2527981
## A2M -0.8454804
## A3GALT2 0.2338000
Here are some metrics about the input data profile:
| Profile metrics | |
|---|---|
| num_genesets | 2408 |
| num_genes_in_profile | 17707 |
| duplicated_genes_present | 0 |
| num_profile_genes_in_sets | 9310 |
| num_profile_genes_not_in_sets | 8397 |
Here is a plot of the input profiles. Note the dynamic ranges.
Here is the contour plot of the profile including all detected genes.
Here are some metrics about the gene sets used: GMT file of genesets: ReactomePathways.gmt
| Gene sets metrics | |
|---|---|
| num_genesets | 2408 |
| num_genesets_excluded | 962 |
| num_genesets_included | 1446 |
Significance is calculated by -log10(p-value). All points shown are FDR<0.05.
Top N= 50 gene sets
| set | setSize | pANOVA | s.dist | p.adjustANOVA |
|---|---|---|---|---|
| Mitochondrial translation elongation | 85 | 6.41e-21 | 0.5880 | 7.06e-18 |
| Mitochondrial translation | 91 | 9.76e-21 | 0.5660 | 7.06e-18 |
| Mitochondrial translation termination | 85 | 3.68e-20 | 0.5770 | 1.77e-17 |
| Translation | 263 | 2.86e-19 | 0.3220 | 1.03e-16 |
| Mitochondrial translation initiation | 85 | 7.75e-19 | 0.5560 | 2.24e-16 |
| The citric acid (TCA) cycle and respiratory electron transport | 165 | 3.56e-13 | 0.3280 | 8.58e-11 |
| Macroautophagy | 108 | 3.98e-12 | 0.3860 | 8.22e-10 |
| Autophagy | 122 | 1.98e-11 | 0.3520 | 3.57e-09 |
| Protein localization | 156 | 4.45e-11 | 0.3060 | 7.14e-09 |
| Metabolism of proteins | 1810 | 1.06e-10 | 0.0924 | 1.53e-08 |
| Defective CFTR causes cystic fibrosis | 58 | 2.33e-09 | 0.4530 | 3.06e-07 |
| ABC transporter disorders | 74 | 3.62e-09 | 0.3970 | 4.36e-07 |
| Metabolism | 1943 | 4.82e-09 | 0.0812 | 5.36e-07 |
| Respiratory electron transport | 96 | 5.36e-09 | 0.3450 | 5.53e-07 |
| Selective autophagy | 56 | 1.25e-08 | 0.4400 | 1.20e-06 |
| ABC-family proteins mediated transport | 97 | 1.32e-08 | 0.3340 | 1.20e-06 |
| Hh mutants that don't undergo autocatalytic processing are degraded by ERAD | 53 | 2.63e-08 | 0.4420 | 2.24e-06 |
| Hh mutants abrogate ligand secretion | 56 | 3.10e-08 | 0.4280 | 2.49e-06 |
| Interleukin-1 signaling | 94 | 4.17e-08 | 0.3270 | 3.18e-06 |
| tRNA Aminoacylation | 42 | 5.94e-08 | 0.4830 | 4.24e-06 |
| Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. | 117 | 6.16e-08 | 0.2900 | 4.24e-06 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | 51 | 8.72e-08 | 0.4330 | 5.49e-06 |
| Regulation of ornithine decarboxylase (ODC) | 49 | 8.74e-08 | 0.4420 | 5.49e-06 |
| NIK-->noncanonical NF-kB signaling | 56 | 9.53e-08 | 0.4120 | 5.74e-06 |
| Degradation of GLI2 by the proteasome | 55 | 1.10e-07 | 0.4140 | 6.39e-06 |
| Regulation of Apoptosis | 50 | 1.34e-07 | 0.4310 | 7.20e-06 |
| Pyruvate metabolism and Citric Acid (TCA) cycle | 52 | 1.34e-07 | 0.4230 | 7.20e-06 |
| Metabolism of polyamines | 57 | 1.49e-07 | 0.4020 | 7.71e-06 |
| Cross-presentation of soluble exogenous antigens (endosomes) | 48 | 1.56e-07 | 0.4380 | 7.80e-06 |
| Mitochondrial Fatty Acid Beta-Oxidation | 36 | 1.69e-07 | 0.5040 | 8.09e-06 |
| Vif-mediated degradation of APOBEC3G | 50 | 1.80e-07 | 0.4270 | 8.09e-06 |
| Degradation of GLI1 by the proteasome | 56 | 1.80e-07 | 0.4030 | 8.09e-06 |
| Vpu mediated degradation of CD4 | 49 | 1.85e-07 | 0.4310 | 8.09e-06 |
| Mitochondrial protein import | 62 | 1.99e-07 | 0.3820 | 8.45e-06 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | 52 | 2.46e-07 | 0.4140 | 1.02e-05 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | 63 | 2.79e-07 | 0.3740 | 1.12e-05 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | 47 | 2.88e-07 | 0.4330 | 1.13e-05 |
| Deubiquitination | 231 | 2.98e-07 | 0.1960 | 1.13e-05 |
| Interleukin-1 family signaling | 127 | 3.64e-07 | 0.2610 | 1.35e-05 |
| GLI3 is processed to GLI3R by the proteasome | 56 | 3.98e-07 | 0.3920 | 1.44e-05 |
| SCF-beta-TrCP mediated degradation of Emi1 | 52 | 4.35e-07 | 0.4050 | 1.53e-05 |
| Cell surface interactions at the vascular wall | 155 | 4.47e-07 | -0.2350 | 1.54e-05 |
| Hedgehog ligand biogenesis | 61 | 5.34e-07 | 0.3710 | 1.80e-05 |
| Degradation of DVL | 54 | 5.86e-07 | 0.3930 | 1.90e-05 |
| Regulation of RUNX2 expression and activity | 69 | 6.03e-07 | 0.3470 | 1.90e-05 |
| Dectin-1 mediated noncanonical NF-kB signaling | 59 | 6.05e-07 | 0.3760 | 1.90e-05 |
| Cellular response to hypoxia | 72 | 6.20e-07 | 0.3400 | 1.91e-05 |
| Autodegradation of the E3 ubiquitin ligase COP1 | 47 | 6.40e-07 | 0.4200 | 1.93e-05 |
| FCGR3A-mediated phagocytosis | 87 | 7.68e-07 | -0.3070 | 2.18e-05 |
| Leishmania phagocytosis | 87 | 7.68e-07 | -0.3070 | 2.18e-05 |
| set | setSize | pANOVA | s.dist | p.adjustANOVA |
|---|---|---|---|---|
| Mitochondrial translation elongation | 85 | 6.41e-21 | 0.588000 | 7.06e-18 |
| Mitochondrial translation | 91 | 9.76e-21 | 0.566000 | 7.06e-18 |
| Mitochondrial translation termination | 85 | 3.68e-20 | 0.577000 | 1.77e-17 |
| Translation | 263 | 2.86e-19 | 0.322000 | 1.03e-16 |
| Mitochondrial translation initiation | 85 | 7.75e-19 | 0.556000 | 2.24e-16 |
| The citric acid (TCA) cycle and respiratory electron transport | 165 | 3.56e-13 | 0.328000 | 8.58e-11 |
| Macroautophagy | 108 | 3.98e-12 | 0.386000 | 8.22e-10 |
| Autophagy | 122 | 1.98e-11 | 0.352000 | 3.57e-09 |
| Protein localization | 156 | 4.45e-11 | 0.306000 | 7.14e-09 |
| Metabolism of proteins | 1810 | 1.06e-10 | 0.092400 | 1.53e-08 |
| Defective CFTR causes cystic fibrosis | 58 | 2.33e-09 | 0.453000 | 3.06e-07 |
| ABC transporter disorders | 74 | 3.62e-09 | 0.397000 | 4.36e-07 |
| Metabolism | 1943 | 4.82e-09 | 0.081200 | 5.36e-07 |
| Respiratory electron transport | 96 | 5.36e-09 | 0.345000 | 5.53e-07 |
| Selective autophagy | 56 | 1.25e-08 | 0.440000 | 1.20e-06 |
| ABC-family proteins mediated transport | 97 | 1.32e-08 | 0.334000 | 1.20e-06 |
| Hh mutants that don't undergo autocatalytic processing are degraded by ERAD | 53 | 2.63e-08 | 0.442000 | 2.24e-06 |
| Hh mutants abrogate ligand secretion | 56 | 3.10e-08 | 0.428000 | 2.49e-06 |
| Interleukin-1 signaling | 94 | 4.17e-08 | 0.327000 | 3.18e-06 |
| tRNA Aminoacylation | 42 | 5.94e-08 | 0.483000 | 4.24e-06 |
| Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. | 117 | 6.16e-08 | 0.290000 | 4.24e-06 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | 51 | 8.72e-08 | 0.433000 | 5.49e-06 |
| Regulation of ornithine decarboxylase (ODC) | 49 | 8.74e-08 | 0.442000 | 5.49e-06 |
| NIK-->noncanonical NF-kB signaling | 56 | 9.53e-08 | 0.412000 | 5.74e-06 |
| Degradation of GLI2 by the proteasome | 55 | 1.10e-07 | 0.414000 | 6.39e-06 |
| Regulation of Apoptosis | 50 | 1.34e-07 | 0.431000 | 7.20e-06 |
| Pyruvate metabolism and Citric Acid (TCA) cycle | 52 | 1.34e-07 | 0.423000 | 7.20e-06 |
| Metabolism of polyamines | 57 | 1.49e-07 | 0.402000 | 7.71e-06 |
| Cross-presentation of soluble exogenous antigens (endosomes) | 48 | 1.56e-07 | 0.438000 | 7.80e-06 |
| Mitochondrial Fatty Acid Beta-Oxidation | 36 | 1.69e-07 | 0.504000 | 8.09e-06 |
| Vif-mediated degradation of APOBEC3G | 50 | 1.80e-07 | 0.427000 | 8.09e-06 |
| Degradation of GLI1 by the proteasome | 56 | 1.80e-07 | 0.403000 | 8.09e-06 |
| Vpu mediated degradation of CD4 | 49 | 1.85e-07 | 0.431000 | 8.09e-06 |
| Mitochondrial protein import | 62 | 1.99e-07 | 0.382000 | 8.45e-06 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | 52 | 2.46e-07 | 0.414000 | 1.02e-05 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | 63 | 2.79e-07 | 0.374000 | 1.12e-05 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | 47 | 2.88e-07 | 0.433000 | 1.13e-05 |
| Deubiquitination | 231 | 2.98e-07 | 0.196000 | 1.13e-05 |
| Interleukin-1 family signaling | 127 | 3.64e-07 | 0.261000 | 1.35e-05 |
| GLI3 is processed to GLI3R by the proteasome | 56 | 3.98e-07 | 0.392000 | 1.44e-05 |
| SCF-beta-TrCP mediated degradation of Emi1 | 52 | 4.35e-07 | 0.405000 | 1.53e-05 |
| Cell surface interactions at the vascular wall | 155 | 4.47e-07 | -0.235000 | 1.54e-05 |
| Hedgehog ligand biogenesis | 61 | 5.34e-07 | 0.371000 | 1.80e-05 |
| Degradation of DVL | 54 | 5.86e-07 | 0.393000 | 1.90e-05 |
| Regulation of RUNX2 expression and activity | 69 | 6.03e-07 | 0.347000 | 1.90e-05 |
| Dectin-1 mediated noncanonical NF-kB signaling | 59 | 6.05e-07 | 0.376000 | 1.90e-05 |
| Cellular response to hypoxia | 72 | 6.20e-07 | 0.340000 | 1.91e-05 |
| Autodegradation of the E3 ubiquitin ligase COP1 | 47 | 6.40e-07 | 0.420000 | 1.93e-05 |
| FCGR3A-mediated phagocytosis | 87 | 7.68e-07 | -0.307000 | 2.18e-05 |
| Leishmania phagocytosis | 87 | 7.68e-07 | -0.307000 | 2.18e-05 |
| Parasite infection | 87 | 7.68e-07 | -0.307000 | 2.18e-05 |
| Degradation of AXIN | 51 | 8.36e-07 | 0.399000 | 2.33e-05 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) | 35 | 8.53e-07 | 0.481000 | 2.33e-05 |
| Neddylation | 225 | 1.07e-06 | 0.189000 | 2.86e-05 |
| Extracellular matrix organization | 271 | 1.10e-06 | -0.172000 | 2.88e-05 |
| Regulation of actin dynamics for phagocytic cup formation | 88 | 1.23e-06 | -0.299000 | 3.16e-05 |
| Ubiquitin Mediated Degradation of Phosphorylated Cdc25A | 48 | 1.75e-06 | 0.399000 | 4.28e-05 |
| p53-Independent DNA Damage Response | 48 | 1.75e-06 | 0.399000 | 4.28e-05 |
| p53-Independent G1/S DNA damage checkpoint | 48 | 1.75e-06 | 0.399000 | 4.28e-05 |
| Ubiquitin-dependent degradation of Cyclin D | 49 | 1.84e-06 | 0.394000 | 4.43e-05 |
| Negative regulation of NOTCH4 signaling | 52 | 2.08e-06 | 0.380000 | 4.94e-05 |
| Degradation of beta-catenin by the destruction complex | 81 | 2.76e-06 | 0.301000 | 6.43e-05 |
| Stabilization of p53 | 51 | 2.87e-06 | 0.379000 | 6.59e-05 |
| Fcgamma receptor (FCGR) dependent phagocytosis | 113 | 3.31e-06 | -0.253000 | 7.48e-05 |
| UCH proteinases | 84 | 3.43e-06 | 0.293000 | 7.64e-05 |
| Downstream TCR signaling | 86 | 3.63e-06 | 0.289000 | 7.96e-05 |
| Regulation of PTEN stability and activity | 66 | 3.87e-06 | 0.329000 | 8.35e-05 |
| Complex I biogenesis | 53 | 6.84e-06 | 0.357000 | 1.45e-04 |
| Ub-specific processing proteases | 159 | 6.98e-06 | 0.207000 | 1.46e-04 |
| Activation of NF-kappaB in B cells | 62 | 9.21e-06 | 0.326000 | 1.88e-04 |
| Asymmetric localization of PCP proteins | 61 | 9.23e-06 | 0.328000 | 1.88e-04 |
| Regulation of RUNX3 expression and activity | 52 | 9.96e-06 | 0.354000 | 2.00e-04 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | 131 | 1.26e-05 | -0.221000 | 2.49e-04 |
| HSF1-dependent transactivation | 30 | 1.62e-05 | 0.455000 | 3.15e-04 |
| MTOR signalling | 38 | 1.63e-05 | 0.404000 | 3.15e-04 |
| Signaling by GPCR | 813 | 2.19e-05 | -0.088000 | 4.16e-04 |
| Membrane Trafficking | 578 | 2.24e-05 | 0.104000 | 4.20e-04 |
| PCP/CE pathway | 89 | 2.84e-05 | 0.257000 | 5.26e-04 |
| DNA Damage/Telomere Stress Induced Senescence | 41 | 2.99e-05 | -0.377000 | 5.48e-04 |
| GPCR downstream signalling | 746 | 3.32e-05 | -0.089600 | 5.94e-04 |
| Citric acid cycle (TCA cycle) | 22 | 3.33e-05 | 0.511000 | 5.94e-04 |
| Cellular responses to stress | 474 | 3.74e-05 | 0.111000 | 6.60e-04 |
| Mitochondrial biogenesis | 87 | 4.08e-05 | 0.255000 | 7.11e-04 |
| Signaling by Rho GTPases | 373 | 4.31e-05 | -0.124000 | 7.41e-04 |
| Mitochondrial tRNA aminoacylation | 21 | 5.05e-05 | 0.511000 | 8.59e-04 |
| Late endosomal microautophagy | 30 | 5.29e-05 | 0.426000 | 8.90e-04 |
| Branched-chain amino acid catabolism | 21 | 7.19e-05 | 0.500000 | 1.20e-03 |
| Chromosome Maintenance | 98 | 7.53e-05 | -0.231000 | 1.24e-03 |
| Gluconeogenesis | 32 | 8.30e-05 | 0.402000 | 1.34e-03 |
| Signaling by NOTCH4 | 78 | 8.42e-05 | 0.258000 | 1.34e-03 |
| Autodegradation of Cdh1 by Cdh1:APC/C | 61 | 8.45e-05 | 0.291000 | 1.34e-03 |
| FCERI mediated Ca+2 mobilization | 58 | 8.51e-05 | -0.298000 | 1.34e-03 |
| Antigen processing-Cross presentation | 92 | 8.68e-05 | 0.237000 | 1.35e-03 |
| MyD88-independent TLR4 cascade | 87 | 9.05e-05 | 0.243000 | 1.38e-03 |
| TRIF(TICAM1)-mediated TLR4 signaling | 87 | 9.05e-05 | 0.243000 | 1.38e-03 |
| TCR signaling | 107 | 9.13e-05 | 0.219000 | 1.38e-03 |
| CLEC7A (Dectin-1) signaling | 94 | 9.72e-05 | 0.233000 | 1.44e-03 |
| Cellular responses to external stimuli | 481 | 9.79e-05 | 0.104000 | 1.44e-03 |
| HIV Infection | 219 | 1.09e-04 | 0.152000 | 1.58e-03 |
| Cytosolic tRNA aminoacylation | 24 | 1.10e-04 | 0.456000 | 1.58e-03 |
| Activation of ATR in response to replication stress | 36 | 1.13e-04 | -0.372000 | 1.62e-03 |
| COPI-mediated anterograde transport | 78 | 1.29e-04 | 0.251000 | 1.83e-03 |
| CDT1 association with the CDC6:ORC:origin complex | 56 | 1.30e-04 | 0.296000 | 1.83e-03 |
| PINK1-PRKN Mediated Mitophagy | 19 | 1.35e-04 | 0.506000 | 1.88e-03 |
| Antigen processing: Ubiquitination & Proteasome degradation | 290 | 1.69e-04 | 0.129000 | 2.33e-03 |
| Deposition of new CENPA-containing nucleosomes at the centromere | 35 | 1.73e-04 | -0.367000 | 2.33e-03 |
| Nucleosome assembly | 35 | 1.73e-04 | -0.367000 | 2.33e-03 |
| Toll Like Receptor 9 (TLR9) Cascade | 84 | 1.74e-04 | 0.237000 | 2.33e-03 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | 54 | 1.82e-04 | 0.294000 | 2.41e-03 |
| Toll Like Receptor 3 (TLR3) Cascade | 85 | 1.86e-04 | 0.235000 | 2.45e-03 |
| Fatty acid metabolism | 165 | 1.92e-04 | 0.168000 | 2.50e-03 |
| Cholesterol biosynthesis | 22 | 2.05e-04 | -0.457000 | 2.63e-03 |
| APC/C:Cdc20 mediated degradation of Securin | 64 | 2.05e-04 | 0.268000 | 2.63e-03 |
| Processing of DNA double-strand break ends | 66 | 2.16e-04 | -0.263000 | 2.74e-03 |
| Xenobiotics | 22 | 2.22e-04 | -0.455000 | 2.79e-03 |
| Glucose metabolism | 88 | 2.40e-04 | 0.227000 | 2.99e-03 |
| DNA Damage Recognition in GG-NER | 37 | 2.93e-04 | 0.344000 | 3.59e-03 |
| Class I MHC mediated antigen processing & presentation | 345 | 2.93e-04 | 0.114000 | 3.59e-03 |
| mitochondrial fatty acid beta-oxidation of saturated fatty acids | 10 | 2.95e-04 | 0.661000 | 3.59e-03 |
| Glycogen metabolism | 25 | 3.02e-04 | 0.417000 | 3.61e-03 |
| Downstream signaling events of B Cell Receptor (BCR) | 75 | 3.02e-04 | 0.241000 | 3.61e-03 |
| Hemostasis | 583 | 3.27e-04 | -0.087300 | 3.88e-03 |
| Mitophagy | 26 | 3.37e-04 | 0.406000 | 3.96e-03 |
| ER-Phagosome pathway | 79 | 3.45e-04 | 0.233000 | 4.02e-03 |
| Transcriptional regulation by RUNX2 | 115 | 3.67e-04 | 0.192000 | 4.25e-03 |
| ER to Golgi Anterograde Transport | 127 | 4.16e-04 | 0.181000 | 4.78e-03 |
| Leishmania infection | 255 | 4.24e-04 | -0.128000 | 4.83e-03 |
| Peroxisomal protein import | 60 | 4.31e-04 | 0.263000 | 4.87e-03 |
| Metabolism of cofactors | 18 | 4.55e-04 | 0.477000 | 5.10e-03 |
| MyD88 dependent cascade initiated on endosome | 80 | 4.61e-04 | 0.227000 | 5.13e-03 |
| Disorders of transmembrane transporters | 169 | 5.04e-04 | 0.155000 | 5.56e-03 |
| Metabolism of amino acids and derivatives | 335 | 5.21e-04 | 0.110000 | 5.71e-03 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | 79 | 5.66e-04 | 0.224000 | 6.11e-03 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | 77 | 5.67e-04 | 0.227000 | 6.11e-03 |
| FCGR activation | 42 | 5.76e-04 | -0.307000 | 6.17e-03 |
| MyD88 cascade initiated on plasma membrane | 76 | 6.35e-04 | 0.227000 | 6.66e-03 |
| Toll Like Receptor 10 (TLR10) Cascade | 76 | 6.35e-04 | 0.227000 | 6.66e-03 |
| Toll Like Receptor 5 (TLR5) Cascade | 76 | 6.35e-04 | 0.227000 | 6.66e-03 |
| Formation of TC-NER Pre-Incision Complex | 50 | 7.05e-04 | 0.277000 | 7.33e-03 |
| Scavenging of heme from plasma | 41 | 7.10e-04 | -0.306000 | 7.34e-03 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | 81 | 7.18e-04 | 0.217000 | 7.35e-03 |
| Regulation of Complement cascade | 71 | 7.21e-04 | -0.232000 | 7.35e-03 |
| Hedgehog 'off' state | 95 | 7.60e-04 | 0.200000 | 7.69e-03 |
| Aggrephagy | 20 | 7.83e-04 | 0.434000 | 7.86e-03 |
| Assembly of collagen fibrils and other multimeric structures | 50 | 7.95e-04 | -0.274000 | 7.93e-03 |
| Mitochondrial calcium ion transport | 22 | 8.08e-04 | 0.413000 | 8.00e-03 |
| COPI-independent Golgi-to-ER retrograde traffic | 33 | 8.54e-04 | 0.335000 | 8.39e-03 |
| Asparagine N-linked glycosylation | 268 | 8.59e-04 | 0.118000 | 8.39e-03 |
| Host Interactions of HIV factors | 123 | 8.80e-04 | 0.174000 | 8.54e-03 |
| Energy dependent regulation of mTOR by LKB1-AMPK | 28 | 9.67e-04 | 0.360000 | 9.31e-03 |
| Cellular response to heat stress | 92 | 9.72e-04 | 0.199000 | 9.31e-03 |
| IRE1alpha activates chaperones | 50 | 1.01e-03 | 0.269000 | 9.62e-03 |
| p53-Dependent G1 DNA Damage Response | 60 | 1.02e-03 | 0.245000 | 9.62e-03 |
| p53-Dependent G1/S DNA damage checkpoint | 60 | 1.02e-03 | 0.245000 | 9.62e-03 |
| Role of phospholipids in phagocytosis | 55 | 1.05e-03 | -0.255000 | 9.80e-03 |
| SCF(Skp2)-mediated degradation of p27/p21 | 58 | 1.12e-03 | 0.247000 | 1.04e-02 |
| PTEN Regulation | 145 | 1.13e-03 | 0.157000 | 1.04e-02 |
| Presynaptic phase of homologous DNA pairing and strand exchange | 38 | 1.13e-03 | -0.305000 | 1.04e-02 |
| Peroxisomal lipid metabolism | 27 | 1.15e-03 | 0.361000 | 1.04e-02 |
| Keratinization | 92 | 1.15e-03 | -0.196000 | 1.04e-02 |
| Meiosis | 67 | 1.20e-03 | -0.229000 | 1.08e-02 |
| Vesicle-mediated transport | 642 | 1.21e-03 | 0.075100 | 1.08e-02 |
| XBP1(S) activates chaperone genes | 48 | 1.22e-03 | 0.270000 | 1.08e-02 |
| mTORC1-mediated signalling | 22 | 1.22e-03 | 0.398000 | 1.08e-02 |
| FCGR3A-mediated IL10 synthesis | 67 | 1.24e-03 | -0.228000 | 1.09e-02 |
| EPHB-mediated forward signaling | 33 | 1.31e-03 | -0.323000 | 1.13e-02 |
| Common Pathway of Fibrin Clot Formation | 18 | 1.31e-03 | -0.437000 | 1.13e-02 |
| MAPK6/MAPK4 signaling | 84 | 1.32e-03 | 0.203000 | 1.13e-02 |
| G1/S DNA Damage Checkpoints | 61 | 1.32e-03 | 0.238000 | 1.13e-02 |
| Pyruvate metabolism | 28 | 1.37e-03 | 0.349000 | 1.17e-02 |
| CDK-mediated phosphorylation and removal of Cdc6 | 69 | 1.46e-03 | 0.222000 | 1.24e-02 |
| Degradation of the extracellular matrix | 101 | 1.52e-03 | -0.183000 | 1.27e-02 |
| Regulation of expression of SLITs and ROBOs | 144 | 1.52e-03 | 0.153000 | 1.27e-02 |
| G2/M DNA damage checkpoint | 64 | 1.53e-03 | -0.229000 | 1.28e-02 |
| Reproduction | 88 | 1.54e-03 | -0.195000 | 1.28e-02 |
| Collagen chain trimerization | 35 | 1.61e-03 | -0.308000 | 1.32e-02 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | 59 | 1.61e-03 | -0.237000 | 1.32e-02 |
| Rho GTPase cycle | 134 | 1.66e-03 | -0.157000 | 1.35e-02 |
| Formation of Fibrin Clot (Clotting Cascade) | 35 | 1.68e-03 | -0.307000 | 1.36e-02 |
| Cell Cycle | 607 | 1.70e-03 | -0.074800 | 1.37e-02 |
| Transcriptional regulation by RUNX3 | 88 | 1.73e-03 | 0.193000 | 1.38e-02 |
| Activation of the pre-replicative complex | 32 | 1.77e-03 | -0.319000 | 1.41e-02 |
| TNFR2 non-canonical NF-kB pathway | 94 | 1.78e-03 | 0.187000 | 1.41e-02 |
| Attenuation phase | 21 | 1.84e-03 | 0.393000 | 1.44e-02 |
| TP53 Regulates Metabolic Genes | 84 | 1.88e-03 | 0.196000 | 1.47e-02 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | 33 | 1.95e-03 | 0.312000 | 1.51e-02 |
| MAP kinase activation | 60 | 1.96e-03 | 0.231000 | 1.51e-02 |
| Role of LAT2/NTAL/LAB on calcium mobilization | 43 | 1.96e-03 | -0.273000 | 1.51e-02 |
| Resolution of Sister Chromatid Cohesion | 103 | 2.00e-03 | -0.176000 | 1.53e-02 |
| Cytosolic sensors of pathogen-associated DNA | 55 | 2.06e-03 | 0.240000 | 1.57e-02 |
| Metabolism of steroids | 134 | 2.10e-03 | -0.154000 | 1.59e-02 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | 70 | 2.13e-03 | 0.212000 | 1.60e-02 |
| Cytochrome P450 - arranged by substrate type | 60 | 2.14e-03 | -0.229000 | 1.60e-02 |
| ATF6 (ATF6-alpha) activates chaperone genes | 10 | 2.20e-03 | 0.559000 | 1.64e-02 |
| Cristae formation | 27 | 2.29e-03 | 0.339000 | 1.70e-02 |
| Hedgehog 'on' state | 82 | 2.40e-03 | 0.194000 | 1.77e-02 |
| Regulation of RAS by GAPs | 65 | 2.41e-03 | 0.218000 | 1.77e-02 |
| RHO GTPase Effectors | 249 | 2.47e-03 | -0.112000 | 1.80e-02 |
| Activation of the phototransduction cascade | 11 | 2.49e-03 | -0.527000 | 1.80e-02 |
| rRNA processing in the mitochondrion | 21 | 2.49e-03 | 0.381000 | 1.80e-02 |
| Collagen formation | 80 | 2.57e-03 | -0.195000 | 1.85e-02 |
| Mitotic Prometaphase | 182 | 2.70e-03 | -0.129000 | 1.94e-02 |
| Fatty acids | 14 | 2.73e-03 | -0.463000 | 1.95e-02 |
| Josephin domain DUBs | 10 | 2.78e-03 | 0.546000 | 1.97e-02 |
| Glycogen synthesis | 14 | 2.83e-03 | 0.461000 | 2.00e-02 |
| MHC class II antigen presentation | 94 | 2.90e-03 | 0.178000 | 2.03e-02 |
| Meiotic recombination | 37 | 2.91e-03 | -0.283000 | 2.03e-02 |
| G alpha (i) signalling events | 347 | 2.96e-03 | -0.093000 | 2.06e-02 |
| Cyclin A:Cdk2-associated events at S phase entry | 83 | 3.01e-03 | 0.188000 | 2.08e-02 |
| HSF1 activation | 24 | 3.08e-03 | 0.349000 | 2.11e-02 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | 74 | 3.09e-03 | 0.199000 | 2.11e-02 |
| Complement cascade | 79 | 3.21e-03 | -0.192000 | 2.19e-02 |
| Carnitine metabolism | 11 | 3.31e-03 | 0.511000 | 2.25e-02 |
| Cyclin E associated events during G1/S transition | 81 | 3.47e-03 | 0.188000 | 2.35e-02 |
| Collagen biosynthesis and modifying enzymes | 58 | 3.60e-03 | -0.221000 | 2.42e-02 |
| Crosslinking of collagen fibrils | 10 | 3.62e-03 | -0.531000 | 2.42e-02 |
| N-Glycan antennae elongation | 14 | 3.64e-03 | -0.449000 | 2.43e-02 |
| Visual phototransduction | 93 | 3.82e-03 | -0.174000 | 2.53e-02 |
| Post-translational modification: synthesis of GPI-anchored proteins | 82 | 3.87e-03 | -0.185000 | 2.54e-02 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | 98 | 3.87e-03 | -0.169000 | 2.54e-02 |
| Beta-oxidation of very long chain fatty acids | 10 | 4.29e-03 | 0.522000 | 2.80e-02 |
| Telomere C-strand (Lagging Strand) Synthesis | 33 | 4.29e-03 | -0.287000 | 2.80e-02 |
| Signaling by ROBO receptors | 189 | 4.36e-03 | 0.120000 | 2.83e-02 |
| Mitochondrial iron-sulfur cluster biogenesis | 11 | 4.48e-03 | 0.495000 | 2.89e-02 |
| Ovarian tumor domain proteases | 35 | 4.75e-03 | 0.276000 | 3.05e-02 |
| Apoptosis | 162 | 4.95e-03 | 0.128000 | 3.16e-02 |
| FCERI mediated MAPK activation | 59 | 4.96e-03 | -0.212000 | 3.16e-02 |
| Homology Directed Repair | 104 | 5.00e-03 | -0.159000 | 3.17e-02 |
| Interleukin-17 signaling | 68 | 5.33e-03 | 0.195000 | 3.37e-02 |
| Recycling of bile acids and salts | 16 | 5.37e-03 | -0.402000 | 3.37e-02 |
| Programmed Cell Death | 172 | 5.62e-03 | 0.122000 | 3.52e-02 |
| Homologous DNA Pairing and Strand Exchange | 41 | 5.70e-03 | -0.250000 | 3.55e-02 |
| trans-Golgi Network Vesicle Budding | 70 | 5.80e-03 | 0.191000 | 3.60e-02 |
| G alpha (q) signalling events | 198 | 5.91e-03 | -0.114000 | 3.64e-02 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | 72 | 5.92e-03 | -0.188000 | 3.64e-02 |
| Classical antibody-mediated complement activation | 35 | 6.00e-03 | -0.268000 | 3.68e-02 |
| RHO GTPases Activate WASPs and WAVEs | 35 | 6.04e-03 | -0.268000 | 3.68e-02 |
| Constitutive Signaling by Aberrant PI3K in Cancer | 71 | 6.07e-03 | -0.188000 | 3.69e-02 |
| Glycolysis | 68 | 6.12e-03 | 0.192000 | 3.70e-02 |
| RHO GTPases Activate Formins | 118 | 6.19e-03 | -0.146000 | 3.72e-02 |
| Transcriptional activation of mitochondrial biogenesis | 53 | 6.21e-03 | 0.217000 | 3.72e-02 |
| Glycogen storage diseases | 14 | 6.24e-03 | 0.422000 | 3.72e-02 |
| CD28 dependent Vav1 pathway | 12 | 6.25e-03 | -0.456000 | 3.72e-02 |
| Regulation of innate immune responses to cytosolic DNA | 13 | 6.58e-03 | 0.435000 | 3.90e-02 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | 69 | 6.61e-03 | 0.189000 | 3.90e-02 |
| HDR through Single Strand Annealing (SSA) | 37 | 6.71e-03 | -0.258000 | 3.94e-02 |
| GPCR ligand binding | 390 | 6.73e-03 | -0.080100 | 3.94e-02 |
| KSRP (KHSRP) binds and destabilizes mRNA | 17 | 7.00e-03 | -0.378000 | 4.08e-02 |
| Transcriptional regulation by RUNX1 | 185 | 7.25e-03 | 0.115000 | 4.21e-02 |
| Miscellaneous substrates | 12 | 7.35e-03 | -0.447000 | 4.25e-02 |
| Assembly of the pre-replicative complex | 65 | 7.65e-03 | 0.191000 | 4.41e-02 |
| Processing of SMDT1 | 15 | 7.83e-03 | 0.397000 | 4.49e-02 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | 26 | 7.89e-03 | -0.301000 | 4.51e-02 |
| Inositol phosphate metabolism | 47 | 7.95e-03 | 0.224000 | 4.53e-02 |
| CD22 mediated BCR regulation | 34 | 8.08e-03 | -0.263000 | 4.58e-02 |
| Extension of Telomeres | 50 | 8.14e-03 | -0.216000 | 4.60e-02 |
| Signaling by Hedgehog | 131 | 8.34e-03 | 0.134000 | 4.69e-02 |
| Mitotic Spindle Checkpoint | 107 | 8.71e-03 | -0.147000 | 4.88e-02 |
| G alpha (12/13) signalling events | 77 | 8.89e-03 | -0.173000 | 4.96e-02 |
| Cyclin A/B1/B2 associated events during G2/M transition | 23 | 9.01e-03 | -0.315000 | 5.01e-02 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | 86 | 9.23e-03 | 0.162000 | 5.06e-02 |
| Toll Like Receptor 2 (TLR2) Cascade | 86 | 9.23e-03 | 0.162000 | 5.06e-02 |
| Toll Like Receptor TLR1:TLR2 Cascade | 86 | 9.23e-03 | 0.162000 | 5.06e-02 |
| Toll Like Receptor TLR6:TLR2 Cascade | 86 | 9.23e-03 | 0.162000 | 5.06e-02 |
| Cell Cycle Checkpoints | 251 | 9.47e-03 | -0.095200 | 5.17e-02 |
| Elastic fibre formation | 38 | 9.66e-03 | -0.243000 | 5.25e-02 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | 91 | 9.97e-03 | -0.156000 | 5.38e-02 |
| Amplification of signal from the kinetochores | 91 | 9.97e-03 | -0.156000 | 5.38e-02 |
| NRAGE signals death through JNK | 56 | 1.00e-02 | -0.199000 | 5.40e-02 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | 70 | 1.01e-02 | 0.178000 | 5.41e-02 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | 117 | 1.03e-02 | -0.137000 | 5.50e-02 |
| Polymerase switching on the C-strand of the telomere | 25 | 1.04e-02 | -0.296000 | 5.51e-02 |
| TAK1 activates NFkB by phosphorylation and activation of IKKs complex | 23 | 1.06e-02 | 0.308000 | 5.62e-02 |
| Condensation of Prophase Chromosomes | 24 | 1.08e-02 | -0.301000 | 5.68e-02 |
| RNA Polymerase III Chain Elongation | 14 | 1.09e-02 | 0.393000 | 5.73e-02 |
| Post-translational protein phosphorylation | 103 | 1.12e-02 | -0.145000 | 5.87e-02 |
| Orc1 removal from chromatin | 68 | 1.15e-02 | 0.177000 | 6.00e-02 |
| Role of second messengers in netrin-1 signaling | 10 | 1.16e-02 | -0.461000 | 6.05e-02 |
| DNA strand elongation | 31 | 1.17e-02 | -0.262000 | 6.06e-02 |
| Glycosphingolipid metabolism | 40 | 1.17e-02 | 0.230000 | 6.06e-02 |
| Signaling by Retinoic Acid | 38 | 1.18e-02 | 0.236000 | 6.07e-02 |
| VLDLR internalisation and degradation | 12 | 1.18e-02 | 0.420000 | 6.07e-02 |
| Signal Transduction | 2291 | 1.21e-02 | -0.032500 | 6.16e-02 |
| Netrin-1 signaling | 49 | 1.21e-02 | -0.207000 | 6.17e-02 |
| Chaperone Mediated Autophagy | 18 | 1.22e-02 | 0.341000 | 6.20e-02 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | 29 | 1.23e-02 | 0.269000 | 6.23e-02 |
| Iron uptake and transport | 54 | 1.28e-02 | 0.196000 | 6.45e-02 |
| Toll-like Receptor Cascades | 138 | 1.28e-02 | 0.123000 | 6.45e-02 |
| Post-translational protein modification | 1269 | 1.29e-02 | 0.041800 | 6.47e-02 |
| EML4 and NUDC in mitotic spindle formation | 95 | 1.33e-02 | -0.147000 | 6.62e-02 |
| HDR through Homologous Recombination (HRR) | 63 | 1.35e-02 | -0.180000 | 6.70e-02 |
| Regulation of APC/C activators between G1/S and early anaphase | 77 | 1.35e-02 | 0.163000 | 6.70e-02 |
| Eicosanoids | 12 | 1.38e-02 | -0.410000 | 6.81e-02 |
| Toll Like Receptor 4 (TLR4) Cascade | 114 | 1.39e-02 | 0.133000 | 6.81e-02 |
| Rab regulation of trafficking | 117 | 1.39e-02 | 0.132000 | 6.81e-02 |
| Dectin-2 family | 19 | 1.39e-02 | -0.326000 | 6.81e-02 |
| Binding and Uptake of Ligands by Scavenger Receptors | 66 | 1.40e-02 | -0.175000 | 6.82e-02 |
| Cleavage of the damaged pyrimidine | 25 | 1.49e-02 | -0.281000 | 7.19e-02 |
| Depyrimidination | 25 | 1.49e-02 | -0.281000 | 7.19e-02 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | 25 | 1.49e-02 | -0.281000 | 7.19e-02 |
| Cell Cycle, Mitotic | 484 | 1.56e-02 | -0.064300 | 7.51e-02 |
| Anti-inflammatory response favouring Leishmania parasite infection | 176 | 1.60e-02 | -0.105000 | 7.63e-02 |
| Leishmania parasite growth and survival | 176 | 1.60e-02 | -0.105000 | 7.63e-02 |
| Base-Excision Repair, AP Site Formation | 27 | 1.62e-02 | -0.267000 | 7.73e-02 |
| Diseases associated with O-glycosylation of proteins | 60 | 1.65e-02 | -0.179000 | 7.82e-02 |
| Regulation of HSF1-mediated heat shock response | 76 | 1.67e-02 | 0.159000 | 7.91e-02 |
| N-glycan antennae elongation in the medial/trans-Golgi | 23 | 1.71e-02 | -0.287000 | 8.07e-02 |
| Pexophagy | 10 | 1.72e-02 | 0.435000 | 8.07e-02 |
| TRAF6 mediated NF-kB activation | 19 | 1.72e-02 | 0.316000 | 8.07e-02 |
| Regulation of pyruvate dehydrogenase (PDH) complex | 15 | 1.74e-02 | 0.355000 | 8.10e-02 |
| Nucleotide Excision Repair | 106 | 1.76e-02 | 0.134000 | 8.16e-02 |
| Mitotic Telophase/Cytokinesis | 13 | 1.76e-02 | -0.380000 | 8.16e-02 |
| FCERI mediated NF-kB activation | 102 | 1.82e-02 | 0.135000 | 8.41e-02 |
| Acetylcholine Neurotransmitter Release Cycle | 15 | 1.89e-02 | 0.350000 | 8.68e-02 |
| DARPP-32 events | 23 | 1.96e-02 | 0.281000 | 9.01e-02 |
| DAP12 interactions | 38 | 1.99e-02 | -0.218000 | 9.09e-02 |
| Amino acids regulate mTORC1 | 50 | 2.00e-02 | 0.190000 | 9.09e-02 |
| Ca2+ pathway | 61 | 2.00e-02 | -0.172000 | 9.09e-02 |
| RNA Polymerase I Transcription Termination | 28 | 2.01e-02 | 0.254000 | 9.10e-02 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | 24 | 2.02e-02 | 0.274000 | 9.10e-02 |
| Creation of C4 and C2 activators | 41 | 2.02e-02 | -0.210000 | 9.10e-02 |
| Metabolism of fat-soluble vitamins | 43 | 2.05e-02 | -0.204000 | 9.21e-02 |
| PI Metabolism | 81 | 2.06e-02 | 0.149000 | 9.21e-02 |
| Resolution of D-Loop Structures | 33 | 2.10e-02 | -0.232000 | 9.35e-02 |
| G0 and Early G1 | 27 | 2.12e-02 | -0.256000 | 9.43e-02 |
| C-type lectin receptors (CLRs) | 125 | 2.16e-02 | 0.119000 | 9.59e-02 |
| RNA Polymerase I Transcription Initiation | 44 | 2.25e-02 | 0.199000 | 9.94e-02 |
| Transport of organic anions | 12 | 2.30e-02 | -0.379000 | 1.01e-01 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | 72 | 2.32e-02 | 0.155000 | 1.02e-01 |
| Calnexin/calreticulin cycle | 24 | 2.36e-02 | 0.267000 | 1.04e-01 |
| Class I peroxisomal membrane protein import | 18 | 2.41e-02 | 0.307000 | 1.05e-01 |
| Telomere Maintenance | 73 | 2.44e-02 | -0.152000 | 1.06e-01 |
| Intrinsic Pathway of Fibrin Clot Formation | 22 | 2.46e-02 | -0.277000 | 1.07e-01 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | 53 | 2.47e-02 | -0.178000 | 1.07e-01 |
| Striated Muscle Contraction | 34 | 2.48e-02 | 0.223000 | 1.07e-01 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | 17 | 2.52e-02 | 0.314000 | 1.08e-01 |
| Packaging Of Telomere Ends | 16 | 2.52e-02 | -0.323000 | 1.08e-01 |
| Meiotic synapsis | 41 | 2.55e-02 | -0.202000 | 1.09e-01 |
| Interleukin-6 signaling | 11 | 2.57e-02 | 0.389000 | 1.09e-01 |
| Regulation of IFNA signaling | 24 | 2.59e-02 | -0.263000 | 1.10e-01 |
| Interleukin-20 family signaling | 20 | 2.65e-02 | 0.287000 | 1.12e-01 |
| Unfolded Protein Response (UPR) | 91 | 2.66e-02 | 0.135000 | 1.12e-01 |
| Constitutive Signaling by AKT1 E17K in Cancer | 25 | 2.69e-02 | 0.256000 | 1.12e-01 |
| Cleavage of the damaged purine | 20 | 2.69e-02 | -0.286000 | 1.12e-01 |
| Depurination | 20 | 2.69e-02 | -0.286000 | 1.12e-01 |
| Recognition and association of DNA glycosylase with site containing an affected purine | 20 | 2.69e-02 | -0.286000 | 1.12e-01 |
| E2F mediated regulation of DNA replication | 21 | 2.69e-02 | -0.279000 | 1.12e-01 |
| Glyoxylate metabolism and glycine degradation | 29 | 2.72e-02 | 0.237000 | 1.13e-01 |
| Glycogen breakdown (glycogenolysis) | 14 | 2.78e-02 | 0.340000 | 1.15e-01 |
| Prolactin receptor signaling | 12 | 2.80e-02 | 0.366000 | 1.16e-01 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | 13 | 2.86e-02 | 0.351000 | 1.18e-01 |
| NCAM1 interactions | 31 | 2.93e-02 | -0.226000 | 1.20e-01 |
| Interleukin-27 signaling | 11 | 3.04e-02 | 0.377000 | 1.24e-01 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | 85 | 3.06e-02 | 0.136000 | 1.24e-01 |
| Rap1 signalling | 14 | 3.06e-02 | 0.334000 | 1.24e-01 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | 12 | 3.06e-02 | 0.360000 | 1.24e-01 |
| Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon | 13 | 3.11e-02 | 0.345000 | 1.26e-01 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | 23 | 3.20e-02 | 0.258000 | 1.29e-01 |
| Glycosaminoglycan metabolism | 117 | 3.23e-02 | -0.115000 | 1.30e-01 |
| SARS-CoV-1 Infection | 47 | 3.24e-02 | 0.180000 | 1.30e-01 |
| CDC6 association with the ORC:origin complex | 11 | 3.30e-02 | -0.371000 | 1.32e-01 |
| VEGFR2 mediated cell proliferation | 19 | 3.30e-02 | -0.283000 | 1.32e-01 |
| Transcriptional regulation of granulopoiesis | 40 | 3.33e-02 | -0.195000 | 1.33e-01 |
| TGF-beta receptor signaling activates SMADs | 30 | 3.40e-02 | 0.224000 | 1.35e-01 |
| Class A/1 (Rhodopsin-like receptors) | 274 | 3.42e-02 | -0.074400 | 1.36e-01 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | 15 | 3.45e-02 | 0.315000 | 1.36e-01 |
| PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases | 14 | 3.45e-02 | -0.326000 | 1.36e-01 |
| Syndecan interactions | 19 | 3.46e-02 | -0.280000 | 1.36e-01 |
| DNA Double-Strand Break Repair | 131 | 3.47e-02 | -0.107000 | 1.36e-01 |
| Diseases associated with glycosylation precursor biosynthesis | 18 | 3.48e-02 | 0.287000 | 1.36e-01 |
| Diseases of signal transduction by growth factor receptors and second messengers | 364 | 3.51e-02 | 0.064400 | 1.37e-01 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | 12 | 3.53e-02 | -0.351000 | 1.37e-01 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | 50 | 3.55e-02 | 0.172000 | 1.37e-01 |
| Signaling by Interleukins | 404 | 3.55e-02 | 0.061100 | 1.37e-01 |
| WNT ligand biogenesis and trafficking | 25 | 3.55e-02 | -0.243000 | 1.37e-01 |
| Retrograde neurotrophin signalling | 14 | 3.59e-02 | 0.324000 | 1.38e-01 |
| Interleukin-10 signaling | 38 | 3.60e-02 | -0.197000 | 1.38e-01 |
| mRNA 3'-end processing | 55 | 3.61e-02 | -0.163000 | 1.38e-01 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | 73 | 3.63e-02 | 0.142000 | 1.38e-01 |
| Transport to the Golgi and subsequent modification | 155 | 3.65e-02 | 0.097400 | 1.39e-01 |
| Golgi Associated Vesicle Biogenesis | 54 | 3.66e-02 | 0.164000 | 1.39e-01 |
| Physiological factors | 12 | 3.67e-02 | 0.348000 | 1.39e-01 |
| Surfactant metabolism | 24 | 3.68e-02 | 0.246000 | 1.39e-01 |
| Base Excision Repair | 54 | 3.71e-02 | -0.164000 | 1.40e-01 |
| TNF signaling | 43 | 3.77e-02 | 0.183000 | 1.42e-01 |
| activated TAK1 mediates p38 MAPK activation | 18 | 3.78e-02 | 0.283000 | 1.42e-01 |
| Dissolution of Fibrin Clot | 12 | 3.82e-02 | -0.346000 | 1.43e-01 |
| Establishment of Sister Chromatid Cohesion | 11 | 3.87e-02 | -0.360000 | 1.44e-01 |
| G beta:gamma signalling through CDC42 | 20 | 3.88e-02 | -0.267000 | 1.44e-01 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | 27 | 3.91e-02 | 0.229000 | 1.45e-01 |
| FLT3 Signaling | 278 | 3.91e-02 | 0.072000 | 1.45e-01 |
| Regulation of TP53 Activity through Phosphorylation | 84 | 3.93e-02 | -0.130000 | 1.45e-01 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | 14 | 3.95e-02 | -0.318000 | 1.45e-01 |
| Synthesis of PIPs at the plasma membrane | 51 | 3.99e-02 | 0.166000 | 1.46e-01 |
| Phospholipid metabolism | 204 | 4.00e-02 | 0.083500 | 1.46e-01 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | 32 | 4.03e-02 | -0.209000 | 1.47e-01 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | 17 | 4.20e-02 | -0.285000 | 1.53e-01 |
| Condensation of Prometaphase Chromosomes | 10 | 4.31e-02 | -0.369000 | 1.56e-01 |
| Activation of gene expression by SREBF (SREBP) | 41 | 4.32e-02 | -0.183000 | 1.56e-01 |
| Transport of Mature Transcript to Cytoplasm | 80 | 4.32e-02 | -0.131000 | 1.56e-01 |
| Post NMDA receptor activation events | 59 | 4.33e-02 | 0.152000 | 1.56e-01 |
| Interferon gamma signaling | 78 | 4.45e-02 | 0.132000 | 1.60e-01 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | 20 | 4.49e-02 | 0.259000 | 1.61e-01 |
| Initial triggering of complement | 48 | 4.51e-02 | -0.167000 | 1.62e-01 |
| Senescence-Associated Secretory Phenotype (SASP) | 56 | 4.55e-02 | -0.155000 | 1.62e-01 |
| G alpha (s) signalling events | 246 | 4.60e-02 | -0.074000 | 1.64e-01 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | 14 | 4.66e-02 | 0.307000 | 1.66e-01 |
| Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS) | 11 | 4.75e-02 | -0.345000 | 1.68e-01 |
| Golgi-to-ER retrograde transport | 112 | 4.76e-02 | 0.108000 | 1.68e-01 |
| TICAM1-dependent activation of IRF3/IRF7 | 10 | 4.84e-02 | 0.360000 | 1.71e-01 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | 21 | 4.90e-02 | -0.248000 | 1.72e-01 |
| Downregulation of TGF-beta receptor signaling | 25 | 4.91e-02 | 0.227000 | 1.72e-01 |
| Erythrocytes take up carbon dioxide and release oxygen | 11 | 5.00e-02 | 0.341000 | 1.74e-01 |
| O2/CO2 exchange in erythrocytes | 11 | 5.00e-02 | 0.341000 | 1.74e-01 |
| Transport of small molecules | 680 | 5.03e-02 | 0.044200 | 1.75e-01 |
| Metabolism of RNA | 630 | 5.07e-02 | 0.045800 | 1.76e-01 |
| DAP12 signaling | 29 | 5.08e-02 | -0.210000 | 1.76e-01 |
| Telomere C-strand synthesis initiation | 13 | 5.15e-02 | -0.312000 | 1.78e-01 |
| Retinoid metabolism and transport | 39 | 5.16e-02 | -0.180000 | 1.78e-01 |
| Beta-catenin independent WNT signaling | 142 | 5.18e-02 | 0.094600 | 1.78e-01 |
| Biological oxidations | 178 | 5.21e-02 | -0.084500 | 1.79e-01 |
| Switching of origins to a post-replicative state | 87 | 5.23e-02 | 0.120000 | 1.79e-01 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | 177 | 5.31e-02 | 0.084400 | 1.82e-01 |
| TNFs bind their physiological receptors | 26 | 5.36e-02 | -0.219000 | 1.82e-01 |
| Lysosome Vesicle Biogenesis | 34 | 5.37e-02 | 0.191000 | 1.82e-01 |
| Unwinding of DNA | 12 | 5.37e-02 | -0.322000 | 1.82e-01 |
| Cellular Senescence | 136 | 5.43e-02 | -0.095700 | 1.84e-01 |
| Chylomicron remodeling | 10 | 5.62e-02 | -0.349000 | 1.90e-01 |
| Interleukin-35 Signalling | 11 | 5.67e-02 | 0.332000 | 1.91e-01 |
| ATF6 (ATF6-alpha) activates chaperones | 12 | 5.80e-02 | 0.316000 | 1.95e-01 |
| The phototransduction cascade | 32 | 5.91e-02 | -0.193000 | 1.98e-01 |
| Cell death signalling via NRAGE, NRIF and NADE | 72 | 5.93e-02 | -0.129000 | 1.98e-01 |
| Metabolism of lipids | 693 | 5.95e-02 | 0.042200 | 1.99e-01 |
| DNA Replication Pre-Initiation | 81 | 5.98e-02 | 0.121000 | 1.99e-01 |
| G beta:gamma signalling through BTK | 18 | 6.01e-02 | -0.256000 | 2.00e-01 |
| Global Genome Nucleotide Excision Repair (GG-NER) | 82 | 6.02e-02 | 0.120000 | 2.00e-01 |
| tRNA processing | 118 | 6.11e-02 | 0.099900 | 2.02e-01 |
| tRNA processing in the mitochondrion | 18 | 6.13e-02 | 0.255000 | 2.02e-01 |
| Receptor Mediated Mitophagy | 11 | 6.16e-02 | 0.325000 | 2.03e-01 |
| Metabolism of carbohydrates | 275 | 6.20e-02 | 0.065500 | 2.04e-01 |
| RMTs methylate histone arginines | 36 | 6.22e-02 | 0.180000 | 2.04e-01 |
| mRNA decay by 3' to 5' exoribonuclease | 16 | 6.25e-02 | -0.269000 | 2.05e-01 |
| Non-integrin membrane-ECM interactions | 41 | 6.36e-02 | -0.167000 | 2.08e-01 |
| Budding and maturation of HIV virion | 25 | 6.38e-02 | 0.214000 | 2.08e-01 |
| Negative regulators of DDX58/IFIH1 signaling | 31 | 6.48e-02 | 0.192000 | 2.10e-01 |
| Signaling by NOTCH | 183 | 6.49e-02 | 0.079200 | 2.10e-01 |
| RAF/MAP kinase cascade | 264 | 6.50e-02 | 0.066100 | 2.10e-01 |
| MAPK1/MAPK3 signaling | 270 | 6.55e-02 | 0.065200 | 2.11e-01 |
| G-protein beta:gamma signalling | 32 | 6.65e-02 | -0.187000 | 2.14e-01 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | 24 | 6.75e-02 | 0.216000 | 2.17e-01 |
| RNA Pol II CTD phosphorylation and interaction with CE | 25 | 7.01e-02 | 0.209000 | 2.24e-01 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | 25 | 7.01e-02 | 0.209000 | 2.24e-01 |
| ER Quality Control Compartment (ERQC) | 19 | 7.03e-02 | 0.240000 | 2.24e-01 |
| TCF dependent signaling in response to WNT | 176 | 7.18e-02 | 0.078700 | 2.29e-01 |
| Signaling by cytosolic FGFR1 fusion mutants | 17 | 7.26e-02 | 0.252000 | 2.30e-01 |
| CLEC7A (Dectin-1) induces NFAT activation | 11 | 7.28e-02 | -0.312000 | 2.30e-01 |
| Biotin transport and metabolism | 11 | 7.29e-02 | 0.312000 | 2.30e-01 |
| PIP3 activates AKT signaling | 265 | 7.31e-02 | 0.064000 | 2.30e-01 |
| Potassium Channels | 100 | 7.32e-02 | -0.104000 | 2.30e-01 |
| Chondroitin sulfate biosynthesis | 20 | 7.33e-02 | -0.231000 | 2.30e-01 |
| Inactivation, recovery and regulation of the phototransduction cascade | 31 | 7.41e-02 | -0.185000 | 2.32e-01 |
| Metabolism of nucleotides | 94 | 7.51e-02 | 0.106000 | 2.35e-01 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | 20 | 7.61e-02 | 0.229000 | 2.37e-01 |
| FOXO-mediated transcription of cell death genes | 14 | 7.61e-02 | 0.274000 | 2.37e-01 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | 20 | 7.68e-02 | -0.229000 | 2.38e-01 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | 20 | 7.68e-02 | -0.229000 | 2.38e-01 |
| Presynaptic depolarization and calcium channel opening | 12 | 7.70e-02 | -0.295000 | 2.38e-01 |
| Processive synthesis on the C-strand of the telomere | 18 | 7.77e-02 | -0.240000 | 2.40e-01 |
| DSCAM interactions | 11 | 7.83e-02 | -0.307000 | 2.41e-01 |
| Defective GALNT12 causes colorectal cancer 1 (CRCS1) | 10 | 7.90e-02 | -0.321000 | 2.43e-01 |
| Dual incision in TC-NER | 61 | 7.99e-02 | 0.130000 | 2.44e-01 |
| APC/C-mediated degradation of cell cycle proteins | 84 | 7.99e-02 | 0.111000 | 2.44e-01 |
| Regulation of mitotic cell cycle | 84 | 7.99e-02 | 0.111000 | 2.44e-01 |
| Glutamate and glutamine metabolism | 13 | 8.02e-02 | 0.280000 | 2.45e-01 |
| RHO GTPases activate CIT | 19 | 8.06e-02 | -0.232000 | 2.45e-01 |
| Regulation of insulin secretion | 75 | 8.14e-02 | -0.116000 | 2.47e-01 |
| Platelet sensitization by LDL | 16 | 8.16e-02 | 0.251000 | 2.47e-01 |
| Phase I - Functionalization of compounds | 93 | 8.17e-02 | -0.104000 | 2.47e-01 |
| Interleukin-6 family signaling | 24 | 8.20e-02 | 0.205000 | 2.47e-01 |
| Extra-nuclear estrogen signaling | 72 | 8.24e-02 | -0.118000 | 2.48e-01 |
| Cytosolic iron-sulfur cluster assembly | 13 | 8.26e-02 | 0.278000 | 2.48e-01 |
| RAF activation | 33 | 8.27e-02 | 0.175000 | 2.48e-01 |
| Transport of bile salts and organic acids, metal ions and amine compounds | 78 | 8.31e-02 | -0.114000 | 2.48e-01 |
| Purine ribonucleoside monophosphate biosynthesis | 10 | 8.32e-02 | 0.316000 | 2.48e-01 |
| Signaling by TGFB family members | 96 | 8.32e-02 | 0.102000 | 2.48e-01 |
| Association of TriC/CCT with target proteins during biosynthesis | 38 | 8.40e-02 | 0.162000 | 2.49e-01 |
| alpha-linolenic (omega3) and linoleic (omega6) acid metabolism | 12 | 8.40e-02 | 0.288000 | 2.49e-01 |
| alpha-linolenic acid (ALA) metabolism | 12 | 8.40e-02 | 0.288000 | 2.49e-01 |
| PRC2 methylates histones and DNA | 23 | 8.43e-02 | -0.208000 | 2.49e-01 |
| Synthesis of substrates in N-glycan biosythesis | 60 | 8.54e-02 | 0.128000 | 2.52e-01 |
| Transferrin endocytosis and recycling | 29 | 8.60e-02 | 0.184000 | 2.53e-01 |
| Defects in vitamin and cofactor metabolism | 22 | 8.61e-02 | 0.211000 | 2.53e-01 |
| PIWI-interacting RNA (piRNA) biogenesis | 25 | 8.64e-02 | 0.198000 | 2.53e-01 |
| Plasma lipoprotein remodeling | 31 | 8.70e-02 | -0.178000 | 2.55e-01 |
| Aflatoxin activation and detoxification | 18 | 8.71e-02 | -0.233000 | 2.55e-01 |
| Leading Strand Synthesis | 13 | 8.79e-02 | -0.273000 | 2.56e-01 |
| Polymerase switching | 13 | 8.79e-02 | -0.273000 | 2.56e-01 |
| RNA Polymerase II Transcription Termination | 63 | 8.83e-02 | -0.124000 | 2.56e-01 |
| Ras activation upon Ca2+ influx through NMDA receptor | 19 | 8.85e-02 | 0.226000 | 2.57e-01 |
| Nucleotide salvage | 22 | 8.99e-02 | 0.209000 | 2.60e-01 |
| O-linked glycosylation | 100 | 9.01e-02 | -0.098100 | 2.60e-01 |
| Class B/2 (Secretin family receptors) | 86 | 9.02e-02 | -0.106000 | 2.60e-01 |
| Signaling by Leptin | 11 | 9.12e-02 | 0.294000 | 2.62e-01 |
| HS-GAG degradation | 20 | 9.18e-02 | -0.218000 | 2.63e-01 |
| Lagging Strand Synthesis | 19 | 9.20e-02 | -0.223000 | 2.63e-01 |
| Adaptive Immune System | 691 | 9.26e-02 | 0.037700 | 2.64e-01 |
| Activation of NMDA receptors and postsynaptic events | 71 | 9.26e-02 | 0.115000 | 2.64e-01 |
| TBC/RABGAPs | 44 | 9.47e-02 | 0.146000 | 2.69e-01 |
| Presynaptic function of Kainate receptors | 21 | 9.49e-02 | -0.211000 | 2.69e-01 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | 13 | 9.49e-02 | -0.268000 | 2.69e-01 |
| RET signaling | 39 | 9.68e-02 | -0.154000 | 2.74e-01 |
| Developmental Biology | 866 | 9.74e-02 | -0.033300 | 2.75e-01 |
| Phase 4 - resting membrane potential | 18 | 9.75e-02 | -0.226000 | 2.75e-01 |
| Diseases of glycosylation | 132 | 9.97e-02 | -0.083000 | 2.80e-01 |
| tRNA modification in the nucleus and cytosol | 42 | 1.01e-01 | 0.146000 | 2.83e-01 |
| FGFR1 mutant receptor activation | 28 | 1.02e-01 | 0.179000 | 2.84e-01 |
| HuR (ELAVL1) binds and stabilizes mRNA | 10 | 1.02e-01 | -0.299000 | 2.84e-01 |
| Cap-dependent Translation Initiation | 93 | 1.02e-01 | 0.098100 | 2.85e-01 |
| Eukaryotic Translation Initiation | 93 | 1.02e-01 | 0.098100 | 2.85e-01 |
| NCAM signaling for neurite out-growth | 52 | 1.04e-01 | -0.130000 | 2.88e-01 |
| HDMs demethylate histones | 21 | 1.04e-01 | -0.205000 | 2.89e-01 |
| Protein methylation | 14 | 1.05e-01 | 0.250000 | 2.92e-01 |
| Activation of Matrix Metalloproteinases | 28 | 1.06e-01 | -0.176000 | 2.94e-01 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | 17 | 1.09e-01 | -0.224000 | 3.01e-01 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | 60 | 1.10e-01 | 0.119000 | 3.02e-01 |
| RNA Polymerase III Transcription Termination | 19 | 1.10e-01 | 0.212000 | 3.02e-01 |
| Uptake and actions of bacterial toxins | 26 | 1.11e-01 | 0.181000 | 3.05e-01 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | 99 | 1.12e-01 | -0.092500 | 3.07e-01 |
| Pre-NOTCH Transcription and Translation | 47 | 1.12e-01 | -0.134000 | 3.07e-01 |
| Amino acid transport across the plasma membrane | 32 | 1.14e-01 | -0.161000 | 3.12e-01 |
| Inwardly rectifying K+ channels | 35 | 1.14e-01 | -0.154000 | 3.12e-01 |
| Signaling by Erythropoietin | 25 | 1.16e-01 | -0.182000 | 3.15e-01 |
| RAB GEFs exchange GTP for GDP on RABs | 85 | 1.16e-01 | 0.098600 | 3.15e-01 |
| Synthesis of IP3 and IP4 in the cytosol | 26 | 1.17e-01 | 0.178000 | 3.17e-01 |
| VEGFA-VEGFR2 Pathway | 91 | 1.18e-01 | -0.094800 | 3.18e-01 |
| Nuclear Envelope Breakdown | 50 | 1.18e-01 | -0.128000 | 3.18e-01 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | 20 | 1.18e-01 | 0.202000 | 3.18e-01 |
| GABA synthesis, release, reuptake and degradation | 18 | 1.19e-01 | 0.212000 | 3.18e-01 |
| HIV elongation arrest and recovery | 34 | 1.19e-01 | 0.155000 | 3.18e-01 |
| Pausing and recovery of HIV elongation | 34 | 1.19e-01 | 0.155000 | 3.18e-01 |
| GABA receptor activation | 57 | 1.20e-01 | -0.119000 | 3.19e-01 |
| Ion homeostasis | 47 | 1.20e-01 | 0.131000 | 3.19e-01 |
| RNA Polymerase III Transcription Initiation | 32 | 1.20e-01 | 0.159000 | 3.19e-01 |
| Glucagon-type ligand receptors | 31 | 1.20e-01 | -0.161000 | 3.20e-01 |
| TRAF3-dependent IRF activation pathway | 12 | 1.22e-01 | 0.258000 | 3.24e-01 |
| Dermatan sulfate biosynthesis | 11 | 1.22e-01 | -0.269000 | 3.24e-01 |
| FOXO-mediated transcription of cell cycle genes | 16 | 1.23e-01 | -0.223000 | 3.26e-01 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | 14 | 1.24e-01 | 0.238000 | 3.26e-01 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | 14 | 1.24e-01 | 0.238000 | 3.26e-01 |
| Signaling by NTRK2 (TRKB) | 25 | 1.26e-01 | -0.177000 | 3.30e-01 |
| Olfactory Signaling Pathway | 123 | 1.26e-01 | -0.080000 | 3.30e-01 |
| Heme biosynthesis | 13 | 1.26e-01 | 0.245000 | 3.30e-01 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | 17 | 1.26e-01 | -0.214000 | 3.30e-01 |
| Phosphorylation of the APC/C | 19 | 1.27e-01 | -0.202000 | 3.31e-01 |
| Chondroitin sulfate/dermatan sulfate metabolism | 49 | 1.27e-01 | -0.126000 | 3.31e-01 |
| Activation of GABAB receptors | 43 | 1.29e-01 | -0.134000 | 3.34e-01 |
| GABA B receptor activation | 43 | 1.29e-01 | -0.134000 | 3.34e-01 |
| DNA methylation | 15 | 1.29e-01 | -0.227000 | 3.34e-01 |
| Synthesis of PIPs at the late endosome membrane | 11 | 1.30e-01 | 0.264000 | 3.36e-01 |
| Activation of the AP-1 family of transcription factors | 10 | 1.30e-01 | 0.276000 | 3.36e-01 |
| Signaling by TGF-beta Receptor Complex | 69 | 1.30e-01 | 0.105000 | 3.36e-01 |
| Adrenaline,noradrenaline inhibits insulin secretion | 28 | 1.31e-01 | -0.165000 | 3.36e-01 |
| Nucleobase biosynthesis | 13 | 1.32e-01 | 0.241000 | 3.39e-01 |
| ADP signalling through P2Y purinoceptor 12 | 22 | 1.32e-01 | -0.185000 | 3.39e-01 |
| Peptide ligand-binding receptors | 158 | 1.33e-01 | -0.069300 | 3.40e-01 |
| ZBP1(DAI) mediated induction of type I IFNs | 19 | 1.33e-01 | 0.199000 | 3.40e-01 |
| Muscle contraction | 177 | 1.34e-01 | 0.065400 | 3.40e-01 |
| MAPK family signaling cascades | 307 | 1.34e-01 | 0.049900 | 3.40e-01 |
| Other semaphorin interactions | 19 | 1.34e-01 | -0.199000 | 3.40e-01 |
| Nitric oxide stimulates guanylate cyclase | 19 | 1.34e-01 | -0.199000 | 3.40e-01 |
| O-linked glycosylation of mucins | 53 | 1.35e-01 | -0.119000 | 3.43e-01 |
| Amine ligand-binding receptors | 34 | 1.36e-01 | -0.148000 | 3.43e-01 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | 15 | 1.36e-01 | -0.222000 | 3.43e-01 |
| Activation of G protein gated Potassium channels | 29 | 1.37e-01 | -0.160000 | 3.44e-01 |
| G protein gated Potassium channels | 29 | 1.37e-01 | -0.160000 | 3.44e-01 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | 29 | 1.37e-01 | -0.160000 | 3.44e-01 |
| mRNA Capping | 27 | 1.38e-01 | 0.165000 | 3.45e-01 |
| Defective B3GALTL causes Peters-plus syndrome (PpS) | 36 | 1.38e-01 | -0.143000 | 3.45e-01 |
| Diseases of carbohydrate metabolism | 32 | 1.39e-01 | 0.151000 | 3.46e-01 |
| Formation of the Early Elongation Complex | 31 | 1.39e-01 | 0.153000 | 3.47e-01 |
| Formation of the HIV-1 Early Elongation Complex | 31 | 1.39e-01 | 0.153000 | 3.47e-01 |
| Intracellular signaling by second messengers | 302 | 1.41e-01 | 0.049300 | 3.52e-01 |
| Negative regulation of MAPK pathway | 42 | 1.42e-01 | 0.131000 | 3.52e-01 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | 37 | 1.42e-01 | 0.139000 | 3.53e-01 |
| Chylomicron assembly | 10 | 1.44e-01 | -0.267000 | 3.56e-01 |
| SARS-CoV Infections | 138 | 1.45e-01 | 0.072000 | 3.56e-01 |
| APC-Cdc20 mediated degradation of Nek2A | 24 | 1.45e-01 | -0.172000 | 3.56e-01 |
| Collagen degradation | 36 | 1.45e-01 | -0.140000 | 3.56e-01 |
| Apoptosis induced DNA fragmentation | 12 | 1.46e-01 | -0.242000 | 3.56e-01 |
| Signaling by Non-Receptor Tyrosine Kinases | 53 | 1.46e-01 | -0.115000 | 3.56e-01 |
| Signaling by PTK6 | 53 | 1.46e-01 | -0.115000 | 3.56e-01 |
| Cellular hexose transport | 19 | 1.46e-01 | 0.193000 | 3.56e-01 |
| Apoptotic cleavage of cell adhesion proteins | 11 | 1.46e-01 | -0.253000 | 3.56e-01 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | 11 | 1.47e-01 | 0.253000 | 3.56e-01 |
| SUMOylation of DNA replication proteins | 44 | 1.47e-01 | -0.127000 | 3.56e-01 |
| Pausing and recovery of Tat-mediated HIV elongation | 32 | 1.47e-01 | 0.148000 | 3.56e-01 |
| Tat-mediated HIV elongation arrest and recovery | 32 | 1.47e-01 | 0.148000 | 3.56e-01 |
| HIV Life Cycle | 142 | 1.48e-01 | 0.070400 | 3.57e-01 |
| Tandem pore domain potassium channels | 11 | 1.48e-01 | -0.252000 | 3.57e-01 |
| Acyl chain remodelling of PC | 26 | 1.48e-01 | 0.164000 | 3.57e-01 |
| RNA Polymerase II Transcription | 1083 | 1.49e-01 | -0.026200 | 3.57e-01 |
| Signaling by FGFR2 IIIa TM | 17 | 1.49e-01 | 0.202000 | 3.57e-01 |
| p75 NTR receptor-mediated signalling | 92 | 1.49e-01 | -0.087100 | 3.57e-01 |
| STING mediated induction of host immune responses | 16 | 1.49e-01 | 0.208000 | 3.58e-01 |
| Response of Mtb to phagocytosis | 21 | 1.50e-01 | 0.182000 | 3.58e-01 |
| Uptake and function of anthrax toxins | 10 | 1.50e-01 | 0.263000 | 3.58e-01 |
| Negative regulation of the PI3K/AKT network | 106 | 1.50e-01 | -0.080900 | 3.58e-01 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | 21 | 1.51e-01 | 0.181000 | 3.60e-01 |
| RA biosynthesis pathway | 18 | 1.53e-01 | 0.195000 | 3.62e-01 |
| RNA Polymerase I Promoter Clearance | 56 | 1.53e-01 | 0.110000 | 3.62e-01 |
| RNA Polymerase I Transcription | 56 | 1.53e-01 | 0.110000 | 3.62e-01 |
| Signaling by NOTCH2 | 29 | 1.53e-01 | 0.153000 | 3.62e-01 |
| Regulation of KIT signaling | 16 | 1.54e-01 | -0.206000 | 3.62e-01 |
| Interferon alpha/beta signaling | 63 | 1.54e-01 | -0.104000 | 3.62e-01 |
| Presynaptic nicotinic acetylcholine receptors | 10 | 1.54e-01 | -0.260000 | 3.62e-01 |
| SHC1 events in EGFR signaling | 14 | 1.55e-01 | -0.219000 | 3.65e-01 |
| Norepinephrine Neurotransmitter Release Cycle | 18 | 1.58e-01 | 0.192000 | 3.70e-01 |
| GRB2 events in EGFR signaling | 13 | 1.58e-01 | -0.226000 | 3.70e-01 |
| Molecules associated with elastic fibres | 28 | 1.59e-01 | -0.154000 | 3.70e-01 |
| Signaling by FGFR4 in disease | 11 | 1.59e-01 | -0.245000 | 3.71e-01 |
| Transcriptional Regulation by MECP2 | 56 | 1.60e-01 | 0.109000 | 3.72e-01 |
| Glutathione conjugation | 30 | 1.62e-01 | -0.148000 | 3.76e-01 |
| Serotonin Neurotransmitter Release Cycle | 18 | 1.62e-01 | 0.190000 | 3.76e-01 |
| Cilium Assembly | 180 | 1.63e-01 | -0.060400 | 3.76e-01 |
| G beta:gamma signalling through PLC beta | 20 | 1.63e-01 | -0.180000 | 3.76e-01 |
| MicroRNA (miRNA) biogenesis | 24 | 1.63e-01 | 0.165000 | 3.76e-01 |
| Late Phase of HIV Life Cycle | 130 | 1.63e-01 | 0.070900 | 3.76e-01 |
| Defects of contact activation system (CAS) and kallikrein/kinin system (KKS) | 16 | 1.63e-01 | -0.201000 | 3.76e-01 |
| Diseases of hemostasis | 16 | 1.63e-01 | -0.201000 | 3.76e-01 |
| G1/S-Specific Transcription | 29 | 1.64e-01 | -0.149000 | 3.76e-01 |
| DCC mediated attractive signaling | 14 | 1.65e-01 | -0.215000 | 3.76e-01 |
| Acetylcholine binding and downstream events | 11 | 1.65e-01 | -0.242000 | 3.76e-01 |
| Postsynaptic nicotinic acetylcholine receptors | 11 | 1.65e-01 | -0.242000 | 3.76e-01 |
| Formation of HIV elongation complex in the absence of HIV Tat | 46 | 1.65e-01 | 0.118000 | 3.77e-01 |
| FGFR2 mutant receptor activation | 28 | 1.66e-01 | 0.151000 | 3.78e-01 |
| Processing of Capped Intron-Containing Pre-mRNA | 227 | 1.66e-01 | -0.053400 | 3.78e-01 |
| Aspartate and asparagine metabolism | 10 | 1.66e-01 | 0.253000 | 3.78e-01 |
| Creatine metabolism | 10 | 1.67e-01 | 0.253000 | 3.78e-01 |
| rRNA modification in the nucleus and cytosol | 57 | 1.67e-01 | 0.106000 | 3.79e-01 |
| Regulation of localization of FOXO transcription factors | 11 | 1.70e-01 | 0.239000 | 3.84e-01 |
| Interaction With Cumulus Cells And The Zona Pellucida | 10 | 1.70e-01 | -0.251000 | 3.84e-01 |
| Caspase-mediated cleavage of cytoskeletal proteins | 12 | 1.70e-01 | 0.229000 | 3.84e-01 |
| TRAF6 mediated IRF7 activation | 26 | 1.71e-01 | -0.155000 | 3.84e-01 |
| Telomere Extension By Telomerase | 23 | 1.71e-01 | -0.165000 | 3.84e-01 |
| Defective GALNT3 causes familial hyperphosphatemic tumoral calcinosis (HFTC) | 10 | 1.72e-01 | -0.249000 | 3.86e-01 |
| TNFR1-induced NFkappaB signaling pathway | 26 | 1.73e-01 | 0.155000 | 3.86e-01 |
| SUMOylation of DNA methylation proteins | 16 | 1.73e-01 | 0.197000 | 3.87e-01 |
| Unblocking of NMDA receptors, glutamate binding and activation | 20 | 1.76e-01 | 0.175000 | 3.90e-01 |
| Folding of actin by CCT/TriC | 10 | 1.76e-01 | 0.247000 | 3.90e-01 |
| Translation of structural proteins | 27 | 1.76e-01 | 0.151000 | 3.90e-01 |
| Synthesis of IP2, IP, and Ins in the cytosol | 14 | 1.76e-01 | 0.209000 | 3.90e-01 |
| SUMOylation | 163 | 1.76e-01 | -0.061500 | 3.90e-01 |
| IRF3-mediated induction of type I IFN | 13 | 1.77e-01 | 0.216000 | 3.92e-01 |
| RIP-mediated NFkB activation via ZBP1 | 15 | 1.78e-01 | 0.201000 | 3.92e-01 |
| Membrane binding and targetting of GAG proteins | 13 | 1.78e-01 | 0.216000 | 3.92e-01 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | 13 | 1.78e-01 | 0.216000 | 3.92e-01 |
| Integrin cell surface interactions | 60 | 1.78e-01 | -0.101000 | 3.92e-01 |
| GPVI-mediated activation cascade | 32 | 1.78e-01 | -0.138000 | 3.92e-01 |
| RHO GTPases activate PKNs | 44 | 1.79e-01 | -0.117000 | 3.93e-01 |
| Defective B3GALT6 causes EDSP2 and SEMDJL1 | 19 | 1.81e-01 | -0.177000 | 3.96e-01 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | 24 | 1.81e-01 | 0.158000 | 3.96e-01 |
| Interleukin-37 signaling | 19 | 1.81e-01 | 0.177000 | 3.96e-01 |
| Sphingolipid de novo biosynthesis | 43 | 1.82e-01 | -0.118000 | 3.97e-01 |
| cGMP effects | 15 | 1.84e-01 | -0.198000 | 4.01e-01 |
| RNA Polymerase I Promoter Escape | 38 | 1.84e-01 | 0.125000 | 4.01e-01 |
| p130Cas linkage to MAPK signaling for integrins | 15 | 1.85e-01 | -0.198000 | 4.01e-01 |
| The canonical retinoid cycle in rods (twilight vision) | 23 | 1.85e-01 | -0.160000 | 4.02e-01 |
| Interleukin-15 signaling | 14 | 1.85e-01 | 0.204000 | 4.02e-01 |
| PD-1 signaling | 18 | 1.87e-01 | 0.180000 | 4.02e-01 |
| IRAK4 deficiency (TLR2/4) | 10 | 1.87e-01 | -0.241000 | 4.02e-01 |
| MAPK targets/ Nuclear events mediated by MAP kinases | 30 | 1.87e-01 | 0.139000 | 4.02e-01 |
| Nuclear Pore Complex (NPC) Disassembly | 34 | 1.88e-01 | -0.131000 | 4.02e-01 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | 29 | 1.88e-01 | 0.141000 | 4.02e-01 |
| Trafficking of AMPA receptors | 29 | 1.88e-01 | 0.141000 | 4.02e-01 |
| Defective EXT1 causes exostoses 1, TRPS2 and CHDS | 13 | 1.89e-01 | -0.211000 | 4.04e-01 |
| Defective EXT2 causes exostoses 2 | 13 | 1.89e-01 | -0.211000 | 4.04e-01 |
| Activation of HOX genes during differentiation | 65 | 1.89e-01 | -0.094100 | 4.04e-01 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | 65 | 1.89e-01 | -0.094100 | 4.04e-01 |
| Plasma lipoprotein assembly | 18 | 1.90e-01 | -0.178000 | 4.05e-01 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | 11 | 1.91e-01 | 0.228000 | 4.05e-01 |
| Long-term potentiation | 22 | 1.91e-01 | 0.161000 | 4.05e-01 |
| Growth hormone receptor signaling | 21 | 1.91e-01 | 0.165000 | 4.05e-01 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | 74 | 1.91e-01 | 0.087900 | 4.05e-01 |
| Organic anion transporters | 10 | 1.92e-01 | 0.239000 | 4.05e-01 |
| Platelet activation, signaling and aggregation | 252 | 1.92e-01 | -0.047800 | 4.05e-01 |
| Removal of the Flap Intermediate from the C-strand | 16 | 1.93e-01 | -0.188000 | 4.07e-01 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | 12 | 1.93e-01 | -0.217000 | 4.07e-01 |
| MET activates RAP1 and RAC1 | 11 | 1.94e-01 | -0.226000 | 4.07e-01 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | 23 | 1.94e-01 | 0.156000 | 4.07e-01 |
| Regulation of TNFR1 signaling | 34 | 1.94e-01 | 0.129000 | 4.07e-01 |
| Pre-NOTCH Expression and Processing | 63 | 1.98e-01 | -0.093900 | 4.14e-01 |
| Cohesin Loading onto Chromatin | 10 | 1.98e-01 | -0.235000 | 4.14e-01 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | 44 | 1.99e-01 | 0.112000 | 4.14e-01 |
| HIV Transcription Elongation | 44 | 1.99e-01 | 0.112000 | 4.14e-01 |
| Tat-mediated elongation of the HIV-1 transcript | 44 | 1.99e-01 | 0.112000 | 4.14e-01 |
| Signaling by FGFR3 fusions in cancer | 10 | 2.00e-01 | -0.234000 | 4.15e-01 |
| Na+/Cl- dependent neurotransmitter transporters | 17 | 2.00e-01 | -0.179000 | 4.15e-01 |
| G beta:gamma signalling through PI3Kgamma | 25 | 2.01e-01 | -0.148000 | 4.16e-01 |
| L1CAM interactions | 98 | 2.02e-01 | 0.074700 | 4.17e-01 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | 35 | 2.04e-01 | -0.124000 | 4.21e-01 |
| Diseases of mitotic cell cycle | 35 | 2.04e-01 | -0.124000 | 4.21e-01 |
| Zinc influx into cells by the SLC39 gene family | 10 | 2.04e-01 | -0.232000 | 4.21e-01 |
| Endosomal/Vacuolar pathway | 10 | 2.06e-01 | -0.231000 | 4.23e-01 |
| Potential therapeutics for SARS | 76 | 2.08e-01 | 0.083600 | 4.26e-01 |
| Transcriptional Regulation by TP53 | 342 | 2.08e-01 | 0.039700 | 4.26e-01 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | 22 | 2.09e-01 | 0.155000 | 4.26e-01 |
| NR1H2 and NR1H3-mediated signaling | 48 | 2.09e-01 | -0.105000 | 4.26e-01 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | 24 | 2.09e-01 | -0.148000 | 4.26e-01 |
| Purine salvage | 13 | 2.10e-01 | 0.201000 | 4.26e-01 |
| HIV Transcription Initiation | 42 | 2.10e-01 | 0.112000 | 4.26e-01 |
| RNA Polymerase II HIV Promoter Escape | 42 | 2.10e-01 | 0.112000 | 4.26e-01 |
| RNA Polymerase II Promoter Escape | 42 | 2.10e-01 | 0.112000 | 4.26e-01 |
| RNA Polymerase II Transcription Initiation | 42 | 2.10e-01 | 0.112000 | 4.26e-01 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | 42 | 2.10e-01 | 0.112000 | 4.26e-01 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | 42 | 2.10e-01 | 0.112000 | 4.26e-01 |
| Digestion and absorption | 21 | 2.12e-01 | -0.157000 | 4.28e-01 |
| O-glycosylation of TSR domain-containing proteins | 37 | 2.12e-01 | -0.118000 | 4.28e-01 |
| Thrombin signalling through proteinase activated receptors (PARs) | 31 | 2.13e-01 | -0.129000 | 4.30e-01 |
| EPHA-mediated growth cone collapse | 15 | 2.15e-01 | -0.185000 | 4.33e-01 |
| Chemokine receptors bind chemokines | 42 | 2.17e-01 | -0.110000 | 4.35e-01 |
| SUMO E3 ligases SUMOylate target proteins | 157 | 2.17e-01 | -0.057200 | 4.35e-01 |
| Activated NOTCH1 Transmits Signal to the Nucleus | 30 | 2.19e-01 | 0.130000 | 4.38e-01 |
| EPH-Ephrin signaling | 90 | 2.21e-01 | -0.074600 | 4.43e-01 |
| CD209 (DC-SIGN) signaling | 19 | 2.24e-01 | -0.161000 | 4.46e-01 |
| Transcriptional Regulation by E2F6 | 32 | 2.25e-01 | -0.124000 | 4.49e-01 |
| Passive transport by Aquaporins | 11 | 2.27e-01 | 0.210000 | 4.52e-01 |
| ABC transporters in lipid homeostasis | 17 | 2.29e-01 | 0.169000 | 4.54e-01 |
| Organelle biogenesis and maintenance | 267 | 2.29e-01 | 0.042900 | 4.54e-01 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | 87 | 2.30e-01 | 0.074500 | 4.55e-01 |
| Deadenylation-dependent mRNA decay | 51 | 2.30e-01 | -0.097200 | 4.55e-01 |
| RAF-independent MAPK1/3 activation | 23 | 2.31e-01 | 0.144000 | 4.56e-01 |
| Phenylalanine and tyrosine metabolism | 11 | 2.32e-01 | -0.208000 | 4.58e-01 |
| Arachidonic acid metabolism | 54 | 2.33e-01 | -0.093900 | 4.59e-01 |
| Signaling by PDGF | 50 | 2.33e-01 | -0.097600 | 4.59e-01 |
| Dual Incision in GG-NER | 39 | 2.34e-01 | 0.110000 | 4.60e-01 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | 29 | 2.34e-01 | -0.128000 | 4.60e-01 |
| Regulation of PTEN gene transcription | 58 | 2.34e-01 | 0.090300 | 4.60e-01 |
| L13a-mediated translational silencing of Ceruloplasmin expression | 85 | 2.37e-01 | 0.074200 | 4.65e-01 |
| Semaphorin interactions | 63 | 2.39e-01 | -0.085700 | 4.69e-01 |
| Interferon Signaling | 178 | 2.40e-01 | 0.051100 | 4.69e-01 |
| Nicotinamide salvaging | 19 | 2.41e-01 | 0.155000 | 4.70e-01 |
| InlB-mediated entry of Listeria monocytogenes into host cell | 14 | 2.41e-01 | 0.181000 | 4.70e-01 |
| p75NTR recruits signalling complexes | 12 | 2.45e-01 | 0.194000 | 4.77e-01 |
| HDR through MMEJ (alt-NHEJ) | 10 | 2.46e-01 | -0.212000 | 4.79e-01 |
| TP53 Regulates Transcription of Cell Cycle Genes | 47 | 2.47e-01 | -0.097700 | 4.79e-01 |
| Glutamate Neurotransmitter Release Cycle | 24 | 2.50e-01 | 0.136000 | 4.83e-01 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | 31 | 2.50e-01 | -0.119000 | 4.83e-01 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | 31 | 2.50e-01 | -0.119000 | 4.83e-01 |
| Infection with Mycobacterium tuberculosis | 25 | 2.53e-01 | 0.132000 | 4.87e-01 |
| Cytokine Signaling in Immune system | 787 | 2.53e-01 | 0.024100 | 4.87e-01 |
| Nucleotide-like (purinergic) receptors | 15 | 2.53e-01 | 0.170000 | 4.88e-01 |
| ADP signalling through P2Y purinoceptor 1 | 24 | 2.54e-01 | -0.134000 | 4.89e-01 |
| Regulation of TLR by endogenous ligand | 15 | 2.59e-01 | -0.168000 | 4.97e-01 |
| Acyl chain remodelling of PI | 16 | 2.59e-01 | 0.163000 | 4.97e-01 |
| Metabolism of Angiotensinogen to Angiotensins | 17 | 2.61e-01 | -0.158000 | 4.99e-01 |
| Urea cycle | 10 | 2.61e-01 | -0.205000 | 4.99e-01 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | 46 | 2.61e-01 | -0.095800 | 4.99e-01 |
| Nucleobase catabolism | 35 | 2.62e-01 | 0.110000 | 4.99e-01 |
| Amyloid fiber formation | 56 | 2.62e-01 | -0.086700 | 4.99e-01 |
| TP53 Regulates Transcription of Cell Death Genes | 34 | 2.63e-01 | -0.111000 | 5.01e-01 |
| GAB1 signalosome | 17 | 2.64e-01 | -0.157000 | 5.01e-01 |
| Diseases associated with glycosaminoglycan metabolism | 39 | 2.64e-01 | -0.103000 | 5.02e-01 |
| Methylation | 14 | 2.66e-01 | 0.172000 | 5.03e-01 |
| Basigin interactions | 24 | 2.68e-01 | -0.131000 | 5.07e-01 |
| Suppression of phagosomal maturation | 12 | 2.69e-01 | 0.184000 | 5.07e-01 |
| Transport of the SLBP Dependant Mature mRNA | 35 | 2.69e-01 | -0.108000 | 5.07e-01 |
| ISG15 antiviral mechanism | 69 | 2.69e-01 | 0.077000 | 5.07e-01 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | 50 | 2.72e-01 | 0.089900 | 5.10e-01 |
| Defective B3GAT3 causes JDSSDHD | 19 | 2.72e-01 | -0.146000 | 5.10e-01 |
| Tryptophan catabolism | 14 | 2.72e-01 | -0.170000 | 5.10e-01 |
| Bicarbonate transporters | 10 | 2.72e-01 | 0.201000 | 5.10e-01 |
| APC/C:Cdc20 mediated degradation of Cyclin B | 22 | 2.73e-01 | -0.135000 | 5.12e-01 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | 16 | 2.74e-01 | -0.158000 | 5.12e-01 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | 11 | 2.74e-01 | 0.190000 | 5.12e-01 |
| Phase II - Conjugation of compounds | 79 | 2.75e-01 | -0.071100 | 5.13e-01 |
| Cell-cell junction organization | 60 | 2.76e-01 | -0.081400 | 5.13e-01 |
| RHO GTPases activate KTN1 | 10 | 2.77e-01 | 0.198000 | 5.13e-01 |
| G alpha (z) signalling events | 48 | 2.77e-01 | -0.090700 | 5.13e-01 |
| Signaling by VEGF | 100 | 2.78e-01 | -0.062900 | 5.13e-01 |
| PI3K/AKT Signaling in Cancer | 97 | 2.78e-01 | -0.063800 | 5.13e-01 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | 17 | 2.79e-01 | -0.152000 | 5.13e-01 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | 17 | 2.79e-01 | -0.152000 | 5.13e-01 |
| WNT5A-dependent internalization of FZD4 | 15 | 2.79e-01 | 0.161000 | 5.13e-01 |
| RHO GTPases activate PAKs | 21 | 2.79e-01 | -0.136000 | 5.13e-01 |
| Neurexins and neuroligins | 54 | 2.79e-01 | -0.085100 | 5.13e-01 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | 54 | 2.81e-01 | 0.084900 | 5.13e-01 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | 54 | 2.81e-01 | 0.084900 | 5.13e-01 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | 54 | 2.81e-01 | 0.084900 | 5.13e-01 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | 54 | 2.81e-01 | 0.084900 | 5.13e-01 |
| Signaling by NOTCH1 in Cancer | 54 | 2.81e-01 | 0.084900 | 5.13e-01 |
| Influenza Infection | 128 | 2.81e-01 | 0.055200 | 5.13e-01 |
| Processive synthesis on the lagging strand | 14 | 2.81e-01 | -0.166000 | 5.13e-01 |
| Thromboxane signalling through TP receptor | 23 | 2.81e-01 | -0.130000 | 5.13e-01 |
| Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane | 11 | 2.83e-01 | 0.187000 | 5.16e-01 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | 16 | 2.84e-01 | -0.155000 | 5.16e-01 |
| COPII-mediated vesicle transport | 61 | 2.85e-01 | 0.079200 | 5.17e-01 |
| Vpr-mediated nuclear import of PICs | 32 | 2.85e-01 | -0.109000 | 5.17e-01 |
| SLC-mediated transmembrane transport | 235 | 2.86e-01 | -0.040500 | 5.18e-01 |
| Downstream signaling of activated FGFR1 | 28 | 2.87e-01 | -0.116000 | 5.19e-01 |
| Regulation of TP53 Activity through Methylation | 16 | 2.87e-01 | 0.154000 | 5.19e-01 |
| Keratan sulfate biosynthesis | 26 | 2.88e-01 | -0.120000 | 5.19e-01 |
| SUMOylation of SUMOylation proteins | 34 | 2.88e-01 | -0.105000 | 5.19e-01 |
| Integration of energy metabolism | 103 | 2.89e-01 | -0.060500 | 5.19e-01 |
| Miscellaneous transport and binding events | 23 | 2.89e-01 | -0.128000 | 5.19e-01 |
| Lysosphingolipid and LPA receptors | 14 | 2.90e-01 | -0.163000 | 5.19e-01 |
| SUMOylation of ubiquitinylation proteins | 38 | 2.90e-01 | -0.099300 | 5.19e-01 |
| SUMOylation of intracellular receptors | 30 | 2.90e-01 | -0.112000 | 5.19e-01 |
| Gene expression (Transcription) | 1215 | 2.90e-01 | -0.018100 | 5.20e-01 |
| Transport of the SLBP independent Mature mRNA | 34 | 2.92e-01 | -0.105000 | 5.21e-01 |
| Caspase activation via Death Receptors in the presence of ligand | 11 | 2.93e-01 | -0.183000 | 5.23e-01 |
| Negative epigenetic regulation of rRNA expression | 57 | 2.93e-01 | 0.080500 | 5.23e-01 |
| Transcription of the HIV genome | 68 | 2.93e-01 | 0.073700 | 5.23e-01 |
| Anchoring of the basal body to the plasma membrane | 94 | 2.94e-01 | -0.062700 | 5.23e-01 |
| NEP/NS2 Interacts with the Cellular Export Machinery | 31 | 2.95e-01 | -0.109000 | 5.24e-01 |
| Neurotransmitter clearance | 10 | 2.98e-01 | -0.190000 | 5.29e-01 |
| Acyl chain remodelling of PE | 26 | 3.01e-01 | 0.117000 | 5.34e-01 |
| AURKA Activation by TPX2 | 70 | 3.02e-01 | -0.071400 | 5.34e-01 |
| MAPK3 (ERK1) activation | 10 | 3.03e-01 | 0.188000 | 5.36e-01 |
| Metabolism of porphyrins | 24 | 3.04e-01 | 0.121000 | 5.36e-01 |
| NOD1/2 Signaling Pathway | 30 | 3.05e-01 | 0.108000 | 5.37e-01 |
| RNA Polymerase III Abortive And Retractive Initiation | 37 | 3.05e-01 | 0.097400 | 5.37e-01 |
| RNA Polymerase III Transcription | 37 | 3.05e-01 | 0.097400 | 5.37e-01 |
| Translation initiation complex formation | 49 | 3.07e-01 | 0.084400 | 5.40e-01 |
| SUMOylation of chromatin organization proteins | 56 | 3.08e-01 | -0.078700 | 5.41e-01 |
| Metabolism of steroid hormones | 27 | 3.13e-01 | -0.112000 | 5.49e-01 |
| MET receptor recycling | 10 | 3.15e-01 | 0.184000 | 5.51e-01 |
| Endogenous sterols | 24 | 3.16e-01 | -0.118000 | 5.52e-01 |
| Signaling by high-kinase activity BRAF mutants | 34 | 3.16e-01 | -0.099400 | 5.52e-01 |
| Regulation of signaling by CBL | 18 | 3.17e-01 | -0.136000 | 5.52e-01 |
| Bile acid and bile salt metabolism | 38 | 3.17e-01 | -0.093800 | 5.52e-01 |
| Heparan sulfate/heparin (HS-GAG) metabolism | 51 | 3.18e-01 | -0.080900 | 5.52e-01 |
| Effects of PIP2 hydrolysis | 26 | 3.18e-01 | -0.113000 | 5.52e-01 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | 10 | 3.18e-01 | 0.182000 | 5.53e-01 |
| LDL clearance | 18 | 3.20e-01 | 0.136000 | 5.54e-01 |
| HDACs deacetylate histones | 39 | 3.20e-01 | -0.092100 | 5.54e-01 |
| Processing and activation of SUMO | 10 | 3.21e-01 | -0.181000 | 5.56e-01 |
| Assembly and cell surface presentation of NMDA receptors | 23 | 3.24e-01 | 0.119000 | 5.59e-01 |
| NRIF signals cell death from the nucleus | 15 | 3.24e-01 | 0.147000 | 5.59e-01 |
| Defective B4GALT7 causes EDS, progeroid type | 19 | 3.25e-01 | -0.130000 | 5.61e-01 |
| Signaling by EGFR in Cancer | 23 | 3.28e-01 | -0.118000 | 5.62e-01 |
| Signaling by FGFR1 | 44 | 3.28e-01 | -0.085200 | 5.62e-01 |
| Signaling by FGFR in disease | 57 | 3.28e-01 | 0.074900 | 5.62e-01 |
| Formation of RNA Pol II elongation complex | 59 | 3.28e-01 | 0.073600 | 5.62e-01 |
| RNA Polymerase II Transcription Elongation | 59 | 3.28e-01 | 0.073600 | 5.62e-01 |
| Metalloprotease DUBs | 18 | 3.28e-01 | 0.133000 | 5.62e-01 |
| Notch-HLH transcription pathway | 26 | 3.30e-01 | -0.110000 | 5.64e-01 |
| Signal regulatory protein family interactions | 12 | 3.30e-01 | 0.162000 | 5.64e-01 |
| Synthesis of glycosylphosphatidylinositol (GPI) | 17 | 3.32e-01 | -0.136000 | 5.65e-01 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | 19 | 3.32e-01 | -0.129000 | 5.65e-01 |
| Metabolism of water-soluble vitamins and cofactors | 119 | 3.33e-01 | 0.051500 | 5.66e-01 |
| mRNA Splicing | 176 | 3.34e-01 | -0.042300 | 5.67e-01 |
| Heme degradation | 13 | 3.34e-01 | -0.155000 | 5.67e-01 |
| Resolution of Abasic Sites (AP sites) | 37 | 3.35e-01 | -0.091600 | 5.68e-01 |
| Regulation of TP53 Activity through Acetylation | 28 | 3.36e-01 | 0.105000 | 5.69e-01 |
| Signaling by FGFR | 74 | 3.37e-01 | -0.064600 | 5.70e-01 |
| Regulation of TP53 Expression and Degradation | 34 | 3.39e-01 | 0.094900 | 5.72e-01 |
| Cargo concentration in the ER | 29 | 3.39e-01 | 0.103000 | 5.72e-01 |
| FGFRL1 modulation of FGFR1 signaling | 11 | 3.42e-01 | -0.165000 | 5.76e-01 |
| Signaling by BMP | 26 | 3.42e-01 | 0.108000 | 5.76e-01 |
| Polo-like kinase mediated events | 15 | 3.45e-01 | -0.141000 | 5.79e-01 |
| Synthesis of DNA | 115 | 3.45e-01 | 0.051000 | 5.79e-01 |
| Elevation of cytosolic Ca2+ levels | 16 | 3.46e-01 | -0.136000 | 5.80e-01 |
| Regulation of TP53 Degradation | 33 | 3.46e-01 | 0.094800 | 5.80e-01 |
| Interleukin-7 signaling | 23 | 3.46e-01 | 0.113000 | 5.80e-01 |
| Mitotic Prophase | 89 | 3.47e-01 | -0.057700 | 5.80e-01 |
| Listeria monocytogenes entry into host cells | 19 | 3.47e-01 | 0.125000 | 5.80e-01 |
| Lysine catabolism | 12 | 3.49e-01 | 0.156000 | 5.82e-01 |
| Erythropoietin activates RAS | 14 | 3.49e-01 | -0.144000 | 5.82e-01 |
| Signaling by NTRKs | 129 | 3.49e-01 | 0.047700 | 5.82e-01 |
| NOTCH3 Intracellular Domain Regulates Transcription | 22 | 3.52e-01 | -0.115000 | 5.84e-01 |
| Vitamin B5 (pantothenate) metabolism | 15 | 3.54e-01 | -0.138000 | 5.88e-01 |
| Insulin receptor recycling | 25 | 3.56e-01 | 0.107000 | 5.90e-01 |
| Signaling by ERBB2 in Cancer | 24 | 3.57e-01 | -0.109000 | 5.91e-01 |
| Removal of the Flap Intermediate | 13 | 3.58e-01 | -0.147000 | 5.91e-01 |
| Signaling by NTRK1 (TRKA) | 110 | 3.58e-01 | 0.050800 | 5.91e-01 |
| Pregnenolone biosynthesis | 11 | 3.63e-01 | -0.158000 | 5.99e-01 |
| Biosynthesis of DHA-derived SPMs | 16 | 3.63e-01 | -0.131000 | 5.99e-01 |
| TP53 Regulates Transcription of DNA Repair Genes | 61 | 3.65e-01 | 0.067100 | 5.99e-01 |
| HATs acetylate histones | 84 | 3.65e-01 | 0.057200 | 5.99e-01 |
| RHO GTPases Activate NADPH Oxidases | 23 | 3.65e-01 | 0.109000 | 5.99e-01 |
| Synthesis of bile acids and bile salts via 27-hydroxycholesterol | 11 | 3.65e-01 | -0.158000 | 5.99e-01 |
| G2/M Transition | 175 | 3.66e-01 | 0.039700 | 5.99e-01 |
| Neuronal System | 368 | 3.67e-01 | -0.027500 | 6.00e-01 |
| Intraflagellar transport | 39 | 3.67e-01 | -0.083400 | 6.00e-01 |
| Prostacyclin signalling through prostacyclin receptor | 19 | 3.67e-01 | -0.119000 | 6.00e-01 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | 12 | 3.68e-01 | -0.150000 | 6.00e-01 |
| Signal amplification | 32 | 3.68e-01 | -0.091900 | 6.00e-01 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | 12 | 3.70e-01 | 0.149000 | 6.02e-01 |
| Formation of ATP by chemiosmotic coupling | 15 | 3.71e-01 | 0.133000 | 6.02e-01 |
| Nuclear import of Rev protein | 33 | 3.71e-01 | -0.090000 | 6.02e-01 |
| Formation of the beta-catenin:TCF transactivating complex | 41 | 3.71e-01 | -0.080700 | 6.02e-01 |
| mRNA Splicing - Major Pathway | 168 | 3.71e-01 | -0.040000 | 6.02e-01 |
| Interleukin-12 family signaling | 50 | 3.72e-01 | 0.073000 | 6.02e-01 |
| SIRT1 negatively regulates rRNA expression | 18 | 3.73e-01 | -0.121000 | 6.03e-01 |
| NF-kB is activated and signals survival | 11 | 3.73e-01 | 0.155000 | 6.03e-01 |
| Cyclin D associated events in G1 | 43 | 3.74e-01 | -0.078300 | 6.03e-01 |
| G1 Phase | 43 | 3.74e-01 | -0.078300 | 6.03e-01 |
| Ribosomal scanning and start codon recognition | 50 | 3.75e-01 | 0.072500 | 6.03e-01 |
| Inhibition of DNA recombination at telomere | 29 | 3.75e-01 | -0.095200 | 6.03e-01 |
| Glycerophospholipid biosynthesis | 124 | 3.75e-01 | 0.046100 | 6.03e-01 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | 28 | 3.76e-01 | 0.096700 | 6.03e-01 |
| Detoxification of Reactive Oxygen Species | 33 | 3.77e-01 | 0.089000 | 6.04e-01 |
| Generic Transcription Pathway | 967 | 3.78e-01 | -0.016900 | 6.05e-01 |
| Transport of vitamins, nucleosides, and related molecules | 41 | 3.79e-01 | -0.079400 | 6.06e-01 |
| Formation of a pool of free 40S subunits | 77 | 3.80e-01 | 0.057900 | 6.07e-01 |
| Ephrin signaling | 19 | 3.81e-01 | -0.116000 | 6.07e-01 |
| FGFR2 ligand binding and activation | 15 | 3.81e-01 | 0.131000 | 6.08e-01 |
| Plasma lipoprotein clearance | 32 | 3.84e-01 | 0.088900 | 6.12e-01 |
| Immune System | 1904 | 3.85e-01 | 0.012200 | 6.13e-01 |
| Organic cation/anion/zwitterion transport | 12 | 3.87e-01 | -0.144000 | 6.14e-01 |
| Metal ion SLC transporters | 26 | 3.89e-01 | -0.097600 | 6.17e-01 |
| Regulation of signaling by NODAL | 10 | 3.89e-01 | -0.157000 | 6.17e-01 |
| p75NTR signals via NF-kB | 14 | 3.90e-01 | 0.133000 | 6.17e-01 |
| Signaling by SCF-KIT | 42 | 3.90e-01 | -0.076700 | 6.17e-01 |
| NoRC negatively regulates rRNA expression | 54 | 3.91e-01 | 0.067600 | 6.17e-01 |
| Transport of Ribonucleoproteins into the Host Nucleus | 31 | 3.93e-01 | -0.088700 | 6.20e-01 |
| Ion transport by P-type ATPases | 51 | 3.93e-01 | -0.069100 | 6.20e-01 |
| Intrinsic Pathway for Apoptosis | 47 | 3.96e-01 | 0.071600 | 6.23e-01 |
| Negative regulation of TCF-dependent signaling by WNT ligand antagonists | 15 | 3.96e-01 | -0.127000 | 6.23e-01 |
| RNA Polymerase II Pre-transcription Events | 79 | 3.97e-01 | 0.055100 | 6.24e-01 |
| Antiviral mechanism by IFN-stimulated genes | 77 | 3.98e-01 | 0.055700 | 6.25e-01 |
| DNA Repair | 281 | 3.99e-01 | -0.029300 | 6.25e-01 |
| Stimuli-sensing channels | 96 | 4.00e-01 | -0.049800 | 6.25e-01 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | 41 | 4.00e-01 | -0.076000 | 6.25e-01 |
| CD28 co-stimulation | 33 | 4.00e-01 | -0.084700 | 6.25e-01 |
| Transcriptional Regulation by VENTX | 36 | 4.01e-01 | -0.080900 | 6.26e-01 |
| Downstream signal transduction | 29 | 4.04e-01 | 0.089500 | 6.30e-01 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | 49 | 4.05e-01 | 0.068800 | 6.31e-01 |
| Apoptotic factor-mediated response | 15 | 4.06e-01 | 0.124000 | 6.31e-01 |
| Neutrophil degranulation | 441 | 4.06e-01 | 0.023100 | 6.31e-01 |
| Retrograde transport at the Trans-Golgi-Network | 46 | 4.07e-01 | 0.070700 | 6.31e-01 |
| Beta defensins | 12 | 4.07e-01 | -0.138000 | 6.31e-01 |
| SUMOylation of DNA damage response and repair proteins | 73 | 4.07e-01 | -0.056100 | 6.31e-01 |
| Mitotic G2-G2/M phases | 177 | 4.09e-01 | 0.036000 | 6.34e-01 |
| Formation of apoptosome | 10 | 4.12e-01 | 0.150000 | 6.37e-01 |
| Regulation of the apoptosome activity | 10 | 4.12e-01 | 0.150000 | 6.37e-01 |
| Gastrin-CREB signalling pathway via PKC and MAPK | 17 | 4.15e-01 | -0.114000 | 6.40e-01 |
| Diseases associated with N-glycosylation of proteins | 16 | 4.16e-01 | -0.117000 | 6.40e-01 |
| RHO GTPases Activate ROCKs | 19 | 4.17e-01 | -0.108000 | 6.40e-01 |
| IL-6-type cytokine receptor ligand interactions | 17 | 4.17e-01 | 0.114000 | 6.40e-01 |
| MECP2 regulates neuronal receptors and channels | 16 | 4.17e-01 | -0.117000 | 6.40e-01 |
| Cargo recognition for clathrin-mediated endocytosis | 101 | 4.18e-01 | 0.046700 | 6.40e-01 |
| Adenylate cyclase activating pathway | 10 | 4.18e-01 | -0.148000 | 6.40e-01 |
| Diseases associated with visual transduction | 13 | 4.19e-01 | -0.130000 | 6.40e-01 |
| Diseases of the neuronal system | 13 | 4.19e-01 | -0.130000 | 6.40e-01 |
| Retinoid cycle disease events | 13 | 4.19e-01 | -0.130000 | 6.40e-01 |
| Hyaluronan uptake and degradation | 12 | 4.21e-01 | 0.134000 | 6.41e-01 |
| Cell recruitment (pro-inflammatory response) | 22 | 4.21e-01 | -0.099100 | 6.41e-01 |
| Purinergic signaling in leishmaniasis infection | 22 | 4.21e-01 | -0.099100 | 6.41e-01 |
| Activation of SMO | 18 | 4.21e-01 | -0.110000 | 6.41e-01 |
| Metabolism of vitamins and cofactors | 179 | 4.22e-01 | 0.034800 | 6.41e-01 |
| Repression of WNT target genes | 14 | 4.23e-01 | 0.124000 | 6.41e-01 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | 19 | 4.23e-01 | -0.106000 | 6.41e-01 |
| TNFR1-induced proapoptotic signaling | 13 | 4.25e-01 | 0.128000 | 6.41e-01 |
| Fc epsilon receptor (FCERI) signaling | 155 | 4.25e-01 | 0.037100 | 6.41e-01 |
| Signaling by ERBB2 ECD mutants | 14 | 4.26e-01 | -0.123000 | 6.41e-01 |
| DNA Double Strand Break Response | 46 | 4.26e-01 | -0.067900 | 6.41e-01 |
| RORA activates gene expression | 18 | 4.26e-01 | -0.108000 | 6.41e-01 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | 10 | 4.26e-01 | -0.145000 | 6.41e-01 |
| Transcription of E2F targets under negative control by DREAM complex | 19 | 4.26e-01 | -0.105000 | 6.41e-01 |
| Sema3A PAK dependent Axon repulsion | 15 | 4.26e-01 | -0.119000 | 6.41e-01 |
| Regulation of PTEN mRNA translation | 21 | 4.29e-01 | -0.099600 | 6.43e-01 |
| Hyaluronan metabolism | 17 | 4.29e-01 | -0.111000 | 6.43e-01 |
| Pyrimidine salvage | 10 | 4.30e-01 | 0.144000 | 6.43e-01 |
| Sphingolipid metabolism | 83 | 4.30e-01 | 0.050100 | 6.43e-01 |
| Assembly Of The HIV Virion | 15 | 4.30e-01 | 0.118000 | 6.43e-01 |
| HCMV Early Events | 67 | 4.30e-01 | -0.055700 | 6.43e-01 |
| Response of EIF2AK1 (HRI) to heme deficiency | 15 | 4.31e-01 | 0.118000 | 6.44e-01 |
| Mucopolysaccharidoses | 11 | 4.32e-01 | -0.137000 | 6.44e-01 |
| Interleukin receptor SHC signaling | 26 | 4.32e-01 | 0.089000 | 6.44e-01 |
| ECM proteoglycans | 53 | 4.32e-01 | -0.062400 | 6.44e-01 |
| Activation of kainate receptors upon glutamate binding | 30 | 4.33e-01 | -0.082800 | 6.44e-01 |
| G-protein activation | 28 | 4.33e-01 | -0.085600 | 6.44e-01 |
| Intra-Golgi traffic | 42 | 4.39e-01 | 0.069000 | 6.52e-01 |
| RNA Polymerase I Promoter Opening | 13 | 4.40e-01 | -0.124000 | 6.53e-01 |
| Apoptotic execution phase | 51 | 4.44e-01 | -0.062000 | 6.57e-01 |
| Export of Viral Ribonucleoproteins from Nucleus | 32 | 4.44e-01 | -0.078200 | 6.57e-01 |
| Formation of tubulin folding intermediates by CCT/TriC | 21 | 4.46e-01 | 0.096100 | 6.59e-01 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | 39 | 4.47e-01 | -0.070300 | 6.61e-01 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | 23 | 4.50e-01 | -0.091000 | 6.63e-01 |
| Signaling by FGFR3 in disease | 20 | 4.50e-01 | -0.097500 | 6.63e-01 |
| Signaling by FGFR3 point mutants in cancer | 20 | 4.50e-01 | -0.097500 | 6.63e-01 |
| Transcriptional regulation by small RNAs | 54 | 4.52e-01 | -0.059200 | 6.65e-01 |
| MAP2K and MAPK activation | 38 | 4.55e-01 | -0.070000 | 6.69e-01 |
| Spry regulation of FGF signaling | 14 | 4.55e-01 | 0.115000 | 6.69e-01 |
| Nonhomologous End-Joining (NHEJ) | 40 | 4.56e-01 | -0.068100 | 6.69e-01 |
| HCMV Infection | 89 | 4.61e-01 | 0.045300 | 6.74e-01 |
| Keratan sulfate/keratin metabolism | 31 | 4.61e-01 | -0.076500 | 6.74e-01 |
| HCMV Late Events | 61 | 4.61e-01 | 0.054600 | 6.74e-01 |
| ESR-mediated signaling | 165 | 4.64e-01 | -0.033100 | 6.77e-01 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | 19 | 4.64e-01 | -0.097000 | 6.77e-01 |
| Other interleukin signaling | 21 | 4.66e-01 | -0.091900 | 6.79e-01 |
| Activation of RAC1 | 13 | 4.68e-01 | -0.116000 | 6.81e-01 |
| Signaling by Activin | 13 | 4.69e-01 | -0.116000 | 6.81e-01 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | 68 | 4.69e-01 | 0.050800 | 6.81e-01 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | 15 | 4.70e-01 | -0.108000 | 6.81e-01 |
| Synthesis of PIPs at the Golgi membrane | 18 | 4.70e-01 | 0.098400 | 6.81e-01 |
| Phospholipase C-mediated cascade: FGFR1 | 13 | 4.70e-01 | -0.116000 | 6.81e-01 |
| Gamma carboxylation, hypusine formation and arylsulfatase activation | 37 | 4.70e-01 | 0.068600 | 6.81e-01 |
| Synthesis of PE | 13 | 4.71e-01 | 0.115000 | 6.81e-01 |
| PKA activation in glucagon signalling | 16 | 4.72e-01 | 0.104000 | 6.82e-01 |
| Adherens junctions interactions | 31 | 4.73e-01 | -0.074500 | 6.82e-01 |
| B-WICH complex positively regulates rRNA expression | 39 | 4.74e-01 | 0.066300 | 6.82e-01 |
| VEGFR2 mediated vascular permeability | 26 | 4.74e-01 | 0.081200 | 6.82e-01 |
| Tight junction interactions | 28 | 4.76e-01 | -0.077900 | 6.84e-01 |
| Digestion | 16 | 4.76e-01 | -0.103000 | 6.84e-01 |
| G2/M Checkpoints | 133 | 4.76e-01 | -0.035800 | 6.84e-01 |
| Interactions of Rev with host cellular proteins | 36 | 4.77e-01 | -0.068500 | 6.84e-01 |
| TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway | 15 | 4.79e-01 | 0.106000 | 6.87e-01 |
| Infectious disease | 757 | 4.80e-01 | 0.015200 | 6.87e-01 |
| Termination of O-glycan biosynthesis | 17 | 4.81e-01 | -0.098800 | 6.88e-01 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | 20 | 4.81e-01 | -0.090900 | 6.88e-01 |
| Ion channel transport | 168 | 4.82e-01 | -0.031400 | 6.89e-01 |
| Signalling to ERKs | 33 | 4.84e-01 | 0.070400 | 6.91e-01 |
| SUMOylation of transcription factors | 16 | 4.85e-01 | 0.101000 | 6.91e-01 |
| Loss of Nlp from mitotic centrosomes | 67 | 4.86e-01 | -0.049200 | 6.91e-01 |
| Loss of proteins required for interphase microtubule organization from the centrosome | 67 | 4.86e-01 | -0.049200 | 6.91e-01 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | 45 | 4.87e-01 | -0.060000 | 6.91e-01 |
| Fertilization | 21 | 4.89e-01 | -0.087200 | 6.93e-01 |
| Interaction between L1 and Ankyrins | 29 | 4.90e-01 | 0.074100 | 6.93e-01 |
| AKT phosphorylates targets in the cytosol | 14 | 4.90e-01 | 0.107000 | 6.93e-01 |
| Formation of the ternary complex, and subsequently, the 43S complex | 44 | 4.91e-01 | 0.060000 | 6.93e-01 |
| TRP channels | 25 | 4.92e-01 | -0.079500 | 6.93e-01 |
| Centrosome maturation | 79 | 4.92e-01 | -0.044800 | 6.93e-01 |
| Recruitment of mitotic centrosome proteins and complexes | 79 | 4.92e-01 | -0.044800 | 6.93e-01 |
| rRNA processing | 187 | 4.92e-01 | 0.029200 | 6.93e-01 |
| RNA polymerase II transcribes snRNA genes | 68 | 4.92e-01 | 0.048200 | 6.93e-01 |
| Metabolism of amine-derived hormones | 17 | 4.93e-01 | -0.096100 | 6.93e-01 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | 12 | 4.93e-01 | -0.114000 | 6.93e-01 |
| Protein-protein interactions at synapses | 83 | 4.94e-01 | -0.043500 | 6.93e-01 |
| Signaling by FGFR1 in disease | 35 | 4.94e-01 | 0.066800 | 6.93e-01 |
| Nuclear signaling by ERBB4 | 29 | 4.96e-01 | 0.073100 | 6.94e-01 |
| Formation of Incision Complex in GG-NER | 42 | 4.97e-01 | 0.060600 | 6.95e-01 |
| SARS-CoV-2 Infection | 64 | 4.98e-01 | 0.049000 | 6.97e-01 |
| Regulation of PLK1 Activity at G2/M Transition | 83 | 4.99e-01 | -0.042900 | 6.97e-01 |
| HS-GAG biosynthesis | 28 | 4.99e-01 | -0.073800 | 6.97e-01 |
| Biosynthesis of specialized proresolving mediators (SPMs) | 18 | 5.01e-01 | -0.091700 | 6.98e-01 |
| Negative regulation of FGFR2 signaling | 29 | 5.03e-01 | 0.071900 | 7.00e-01 |
| DNA Replication | 122 | 5.03e-01 | 0.035100 | 7.00e-01 |
| Depolymerisation of the Nuclear Lamina | 15 | 5.05e-01 | -0.099500 | 7.02e-01 |
| Insulin receptor signalling cascade | 50 | 5.07e-01 | -0.054200 | 7.02e-01 |
| PKMTs methylate histone lysines | 43 | 5.08e-01 | -0.058300 | 7.02e-01 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | 24 | 5.08e-01 | -0.078000 | 7.02e-01 |
| A tetrasaccharide linker sequence is required for GAG synthesis | 25 | 5.09e-01 | -0.076300 | 7.02e-01 |
| Recruitment of NuMA to mitotic centrosomes | 78 | 5.10e-01 | -0.043200 | 7.02e-01 |
| Misspliced GSK3beta mutants stabilize beta-catenin | 14 | 5.10e-01 | 0.102000 | 7.02e-01 |
| S33 mutants of beta-catenin aren't phosphorylated | 14 | 5.10e-01 | 0.102000 | 7.02e-01 |
| S37 mutants of beta-catenin aren't phosphorylated | 14 | 5.10e-01 | 0.102000 | 7.02e-01 |
| S45 mutants of beta-catenin aren't phosphorylated | 14 | 5.10e-01 | 0.102000 | 7.02e-01 |
| T41 mutants of beta-catenin aren't phosphorylated | 14 | 5.10e-01 | 0.102000 | 7.02e-01 |
| phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex | 14 | 5.10e-01 | 0.102000 | 7.02e-01 |
| ROS and RNS production in phagocytes | 34 | 5.11e-01 | 0.065200 | 7.02e-01 |
| Interactions of Vpr with host cellular proteins | 34 | 5.12e-01 | -0.065100 | 7.02e-01 |
| SUMOylation of RNA binding proteins | 45 | 5.12e-01 | -0.056500 | 7.02e-01 |
| Signaling by Hippo | 20 | 5.14e-01 | -0.084300 | 7.04e-01 |
| Interleukin-2 family signaling | 41 | 5.15e-01 | 0.058800 | 7.05e-01 |
| Downstream signaling of activated FGFR3 | 23 | 5.16e-01 | -0.078300 | 7.05e-01 |
| Synthesis of PIPs at the early endosome membrane | 16 | 5.16e-01 | 0.093900 | 7.05e-01 |
| Voltage gated Potassium channels | 41 | 5.18e-01 | -0.058400 | 7.06e-01 |
| Signal attenuation | 10 | 5.18e-01 | -0.118000 | 7.06e-01 |
| Diseases of DNA repair | 10 | 5.18e-01 | -0.118000 | 7.06e-01 |
| Signaling by FGFR2 in disease | 38 | 5.21e-01 | 0.060100 | 7.10e-01 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | 42 | 5.24e-01 | 0.056900 | 7.12e-01 |
| Zinc transporters | 17 | 5.25e-01 | -0.089100 | 7.13e-01 |
| FRS-mediated FGFR1 signaling | 20 | 5.25e-01 | -0.082100 | 7.13e-01 |
| Diseases associated with the TLR signaling cascade | 20 | 5.27e-01 | -0.081800 | 7.13e-01 |
| Diseases of Immune System | 20 | 5.27e-01 | -0.081800 | 7.13e-01 |
| Postmitotic nuclear pore complex (NPC) reformation | 26 | 5.27e-01 | -0.071700 | 7.13e-01 |
| Cytochrome c-mediated apoptotic response | 12 | 5.30e-01 | 0.105000 | 7.17e-01 |
| Interleukin-4 and Interleukin-13 signaling | 101 | 5.34e-01 | -0.035800 | 7.22e-01 |
| Signaling by ERBB2 KD Mutants | 23 | 5.35e-01 | -0.074700 | 7.23e-01 |
| Glucagon signaling in metabolic regulation | 31 | 5.37e-01 | -0.064100 | 7.24e-01 |
| Signaling by WNT | 271 | 5.39e-01 | 0.021700 | 7.25e-01 |
| Activation of Ca-permeable Kainate Receptor | 10 | 5.39e-01 | 0.112000 | 7.25e-01 |
| Ionotropic activity of kainate receptors | 10 | 5.39e-01 | 0.112000 | 7.25e-01 |
| Cardiac conduction | 117 | 5.40e-01 | 0.032800 | 7.26e-01 |
| MET promotes cell motility | 29 | 5.45e-01 | -0.064900 | 7.32e-01 |
| VxPx cargo-targeting to cilium | 21 | 5.46e-01 | -0.076000 | 7.33e-01 |
| Frs2-mediated activation | 12 | 5.47e-01 | 0.100000 | 7.34e-01 |
| Nuclear Events (kinase and transcription factor activation) | 57 | 5.51e-01 | 0.045700 | 7.38e-01 |
| Regulation of lipid metabolism by PPARalpha | 116 | 5.53e-01 | 0.031900 | 7.39e-01 |
| Activated point mutants of FGFR2 | 14 | 5.53e-01 | 0.091600 | 7.39e-01 |
| Signaling by MET | 66 | 5.53e-01 | 0.042200 | 7.39e-01 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | 14 | 5.55e-01 | 0.091000 | 7.40e-01 |
| Innate Immune System | 947 | 5.56e-01 | 0.011400 | 7.40e-01 |
| Eukaryotic Translation Elongation | 70 | 5.57e-01 | 0.040600 | 7.41e-01 |
| Influenza Viral RNA Transcription and Replication | 109 | 5.57e-01 | 0.032600 | 7.41e-01 |
| PPARA activates gene expression | 114 | 5.58e-01 | 0.031700 | 7.42e-01 |
| Trafficking and processing of endosomal TLR | 12 | 5.60e-01 | 0.097300 | 7.43e-01 |
| Signalling to RAS | 19 | 5.62e-01 | 0.076900 | 7.45e-01 |
| SLC transporter disorders | 95 | 5.62e-01 | -0.034400 | 7.45e-01 |
| Caspase activation via extrinsic apoptotic signalling pathway | 21 | 5.63e-01 | -0.072900 | 7.45e-01 |
| FOXO-mediated transcription | 64 | 5.64e-01 | 0.041700 | 7.47e-01 |
| Reduction of cytosolic Ca++ levels | 12 | 5.69e-01 | 0.094900 | 7.52e-01 |
| FGFR1 ligand binding and activation | 12 | 5.70e-01 | -0.094700 | 7.52e-01 |
| PKA activation | 16 | 5.70e-01 | 0.082000 | 7.52e-01 |
| Epigenetic regulation of gene expression | 94 | 5.70e-01 | 0.033900 | 7.52e-01 |
| The NLRP3 inflammasome | 15 | 5.72e-01 | 0.084300 | 7.53e-01 |
| Downregulation of ERBB2 signaling | 26 | 5.72e-01 | 0.064000 | 7.53e-01 |
| Sodium/Calcium exchangers | 11 | 5.73e-01 | 0.098200 | 7.53e-01 |
| Prefoldin mediated transfer of substrate to CCT/TriC | 25 | 5.73e-01 | 0.065100 | 7.53e-01 |
| The role of Nef in HIV-1 replication and disease pathogenesis | 27 | 5.74e-01 | 0.062500 | 7.53e-01 |
| SUMOylation of immune response proteins | 10 | 5.77e-01 | 0.102000 | 7.55e-01 |
| Signaling by the B Cell Receptor (BCR) | 133 | 5.77e-01 | 0.028000 | 7.55e-01 |
| Nuclear Receptor transcription pathway | 53 | 5.78e-01 | -0.044200 | 7.55e-01 |
| Rev-mediated nuclear export of HIV RNA | 34 | 5.78e-01 | -0.055200 | 7.55e-01 |
| PI3K events in ERBB4 signaling | 10 | 5.80e-01 | 0.101000 | 7.57e-01 |
| Activation of BAD and translocation to mitochondria | 15 | 5.80e-01 | 0.082400 | 7.57e-01 |
| Signal transduction by L1 | 21 | 5.81e-01 | 0.069600 | 7.57e-01 |
| Deactivation of the beta-catenin transactivating complex | 39 | 5.81e-01 | -0.051000 | 7.57e-01 |
| Sialic acid metabolism | 31 | 5.82e-01 | 0.057200 | 7.57e-01 |
| CD28 dependent PI3K/Akt signaling | 22 | 5.84e-01 | 0.067500 | 7.59e-01 |
| G-protein mediated events | 51 | 5.84e-01 | -0.044300 | 7.59e-01 |
| Oncogene Induced Senescence | 30 | 5.86e-01 | -0.057400 | 7.61e-01 |
| Prolonged ERK activation events | 14 | 5.87e-01 | 0.083900 | 7.61e-01 |
| ERBB2 Activates PTK6 Signaling | 13 | 5.88e-01 | -0.086900 | 7.61e-01 |
| Incretin synthesis, secretion, and inactivation | 20 | 5.88e-01 | 0.070000 | 7.61e-01 |
| Pentose phosphate pathway | 14 | 5.88e-01 | 0.083600 | 7.61e-01 |
| NS1 Mediated Effects on Host Pathways | 40 | 5.90e-01 | -0.049300 | 7.62e-01 |
| Transport of inorganic cations/anions and amino acids/oligopeptides | 103 | 5.93e-01 | -0.030500 | 7.65e-01 |
| Circadian Clock | 68 | 5.93e-01 | 0.037500 | 7.65e-01 |
| ERKs are inactivated | 12 | 5.94e-01 | 0.088900 | 7.66e-01 |
| Processing of Capped Intronless Pre-mRNA | 26 | 5.96e-01 | 0.060000 | 7.68e-01 |
| Signaling by NOTCH1 | 69 | 6.02e-01 | 0.036300 | 7.75e-01 |
| Adenylate cyclase inhibitory pathway | 14 | 6.03e-01 | -0.080400 | 7.75e-01 |
| Costimulation by the CD28 family | 64 | 6.03e-01 | 0.037600 | 7.75e-01 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | 13 | 6.05e-01 | 0.082900 | 7.75e-01 |
| ADORA2B mediated anti-inflammatory cytokines production | 113 | 6.05e-01 | -0.028200 | 7.75e-01 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | 78 | 6.06e-01 | 0.033800 | 7.75e-01 |
| Killing mechanisms | 12 | 6.06e-01 | 0.085900 | 7.75e-01 |
| WNT5:FZD7-mediated leishmania damping | 12 | 6.06e-01 | 0.085900 | 7.75e-01 |
| Positive epigenetic regulation of rRNA expression | 52 | 6.07e-01 | 0.041300 | 7.75e-01 |
| Cell junction organization | 85 | 6.07e-01 | -0.032300 | 7.75e-01 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | 10 | 6.07e-01 | 0.093800 | 7.75e-01 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | 10 | 6.08e-01 | -0.093600 | 7.75e-01 |
| PI-3K cascade:FGFR1 | 18 | 6.09e-01 | -0.069700 | 7.75e-01 |
| SHC-mediated cascade:FGFR1 | 18 | 6.11e-01 | -0.069200 | 7.78e-01 |
| Disease | 1431 | 6.12e-01 | 0.008070 | 7.78e-01 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | 31 | 6.15e-01 | -0.052100 | 7.81e-01 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | 30 | 6.17e-01 | -0.052800 | 7.83e-01 |
| Negative regulation of MET activity | 20 | 6.18e-01 | 0.064500 | 7.83e-01 |
| Negative regulation of FGFR4 signaling | 26 | 6.19e-01 | 0.056400 | 7.83e-01 |
| PKA-mediated phosphorylation of CREB | 18 | 6.23e-01 | 0.066900 | 7.89e-01 |
| Selenoamino acid metabolism | 92 | 6.25e-01 | 0.029500 | 7.90e-01 |
| Signaling by ERBB4 | 53 | 6.26e-01 | 0.038700 | 7.91e-01 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | 30 | 6.28e-01 | 0.051100 | 7.93e-01 |
| mRNA decay by 5' to 3' exoribonuclease | 15 | 6.30e-01 | -0.071800 | 7.95e-01 |
| Signaling by NODAL | 18 | 6.32e-01 | -0.065200 | 7.96e-01 |
| SHC1 events in ERBB2 signaling | 22 | 6.33e-01 | -0.058700 | 7.96e-01 |
| Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) | 11 | 6.34e-01 | 0.083000 | 7.96e-01 |
| Death Receptor Signalling | 132 | 6.34e-01 | -0.024000 | 7.96e-01 |
| DAG and IP3 signaling | 38 | 6.34e-01 | -0.044600 | 7.96e-01 |
| Kinesins | 40 | 6.36e-01 | -0.043300 | 7.96e-01 |
| Blood group systems biosynthesis | 18 | 6.38e-01 | 0.064100 | 7.96e-01 |
| Eicosanoid ligand-binding receptors | 13 | 6.39e-01 | 0.075000 | 7.96e-01 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | 49 | 6.39e-01 | -0.038700 | 7.96e-01 |
| PI3K events in ERBB2 signaling | 16 | 6.40e-01 | -0.067500 | 7.96e-01 |
| Triglyceride metabolism | 35 | 6.40e-01 | 0.045600 | 7.96e-01 |
| ERK/MAPK targets | 21 | 6.41e-01 | 0.058700 | 7.96e-01 |
| AMER1 mutants destabilize the destruction complex | 13 | 6.41e-01 | 0.074600 | 7.96e-01 |
| APC truncation mutants have impaired AXIN binding | 13 | 6.41e-01 | 0.074600 | 7.96e-01 |
| AXIN missense mutants destabilize the destruction complex | 13 | 6.41e-01 | 0.074600 | 7.96e-01 |
| AXIN mutants destabilize the destruction complex, activating WNT signaling | 13 | 6.41e-01 | 0.074600 | 7.96e-01 |
| Truncations of AMER1 destabilize the destruction complex | 13 | 6.41e-01 | 0.074600 | 7.96e-01 |
| truncated APC mutants destabilize the destruction complex | 13 | 6.41e-01 | 0.074600 | 7.96e-01 |
| Signaling by NOTCH3 | 44 | 6.45e-01 | 0.040100 | 8.00e-01 |
| NGF-stimulated transcription | 36 | 6.47e-01 | 0.044100 | 8.02e-01 |
| Response to elevated platelet cytosolic Ca2+ | 128 | 6.48e-01 | -0.023400 | 8.02e-01 |
| SHC-mediated cascade:FGFR2 | 20 | 6.49e-01 | 0.058800 | 8.03e-01 |
| Synthesis of PA | 38 | 6.50e-01 | -0.042600 | 8.03e-01 |
| Signaling by KIT in disease | 20 | 6.52e-01 | 0.058300 | 8.03e-01 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | 20 | 6.52e-01 | 0.058300 | 8.03e-01 |
| G1/S Transition | 127 | 6.52e-01 | 0.023200 | 8.03e-01 |
| PI-3K cascade:FGFR2 | 20 | 6.52e-01 | 0.058300 | 8.03e-01 |
| Class C/3 (Metabotropic glutamate/pheromone receptors) | 30 | 6.52e-01 | -0.047600 | 8.03e-01 |
| Alpha-protein kinase 1 signaling pathway | 10 | 6.55e-01 | 0.081600 | 8.05e-01 |
| Peptide hormone biosynthesis | 10 | 6.55e-01 | 0.081600 | 8.05e-01 |
| Glutathione synthesis and recycling | 12 | 6.57e-01 | 0.074100 | 8.06e-01 |
| Golgi Cisternae Pericentriolar Stack Reorganization | 12 | 6.58e-01 | 0.073800 | 8.07e-01 |
| FGFR2c ligand binding and activation | 11 | 6.58e-01 | 0.077000 | 8.07e-01 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | 26 | 6.60e-01 | -0.049800 | 8.07e-01 |
| Assembly of active LPL and LIPC lipase complexes | 19 | 6.60e-01 | -0.058200 | 8.07e-01 |
| Major pathway of rRNA processing in the nucleolus and cytosol | 157 | 6.61e-01 | -0.020300 | 8.07e-01 |
| NOTCH4 Intracellular Domain Regulates Transcription | 18 | 6.61e-01 | -0.059600 | 8.07e-01 |
| LGI-ADAM interactions | 13 | 6.62e-01 | 0.070100 | 8.07e-01 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | 43 | 6.62e-01 | 0.038500 | 8.07e-01 |
| Dopamine Neurotransmitter Release Cycle | 23 | 6.67e-01 | 0.051800 | 8.13e-01 |
| Regulation of TP53 Activity | 149 | 6.68e-01 | -0.020400 | 8.13e-01 |
| Mitotic Metaphase and Anaphase | 218 | 6.69e-01 | 0.016800 | 8.14e-01 |
| CTLA4 inhibitory signaling | 21 | 6.70e-01 | 0.053700 | 8.14e-01 |
| Gap junction assembly | 16 | 6.70e-01 | -0.061500 | 8.14e-01 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | 13 | 6.73e-01 | 0.067700 | 8.16e-01 |
| Regulation of beta-cell development | 36 | 6.79e-01 | -0.039800 | 8.22e-01 |
| RIPK1-mediated regulated necrosis | 24 | 6.80e-01 | -0.048700 | 8.22e-01 |
| Regulated Necrosis | 24 | 6.80e-01 | -0.048700 | 8.22e-01 |
| Regulation of necroptotic cell death | 24 | 6.80e-01 | -0.048700 | 8.22e-01 |
| Removal of aminoterminal propeptides from gamma-carboxylated proteins | 10 | 6.82e-01 | 0.074700 | 8.24e-01 |
| Phospholipase C-mediated cascade; FGFR2 | 15 | 6.83e-01 | 0.061000 | 8.24e-01 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | 71 | 6.83e-01 | 0.028000 | 8.24e-01 |
| Signaling by FGFR3 | 36 | 6.84e-01 | -0.039200 | 8.24e-01 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | 13 | 6.84e-01 | -0.065100 | 8.24e-01 |
| Downstream signaling of activated FGFR4 | 24 | 6.87e-01 | -0.047500 | 8.26e-01 |
| Metabolic disorders of biological oxidation enzymes | 32 | 6.88e-01 | -0.041000 | 8.26e-01 |
| ERBB2 Regulates Cell Motility | 15 | 6.88e-01 | -0.059800 | 8.26e-01 |
| Reversible hydration of carbon dioxide | 12 | 6.89e-01 | -0.066800 | 8.26e-01 |
| Scavenging by Class A Receptors | 17 | 6.90e-01 | -0.056000 | 8.27e-01 |
| Lewis blood group biosynthesis | 14 | 6.93e-01 | 0.060900 | 8.29e-01 |
| Mitotic Anaphase | 217 | 6.93e-01 | 0.015600 | 8.29e-01 |
| Synthesis of bile acids and bile salts via 24-hydroxycholesterol | 10 | 6.93e-01 | 0.072000 | 8.29e-01 |
| Neurotransmitter release cycle | 48 | 6.94e-01 | 0.032900 | 8.29e-01 |
| Signaling by Receptor Tyrosine Kinases | 458 | 6.96e-01 | -0.010700 | 8.31e-01 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | 19 | 6.99e-01 | 0.051300 | 8.33e-01 |
| Neurodegenerative Diseases | 19 | 6.99e-01 | 0.051300 | 8.33e-01 |
| Protein folding | 95 | 7.02e-01 | 0.022700 | 8.34e-01 |
| Signaling by PDGFRA extracellular domain mutants | 12 | 7.02e-01 | 0.063800 | 8.34e-01 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | 12 | 7.02e-01 | 0.063800 | 8.34e-01 |
| M Phase | 346 | 7.02e-01 | -0.012000 | 8.34e-01 |
| CRMPs in Sema3A signaling | 16 | 7.03e-01 | -0.055000 | 8.35e-01 |
| PLC beta mediated events | 50 | 7.05e-01 | -0.030900 | 8.36e-01 |
| Triglyceride catabolism | 22 | 7.06e-01 | 0.046500 | 8.36e-01 |
| Defects in cobalamin (B12) metabolism | 14 | 7.09e-01 | 0.057700 | 8.39e-01 |
| SHC1 events in ERBB4 signaling | 14 | 7.11e-01 | 0.057200 | 8.41e-01 |
| Receptor-type tyrosine-protein phosphatases | 18 | 7.11e-01 | 0.050400 | 8.41e-01 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | 41 | 7.14e-01 | -0.033100 | 8.44e-01 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | 22 | 7.16e-01 | 0.044900 | 8.45e-01 |
| FGFR2 alternative splicing | 22 | 7.19e-01 | -0.044400 | 8.47e-01 |
| Diseases of programmed cell death | 25 | 7.19e-01 | 0.041600 | 8.47e-01 |
| Signaling by ERBB2 TMD/JMD mutants | 20 | 7.21e-01 | -0.046100 | 8.49e-01 |
| TICAM1, RIP1-mediated IKK complex recruitment | 16 | 7.22e-01 | 0.051400 | 8.49e-01 |
| Regulation of FZD by ubiquitination | 19 | 7.24e-01 | 0.046900 | 8.51e-01 |
| IGF1R signaling cascade | 48 | 7.24e-01 | -0.029400 | 8.51e-01 |
| Maturation of nucleoprotein | 10 | 7.25e-01 | 0.064300 | 8.51e-01 |
| rRNA processing in the nucleus and cytosol | 166 | 7.25e-01 | -0.015800 | 8.51e-01 |
| Signaling by PDGFR in disease | 19 | 7.27e-01 | 0.046300 | 8.52e-01 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | 17 | 7.27e-01 | -0.048800 | 8.52e-01 |
| Vitamin D (calciferol) metabolism | 11 | 7.29e-01 | -0.060400 | 8.52e-01 |
| FGFR4 ligand binding and activation | 11 | 7.29e-01 | 0.060400 | 8.52e-01 |
| DNA Damage Bypass | 44 | 7.32e-01 | 0.029900 | 8.55e-01 |
| MASTL Facilitates Mitotic Progression | 10 | 7.32e-01 | 0.062500 | 8.55e-01 |
| IRS-mediated signalling | 44 | 7.33e-01 | -0.029700 | 8.55e-01 |
| Platelet calcium homeostasis | 28 | 7.34e-01 | -0.037100 | 8.55e-01 |
| IKK complex recruitment mediated by RIP1 | 18 | 7.35e-01 | 0.046200 | 8.55e-01 |
| Platelet homeostasis | 82 | 7.36e-01 | -0.021600 | 8.56e-01 |
| Carboxyterminal post-translational modifications of tubulin | 33 | 7.37e-01 | 0.033700 | 8.57e-01 |
| RUNX2 regulates osteoblast differentiation | 24 | 7.39e-01 | 0.039300 | 8.57e-01 |
| Viral mRNA Translation | 66 | 7.39e-01 | 0.023700 | 8.57e-01 |
| Smooth Muscle Contraction | 32 | 7.40e-01 | 0.033900 | 8.57e-01 |
| Constitutive Signaling by EGFRvIII | 14 | 7.40e-01 | -0.051200 | 8.57e-01 |
| Signaling by EGFRvIII in Cancer | 14 | 7.40e-01 | -0.051200 | 8.57e-01 |
| Plasma lipoprotein assembly, remodeling, and clearance | 68 | 7.42e-01 | -0.023100 | 8.59e-01 |
| Clathrin-mediated endocytosis | 138 | 7.46e-01 | 0.016000 | 8.62e-01 |
| IRS-related events triggered by IGF1R | 47 | 7.47e-01 | -0.027200 | 8.62e-01 |
| BMAL1:CLOCK,NPAS2 activates circadian gene expression | 27 | 7.47e-01 | -0.035900 | 8.62e-01 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | 13 | 7.48e-01 | 0.051400 | 8.63e-01 |
| Pre-NOTCH Processing in Golgi | 18 | 7.49e-01 | -0.043500 | 8.63e-01 |
| Estrogen-dependent gene expression | 96 | 7.51e-01 | 0.018800 | 8.64e-01 |
| Oncogenic MAPK signaling | 78 | 7.51e-01 | -0.020800 | 8.64e-01 |
| Signaling by NTRK3 (TRKC) | 17 | 7.53e-01 | 0.044000 | 8.66e-01 |
| Cell-extracellular matrix interactions | 16 | 7.55e-01 | 0.045100 | 8.67e-01 |
| Synthesis of bile acids and bile salts | 29 | 7.56e-01 | 0.033400 | 8.67e-01 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | 10 | 7.57e-01 | 0.056600 | 8.68e-01 |
| Transport of Mature mRNA Derived from an Intronless Transcript | 40 | 7.57e-01 | -0.028200 | 8.68e-01 |
| Transcriptional regulation of white adipocyte differentiation | 81 | 7.60e-01 | -0.019700 | 8.70e-01 |
| Termination of translesion DNA synthesis | 30 | 7.61e-01 | -0.032200 | 8.70e-01 |
| EGFR downregulation | 30 | 7.61e-01 | -0.032100 | 8.70e-01 |
| Post-chaperonin tubulin folding pathway | 18 | 7.63e-01 | -0.041100 | 8.71e-01 |
| Regulation of MECP2 expression and activity | 29 | 7.67e-01 | 0.031900 | 8.75e-01 |
| MET activates RAS signaling | 11 | 7.69e-01 | -0.051200 | 8.75e-01 |
| Signaling by FGFR4 | 36 | 7.69e-01 | -0.028200 | 8.75e-01 |
| Translocation of ZAP-70 to Immunological synapse | 14 | 7.70e-01 | 0.045200 | 8.75e-01 |
| CS/DS degradation | 14 | 7.71e-01 | -0.044900 | 8.75e-01 |
| GP1b-IX-V activation signalling | 10 | 7.71e-01 | -0.053100 | 8.75e-01 |
| Signaling by WNT in cancer | 33 | 7.72e-01 | -0.029100 | 8.75e-01 |
| Metabolism of nitric oxide: NOS3 activation and regulation | 14 | 7.72e-01 | 0.044700 | 8.75e-01 |
| Phase 2 - plateau phase | 15 | 7.73e-01 | -0.043000 | 8.75e-01 |
| Mismatch Repair | 14 | 7.73e-01 | 0.044500 | 8.75e-01 |
| Defensins | 21 | 7.74e-01 | 0.036300 | 8.75e-01 |
| FRS-mediated FGFR2 signaling | 22 | 7.74e-01 | 0.035400 | 8.75e-01 |
| Activated NTRK2 signals through FRS2 and FRS3 | 11 | 7.74e-01 | 0.049900 | 8.75e-01 |
| Signaling by ERBB2 | 47 | 7.76e-01 | -0.024000 | 8.76e-01 |
| Insulin processing | 27 | 7.78e-01 | -0.031300 | 8.78e-01 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | 19 | 7.79e-01 | 0.037100 | 8.79e-01 |
| Negative regulation of FGFR3 signaling | 25 | 7.81e-01 | 0.032200 | 8.80e-01 |
| Chaperonin-mediated protein folding | 89 | 7.82e-01 | 0.017000 | 8.81e-01 |
| Triglyceride biosynthesis | 13 | 7.84e-01 | 0.044000 | 8.82e-01 |
| Gap junction trafficking and regulation | 26 | 7.84e-01 | -0.031000 | 8.82e-01 |
| Eukaryotic Translation Termination | 70 | 7.85e-01 | 0.018900 | 8.82e-01 |
| Synthesis of PC | 27 | 7.87e-01 | -0.030100 | 8.83e-01 |
| Acyl chain remodelling of PG | 17 | 7.87e-01 | 0.037800 | 8.83e-01 |
| EPH-ephrin mediated repulsion of cells | 48 | 7.88e-01 | 0.022400 | 8.83e-01 |
| Caspase activation via Dependence Receptors in the absence of ligand | 10 | 7.91e-01 | 0.048500 | 8.85e-01 |
| P2Y receptors | 11 | 7.91e-01 | -0.046000 | 8.86e-01 |
| Transcriptional regulation of pluripotent stem cells | 28 | 7.93e-01 | 0.028700 | 8.86e-01 |
| Formation of the cornified envelope | 35 | 7.94e-01 | 0.025600 | 8.87e-01 |
| Sema4D in semaphorin signaling | 24 | 7.98e-01 | -0.030200 | 8.91e-01 |
| Downregulation of ERBB2:ERBB3 signaling | 12 | 7.99e-01 | 0.042400 | 8.92e-01 |
| Interleukin-2 signaling | 12 | 8.00e-01 | -0.042300 | 8.92e-01 |
| BBSome-mediated cargo-targeting to cilium | 22 | 8.01e-01 | 0.031100 | 8.92e-01 |
| Chromatin modifying enzymes | 208 | 8.02e-01 | 0.010100 | 8.92e-01 |
| Chromatin organization | 208 | 8.02e-01 | 0.010100 | 8.92e-01 |
| Regulation of gene expression by Hypoxia-inducible Factor | 11 | 8.04e-01 | 0.043200 | 8.93e-01 |
| Integrin signaling | 27 | 8.06e-01 | -0.027300 | 8.95e-01 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | 12 | 8.09e-01 | 0.040400 | 8.97e-01 |
| RUNX3 regulates NOTCH signaling | 12 | 8.10e-01 | -0.040100 | 8.98e-01 |
| Inflammasomes | 20 | 8.12e-01 | 0.030700 | 8.99e-01 |
| Regulated proteolysis of p75NTR | 11 | 8.13e-01 | 0.041300 | 8.99e-01 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | 22 | 8.13e-01 | 0.029200 | 8.99e-01 |
| Signaling by EGFR | 49 | 8.14e-01 | -0.019400 | 9.00e-01 |
| SHC-mediated cascade:FGFR4 | 17 | 8.15e-01 | 0.032700 | 9.01e-01 |
| Peptide hormone metabolism | 81 | 8.17e-01 | -0.014900 | 9.02e-01 |
| PI-3K cascade:FGFR4 | 17 | 8.19e-01 | 0.032100 | 9.02e-01 |
| Translesion synthesis by POLI | 16 | 8.19e-01 | 0.033100 | 9.02e-01 |
| Nuclear Envelope (NE) Reassembly | 64 | 8.20e-01 | 0.016500 | 9.03e-01 |
| PECAM1 interactions | 11 | 8.22e-01 | -0.039300 | 9.04e-01 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | 29 | 8.26e-01 | 0.023600 | 9.08e-01 |
| Synaptic adhesion-like molecules | 21 | 8.28e-01 | -0.027300 | 9.10e-01 |
| Antimicrobial peptides | 47 | 8.30e-01 | 0.018100 | 9.11e-01 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | 10 | 8.31e-01 | 0.039100 | 9.11e-01 |
| RHO GTPases activate IQGAPs | 11 | 8.32e-01 | 0.037000 | 9.12e-01 |
| Fatty acyl-CoA biosynthesis | 35 | 8.33e-01 | 0.020600 | 9.13e-01 |
| FRS-mediated FGFR3 signaling | 18 | 8.37e-01 | -0.028000 | 9.15e-01 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | 35 | 8.38e-01 | 0.020000 | 9.15e-01 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | 23 | 8.39e-01 | 0.024500 | 9.15e-01 |
| NOTCH2 intracellular domain regulates transcription | 10 | 8.39e-01 | -0.037100 | 9.15e-01 |
| Translesion Synthesis by POLH | 16 | 8.39e-01 | 0.029300 | 9.15e-01 |
| ATF4 activates genes in response to endoplasmic reticulum stress | 26 | 8.41e-01 | -0.022800 | 9.15e-01 |
| Degradation of cysteine and homocysteine | 11 | 8.41e-01 | 0.035000 | 9.15e-01 |
| Fanconi Anemia Pathway | 35 | 8.42e-01 | -0.019500 | 9.15e-01 |
| COPI-dependent Golgi-to-ER retrograde traffic | 79 | 8.42e-01 | 0.012900 | 9.15e-01 |
| Platelet degranulation | 123 | 8.42e-01 | -0.010400 | 9.15e-01 |
| Purine catabolism | 17 | 8.44e-01 | 0.027600 | 9.15e-01 |
| Regulation of TP53 Activity through Association with Co-factors | 13 | 8.44e-01 | -0.031600 | 9.15e-01 |
| PCNA-Dependent Long Patch Base Excision Repair | 20 | 8.44e-01 | -0.025500 | 9.15e-01 |
| PI3K Cascade | 40 | 8.44e-01 | -0.018000 | 9.15e-01 |
| Selenocysteine synthesis | 69 | 8.45e-01 | -0.013600 | 9.15e-01 |
| Oxidative Stress Induced Senescence | 69 | 8.46e-01 | 0.013500 | 9.16e-01 |
| Generation of second messenger molecules | 28 | 8.48e-01 | 0.020900 | 9.16e-01 |
| Phospholipase C-mediated cascade; FGFR3 | 11 | 8.48e-01 | -0.033300 | 9.16e-01 |
| Factors involved in megakaryocyte development and platelet production | 124 | 8.49e-01 | -0.009940 | 9.16e-01 |
| Myogenesis | 28 | 8.49e-01 | -0.020800 | 9.16e-01 |
| MET activates PTK2 signaling | 18 | 8.52e-01 | -0.025500 | 9.18e-01 |
| Laminin interactions | 23 | 8.57e-01 | -0.021800 | 9.21e-01 |
| Metabolism of non-coding RNA | 51 | 8.57e-01 | 0.014600 | 9.21e-01 |
| snRNP Assembly | 51 | 8.57e-01 | 0.014600 | 9.21e-01 |
| Recognition of DNA damage by PCNA-containing replication complex | 28 | 8.58e-01 | 0.019600 | 9.21e-01 |
| E3 ubiquitin ligases ubiquitinate target proteins | 46 | 8.58e-01 | -0.015300 | 9.21e-01 |
| Beta-catenin phosphorylation cascade | 16 | 8.61e-01 | 0.025200 | 9.23e-01 |
| Phosphorylation of CD3 and TCR zeta chains | 17 | 8.62e-01 | 0.024400 | 9.23e-01 |
| Downstream signaling of activated FGFR2 | 27 | 8.62e-01 | -0.019300 | 9.23e-01 |
| Disorders of Developmental Biology | 13 | 8.64e-01 | -0.027400 | 9.23e-01 |
| Disorders of Nervous System Development | 13 | 8.64e-01 | -0.027400 | 9.23e-01 |
| Loss of function of MECP2 in Rett syndrome | 13 | 8.64e-01 | -0.027400 | 9.23e-01 |
| Pervasive developmental disorders | 13 | 8.64e-01 | -0.027400 | 9.23e-01 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | 10 | 8.66e-01 | 0.030700 | 9.25e-01 |
| Deadenylation of mRNA | 20 | 8.67e-01 | 0.021600 | 9.25e-01 |
| Processing of Intronless Pre-mRNAs | 18 | 8.72e-01 | 0.022000 | 9.30e-01 |
| Recycling pathway of L1 | 27 | 8.73e-01 | 0.017800 | 9.30e-01 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | 90 | 8.75e-01 | 0.009570 | 9.31e-01 |
| Nonsense-Mediated Decay (NMD) | 90 | 8.75e-01 | 0.009570 | 9.31e-01 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | 27 | 8.76e-01 | 0.017400 | 9.31e-01 |
| Signaling by FGFR2 | 62 | 8.78e-01 | -0.011300 | 9.33e-01 |
| SRP-dependent cotranslational protein targeting to membrane | 89 | 8.80e-01 | -0.009230 | 9.35e-01 |
| Synthesis of very long-chain fatty acyl-CoAs | 24 | 8.82e-01 | -0.017500 | 9.35e-01 |
| Phospholipase C-mediated cascade; FGFR4 | 12 | 8.82e-01 | 0.024700 | 9.35e-01 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | 41 | 8.83e-01 | -0.013200 | 9.36e-01 |
| Platelet Adhesion to exposed collagen | 13 | 8.84e-01 | -0.023400 | 9.36e-01 |
| Signaling by Insulin receptor | 73 | 8.87e-01 | 0.009580 | 9.38e-01 |
| FGFR3 ligand binding and activation | 11 | 8.88e-01 | 0.024500 | 9.38e-01 |
| FGFR3c ligand binding and activation | 11 | 8.88e-01 | 0.024500 | 9.38e-01 |
| Platelet Aggregation (Plug Formation) | 37 | 8.89e-01 | -0.013300 | 9.38e-01 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | 17 | 8.91e-01 | 0.019200 | 9.38e-01 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | 17 | 8.91e-01 | 0.019200 | 9.38e-01 |
| Cargo trafficking to the periciliary membrane | 49 | 8.91e-01 | -0.011300 | 9.38e-01 |
| Nephrin family interactions | 21 | 8.92e-01 | -0.017200 | 9.38e-01 |
| Peptide chain elongation | 66 | 8.94e-01 | 0.009510 | 9.40e-01 |
| Keratan sulfate degradation | 12 | 8.96e-01 | -0.021800 | 9.41e-01 |
| eNOS activation | 10 | 8.97e-01 | -0.023700 | 9.42e-01 |
| Viral Messenger RNA Synthesis | 41 | 8.98e-01 | 0.011600 | 9.42e-01 |
| Interleukin-12 signaling | 40 | 8.98e-01 | 0.011700 | 9.42e-01 |
| Signaling by Nuclear Receptors | 235 | 9.01e-01 | -0.004720 | 9.44e-01 |
| Initiation of Nuclear Envelope (NE) Reformation | 16 | 9.04e-01 | 0.017400 | 9.47e-01 |
| NOTCH1 Intracellular Domain Regulates Transcription | 43 | 9.05e-01 | -0.010600 | 9.47e-01 |
| Gamma-carboxylation, transport, and amino-terminal cleavage of proteins | 11 | 9.08e-01 | -0.020100 | 9.47e-01 |
| Mitotic G1 phase and G1/S transition | 143 | 9.09e-01 | 0.005550 | 9.47e-01 |
| Signaling by BRAF and RAF fusions | 61 | 9.11e-01 | 0.008320 | 9.47e-01 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | 42 | 9.11e-01 | 0.010000 | 9.47e-01 |
| Signaling by RAS mutants | 42 | 9.11e-01 | 0.010000 | 9.47e-01 |
| Signaling by moderate kinase activity BRAF mutants | 42 | 9.11e-01 | 0.010000 | 9.47e-01 |
| Signaling downstream of RAS mutants | 42 | 9.11e-01 | 0.010000 | 9.47e-01 |
| Vasopressin regulates renal water homeostasis via Aquaporins | 41 | 9.11e-01 | -0.010100 | 9.47e-01 |
| Negative regulation of FGFR1 signaling | 27 | 9.11e-01 | -0.012400 | 9.47e-01 |
| Regulation of IFNG signaling | 14 | 9.12e-01 | 0.017000 | 9.47e-01 |
| Axon guidance | 490 | 9.13e-01 | 0.002910 | 9.47e-01 |
| Metabolism of folate and pterines | 17 | 9.16e-01 | 0.014900 | 9.49e-01 |
| Neurotransmitter receptors and postsynaptic signal transmission | 172 | 9.16e-01 | -0.004690 | 9.49e-01 |
| Synthesis, secretion, and deacylation of Ghrelin | 18 | 9.17e-01 | -0.014100 | 9.50e-01 |
| Separation of Sister Chromatids | 165 | 9.19e-01 | 0.004570 | 9.52e-01 |
| Nervous system development | 513 | 9.20e-01 | 0.002590 | 9.52e-01 |
| Early Phase of HIV Life Cycle | 13 | 9.25e-01 | -0.015000 | 9.56e-01 |
| Acyl chain remodelling of PS | 21 | 9.29e-01 | -0.011300 | 9.59e-01 |
| Activation of BH3-only proteins | 27 | 9.29e-01 | 0.009910 | 9.59e-01 |
| RUNX2 regulates bone development | 30 | 9.32e-01 | 0.009040 | 9.61e-01 |
| Regulation of RUNX1 Expression and Activity | 23 | 9.37e-01 | -0.009580 | 9.63e-01 |
| Trafficking of GluR2-containing AMPA receptors | 17 | 9.37e-01 | -0.011100 | 9.63e-01 |
| Gamma-carboxylation of protein precursors | 10 | 9.38e-01 | -0.014300 | 9.63e-01 |
| PERK regulates gene expression | 31 | 9.38e-01 | -0.008090 | 9.63e-01 |
| CaM pathway | 32 | 9.38e-01 | 0.007950 | 9.63e-01 |
| Calmodulin induced events | 32 | 9.38e-01 | 0.007950 | 9.63e-01 |
| Aquaporin-mediated transport | 49 | 9.39e-01 | 0.006330 | 9.64e-01 |
| mRNA Splicing - Minor Pathway | 48 | 9.40e-01 | -0.006240 | 9.64e-01 |
| Translesion synthesis by POLK | 16 | 9.40e-01 | 0.010800 | 9.64e-01 |
| Interconversion of nucleotide di- and triphosphates | 28 | 9.44e-01 | -0.007740 | 9.66e-01 |
| Pyrimidine catabolism | 12 | 9.48e-01 | -0.010900 | 9.70e-01 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | 18 | 9.49e-01 | 0.008780 | 9.70e-01 |
| FRS-mediated FGFR4 signaling | 19 | 9.50e-01 | 0.008370 | 9.70e-01 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | 11 | 9.50e-01 | 0.010900 | 9.70e-01 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | 13 | 9.51e-01 | -0.009840 | 9.70e-01 |
| PI-3K cascade:FGFR3 | 16 | 9.60e-01 | -0.007270 | 9.79e-01 |
| Gap junction trafficking | 24 | 9.62e-01 | 0.005650 | 9.80e-01 |
| Cell-Cell communication | 117 | 9.63e-01 | -0.002500 | 9.80e-01 |
| SHC-mediated cascade:FGFR3 | 16 | 9.63e-01 | -0.006650 | 9.80e-01 |
| tRNA processing in the nucleus | 57 | 9.64e-01 | 0.003490 | 9.80e-01 |
| Ca-dependent events | 34 | 9.65e-01 | -0.004380 | 9.80e-01 |
| RAB geranylgeranylation | 60 | 9.66e-01 | -0.003190 | 9.81e-01 |
| Gene Silencing by RNA | 84 | 9.69e-01 | -0.002440 | 9.83e-01 |
| Protein ubiquitination | 65 | 9.69e-01 | 0.002760 | 9.83e-01 |
| Translesion synthesis by REV1 | 15 | 9.76e-01 | 0.004540 | 9.89e-01 |
| Signaling by RAF1 mutants | 38 | 9.80e-01 | -0.002370 | 9.92e-01 |
| Transmission across Chemical Synapses | 234 | 9.81e-01 | 0.000910 | 9.93e-01 |
| Opioid Signalling | 87 | 9.82e-01 | 0.001400 | 9.93e-01 |
| Diseases of metabolism | 228 | 9.84e-01 | 0.000781 | 9.94e-01 |
| Tie2 Signaling | 18 | 9.86e-01 | 0.002310 | 9.95e-01 |
| Cytosolic sulfonation of small molecules | 23 | 9.87e-01 | -0.001990 | 9.95e-01 |
| p38MAPK events | 13 | 9.87e-01 | 0.002550 | 9.95e-01 |
| RAS processing | 19 | 9.88e-01 | 0.002020 | 9.95e-01 |
| GRB2 events in ERBB2 signaling | 16 | 9.89e-01 | 0.001980 | 9.95e-01 |
| SUMOylation of transcription cofactors | 43 | 9.91e-01 | 0.001030 | 9.95e-01 |
| Regulation of gene expression in beta cells | 19 | 9.91e-01 | 0.001490 | 9.95e-01 |
| S Phase | 157 | 9.91e-01 | 0.000515 | 9.95e-01 |
| Sema4D induced cell migration and growth-cone collapse | 20 | 9.91e-01 | 0.001400 | 9.95e-01 |
| Nicotinate metabolism | 31 | 9.92e-01 | -0.001010 | 9.96e-01 |
| Phase 0 - rapid depolarisation | 30 | 9.95e-01 | 0.000603 | 9.98e-01 |
| Sulfur amino acid metabolism | 25 | 9.96e-01 | 0.000575 | 9.98e-01 |
| Apoptotic cleavage of cellular proteins | 38 | 9.98e-01 | -0.000284 | 9.99e-01 |
| FGFR3 mutant receptor activation | 10 | 9.99e-01 | 0.000147 | 9.99e-01 |
| Signaling by activated point mutants of FGFR3 | 10 | 9.99e-01 | 0.000147 | 9.99e-01 |
Mitochondrial translation elongation
| 710 | |
|---|---|
| set | Mitochondrial translation elongation |
| setSize | 85 |
| pANOVA | 6.41e-21 |
| s.dist | 0.588 |
| p.adjustANOVA | 7.06e-18 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| MRPS18B | 9007.5 |
| PTCD3 | 8917.5 |
| MRPL30 | 8739.0 |
| MRPL38 | 8381.5 |
| MRPL37 | 8373.5 |
| GFM1 | 8370.5 |
| MRPS34 | 8288.5 |
| MRPL10 | 8203.5 |
| MRPL36 | 8147.5 |
| MRPS5 | 8097.5 |
| MRPS17 | 7940.0 |
| MRPL4 | 7909.5 |
| MRPL12 | 7898.5 |
| MRPL28 | 7858.5 |
| MRPL45 | 7805.5 |
| TSFM | 7754.5 |
| MRPS15 | 7718.5 |
| MRPL1 | 7666.5 |
| MRPS30 | 7513.5 |
| MRPL9 | 7452.5 |
| GeneID | Gene Rank |
|---|---|
| MRPS18B | 9007.5 |
| PTCD3 | 8917.5 |
| MRPL30 | 8739.0 |
| MRPL38 | 8381.5 |
| MRPL37 | 8373.5 |
| GFM1 | 8370.5 |
| MRPS34 | 8288.5 |
| MRPL10 | 8203.5 |
| MRPL36 | 8147.5 |
| MRPS5 | 8097.5 |
| MRPS17 | 7940.0 |
| MRPL4 | 7909.5 |
| MRPL12 | 7898.5 |
| MRPL28 | 7858.5 |
| MRPL45 | 7805.5 |
| TSFM | 7754.5 |
| MRPS15 | 7718.5 |
| MRPL1 | 7666.5 |
| MRPS30 | 7513.5 |
| MRPL9 | 7452.5 |
| MRPL19 | 7446.5 |
| MRPL44 | 7423.5 |
| TUFM | 7412.5 |
| OXA1L | 7295.5 |
| MRPL14 | 7233.5 |
| MRPL42 | 7151.5 |
| MRPL58 | 7145.5 |
| MRPS9 | 7125.5 |
| MRPS21 | 7123.5 |
| MRPL33 | 7108.5 |
| MRPL46 | 7097.5 |
| MRPS2 | 7088.5 |
| MRPL15 | 7081.5 |
| MRPS14 | 7080.5 |
| MRPS23 | 7023.5 |
| MRPL34 | 7010.5 |
| DAP3 | 6808.5 |
| MRPL53 | 6767.5 |
| MRPL39 | 6593.5 |
| MRPL17 | 6570.5 |
| MRPL11 | 6448.5 |
| MRPL54 | 6383.5 |
| MRPS6 | 6299.5 |
| MRPL47 | 6290.5 |
| MRPS18A | 6180.5 |
| MRPL50 | 6063.5 |
| MRPS24 | 6060.5 |
| MRPL24 | 6022.5 |
| MRPL13 | 5793.5 |
| MRPL3 | 5792.5 |
| MRPS7 | 5442.5 |
| MRPL22 | 5316.5 |
| GADD45GIP1 | 5315.5 |
| MRPL49 | 5221.5 |
| MRPL55 | 5154.5 |
| MRPS26 | 5107.5 |
| MRPS11 | 5060.5 |
| MRPL2 | 4996.5 |
| MRPS12 | 4860.5 |
| MRPL35 | 4577.5 |
| MRPL20 | 4398.5 |
| MRPL52 | 4008.5 |
| MRPL32 | 3649.5 |
| MRPS27 | 3638.5 |
| MRPS31 | 3476.5 |
| MRPL40 | 3261.5 |
| MRPS18C | 3041.5 |
| ERAL1 | 2960.5 |
| MRPS10 | 2736.5 |
| MRPS22 | 2728.5 |
| MRPS33 | 2646.5 |
| CHCHD1 | 2605.5 |
| MRPL18 | 2121.5 |
| MRPS25 | 1771.5 |
| MRPL21 | 1681.5 |
| MRPL41 | 1669.5 |
| MRPL16 | 1300.5 |
| MRPL51 | 1260.5 |
| MRPL48 | 1028.5 |
| MRPL43 | -1166.5 |
| MRPS16 | -1420.5 |
| MRPL27 | -1728.5 |
| MRPS28 | -1815.5 |
| MRPS35 | -2568.5 |
| MRPS36 | -2886.5 |
Mitochondrial translation
| 709 | |
|---|---|
| set | Mitochondrial translation |
| setSize | 91 |
| pANOVA | 9.76e-21 |
| s.dist | 0.566 |
| p.adjustANOVA | 7.06e-18 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| MRPS18B | 9007.5 |
| PTCD3 | 8917.5 |
| MRPL30 | 8739.0 |
| MRPL38 | 8381.5 |
| MRPL37 | 8373.5 |
| GFM1 | 8370.5 |
| GFM2 | 8363.5 |
| MRPS34 | 8288.5 |
| MRPL10 | 8203.5 |
| MRPL36 | 8147.5 |
| MRPS5 | 8097.5 |
| MRPS17 | 7940.0 |
| MRPL4 | 7909.5 |
| MRPL12 | 7898.5 |
| MRPL28 | 7858.5 |
| MRPL45 | 7805.5 |
| TSFM | 7754.5 |
| MRPS15 | 7718.5 |
| MRPL1 | 7666.5 |
| MRPS30 | 7513.5 |
| GeneID | Gene Rank |
|---|---|
| MRPS18B | 9007.5 |
| PTCD3 | 8917.5 |
| MRPL30 | 8739.0 |
| MRPL38 | 8381.5 |
| MRPL37 | 8373.5 |
| GFM1 | 8370.5 |
| GFM2 | 8363.5 |
| MRPS34 | 8288.5 |
| MRPL10 | 8203.5 |
| MRPL36 | 8147.5 |
| MRPS5 | 8097.5 |
| MRPS17 | 7940.0 |
| MRPL4 | 7909.5 |
| MRPL12 | 7898.5 |
| MRPL28 | 7858.5 |
| MRPL45 | 7805.5 |
| TSFM | 7754.5 |
| MRPS15 | 7718.5 |
| MRPL1 | 7666.5 |
| MRPS30 | 7513.5 |
| MRPL9 | 7452.5 |
| MRPL19 | 7446.5 |
| MRPL44 | 7423.5 |
| TUFM | 7412.5 |
| OXA1L | 7295.5 |
| MRPL14 | 7233.5 |
| MRPL42 | 7151.5 |
| MRPL58 | 7145.5 |
| MRPS9 | 7125.5 |
| MRPS21 | 7123.5 |
| MRPL33 | 7108.5 |
| MRPL46 | 7097.5 |
| MRPS2 | 7088.5 |
| MRPL15 | 7081.5 |
| MRPS14 | 7080.5 |
| MRPS23 | 7023.5 |
| MRPL34 | 7010.5 |
| DAP3 | 6808.5 |
| MRPL53 | 6767.5 |
| MRPL39 | 6593.5 |
| MRPL17 | 6570.5 |
| MRPL11 | 6448.5 |
| MRPL54 | 6383.5 |
| MRPS6 | 6299.5 |
| MRPL47 | 6290.5 |
| MRPS18A | 6180.5 |
| MRPL50 | 6063.5 |
| MRPS24 | 6060.5 |
| MRPL24 | 6022.5 |
| MRPL13 | 5793.5 |
| MRPL3 | 5792.5 |
| MRPS7 | 5442.5 |
| MRPL22 | 5316.5 |
| GADD45GIP1 | 5315.5 |
| MRPL49 | 5221.5 |
| MRPL55 | 5154.5 |
| MRPS26 | 5107.5 |
| MRPS11 | 5060.5 |
| MRPL2 | 4996.5 |
| MRPS12 | 4860.5 |
| MRPL35 | 4577.5 |
| MRPL20 | 4398.5 |
| MRPL52 | 4008.5 |
| MRPL32 | 3649.5 |
| MRPS27 | 3638.5 |
| MRPS31 | 3476.5 |
| MRRF | 3438.5 |
| MRPL40 | 3261.5 |
| MRPS18C | 3041.5 |
| MTRF1L | 3028.5 |
| ERAL1 | 2960.5 |
| MTIF2 | 2857.5 |
| MRPS10 | 2736.5 |
| MRPS22 | 2728.5 |
| MRPS33 | 2646.5 |
| CHCHD1 | 2605.5 |
| MRPL18 | 2121.5 |
| MTIF3 | 2088.5 |
| MRPS25 | 1771.5 |
| MRPL21 | 1681.5 |
| MRPL41 | 1669.5 |
| MRPL16 | 1300.5 |
| MRPL51 | 1260.5 |
| MRPL48 | 1028.5 |
| MRPL43 | -1166.5 |
| MRPS16 | -1420.5 |
| MRPL27 | -1728.5 |
| MRPS28 | -1815.5 |
| MRPS35 | -2568.5 |
| MRPS36 | -2886.5 |
| MTFMT | -5744.5 |
Mitochondrial translation termination
| 712 | |
|---|---|
| set | Mitochondrial translation termination |
| setSize | 85 |
| pANOVA | 3.68e-20 |
| s.dist | 0.577 |
| p.adjustANOVA | 1.77e-17 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| MRPS18B | 9007.5 |
| PTCD3 | 8917.5 |
| MRPL30 | 8739.0 |
| MRPL38 | 8381.5 |
| MRPL37 | 8373.5 |
| GFM2 | 8363.5 |
| MRPS34 | 8288.5 |
| MRPL10 | 8203.5 |
| MRPL36 | 8147.5 |
| MRPS5 | 8097.5 |
| MRPS17 | 7940.0 |
| MRPL4 | 7909.5 |
| MRPL12 | 7898.5 |
| MRPL28 | 7858.5 |
| MRPL45 | 7805.5 |
| MRPS15 | 7718.5 |
| MRPL1 | 7666.5 |
| MRPS30 | 7513.5 |
| MRPL9 | 7452.5 |
| MRPL19 | 7446.5 |
| GeneID | Gene Rank |
|---|---|
| MRPS18B | 9007.5 |
| PTCD3 | 8917.5 |
| MRPL30 | 8739.0 |
| MRPL38 | 8381.5 |
| MRPL37 | 8373.5 |
| GFM2 | 8363.5 |
| MRPS34 | 8288.5 |
| MRPL10 | 8203.5 |
| MRPL36 | 8147.5 |
| MRPS5 | 8097.5 |
| MRPS17 | 7940.0 |
| MRPL4 | 7909.5 |
| MRPL12 | 7898.5 |
| MRPL28 | 7858.5 |
| MRPL45 | 7805.5 |
| MRPS15 | 7718.5 |
| MRPL1 | 7666.5 |
| MRPS30 | 7513.5 |
| MRPL9 | 7452.5 |
| MRPL19 | 7446.5 |
| MRPL44 | 7423.5 |
| OXA1L | 7295.5 |
| MRPL14 | 7233.5 |
| MRPL42 | 7151.5 |
| MRPL58 | 7145.5 |
| MRPS9 | 7125.5 |
| MRPS21 | 7123.5 |
| MRPL33 | 7108.5 |
| MRPL46 | 7097.5 |
| MRPS2 | 7088.5 |
| MRPL15 | 7081.5 |
| MRPS14 | 7080.5 |
| MRPS23 | 7023.5 |
| MRPL34 | 7010.5 |
| DAP3 | 6808.5 |
| MRPL53 | 6767.5 |
| MRPL39 | 6593.5 |
| MRPL17 | 6570.5 |
| MRPL11 | 6448.5 |
| MRPL54 | 6383.5 |
| MRPS6 | 6299.5 |
| MRPL47 | 6290.5 |
| MRPS18A | 6180.5 |
| MRPL50 | 6063.5 |
| MRPS24 | 6060.5 |
| MRPL24 | 6022.5 |
| MRPL13 | 5793.5 |
| MRPL3 | 5792.5 |
| MRPS7 | 5442.5 |
| MRPL22 | 5316.5 |
| GADD45GIP1 | 5315.5 |
| MRPL49 | 5221.5 |
| MRPL55 | 5154.5 |
| MRPS26 | 5107.5 |
| MRPS11 | 5060.5 |
| MRPL2 | 4996.5 |
| MRPS12 | 4860.5 |
| MRPL35 | 4577.5 |
| MRPL20 | 4398.5 |
| MRPL52 | 4008.5 |
| MRPL32 | 3649.5 |
| MRPS27 | 3638.5 |
| MRPS31 | 3476.5 |
| MRRF | 3438.5 |
| MRPL40 | 3261.5 |
| MRPS18C | 3041.5 |
| MTRF1L | 3028.5 |
| ERAL1 | 2960.5 |
| MRPS10 | 2736.5 |
| MRPS22 | 2728.5 |
| MRPS33 | 2646.5 |
| CHCHD1 | 2605.5 |
| MRPL18 | 2121.5 |
| MRPS25 | 1771.5 |
| MRPL21 | 1681.5 |
| MRPL41 | 1669.5 |
| MRPL16 | 1300.5 |
| MRPL51 | 1260.5 |
| MRPL48 | 1028.5 |
| MRPL43 | -1166.5 |
| MRPS16 | -1420.5 |
| MRPL27 | -1728.5 |
| MRPS28 | -1815.5 |
| MRPS35 | -2568.5 |
| MRPS36 | -2886.5 |
Translation
| 1343 | |
|---|---|
| set | Translation |
| setSize | 263 |
| pANOVA | 2.86e-19 |
| s.dist | 0.322 |
| p.adjustANOVA | 1.03e-16 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| MRPS18B | 9007.5 |
| PTCD3 | 8917.5 |
| VARS1 | 8908.5 |
| RPL13A | 8886.5 |
| VARS2 | 8870.5 |
| IARS2 | 8848.5 |
| NARS1 | 8747.5 |
| MRPL30 | 8739.0 |
| IARS1 | 8710.5 |
| FARS2 | 8703.5 |
| NARS2 | 8624.5 |
| RPLP2 | 8590.5 |
| EIF4G1 | 8580.5 |
| GSPT1 | 8520.5 |
| LARS2 | 8505.5 |
| MRPL38 | 8381.5 |
| MRPL37 | 8373.5 |
| GFM1 | 8370.5 |
| GFM2 | 8363.5 |
| MRPS34 | 8288.5 |
| GeneID | Gene Rank |
|---|---|
| MRPS18B | 9007.5 |
| PTCD3 | 8917.5 |
| VARS1 | 8908.5 |
| RPL13A | 8886.5 |
| VARS2 | 8870.5 |
| IARS2 | 8848.5 |
| NARS1 | 8747.5 |
| MRPL30 | 8739.0 |
| IARS1 | 8710.5 |
| FARS2 | 8703.5 |
| NARS2 | 8624.5 |
| RPLP2 | 8590.5 |
| EIF4G1 | 8580.5 |
| GSPT1 | 8520.5 |
| LARS2 | 8505.5 |
| MRPL38 | 8381.5 |
| MRPL37 | 8373.5 |
| GFM1 | 8370.5 |
| GFM2 | 8363.5 |
| MRPS34 | 8288.5 |
| MRPL10 | 8203.5 |
| SEC61G | 8169.5 |
| MRPL36 | 8147.5 |
| MRPS5 | 8097.5 |
| RPS9 | 7978.5 |
| MARS2 | 7972.5 |
| EIF2B5 | 7944.5 |
| MRPS17 | 7940.0 |
| AARS1 | 7920.5 |
| MRPL4 | 7909.5 |
| MRPL12 | 7898.5 |
| MRPL28 | 7858.5 |
| WARS1 | 7854.5 |
| MRPL45 | 7805.5 |
| EEF2 | 7789.5 |
| EPRS1 | 7782.5 |
| TSFM | 7754.5 |
| MRPS15 | 7718.5 |
| MRPL1 | 7666.5 |
| EIF4E | 7655.5 |
| EIF3K | 7589.5 |
| MRPS30 | 7513.5 |
| HARS2 | 7498.5 |
| EEF1G | 7481.5 |
| MRPL9 | 7452.5 |
| MRPL19 | 7446.5 |
| MRPL44 | 7423.5 |
| TUFM | 7412.5 |
| UBA52 | 7357.5 |
| OXA1L | 7295.5 |
| AIMP2 | 7246.5 |
| MRPL14 | 7233.5 |
| MRPL42 | 7151.5 |
| MRPL58 | 7145.5 |
| MRPS9 | 7125.5 |
| MRPS21 | 7123.5 |
| MRPL33 | 7108.5 |
| DARS2 | 7106.5 |
| MRPL46 | 7097.5 |
| MRPS2 | 7088.5 |
| MRPL15 | 7081.5 |
| MRPS14 | 7080.5 |
| EEF1A2 | 7029.5 |
| MRPS23 | 7023.5 |
| MRPL34 | 7010.5 |
| EEF1D | 6906.5 |
| DAP3 | 6808.5 |
| RPL28 | 6806.5 |
| EIF3C | 6805.0 |
| EARS2 | 6792.5 |
| MRPL53 | 6767.5 |
| RPL19 | 6608.5 |
| MRPL39 | 6593.5 |
| MRPL17 | 6570.5 |
| EIF4A2 | 6546.5 |
| RPL29 | 6487.5 |
| RPS10 | 6457.0 |
| KARS1 | 6454.5 |
| MRPL11 | 6448.5 |
| MRPL54 | 6383.5 |
| RPN2 | 6347.5 |
| N6AMT1 | 6322.5 |
| RPS11 | 6306.5 |
| MRPS6 | 6299.5 |
| MRPL47 | 6290.5 |
| EIF2B1 | 6227.5 |
| EIF5B | 6216.5 |
| MRPS18A | 6180.5 |
| SRP68 | 6138.5 |
| MRPL50 | 6063.5 |
| MRPS24 | 6060.5 |
| MRPL24 | 6022.5 |
| RPL35 | 5961.5 |
| RPL13 | 5882.5 |
| MARS1 | 5857.5 |
| MRPL13 | 5793.5 |
| MRPL3 | 5792.5 |
| EIF3G | 5745.5 |
| PPA1 | 5736.5 |
| AARS2 | 5661.5 |
| RPSA | 5610.5 |
| EIF2B2 | 5602.5 |
| EIF3L | 5597.5 |
| SEC11C | 5517.5 |
| RPS14 | 5480.5 |
| MRPS7 | 5442.5 |
| TARS2 | 5405.5 |
| EIF3J | 5336.5 |
| MRPL22 | 5316.5 |
| GADD45GIP1 | 5315.5 |
| RPS7 | 5274.5 |
| MRPL49 | 5221.5 |
| RPL3L | 5191.5 |
| MRPL55 | 5154.5 |
| MRPS26 | 5107.5 |
| MRPS11 | 5060.5 |
| MRPL2 | 4996.5 |
| RPL18 | 4957.5 |
| RPL10A | 4938.5 |
| MRPS12 | 4860.5 |
| EIF2S2 | 4761.5 |
| RPL18A | 4656.5 |
| MRPL35 | 4577.5 |
| RPL9 | 4522.5 |
| GARS1 | 4498.5 |
| DDOST | 4494.5 |
| RPS4X | 4442.5 |
| RARS2 | 4410.5 |
| MRPL20 | 4398.5 |
| YARS1 | 4257.5 |
| RPL15 | 4191.5 |
| CARS1 | 4157.5 |
| ETF1 | 4118.5 |
| HARS1 | 4044.5 |
| MRPL52 | 4008.5 |
| SRPRA | 3989.5 |
| SARS2 | 3976.0 |
| EIF3B | 3961.5 |
| TARS1 | 3797.5 |
| EIF3H | 3755.5 |
| MRPL32 | 3649.5 |
| MRPS27 | 3638.5 |
| SSR4 | 3584.5 |
| MRPS31 | 3476.5 |
| APEH | 3470.5 |
| MRRF | 3438.5 |
| EIF2B4 | 3425.5 |
| RPS26 | 3411.5 |
| EIF4EBP1 | 3336.5 |
| MRPL40 | 3261.5 |
| RPS6 | 3167.5 |
| FARSA | 3117.5 |
| RPL23 | 3101.5 |
| EIF3A | 3054.5 |
| MRPS18C | 3041.5 |
| MTRF1L | 3028.5 |
| EIF2S3 | 3002.0 |
| ERAL1 | 2960.5 |
| EIF3D | 2883.5 |
| MTIF2 | 2857.5 |
| SPCS1 | 2770.5 |
| MRPS10 | 2736.5 |
| MRPS22 | 2728.5 |
| AIMP1 | 2707.5 |
| MRPS33 | 2646.5 |
| CHCHD1 | 2605.5 |
| RPL8 | 2340.5 |
| RPS27A | 2261.5 |
| PARS2 | 2174.5 |
| MRPL18 | 2121.5 |
| MTIF3 | 2088.5 |
| RPL24 | 2057.5 |
| RPS5 | 2028.5 |
| SRP14 | 1989.5 |
| QARS1 | 1901.5 |
| EIF1AX | 1826.5 |
| RPL22 | 1825.5 |
| SSR3 | 1807.5 |
| MRPS25 | 1771.5 |
| SARS1 | 1720.5 |
| MRPL21 | 1681.5 |
| MRPL41 | 1669.5 |
| SRP9 | 1648.5 |
| RPN1 | 1646.5 |
| FARSB | 1504.5 |
| RARS1 | 1477.5 |
| MRPL16 | 1300.5 |
| MRPL51 | 1260.5 |
| SPCS2 | 1231.5 |
| CARS2 | 1179.5 |
| RPS8 | 1133.5 |
| RPS27L | 1090.5 |
| MRPL48 | 1028.5 |
| EIF3E | 897.5 |
| SRP19 | 616.5 |
| LARS1 | 552.5 |
| RPS15 | 545.5 |
| RPL37 | 367.5 |
| RPL37A | 302.5 |
| RPS3A | 133.5 |
| RPL21 | 45.0 |
| RPL32 | 0.5 |
| RPS28 | -86.5 |
| MRPL43 | -1166.5 |
| EEF1B2 | -1217.5 |
| YARS2 | -1276.5 |
| MRPS16 | -1420.5 |
| RPL36 | -1676.5 |
| RPL31 | -1702.5 |
| MRPL27 | -1728.5 |
| MRPS28 | -1815.5 |
| SRP54 | -1887.5 |
| DARS1 | -1997.5 |
| EIF4A1 | -2162.5 |
| EIF2B3 | -2357.5 |
| RPL7A | -2363.5 |
| SEC61A1 | -2411.5 |
| MRPS35 | -2568.5 |
| RPS23 | -2786.5 |
| MRPS36 | -2886.5 |
| EIF3F | -2965.5 |
| SEC11A | -3017.5 |
| WARS2 | -3221.5 |
| RPL7 | -3262.5 |
| SPCS3 | -3307.5 |
| RPS3 | -3309.5 |
| RPS2 | -3580.5 |
| EEF1A1 | -3659.5 |
| EIF2S1 | -4178.5 |
| RPL5 | -4208.5 |
| RPS15A | -4306.5 |
| EIF5 | -4315.5 |
| RPS25 | -4440.5 |
| RPL10L | -4738.5 |
| TRMT112 | -4815.5 |
| EIF3M | -4836.5 |
| RPL38 | -4919.5 |
| RPL35A | -4964.5 |
| SSR2 | -5139.5 |
| SEC61B | -5336.5 |
| SRPRB | -5708.5 |
| SEC61A2 | -5711.5 |
| MTFMT | -5744.5 |
| RPL27 | -5778.5 |
| PPA2 | -5799.5 |
| EEF1E1 | -6270.0 |
| RPS18 | -6410.5 |
| RPS19 | -6473.5 |
| TRAM1 | -6569.5 |
| EIF4H | -6631.5 |
| RPL30 | -6652.5 |
| RPS21 | -6677.5 |
| RPLP1 | -6712.5 |
| GSPT2 | -6727.5 |
| FAU | -6841.5 |
| RPS17 | -7220.5 |
| RPL3 | -7355.5 |
| RPS16 | -7482.5 |
| SRP72 | -7684.5 |
| RPL6 | -7781.5 |
| RPL23A | -8061.5 |
| SSR1 | -8085.5 |
| RPS13 | -8475.5 |
Mitochondrial translation initiation
| 711 | |
|---|---|
| set | Mitochondrial translation initiation |
| setSize | 85 |
| pANOVA | 7.75e-19 |
| s.dist | 0.556 |
| p.adjustANOVA | 2.24e-16 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| MRPS18B | 9007.5 |
| PTCD3 | 8917.5 |
| MRPL30 | 8739.0 |
| MRPL38 | 8381.5 |
| MRPL37 | 8373.5 |
| MRPS34 | 8288.5 |
| MRPL10 | 8203.5 |
| MRPL36 | 8147.5 |
| MRPS5 | 8097.5 |
| MRPS17 | 7940.0 |
| MRPL4 | 7909.5 |
| MRPL12 | 7898.5 |
| MRPL28 | 7858.5 |
| MRPL45 | 7805.5 |
| MRPS15 | 7718.5 |
| MRPL1 | 7666.5 |
| MRPS30 | 7513.5 |
| MRPL9 | 7452.5 |
| MRPL19 | 7446.5 |
| MRPL44 | 7423.5 |
| GeneID | Gene Rank |
|---|---|
| MRPS18B | 9007.5 |
| PTCD3 | 8917.5 |
| MRPL30 | 8739.0 |
| MRPL38 | 8381.5 |
| MRPL37 | 8373.5 |
| MRPS34 | 8288.5 |
| MRPL10 | 8203.5 |
| MRPL36 | 8147.5 |
| MRPS5 | 8097.5 |
| MRPS17 | 7940.0 |
| MRPL4 | 7909.5 |
| MRPL12 | 7898.5 |
| MRPL28 | 7858.5 |
| MRPL45 | 7805.5 |
| MRPS15 | 7718.5 |
| MRPL1 | 7666.5 |
| MRPS30 | 7513.5 |
| MRPL9 | 7452.5 |
| MRPL19 | 7446.5 |
| MRPL44 | 7423.5 |
| OXA1L | 7295.5 |
| MRPL14 | 7233.5 |
| MRPL42 | 7151.5 |
| MRPL58 | 7145.5 |
| MRPS9 | 7125.5 |
| MRPS21 | 7123.5 |
| MRPL33 | 7108.5 |
| MRPL46 | 7097.5 |
| MRPS2 | 7088.5 |
| MRPL15 | 7081.5 |
| MRPS14 | 7080.5 |
| MRPS23 | 7023.5 |
| MRPL34 | 7010.5 |
| DAP3 | 6808.5 |
| MRPL53 | 6767.5 |
| MRPL39 | 6593.5 |
| MRPL17 | 6570.5 |
| MRPL11 | 6448.5 |
| MRPL54 | 6383.5 |
| MRPS6 | 6299.5 |
| MRPL47 | 6290.5 |
| MRPS18A | 6180.5 |
| MRPL50 | 6063.5 |
| MRPS24 | 6060.5 |
| MRPL24 | 6022.5 |
| MRPL13 | 5793.5 |
| MRPL3 | 5792.5 |
| MRPS7 | 5442.5 |
| MRPL22 | 5316.5 |
| GADD45GIP1 | 5315.5 |
| MRPL49 | 5221.5 |
| MRPL55 | 5154.5 |
| MRPS26 | 5107.5 |
| MRPS11 | 5060.5 |
| MRPL2 | 4996.5 |
| MRPS12 | 4860.5 |
| MRPL35 | 4577.5 |
| MRPL20 | 4398.5 |
| MRPL52 | 4008.5 |
| MRPL32 | 3649.5 |
| MRPS27 | 3638.5 |
| MRPS31 | 3476.5 |
| MRPL40 | 3261.5 |
| MRPS18C | 3041.5 |
| ERAL1 | 2960.5 |
| MTIF2 | 2857.5 |
| MRPS10 | 2736.5 |
| MRPS22 | 2728.5 |
| MRPS33 | 2646.5 |
| CHCHD1 | 2605.5 |
| MRPL18 | 2121.5 |
| MTIF3 | 2088.5 |
| MRPS25 | 1771.5 |
| MRPL21 | 1681.5 |
| MRPL41 | 1669.5 |
| MRPL16 | 1300.5 |
| MRPL51 | 1260.5 |
| MRPL48 | 1028.5 |
| MRPL43 | -1166.5 |
| MRPS16 | -1420.5 |
| MRPL27 | -1728.5 |
| MRPS28 | -1815.5 |
| MRPS35 | -2568.5 |
| MRPS36 | -2886.5 |
| MTFMT | -5744.5 |
The citric acid (TCA) cycle and respiratory electron transport
| 1303 | |
|---|---|
| set | The citric acid (TCA) cycle and respiratory electron transport |
| setSize | 165 |
| pANOVA | 3.56e-13 |
| s.dist | 0.328 |
| p.adjustANOVA | 8.58e-11 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| ACO2 | 8817.5 |
| NDUFA12 | 8677.5 |
| ATP5F1D | 8640.5 |
| PDP1 | 8638.5 |
| NDUFA8 | 8607.5 |
| PDHX | 8564.5 |
| ATP5PB | 8530.5 |
| NDUFS5 | 8426.5 |
| PDHB | 8238.5 |
| BSG | 8186.5 |
| ECSIT | 8154.5 |
| DLST | 8106.5 |
| COX11 | 8096.5 |
| ACAD9 | 8063.5 |
| ME3 | 8005.5 |
| FAHD1 | 7997.5 |
| NDUFS7 | 7874.5 |
| MT-CO1 | 7459.5 |
| LDHB | 7435.0 |
| IDH2 | 7427.5 |
| GeneID | Gene Rank |
|---|---|
| ACO2 | 8817.5 |
| NDUFA12 | 8677.5 |
| ATP5F1D | 8640.5 |
| PDP1 | 8638.5 |
| NDUFA8 | 8607.5 |
| PDHX | 8564.5 |
| ATP5PB | 8530.5 |
| NDUFS5 | 8426.5 |
| PDHB | 8238.5 |
| BSG | 8186.5 |
| ECSIT | 8154.5 |
| DLST | 8106.5 |
| COX11 | 8096.5 |
| ACAD9 | 8063.5 |
| ME3 | 8005.5 |
| FAHD1 | 7997.5 |
| NDUFS7 | 7874.5 |
| MT-CO1 | 7459.5 |
| LDHB | 7435.0 |
| IDH2 | 7427.5 |
| LDHC | 7413.5 |
| TACO1 | 7403.5 |
| NDUFA13 | 7316.5 |
| TRAP1 | 7311.5 |
| ETFDH | 7282.5 |
| PDK2 | 7219.5 |
| TIMMDC1 | 7186.5 |
| IDH3A | 7182.5 |
| NDUFAF3 | 7105.5 |
| SCO1 | 6994.5 |
| NDUFS2 | 6971.5 |
| MT-CO2 | 6945.5 |
| NDUFV1 | 6920.5 |
| SDHB | 6907.5 |
| DLAT | 6848.5 |
| HAGH | 6790.5 |
| NDUFAF4 | 6785.5 |
| IDH3B | 6732.5 |
| PDHA1 | 6639.5 |
| FH | 6469.5 |
| ADHFE1 | 6444.5 |
| NDUFB10 | 6419.5 |
| COX7A2L | 6410.5 |
| UQCRC1 | 6324.5 |
| NDUFS3 | 6318.5 |
| UQCRFS1 | 6235.5 |
| ETFB | 6145.5 |
| NDUFV2 | 6127.5 |
| PDPR | 6116.5 |
| NDUFA10 | 6103.5 |
| DMAC2L | 5929.5 |
| COX5B | 5910.5 |
| CS | 5894.5 |
| NDUFA6 | 5887.5 |
| MPC1 | 5835.5 |
| NDUFA2 | 5728.5 |
| ETFA | 5655.5 |
| NDUFB9 | 5536.5 |
| NDUFS8 | 5518.5 |
| CYC1 | 5440.5 |
| SURF1 | 5398.5 |
| NDUFA11 | 5077.0 |
| ATP5F1B | 5063.5 |
| UQCRH | 4971.0 |
| MPC2 | 4845.5 |
| COX18 | 4765.5 |
| UQCRQ | 4627.5 |
| NDUFB8 | 4615.0 |
| SDHC | 4606.5 |
| NDUFB2 | 4587.5 |
| OGDH | 4470.5 |
| L2HGDH | 4434.5 |
| NDUFAB1 | 4350.5 |
| VDAC1 | 4260.5 |
| SDHA | 4232.0 |
| PDK1 | 4175.5 |
| UCP2 | 4090.5 |
| NDUFA7 | 3973.0 |
| COX4I1 | 3926.5 |
| UQCR10 | 3843.5 |
| SLC25A27 | 3731.5 |
| NDUFA9 | 3708.5 |
| COX14 | 3517.5 |
| NDUFA5 | 3514.5 |
| UQCRC2 | 3503.5 |
| ATP5PD | 3402.5 |
| NDUFB6 | 3329.5 |
| SUCLG1 | 3325.5 |
| SUCLA2 | 3268.5 |
| NDUFC1 | 3113.5 |
| NDUFS1 | 3068.5 |
| DLD | 2984.5 |
| NDUFAF1 | 2966.5 |
| ATP5PO | 2930.0 |
| COQ10B | 2915.5 |
| NDUFAF7 | 2842.5 |
| COX7B | 2750.5 |
| UQCR11 | 2718.0 |
| NDUFC2 | 2669.0 |
| ATP5MF | 2647.5 |
| IDH3G | 2586.5 |
| MT-ND1 | 2529.5 |
| PPARD | 2501.5 |
| NDUFB7 | 2448.5 |
| NDUFS4 | 2412.5 |
| PDP2 | 2306.5 |
| NDUFA3 | 2298.5 |
| SDHD | 2278.0 |
| NDUFAF5 | 2012.5 |
| MT-ND3 | 1861.5 |
| CYCS | 1802.5 |
| MT-CO3 | 1568.5 |
| LDHA | 1562.5 |
| MT-CYB | 1377.5 |
| MT-ND5 | 1325.5 |
| GLO1 | 1280.5 |
| NDUFA4 | 1265.5 |
| MT-ATP6 | 1243.5 |
| MDH2 | 1129.5 |
| COX6A1 | 1068.5 |
| NDUFB5 | 1061.5 |
| NNT | 785.5 |
| COX20 | 681.5 |
| D2HGDH | 530.5 |
| COX5A | 481.5 |
| RXRA | 395.5 |
| MT-ND4 | 390.5 |
| ATP5MC3 | 319.5 |
| MT-ND2 | 306.5 |
| ME2 | 9.5 |
| ME1 | -80.5 |
| SUCLG2 | -231.5 |
| UCP1 | -358.5 |
| NDUFB11 | -363.5 |
| SLC16A1 | -369.5 |
| SLC16A3 | -371.5 |
| ATP5PF | -401.5 |
| PDK4 | -495.5 |
| MT-ND6 | -790.5 |
| NUBPL | -1174.5 |
| COX19 | -1192.5 |
| ATP5F1E | -1407.5 |
| COQ10A | -2127.5 |
| COX7C | -2174.5 |
| TMEM126B | -2544.5 |
| ATP5MG | -2690.0 |
| NDUFAF6 | -2759.5 |
| NDUFS6 | -2838.5 |
| ATP5ME | -3145.5 |
| NDUFB3 | -3539.5 |
| NDUFA1 | -3668.5 |
| NDUFB4 | -3950.5 |
| SLC25A14 | -4573.5 |
| MT-ATP8 | -4868.5 |
| UCP3 | -5025.5 |
| COX8A | -5052.5 |
| SLC16A8 | -5262.5 |
| COX6B1 | -5355.5 |
| ATP5F1A | -6042.5 |
| PDK3 | -6753.5 |
| NDUFV3 | -6831.5 |
| PM20D1 | -7706.5 |
| UQCRB | -7789.5 |
| GSTZ1 | -7866.5 |
| COX16 | -7904.5 |
Macroautophagy
| 664 | |
|---|---|
| set | Macroautophagy |
| setSize | 108 |
| pANOVA | 3.98e-12 |
| s.dist | 0.386 |
| p.adjustANOVA | 8.22e-10 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| CSNK2B | 8941.5 |
| PARK7 | 8928.5 |
| PRKAB2 | 8910.5 |
| TSC2 | 8824.5 |
| IFT88 | 8744.5 |
| SQSTM1 | 8697.5 |
| ARL13B | 8606.5 |
| MFN2 | 8568.5 |
| ATG16L1 | 8537.5 |
| PINK1 | 8514.5 |
| MTMR3 | 8415.5 |
| MTOR | 8379.5 |
| TOMM40 | 8333.5 |
| MAP1LC3B | 8304.0 |
| LAMTOR2 | 8098.5 |
| CHMP7 | 7921.5 |
| HSPA8 | 7910.5 |
| ATG4D | 7848.5 |
| MFN1 | 7800.5 |
| ATG10 | 7735.5 |
| GeneID | Gene Rank |
|---|---|
| CSNK2B | 8941.5 |
| PARK7 | 8928.5 |
| PRKAB2 | 8910.5 |
| TSC2 | 8824.5 |
| IFT88 | 8744.5 |
| SQSTM1 | 8697.5 |
| ARL13B | 8606.5 |
| MFN2 | 8568.5 |
| ATG16L1 | 8537.5 |
| PINK1 | 8514.5 |
| MTMR3 | 8415.5 |
| MTOR | 8379.5 |
| TOMM40 | 8333.5 |
| MAP1LC3B | 8304.0 |
| LAMTOR2 | 8098.5 |
| CHMP7 | 7921.5 |
| HSPA8 | 7910.5 |
| ATG4D | 7848.5 |
| MFN1 | 7800.5 |
| ATG10 | 7735.5 |
| PLIN3 | 7535.5 |
| NBR1 | 7530.5 |
| ATG4B | 7497.5 |
| UBA52 | 7357.5 |
| USP30 | 7330.5 |
| PIK3C3 | 7250.5 |
| DYNC1LI1 | 7142.5 |
| DYNC1H1 | 6922.5 |
| WIPI1 | 6633.5 |
| WIPI2 | 6622.5 |
| WDR45 | 6616.5 |
| ATG101 | 6600.5 |
| VCP | 6599.5 |
| PLIN2 | 6558.5 |
| MTMR14 | 6538.5 |
| TOMM6 | 6247.5 |
| PRKAA2 | 6239.5 |
| DYNLL2 | 6153.5 |
| CHMP3 | 6105.0 |
| CHMP4C | 6023.5 |
| LAMTOR4 | 5855.5 |
| LAMTOR1 | 5813.5 |
| PRKAB1 | 5775.5 |
| GABARAPL1 | 5606.5 |
| CHMP2B | 5497.5 |
| RPTOR | 5295.5 |
| ATG5 | 5242.5 |
| MAP1LC3A | 5210.5 |
| DYNC1I2 | 5195.5 |
| ATG12 | 5189.5 |
| CHMP4B | 5087.5 |
| CSNK2A1 | 5083.0 |
| CHMP6 | 4654.5 |
| RHEB | 4650.5 |
| ATG9A | 4630.5 |
| ATG4C | 4511.5 |
| HDAC6 | 4383.5 |
| RRAGC | 4344.5 |
| VDAC1 | 4260.5 |
| UBE2N | 3887.0 |
| EPAS1 | 3670.5 |
| LAMTOR3 | 3663.5 |
| ATG4A | 3180.5 |
| TOMM20 | 3158.5 |
| GABARAP | 3124.5 |
| PRKAG3 | 3034.5 |
| RRAGD | 2970.5 |
| TOMM22 | 2933.5 |
| TOMM70 | 2806.5 |
| WDR45B | 2742.5 |
| DYNC1I1 | 2733.5 |
| PCNT | 2681.5 |
| RPS27A | 2261.5 |
| ATG13 | 2194.5 |
| HSF1 | 1964.5 |
| PIK3R4 | 1910.5 |
| FUNDC1 | 1863.5 |
| TSC1 | 1679.5 |
| RRAGA | 1100.5 |
| DYNLL1 | 767.5 |
| MLST8 | 534.5 |
| GABARAPL2 | 501.5 |
| ULK1 | 458.5 |
| CFTR | 341.5 |
| CHMP2A | 160.5 |
| PGAM5 | 146.5 |
| UBC | 100.5 |
| ATG7 | -152.5 |
| PEX5 | -258.5 |
| PRKAG2 | -768.5 |
| RB1CC1 | -785.5 |
| ATG14 | -1324.5 |
| LAMTOR5 | -1790.5 |
| MTERF3 | -1961.5 |
| SRC | -2361.5 |
| DYNC1LI2 | -2368.5 |
| RRAGB | -2380.5 |
| CETN1 | -2424.5 |
| AMBRA1 | -2944.5 |
| ATG9B | -3412.5 |
| CSNK2A2 | -4612.5 |
| ATM | -4881.5 |
| TOMM7 | -4954.5 |
| UVRAG | -5167.5 |
| SLC38A9 | -6332.5 |
| PRKAA1 | -7243.5 |
| BECN1 | -7524.5 |
| ATG3 | -7988.5 |
Autophagy
| 103 | |
|---|---|
| set | Autophagy |
| setSize | 122 |
| pANOVA | 1.98e-11 |
| s.dist | 0.352 |
| p.adjustANOVA | 3.57e-09 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| CSNK2B | 8941.5 |
| PARK7 | 8928.5 |
| PRKAB2 | 8910.5 |
| TSC2 | 8824.5 |
| IFT88 | 8744.5 |
| SQSTM1 | 8697.5 |
| ARL13B | 8606.5 |
| MFN2 | 8568.5 |
| ATG16L1 | 8537.5 |
| PINK1 | 8514.5 |
| HSP90AB1 | 8445.5 |
| VPS37C | 8441.5 |
| MTMR3 | 8415.5 |
| MTOR | 8379.5 |
| TOMM40 | 8333.5 |
| MAP1LC3B | 8304.0 |
| LAMTOR2 | 8098.5 |
| CHMP7 | 7921.5 |
| HSPA8 | 7910.5 |
| ATG4D | 7848.5 |
| GeneID | Gene Rank |
|---|---|
| CSNK2B | 8941.5 |
| PARK7 | 8928.5 |
| PRKAB2 | 8910.5 |
| TSC2 | 8824.5 |
| IFT88 | 8744.5 |
| SQSTM1 | 8697.5 |
| ARL13B | 8606.5 |
| MFN2 | 8568.5 |
| ATG16L1 | 8537.5 |
| PINK1 | 8514.5 |
| HSP90AB1 | 8445.5 |
| VPS37C | 8441.5 |
| MTMR3 | 8415.5 |
| MTOR | 8379.5 |
| TOMM40 | 8333.5 |
| MAP1LC3B | 8304.0 |
| LAMTOR2 | 8098.5 |
| CHMP7 | 7921.5 |
| HSPA8 | 7910.5 |
| ATG4D | 7848.5 |
| MFN1 | 7800.5 |
| ATG10 | 7735.5 |
| PLIN3 | 7535.5 |
| NBR1 | 7530.5 |
| ATG4B | 7497.5 |
| UBA52 | 7357.5 |
| USP30 | 7330.5 |
| PIK3C3 | 7250.5 |
| DYNC1LI1 | 7142.5 |
| DYNC1H1 | 6922.5 |
| WIPI1 | 6633.5 |
| WIPI2 | 6622.5 |
| WDR45 | 6616.5 |
| ATG101 | 6600.5 |
| VCP | 6599.5 |
| PLIN2 | 6558.5 |
| MTMR14 | 6538.5 |
| MVB12A | 6344.5 |
| TOMM6 | 6247.5 |
| PRKAA2 | 6239.5 |
| DYNLL2 | 6153.5 |
| CHMP3 | 6105.0 |
| VPS28 | 6061.5 |
| CHMP4C | 6023.5 |
| LAMTOR4 | 5855.5 |
| LAMTOR1 | 5813.5 |
| PRKAB1 | 5775.5 |
| GABARAPL1 | 5606.5 |
| CHMP2B | 5497.5 |
| RPTOR | 5295.5 |
| ATG5 | 5242.5 |
| MAP1LC3A | 5210.5 |
| DYNC1I2 | 5195.5 |
| ATG12 | 5189.5 |
| CHMP4B | 5087.5 |
| CSNK2A1 | 5083.0 |
| UBAP1 | 4743.5 |
| CHMP6 | 4654.5 |
| RHEB | 4650.5 |
| ATG9A | 4630.5 |
| ATG4C | 4511.5 |
| HDAC6 | 4383.5 |
| RRAGC | 4344.5 |
| VDAC1 | 4260.5 |
| UBE2N | 3887.0 |
| EPAS1 | 3670.5 |
| LAMTOR3 | 3663.5 |
| ATG4A | 3180.5 |
| TOMM20 | 3158.5 |
| GABARAP | 3124.5 |
| PRKAG3 | 3034.5 |
| RRAGD | 2970.5 |
| TOMM22 | 2933.5 |
| TOMM70 | 2806.5 |
| WDR45B | 2742.5 |
| DYNC1I1 | 2733.5 |
| PCNT | 2681.5 |
| RPS27A | 2261.5 |
| ATG13 | 2194.5 |
| HSF1 | 1964.5 |
| PIK3R4 | 1910.5 |
| FUNDC1 | 1863.5 |
| MVB12B | 1759.5 |
| TSC1 | 1679.5 |
| RNASE1 | 1484.5 |
| RRAGA | 1100.5 |
| DYNLL1 | 767.5 |
| MLST8 | 534.5 |
| GABARAPL2 | 501.5 |
| ULK1 | 458.5 |
| TSG101 | 385.5 |
| CFTR | 341.5 |
| CHMP2A | 160.5 |
| PGAM5 | 146.5 |
| UBC | 100.5 |
| VPS37A | -109.5 |
| ATG7 | -152.5 |
| PEX5 | -258.5 |
| PRKAG2 | -768.5 |
| RB1CC1 | -785.5 |
| ATG14 | -1324.5 |
| LAMTOR5 | -1790.5 |
| MTERF3 | -1961.5 |
| SRC | -2361.5 |
| DYNC1LI2 | -2368.5 |
| RRAGB | -2380.5 |
| CETN1 | -2424.5 |
| AMBRA1 | -2944.5 |
| ATG9B | -3412.5 |
| EEF1A1 | -3659.5 |
| VPS37D | -4235.5 |
| LAMP2 | -4242.5 |
| CSNK2A2 | -4612.5 |
| ATM | -4881.5 |
| TOMM7 | -4954.5 |
| UVRAG | -5167.5 |
| VPS37B | -5376.5 |
| SLC38A9 | -6332.5 |
| PRKAA1 | -7243.5 |
| BECN1 | -7524.5 |
| GFAP | -7775.5 |
| ATG3 | -7988.5 |
Protein localization
| 925 | |
|---|---|
| set | Protein localization |
| setSize | 156 |
| pANOVA | 4.45e-11 |
| s.dist | 0.306 |
| p.adjustANOVA | 7.14e-09 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| PEX16 | 8967.5 |
| TIMM50 | 8913.5 |
| ACO2 | 8817.5 |
| LDHD | 8757.5 |
| ECI2 | 8721.5 |
| LONP2 | 8717.5 |
| ACOX1 | 8680.5 |
| AMACR | 8598.5 |
| CRAT | 8595.5 |
| CMC2 | 8574.5 |
| HSD17B4 | 8517.5 |
| PITRM1 | 8463.5 |
| PEX19 | 8449.5 |
| PECR | 8397.5 |
| BAG6 | 8345.5 |
| TOMM40 | 8333.5 |
| FXN | 8330.5 |
| GET3 | 8251.5 |
| PEX10 | 8221.5 |
| PMPCA | 8171.5 |
| GeneID | Gene Rank |
|---|---|
| PEX16 | 8967.5 |
| TIMM50 | 8913.5 |
| ACO2 | 8817.5 |
| LDHD | 8757.5 |
| ECI2 | 8721.5 |
| LONP2 | 8717.5 |
| ACOX1 | 8680.5 |
| AMACR | 8598.5 |
| CRAT | 8595.5 |
| CMC2 | 8574.5 |
| HSD17B4 | 8517.5 |
| PITRM1 | 8463.5 |
| PEX19 | 8449.5 |
| PECR | 8397.5 |
| BAG6 | 8345.5 |
| TOMM40 | 8333.5 |
| FXN | 8330.5 |
| GET3 | 8251.5 |
| PEX10 | 8221.5 |
| PMPCA | 8171.5 |
| SEC61G | 8169.5 |
| ACOT8 | 8091.5 |
| MLYCD | 8087.5 |
| SGTA | 7938.5 |
| APP | 7804.5 |
| PAOX | 7705.0 |
| SLC25A13 | 7672.5 |
| SLC25A12 | 7665.5 |
| GRPEL1 | 7654.5 |
| CHCHD5 | 7532.5 |
| UBA52 | 7357.5 |
| PHYH | 7272.5 |
| UBE2D3 | 7189.5 |
| TIMM44 | 7140.5 |
| HAO2 | 7043.5 |
| ABCD1 | 7028.5 |
| PXMP2 | 6909.5 |
| PEX26 | 6833.5 |
| GET1 | 6611.5 |
| MTX1 | 6581.5 |
| NUDT19 | 6554.5 |
| IDH1 | 6455.5 |
| HAO1 | 6395.5 |
| DHRS4 | 6392.0 |
| PEX14 | 6265.5 |
| GDAP1 | 6263.5 |
| ABCD3 | 6258.5 |
| TOMM6 | 6247.5 |
| TIMM23 | 6237.5 |
| PMPCB | 6193.5 |
| TIMM8A | 6184.5 |
| HMOX1 | 6170.5 |
| SAMM50 | 6128.5 |
| UBE2J2 | 6118.5 |
| PEX1 | 6091.5 |
| TIMM21 | 6056.5 |
| CHCHD4 | 6017.5 |
| CS | 5894.5 |
| TIMM8B | 5797.5 |
| HSPD1 | 5605.5 |
| TAZ | 5561.5 |
| UBL4A | 5498.5 |
| CYC1 | 5440.5 |
| ACOT2 | 5390.0 |
| ECH1 | 5378.5 |
| COQ2 | 5364.5 |
| TIMM10 | 5314.5 |
| SLC25A4 | 5264.5 |
| ACOX2 | 5204.5 |
| HSPA9 | 5108.5 |
| TIMM10B | 5095.0 |
| ABCD2 | 5081.5 |
| ATP5F1B | 5063.5 |
| CHCHD3 | 5047.5 |
| TYSND1 | 4821.5 |
| NDUFB8 | 4615.0 |
| PEX7 | 4597.5 |
| PXMP4 | 4371.5 |
| VDAC1 | 4260.5 |
| EMD | 4197.5 |
| TIMM17A | 3995.5 |
| EHHADH | 3987.5 |
| HMGCL | 3899.5 |
| TIMM22 | 3837.5 |
| OTC | 3799.5 |
| CAT | 3746.5 |
| BCS1L | 3714.5 |
| PEX2 | 3648.5 |
| SLC25A17 | 3212.5 |
| UBE2D1 | 3169.5 |
| TOMM20 | 3158.5 |
| COA4 | 3056.5 |
| TOMM22 | 2933.5 |
| TOMM70 | 2806.5 |
| ACAA1 | 2649.5 |
| IDH3G | 2586.5 |
| ACOX3 | 2390.5 |
| PEX6 | 2355.5 |
| RPS27A | 2261.5 |
| PAM16 | 1923.5 |
| CHCHD7 | 1405.5 |
| TIMM9 | 1333.5 |
| GNPAT | 1278.5 |
| COA6 | 1213.5 |
| CMC4 | 1002.5 |
| MTX2 | 965.5 |
| PRNP | 772.5 |
| CYB5A | 701.5 |
| COX17 | 646.5 |
| UBE2D2 | 126.5 |
| UBC | 100.5 |
| TIMM13 | 27.5 |
| VAMP2 | -124.0 |
| PEX12 | -239.5 |
| PEX5 | -258.5 |
| IDE | -266.5 |
| DNAJC19 | -270.5 |
| MPV17 | -541.5 |
| CAMLG | -1154.5 |
| DAO | -1182.5 |
| COX19 | -1192.5 |
| ZFAND6 | -1338.5 |
| OTOF | -1453.5 |
| AGXT | -1460.5 |
| SLC27A2 | -1841.5 |
| STX5 | -1984.5 |
| PEX13 | -2723.5 |
| USP9X | -2762.5 |
| HACL1 | -2803.5 |
| PIPOX | -3049.5 |
| SERP1 | -3120.5 |
| PEX11B | -3698.5 |
| GRPEL2 | -4259.5 |
| ALDH3A2 | -4314.5 |
| AGPS | -4511.5 |
| GFER | -4610.5 |
| PEX3 | -4652.5 |
| HSCB | -4732.5 |
| TOMM7 | -4954.5 |
| EPHX2 | -5201.5 |
| GSTK1 | -5244.5 |
| SEC61B | -5336.5 |
| GET4 | -5543.5 |
| ACBD5 | -5836.5 |
| DDO | -6010.5 |
| ATP5F1A | -6042.5 |
| CROT | -6097.5 |
| ACOT4 | -6347.5 |
| VAPA | -6554.5 |
| BAAT | -6684.5 |
| TIMM17B | -6725.5 |
| NUDT7 | -6823.5 |
| NOS2 | -6925.5 |
| STX1A | -7287.5 |
| CHCHD10 | -7851.5 |
| CHCHD2 | -7918.5 |
Metabolism of proteins
| 688 | |
|---|---|
| set | Metabolism of proteins |
| setSize | 1810 |
| pANOVA | 1.06e-10 |
| s.dist | 0.0924 |
| p.adjustANOVA | 1.53e-08 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| ANK2 | 9013.5 |
| MRPS18B | 9007.5 |
| GAS6 | 9006.5 |
| ADAMTSL1 | 9001.5 |
| MIA2 | 8992.5 |
| COPE | 8984.5 |
| COPG1 | 8946.5 |
| TTLL9 | 8942.5 |
| CSNK2B | 8941.5 |
| DDIT3 | 8934.5 |
| PARK7 | 8928.5 |
| PTCD3 | 8917.5 |
| DAXX | 8914.5 |
| VARS1 | 8908.5 |
| MFGE8 | 8899.5 |
| ALG3 | 8889.5 |
| RPL13A | 8886.5 |
| FBXO31 | 8879.5 |
| VARS2 | 8870.5 |
| RPA1 | 8853.5 |
| GeneID | Gene Rank |
|---|---|
| ANK2 | 9013.5 |
| MRPS18B | 9007.5 |
| GAS6 | 9006.5 |
| ADAMTSL1 | 9001.5 |
| MIA2 | 8992.5 |
| COPE | 8984.5 |
| COPG1 | 8946.5 |
| TTLL9 | 8942.5 |
| CSNK2B | 8941.5 |
| DDIT3 | 8934.5 |
| PARK7 | 8928.5 |
| PTCD3 | 8917.5 |
| DAXX | 8914.5 |
| VARS1 | 8908.5 |
| MFGE8 | 8899.5 |
| ALG3 | 8889.5 |
| RPL13A | 8886.5 |
| FBXO31 | 8879.5 |
| VARS2 | 8870.5 |
| RPA1 | 8853.5 |
| IARS2 | 8848.5 |
| RAD52 | 8823.5 |
| GALNT2 | 8816.5 |
| FBXL19 | 8799.5 |
| USP2 | 8778.5 |
| DNAJB9 | 8768.5 |
| USP20 | 8761.5 |
| PSMB8 | 8750.5 |
| CUL4A | 8748.5 |
| NARS1 | 8747.5 |
| MRPL30 | 8739.0 |
| DCAF11 | 8735.0 |
| NSMCE1 | 8727.5 |
| SPTAN1 | 8726.5 |
| NEU1 | 8725.5 |
| DCTN1 | 8719.0 |
| LONP2 | 8717.5 |
| RANGAP1 | 8716.5 |
| SPTBN1 | 8714.5 |
| IARS1 | 8710.5 |
| PSMD1 | 8707.5 |
| FARS2 | 8703.5 |
| CALU | 8681.5 |
| EXOC3 | 8672.5 |
| FOXO4 | 8664.5 |
| NICN1 | 8655.5 |
| NARS2 | 8624.5 |
| GPS1 | 8619.5 |
| RAD23A | 8618.5 |
| GORASP1 | 8615.5 |
| RPLP2 | 8590.5 |
| EIF4G1 | 8580.5 |
| PPP6R1 | 8570.5 |
| TOP1 | 8567.5 |
| PFDN6 | 8550.5 |
| COMMD9 | 8546.5 |
| SELENOS | 8543.5 |
| PRMT3 | 8532.5 |
| DCAF8 | 8526.5 |
| GSPT1 | 8520.5 |
| YIF1A | 8509.5 |
| LARS2 | 8505.5 |
| ZBTB17 | 8498.5 |
| ATP6V0D1 | 8493.5 |
| TNIP1 | 8492.5 |
| RNF5 | 8489.5 |
| RING1 | 8483.5 |
| CCT3 | 8472.5 |
| USP25 | 8470.5 |
| TBCD | 8459.5 |
| RHOT1 | 8433.5 |
| COMMD4 | 8430.5 |
| KLHL22 | 8420.0 |
| DCTN2 | 8402.5 |
| TTLL7 | 8389.5 |
| USP4 | 8388.5 |
| MRPL38 | 8381.5 |
| MRPL37 | 8373.5 |
| GFM1 | 8370.5 |
| GFM2 | 8363.5 |
| CTBP1 | 8359.5 |
| ARL2 | 8351.5 |
| GBF1 | 8347.5 |
| CDC34 | 8326.5 |
| SULT1A3 | 8318.0 |
| FBXW10 | 8307.0 |
| HDGF | 8302.5 |
| WRAP53 | 8290.5 |
| MRPS34 | 8288.5 |
| COG4 | 8282.5 |
| LMNA | 8271.5 |
| RUVBL1 | 8255.5 |
| MAVS | 8242.5 |
| RAB30 | 8230.5 |
| USP15 | 8228.5 |
| PEX10 | 8221.5 |
| B4GALT5 | 8216.5 |
| MRPL10 | 8203.5 |
| QSOX1 | 8202.5 |
| FN3K | 8187.5 |
| ANK3 | 8175.5 |
| MAN2A2 | 8172.5 |
| SEC61G | 8169.5 |
| HERPUD1 | 8157.5 |
| MRPL36 | 8147.5 |
| NFRKB | 8144.5 |
| SPSB3 | 8137.5 |
| ST3GAL1 | 8113.5 |
| NOD1 | 8105.5 |
| NUP50 | 8100.5 |
| MRPS5 | 8097.5 |
| TECTA | 8092.5 |
| KIF5A | 8088.5 |
| EXTL1 | 8084.5 |
| OTULIN | 8083.5 |
| MAT2B | 8081.5 |
| HIC1 | 8078.5 |
| HERC2 | 8073.5 |
| DCAF5 | 8013.5 |
| ACTR8 | 8001.5 |
| TUBA4A | 7992.5 |
| IGF2 | 7988.5 |
| COPS2 | 7987.5 |
| WFS1 | 7981.5 |
| RPS9 | 7978.5 |
| UBE2R2 | 7975.5 |
| MARS2 | 7972.5 |
| CNIH3 | 7953.5 |
| CHM | 7950.5 |
| EIF2B5 | 7944.5 |
| MRPS17 | 7940.0 |
| COPS7A | 7934.5 |
| AARS1 | 7920.5 |
| PIAS4 | 7919.5 |
| HSPA8 | 7910.5 |
| MRPL4 | 7909.5 |
| MRPL12 | 7898.5 |
| RNF40 | 7887.5 |
| FEM1A | 7869.5 |
| HGS | 7865.5 |
| MRPL28 | 7858.5 |
| WARS1 | 7854.5 |
| MLEC | 7849.5 |
| NAPA | 7830.5 |
| SPSB4 | 7829.5 |
| STS | 7827.5 |
| ART3 | 7824.5 |
| FKBP8 | 7818.5 |
| MEPE | 7815.5 |
| NFYC | 7813.5 |
| LARGE1 | 7807.5 |
| MRPL45 | 7805.5 |
| APP | 7804.5 |
| GNB3 | 7796.5 |
| EEF2 | 7789.5 |
| EPRS1 | 7782.5 |
| ATF4 | 7774.5 |
| DDA1 | 7763.5 |
| TSFM | 7754.5 |
| MIA3 | 7748.5 |
| KIFC3 | 7743.5 |
| NEDD8 | 7736.5 |
| ASB9 | 7731.5 |
| MRPS15 | 7718.5 |
| SYVN1 | 7703.5 |
| FBXW8 | 7695.5 |
| COG1 | 7689.5 |
| USP48 | 7686.5 |
| GNAT3 | 7676.5 |
| MRPL1 | 7666.5 |
| DCUN1D2 | 7661.5 |
| EIF4E | 7655.5 |
| ANKRD9 | 7645.5 |
| ATF3 | 7639.5 |
| TUBA8 | 7628.5 |
| PSMC1 | 7622.5 |
| PMM2 | 7602.5 |
| WAC | 7598.5 |
| C4A | 7594.0 |
| EIF3K | 7589.5 |
| USP19 | 7579.5 |
| FBXW5 | 7571.5 |
| DOHH | 7552.5 |
| TATDN2 | 7538.0 |
| MRPS30 | 7513.5 |
| USP5 | 7503.5 |
| HARS2 | 7498.5 |
| ASB10 | 7484.5 |
| EEF1G | 7481.5 |
| RAB4A | 7480.5 |
| DPH5 | 7476.5 |
| PAX6 | 7474.5 |
| MRPL9 | 7452.5 |
| MRPL19 | 7446.5 |
| MRPL44 | 7423.5 |
| RAB1B | 7416.5 |
| TUFM | 7412.5 |
| LAMB2 | 7390.5 |
| PCSK9 | 7387.5 |
| SKP1 | 7381.5 |
| UBE2M | 7376.5 |
| CAPZB | 7374.5 |
| UBA52 | 7357.5 |
| SPTA1 | 7356.5 |
| UIMC1 | 7349.5 |
| TTL | 7348.5 |
| PSMA6 | 7345.5 |
| ASB12 | 7338.5 |
| INO80E | 7337.5 |
| ADAMTS20 | 7332.5 |
| USP30 | 7330.5 |
| COPS4 | 7310.5 |
| MCFD2 | 7307.5 |
| NPPA | 7300.5 |
| OXA1L | 7295.5 |
| HSPA5 | 7276.5 |
| EXTL2 | 7266.5 |
| NUP58 | 7254.5 |
| TNIP2 | 7247.5 |
| AIMP2 | 7246.5 |
| MRPL14 | 7233.5 |
| AGBL1 | 7227.5 |
| REN | 7205.5 |
| AAAS | 7196.5 |
| CUL2 | 7195.5 |
| UBE2D3 | 7189.5 |
| KLHDC3 | 7188.5 |
| PROZ | 7183.5 |
| HYOU1 | 7179.5 |
| RAB5B | 7162.5 |
| RAB22A | 7156.5 |
| MRPL42 | 7151.5 |
| MRPL58 | 7145.5 |
| DYNC1LI1 | 7142.5 |
| NFYA | 7132.5 |
| MRPS9 | 7125.5 |
| MRPS21 | 7123.5 |
| CRHR2 | 7121.5 |
| ST6GALNAC4 | 7119.5 |
| ASB1 | 7112.5 |
| MRPL33 | 7108.5 |
| DARS2 | 7106.5 |
| SEC24D | 7100.5 |
| MRPL46 | 7097.5 |
| ANK1 | 7089.5 |
| MRPS2 | 7088.5 |
| MRPL15 | 7081.5 |
| MRPS14 | 7080.5 |
| NCSTN | 7078.5 |
| PTEN | 7076.5 |
| CCT6A | 7075.5 |
| RAB36 | 7069.5 |
| SKIV2L | 7051.5 |
| LMCD1 | 7050.5 |
| DHPS | 7035.0 |
| EEF1A2 | 7029.5 |
| PSMD4 | 7024.5 |
| MRPS23 | 7023.5 |
| UBE2G2 | 7017.5 |
| MRPL34 | 7010.5 |
| USP13 | 7000.5 |
| VDR | 6987.5 |
| TAF10 | 6985.5 |
| LMAN1 | 6981.5 |
| TMEM115 | 6978.5 |
| ST3GAL5 | 6969.5 |
| GGA3 | 6955.5 |
| ST6GALNAC6 | 6936.0 |
| DYNC1H1 | 6922.5 |
| FPGT | 6916.5 |
| PSMB5 | 6910.5 |
| EEF1D | 6906.5 |
| ASNS | 6904.5 |
| GAPDHS | 6874.5 |
| POFUT2 | 6868.5 |
| SOCS2 | 6842.5 |
| ASB6 | 6841.5 |
| CBX8 | 6838.5 |
| NEURL2 | 6829.5 |
| PSMB9 | 6825.5 |
| UBA1 | 6820.5 |
| ESR1 | 6813.5 |
| DAP3 | 6808.5 |
| RPL28 | 6806.5 |
| EIF3C | 6805.0 |
| ACADVL | 6798.5 |
| EARS2 | 6792.5 |
| TPGS1 | 6786.5 |
| BMI1 | 6780.0 |
| THSD7B | 6773.5 |
| GPAA1 | 6770.5 |
| MRPL53 | 6767.5 |
| CANX | 6765.5 |
| TRAPPC5 | 6759.5 |
| FBXO40 | 6751.5 |
| ACTR1A | 6743.5 |
| NAPB | 6739.5 |
| INO80B | 6726.0 |
| PPARA | 6721.5 |
| MEN1 | 6707.5 |
| MDM2 | 6693.5 |
| RNF185 | 6684.5 |
| METTL21A | 6669.5 |
| OTUD3 | 6668.5 |
| GNG8 | 6665.5 |
| FUCA1 | 6664.5 |
| SPP1 | 6663.5 |
| CBX4 | 6653.5 |
| WIPI1 | 6633.5 |
| TRAF2 | 6628.5 |
| TNFAIP3 | 6624.5 |
| ST6GALNAC2 | 6618.5 |
| RPL19 | 6608.5 |
| MSRB2 | 6607.5 |
| DNMT3B | 6605.5 |
| VCP | 6599.5 |
| MRPL39 | 6593.5 |
| GATA4 | 6591.5 |
| TRAPPC6A | 6582.5 |
| BAP1 | 6571.5 |
| MRPL17 | 6570.5 |
| PIGB | 6565.5 |
| CSF2RA | 6556.5 |
| SLC30A5 | 6555.5 |
| EIF4A2 | 6546.5 |
| DHDDS | 6534.5 |
| PIGC | 6530.5 |
| PSMA8 | 6529.5 |
| GNG5 | 6527.5 |
| KEAP1 | 6518.5 |
| DDB1 | 6499.5 |
| SFTPB | 6488.5 |
| RPL29 | 6487.5 |
| GCNT7 | 6473.5 |
| CCT7 | 6470.5 |
| USP21 | 6463.5 |
| UBXN1 | 6458.5 |
| RPS10 | 6457.0 |
| KARS1 | 6454.5 |
| MRPL11 | 6448.5 |
| PSME1 | 6431.5 |
| FUOM | 6424.5 |
| FBXL22 | 6398.5 |
| MRPL54 | 6383.5 |
| RPN2 | 6347.5 |
| POMT1 | 6342.5 |
| ALG12 | 6339.5 |
| SAR1B | 6335.5 |
| MVD | 6331.5 |
| N6AMT1 | 6322.5 |
| PARP1 | 6319.5 |
| AMFR | 6316.5 |
| RPS11 | 6306.5 |
| MRPS6 | 6299.5 |
| MRPL47 | 6290.5 |
| PENK | 6289.5 |
| DCTN5 | 6287.5 |
| P4HB | 6271.5 |
| PEX14 | 6265.5 |
| EIF2B1 | 6227.5 |
| BTBD1 | 6223.5 |
| SFTPD | 6222.5 |
| MPI | 6217.5 |
| EIF5B | 6216.5 |
| RAB4B | 6215.0 |
| VDAC2 | 6210.5 |
| SEC16B | 6207.5 |
| RAB3A | 6182.5 |
| MRPS18A | 6180.5 |
| BGLAP | 6176.5 |
| ADORA2A | 6160.5 |
| PSMD14 | 6156.5 |
| DYNLL2 | 6153.5 |
| ADAMTS7 | 6147.5 |
| ETFB | 6145.5 |
| SRP68 | 6138.5 |
| INO80C | 6134.5 |
| RTN4RL1 | 6122.5 |
| SMC3 | 6121.5 |
| UBE2J2 | 6118.5 |
| TRAPPC4 | 6114.5 |
| MBD5 | 6111.5 |
| TRAPPC10 | 6107.0 |
| NUS1 | 6096.5 |
| PSMB6 | 6079.5 |
| STAT3 | 6074.5 |
| MRPL50 | 6063.5 |
| MRPS24 | 6060.5 |
| HSP90B1 | 6043.5 |
| KAT2B | 6027.5 |
| MRPL24 | 6022.5 |
| USP47 | 6014.5 |
| FBXO30 | 6011.5 |
| MBOAT4 | 5997.5 |
| DMP1 | 5991.5 |
| PSMB7 | 5988.5 |
| RAB25 | 5987.5 |
| DPAGT1 | 5977.5 |
| OTUB1 | 5970.5 |
| RPL35 | 5961.5 |
| ATXN3 | 5958.0 |
| ATXN3L | 5958.0 |
| PSMD7 | 5955.5 |
| DPH3 | 5953.5 |
| CTSD | 5945.0 |
| ADAMTSL5 | 5934.5 |
| NFKB2 | 5930.5 |
| METTL22 | 5926.5 |
| ELOC | 5925.5 |
| FBXO11 | 5918.5 |
| TGFBR2 | 5914.5 |
| SRD5A3 | 5897.5 |
| COPS3 | 5891.5 |
| SNCA | 5890.5 |
| RPL13 | 5882.5 |
| ARFGEF2 | 5877.5 |
| RAB21 | 5868.5 |
| MUL1 | 5864.5 |
| COPS8 | 5863.5 |
| MARS1 | 5857.5 |
| FBXO17 | 5852.5 |
| RBBP5 | 5832.5 |
| MYC | 5828.5 |
| UBE2S | 5823.5 |
| RTF1 | 5815.5 |
| CUL1 | 5811.5 |
| LMAN2L | 5803.5 |
| MRPL13 | 5793.5 |
| MRPL3 | 5792.5 |
| PSMD11 | 5787.5 |
| IKBKG | 5786.5 |
| CREBRF | 5771.5 |
| TMEM132A | 5761.5 |
| SLC34A2 | 5755.5 |
| EIF3G | 5745.5 |
| PPA1 | 5736.5 |
| PLA2G7 | 5717.5 |
| CREB3L2 | 5716.5 |
| MDGA1 | 5705.5 |
| MSRB1 | 5687.5 |
| PSMD8 | 5682.5 |
| TRAPPC2L | 5676.5 |
| APOL1 | 5666.0 |
| AARS2 | 5661.5 |
| RAD23B | 5659.5 |
| GOLM1 | 5651.5 |
| ST3GAL3 | 5647.5 |
| ASB2 | 5646.5 |
| TTLL8 | 5644.5 |
| EXTL3 | 5629.5 |
| LMAN2 | 5626.5 |
| SOCS3 | 5624.5 |
| RPSA | 5610.5 |
| EIF2B2 | 5602.5 |
| EIF3L | 5597.5 |
| APLP2 | 5581.5 |
| NUB1 | 5569.5 |
| MYRIP | 5566.5 |
| PSMA4 | 5533.5 |
| ASB5 | 5531.5 |
| SEC11C | 5517.5 |
| PSMD3 | 5512.5 |
| RBBP7 | 5506.5 |
| PCMT1 | 5488.5 |
| RPS14 | 5480.5 |
| KLHL21 | 5463.5 |
| MRPS7 | 5442.5 |
| TADA3 | 5438.5 |
| SENP2 | 5433.5 |
| USP12 | 5428.5 |
| NR1H3 | 5426.5 |
| APH1A | 5425.5 |
| PSMC2 | 5421.5 |
| TARS2 | 5405.5 |
| FBXL15 | 5402.5 |
| NANS | 5353.5 |
| ARF5 | 5340.5 |
| EIF3J | 5336.5 |
| NR3C1 | 5325.5 |
| MRPL22 | 5316.5 |
| GADD45GIP1 | 5315.5 |
| CD59 | 5311.0 |
| H2AZ1 | 5299.5 |
| KAT2A | 5284.5 |
| RPS7 | 5274.5 |
| SAFB | 5272.5 |
| MITF | 5268.5 |
| RAB11B | 5266.5 |
| SMAD7 | 5247.5 |
| COMMD5 | 5237.5 |
| ARF1 | 5233.5 |
| USO1 | 5229.5 |
| PSME4 | 5222.5 |
| MRPL49 | 5221.5 |
| PSMB1 | 5207.5 |
| ADGRF5 | 5202.5 |
| FBXO21 | 5197.5 |
| DYNC1I2 | 5195.5 |
| RPL3L | 5191.5 |
| TRAF3 | 5171.5 |
| B2M | 5167.5 |
| COPG2 | 5161.5 |
| TRAPPC9 | 5159.5 |
| UBE2G1 | 5157.5 |
| MRPL55 | 5154.5 |
| GNAI1 | 5149.5 |
| COPS5 | 5147.5 |
| RNF123 | 5138.5 |
| GLB1 | 5131.5 |
| ASB8 | 5124.5 |
| USP14 | 5122.5 |
| SCMH1 | 5110.5 |
| MRPS26 | 5107.5 |
| PSMD10 | 5093.5 |
| RAB35 | 5091.5 |
| CSNK2A1 | 5083.0 |
| B3GNT4 | 5073.5 |
| MRPS11 | 5060.5 |
| RAB6A | 5054.5 |
| SATB1 | 5049.5 |
| CREB3L3 | 5035.5 |
| MDGA2 | 5030.5 |
| PFDN1 | 5016.5 |
| DCTN6 | 5013.5 |
| TBCB | 5009.5 |
| SFTPC | 5007.5 |
| NAPSA | 5002.5 |
| SPTB | 5001.5 |
| MRPL2 | 4996.5 |
| PSMC3 | 4982.5 |
| PLAUR | 4965.5 |
| DPH2 | 4963.5 |
| RPL18 | 4957.5 |
| EIF5A | 4949.0 |
| RPL10A | 4938.5 |
| KTN1 | 4932.5 |
| PIGK | 4930.5 |
| NEU2 | 4929.5 |
| CD55 | 4922.5 |
| EXOSC6 | 4913.5 |
| ADRM1 | 4905.5 |
| FBXO9 | 4904.5 |
| COMMD3 | 4874.5 |
| GALNT18 | 4871.5 |
| PMM1 | 4867.5 |
| MRPS12 | 4860.5 |
| COG7 | 4858.5 |
| FCGR3B | 4854.0 |
| B3GALNT2 | 4852.5 |
| COG5 | 4835.5 |
| NR4A2 | 4829.5 |
| PSMA2 | 4823.0 |
| TTLL13P | 4818.0 |
| OS9 | 4799.5 |
| GALNTL5 | 4794.5 |
| TFAP2B | 4790.5 |
| PPP2R5B | 4784.5 |
| RAB5C | 4783.5 |
| WSB2 | 4768.5 |
| EIF2S2 | 4761.5 |
| PSMC4 | 4751.5 |
| ISL1 | 4716.5 |
| TLN1 | 4705.5 |
| CUL5 | 4698.5 |
| EXOC7 | 4692.5 |
| BET1L | 4690.5 |
| PSMD2 | 4685.5 |
| THRB | 4674.5 |
| RPL18A | 4656.5 |
| PSMD5 | 4655.5 |
| OTUD5 | 4643.5 |
| EXOC4 | 4639.5 |
| THSD1 | 4628.5 |
| TBC1D20 | 4621.5 |
| USP24 | 4607.5 |
| H2AC1 | 4603.5 |
| GNGT2 | 4590.5 |
| MRPL35 | 4577.5 |
| DOLK | 4576.5 |
| ADRA2C | 4558.5 |
| MYDGF | 4557.5 |
| SEL1L | 4548.5 |
| GATA6 | 4534.5 |
| CCDC59 | 4523.5 |
| RPL9 | 4522.5 |
| ADORA2B | 4518.5 |
| PHC2 | 4513.5 |
| B3GNT6 | 4510.5 |
| GARS1 | 4498.5 |
| DDOST | 4494.5 |
| KIN | 4487.5 |
| AOPEP | 4478.5 |
| SHISA5 | 4475.5 |
| NUP62 | 4455.5 |
| XPC | 4452.5 |
| RPS4X | 4442.5 |
| SENP5 | 4439.5 |
| CCT5 | 4438.5 |
| GATA3 | 4430.5 |
| PSMD6 | 4428.5 |
| COG2 | 4421.5 |
| CALR | 4416.5 |
| RARS2 | 4410.5 |
| SLC35C1 | 4406.5 |
| MRPL20 | 4398.5 |
| DNAJC3 | 4351.5 |
| PSMC5 | 4349.5 |
| RAB11A | 4327.5 |
| APC | 4290.5 |
| H2AC21 | 4285.5 |
| PREB | 4275.5 |
| HIPK2 | 4273.5 |
| CPE | 4263.5 |
| PFDN5 | 4262.5 |
| VDAC1 | 4260.5 |
| YARS1 | 4257.5 |
| NEU4 | 4217.5 |
| TUBB4B | 4215.5 |
| USP11 | 4212.5 |
| TP53BP1 | 4208.5 |
| RPL15 | 4191.5 |
| POMC | 4179.5 |
| ADAMTS15 | 4172.5 |
| CTNNB1 | 4165.5 |
| RBX1 | 4159.5 |
| CARS1 | 4157.5 |
| CCT8 | 4121.5 |
| ETF1 | 4118.5 |
| GALNT15 | 4101.5 |
| ENGASE | 4091.5 |
| AXIN2 | 4074.5 |
| FOLR2 | 4060.5 |
| HARS1 | 4044.5 |
| PRKCSH | 4043.5 |
| PGAP1 | 4042.5 |
| WDR48 | 4040.5 |
| CNIH1 | 4023.5 |
| DDX58 | 4015.5 |
| MRPL52 | 4008.5 |
| KLHL3 | 4002.5 |
| IGFBP6 | 3999.5 |
| SRPRA | 3989.5 |
| SARS2 | 3976.0 |
| KLHL25 | 3970.5 |
| PSMA7 | 3962.5 |
| EIF3B | 3961.5 |
| JOSD1 | 3957.5 |
| ARFGAP2 | 3941.5 |
| STAMBP | 3927.5 |
| ADAMTS10 | 3907.5 |
| DNMT3A | 3900.5 |
| PNPLA2 | 3894.5 |
| POMGNT2 | 3893.5 |
| UBE2N | 3887.0 |
| USP10 | 3877.5 |
| ADRA2A | 3874.5 |
| TMEM129 | 3873.5 |
| NPL | 3871.5 |
| ENPEP | 3862.5 |
| RAB40C | 3852.5 |
| SUDS3 | 3848.5 |
| HRC | 3828.5 |
| DNAJB11 | 3817.0 |
| SLC30A6 | 3807.5 |
| TARS1 | 3797.5 |
| HIF3A | 3792.5 |
| AGTPBP1 | 3790.5 |
| GFPT1 | 3782.5 |
| KBTBD8 | 3780.5 |
| MARCHF6 | 3779.5 |
| LRRC49 | 3760.5 |
| EIF3H | 3755.5 |
| DCP2 | 3743.5 |
| OTUB2 | 3739.5 |
| TNIP3 | 3734.5 |
| GANAB | 3728.5 |
| PGR | 3723.5 |
| IZUMO1R | 3694.5 |
| TADA2B | 3675.5 |
| EPAS1 | 3670.5 |
| PIGS | 3657.5 |
| MRPL32 | 3649.5 |
| PEX2 | 3648.5 |
| USP49 | 3646.5 |
| MRPS27 | 3638.5 |
| GMPPB | 3635.5 |
| APOA1 | 3608.5 |
| MUC4 | 3605.5 |
| WDR5 | 3598.5 |
| CCNE1 | 3590.5 |
| SSR4 | 3584.5 |
| DCTN3 | 3564.5 |
| DERL1 | 3559.5 |
| BABAM1 | 3557.5 |
| WDTC1 | 3554.5 |
| RABGGTA | 3527.5 |
| IKBKE | 3512.5 |
| EXOSC5 | 3498.5 |
| TUBA1B | 3495.5 |
| JOSD2 | 3490.5 |
| CBX2 | 3478.5 |
| MRPS31 | 3476.5 |
| INHBE | 3474.5 |
| APEH | 3470.5 |
| MPDU1 | 3465.5 |
| GGA2 | 3462.5 |
| USP16 | 3451.5 |
| HDAC2 | 3446.5 |
| FBXO27 | 3439.5 |
| MRRF | 3438.5 |
| CCT4 | 3429.5 |
| EIF2B4 | 3425.5 |
| GAN | 3422.5 |
| GHRL | 3419.5 |
| RPS26 | 3411.5 |
| GNAO1 | 3374.5 |
| CALM1 | 3372.5 |
| OTUD7B | 3367.5 |
| EIF4EBP1 | 3336.5 |
| B3GNT5 | 3294.5 |
| SPON1 | 3293.5 |
| NUP153 | 3291.5 |
| CST3 | 3278.5 |
| ADAMTSL4 | 3269.5 |
| DERL2 | 3262.5 |
| MRPL40 | 3261.5 |
| FBXL20 | 3258.5 |
| CCT2 | 3257.5 |
| TAB1 | 3233.5 |
| NUP35 | 3225.5 |
| PSMD12 | 3211.5 |
| GSK3A | 3191.5 |
| EIF5A2 | 3188.5 |
| UBE2D1 | 3169.5 |
| STC2 | 3168.5 |
| RPS6 | 3167.5 |
| TOMM20 | 3158.5 |
| TMED10 | 3153.5 |
| FBXW12 | 3144.5 |
| RENBP | 3132.5 |
| FARSA | 3117.5 |
| RGS6 | 3103.5 |
| RPL23 | 3101.5 |
| NUP42 | 3099.5 |
| IL33 | 3098.5 |
| TPP1 | 3094.5 |
| NSMCE3 | 3081.5 |
| RNF146 | 3078.5 |
| ASB17 | 3075.5 |
| SLC30A8 | 3069.5 |
| EIF3A | 3054.5 |
| COMMD7 | 3053.0 |
| CNTN3 | 3046.5 |
| MGAT2 | 3043.5 |
| MRPS18C | 3041.5 |
| MTRF1L | 3028.5 |
| EIF2S3 | 3002.0 |
| NUDT14 | 2990.5 |
| MBD1 | 2985.5 |
| ERAL1 | 2960.5 |
| EP300 | 2949.5 |
| PSMB2 | 2944.5 |
| VDAC3 | 2927.5 |
| TTLL6 | 2918.5 |
| ARSA | 2907.5 |
| EDEM2 | 2905.5 |
| CMAS | 2889.5 |
| EIF3D | 2883.5 |
| FBXO6 | 2870.5 |
| MTIF2 | 2857.5 |
| DAG1 | 2817.5 |
| TOMM70 | 2806.5 |
| COMMD1 | 2777.5 |
| LYPD3 | 2772.5 |
| SPCS1 | 2770.5 |
| LRRC41 | 2769.5 |
| RAB40B | 2765.5 |
| B3GNTL1 | 2755.5 |
| ST3GAL6 | 2752.5 |
| RCE1 | 2747.5 |
| MRPS10 | 2736.5 |
| DYNC1I1 | 2733.5 |
| MRPS22 | 2728.5 |
| AIMP1 | 2707.5 |
| DNAJC24 | 2699.5 |
| GBA | 2686.5 |
| B4GALT3 | 2679.5 |
| SUMF1 | 2678.5 |
| MRPS33 | 2646.5 |
| TPR | 2614.5 |
| CHCHD1 | 2605.5 |
| KLHL41 | 2601.5 |
| SMURF2 | 2597.5 |
| TSPAN15 | 2576.5 |
| POLB | 2550.5 |
| PSME2 | 2547.5 |
| TRIM28 | 2545.5 |
| AP3M1 | 2544.5 |
| RAB33A | 2537.5 |
| GALNT3 | 2536.5 |
| TTLL12 | 2488.5 |
| H2BC1 | 2483.5 |
| RAB9B | 2475.5 |
| FOXK1 | 2423.5 |
| PHC1 | 2419.5 |
| TRAPPC6B | 2394.5 |
| YY1 | 2391.5 |
| XBP1 | 2388.5 |
| LGALS1 | 2386.5 |
| MGAT1 | 2351.5 |
| TRAPPC1 | 2349.5 |
| CHRDL1 | 2342.5 |
| RPL8 | 2340.5 |
| ARF3 | 2323.5 |
| ZRANB1 | 2308.5 |
| CBX5 | 2304.5 |
| PIGT | 2300.5 |
| RPS27A | 2261.5 |
| YOD1 | 2244.5 |
| ABCA3 | 2242.5 |
| CCDC8 | 2233.5 |
| TSHB | 2225.5 |
| RAB20 | 2222.5 |
| DCAF4 | 2206.0 |
| NUCB1 | 2192.5 |
| PARS2 | 2174.5 |
| ADAM10 | 2171.5 |
| BACE1 | 2157.5 |
| VBP1 | 2152.5 |
| RAB13 | 2137.0 |
| MRPL18 | 2121.5 |
| CXXC1 | 2096.5 |
| MTIF3 | 2088.5 |
| SPTBN5 | 2087.5 |
| FBXO32 | 2080.5 |
| RAB5A | 2068.5 |
| GALNT9 | 2059.5 |
| RPL24 | 2057.5 |
| UBE2F | 2049.0 |
| RAB10 | 2046.5 |
| RPS5 | 2028.5 |
| OBSL1 | 2025.5 |
| TTLL3 | 2019.0 |
| RHOA | 2014.5 |
| UGGT1 | 2006.5 |
| RABGGTB | 1993.5 |
| NFYB | 1992.5 |
| MELTF | 1990.5 |
| SRP14 | 1989.5 |
| CUL9 | 1983.5 |
| TFPT | 1969.5 |
| TTF1 | 1943.5 |
| COMMD8 | 1941.5 |
| CTSA | 1936.5 |
| CTDSP2 | 1935.5 |
| COPA | 1926.5 |
| SAE1 | 1914.5 |
| QARS1 | 1901.5 |
| SMC1A | 1891.5 |
| ADAMTS1 | 1877.5 |
| PSMA1 | 1867.5 |
| EIF1AX | 1826.5 |
| RPL22 | 1825.5 |
| SSR3 | 1807.5 |
| SEMG1 | 1806.0 |
| TECTB | 1795.5 |
| SOCS5 | 1794.5 |
| COPB2 | 1778.5 |
| MRPS25 | 1771.5 |
| MAN1A2 | 1767.5 |
| UCHL5 | 1761.5 |
| LY6D | 1755.5 |
| DPH6 | 1751.5 |
| GOSR2 | 1741.0 |
| UBA3 | 1735.5 |
| SARS1 | 1720.5 |
| ASB14 | 1714.5 |
| MRPL21 | 1681.5 |
| TSPAN5 | 1675.5 |
| MRPL41 | 1669.5 |
| SRP9 | 1648.5 |
| RPN1 | 1646.5 |
| FBXL12 | 1644.5 |
| PRSS21 | 1641.0 |
| CDX2 | 1614.5 |
| ACTR10 | 1585.5 |
| SP3 | 1581.5 |
| PSMB4 | 1567.5 |
| ING2 | 1559.5 |
| CEBPG | 1551.5 |
| PPP6R3 | 1521.5 |
| KLHL42 | 1513.5 |
| RAB12 | 1511.5 |
| FARSB | 1504.5 |
| CREB3 | 1499.5 |
| PSMC6 | 1488.5 |
| RARS1 | 1477.5 |
| SLC17A5 | 1470.5 |
| TSPAN33 | 1466.5 |
| ASB13 | 1465.5 |
| INHBC | 1464.5 |
| GCNT1 | 1450.5 |
| IGFBP2 | 1448.5 |
| ST3GAL4 | 1445.5 |
| PSME3 | 1442.5 |
| ASB18 | 1438.5 |
| SEMA5A | 1419.5 |
| PFDN2 | 1418.5 |
| ITIH2 | 1402.5 |
| XRCC4 | 1393.5 |
| CTSZ | 1359.5 |
| RANBP2 | 1353.5 |
| VGF | 1314.5 |
| AMDHD2 | 1304.0 |
| MRPL16 | 1300.5 |
| PTP4A2 | 1297.5 |
| GMPPA | 1290.5 |
| ERO1A | 1289.5 |
| SATB2 | 1284.5 |
| FSHB | 1274.5 |
| RAB2A | 1266.5 |
| MRPL51 | 1260.5 |
| PCSK1 | 1258.5 |
| H2BC11 | 1257.5 |
| USP8 | 1256.5 |
| MUC1 | 1254.5 |
| MATN3 | 1246.5 |
| SPCS2 | 1231.5 |
| SOCS6 | 1180.5 |
| CARS2 | 1179.5 |
| PIGX | 1176.5 |
| LEO1 | 1162.5 |
| RAB14 | 1158.5 |
| ZDHHC2 | 1157.5 |
| DCAF13 | 1143.5 |
| RPS8 | 1133.5 |
| PPARGC1A | 1116.5 |
| ADAMTSL2 | 1114.5 |
| RRAGA | 1100.5 |
| COG3 | 1093.5 |
| RPS27L | 1090.5 |
| TRIM27 | 1088.5 |
| MCRS1 | 1074.5 |
| NAPG | 1073.5 |
| RNF7 | 1064.5 |
| GALNT14 | 1059.5 |
| MRPL48 | 1028.5 |
| CAPZA2 | 1017.5 |
| ITM2B | 983.5 |
| CES1 | 953.5 |
| EIF3E | 897.5 |
| CGA | 845.5 |
| GZMH | 845.5 |
| IAPP | 845.5 |
| KLK13 | 845.5 |
| LYPD5 | 845.5 |
| UMOD | 845.5 |
| FBXO4 | 807.5 |
| HDAC3 | 774.5 |
| ARRB1 | 770.5 |
| DYNLL1 | 767.5 |
| TUBB3 | 760.0 |
| MAN1C1 | 758.5 |
| ARFGAP3 | 737.5 |
| CFP | 733.5 |
| FSTL3 | 715.5 |
| COPS6 | 698.5 |
| DCUN1D3 | 688.5 |
| FBXO22 | 659.5 |
| RAB18 | 658.5 |
| IGFALS | 652.5 |
| F2 | 644.5 |
| SRP19 | 616.5 |
| ARSL | 606.5 |
| SMC6 | 600.5 |
| CUL7 | 597.5 |
| CUL4B | 587.5 |
| TTLL4 | 576.5 |
| CUL3 | 572.5 |
| SUMO3 | 571.5 |
| BTBD6 | 559.5 |
| KIF13A | 558.5 |
| LARS1 | 552.5 |
| DCAF6 | 546.5 |
| RPS15 | 545.5 |
| F9 | 544.5 |
| CALB1 | 528.5 |
| EXOC1 | 518.5 |
| APOA5 | 517.5 |
| UAP1 | 507.5 |
| WDR20 | 500.5 |
| ART4 | 498.5 |
| SENP8 | 470.5 |
| COMMD2 | 469.5 |
| ADAMTS16 | 468.5 |
| CCL2 | 464.5 |
| CNIH2 | 455.5 |
| ALG5 | 453.5 |
| FKBP14 | 439.5 |
| PIGH | 434.5 |
| ADD1 | 414.5 |
| IGFBP5 | 409.5 |
| HDAC7 | 402.5 |
| RXRA | 395.5 |
| PSMB3 | 391.5 |
| BARD1 | 384.5 |
| RPL37 | 367.5 |
| KLK2 | 344.0 |
| KLK3 | 344.0 |
| CFTR | 341.5 |
| GSN | 316.5 |
| EXOC5 | 307.5 |
| RPL37A | 302.5 |
| FBXW2 | 264.5 |
| BIRC2 | 238.5 |
| CTSC | 225.5 |
| ATP6AP2 | 220.5 |
| MUC5B | 199.5 |
| TMED2 | 181.5 |
| LY6H | 172.5 |
| NCOA2 | 159.5 |
| RPS3A | 133.5 |
| UBE2D2 | 126.5 |
| CETN2 | 125.5 |
| NRN1 | 109.5 |
| ADAMTS9 | 102.5 |
| COPS7B | 101.5 |
| UBC | 100.5 |
| FOXL2 | 88.5 |
| GALNT11 | 81.5 |
| LYPD6B | 53.0 |
| ODAM | 53.0 |
| RPL21 | 45.0 |
| PDIA6 | 16.5 |
| PSMA5 | 5.5 |
| RPL32 | 0.5 |
| CNTN5 | -13.5 |
| SEC23A | -37.5 |
| DCUN1D5 | -55.5 |
| NUP54 | -72.5 |
| RPS28 | -86.5 |
| GNG3 | -91.5 |
| SPSB2 | -102.5 |
| CTR9 | -103.5 |
| VAMP2 | -124.0 |
| NUP205 | -128.5 |
| ATXN7 | -150.5 |
| PIGA | -165.5 |
| DPM1 | -182.5 |
| CCP110 | -194.5 |
| ADAMTSL3 | -195.5 |
| PML | -220.5 |
| PEX12 | -239.5 |
| NCOR2 | -240.5 |
| PEX5 | -258.5 |
| IDE | -266.5 |
| PIGQ | -284.5 |
| SEC16A | -288.5 |
| NEU3 | -291.5 |
| PAPPA2 | -293.5 |
| RAB44 | -325.5 |
| ASB15 | -327.5 |
| TRAF6 | -331.5 |
| SPP2 | -345.5 |
| SUMO1 | -348.5 |
| CEBPB | -366.5 |
| APCS | -372.5 |
| ST8SIA4 | -377.5 |
| COPZ1 | -411.5 |
| RNF103 | -425.5 |
| PIGM | -432.5 |
| TFAP2A | -436.5 |
| ADAMTS8 | -440.5 |
| NDC1 | -444.5 |
| B3GNT3 | -475.5 |
| C1GALT1C1 | -482.5 |
| SBSPON | -483.5 |
| KLHL9 | -513.5 |
| FURIN | -528.5 |
| GMDS | -539.5 |
| AGBL2 | -547.5 |
| INHBA | -562.5 |
| FEM1C | -578.5 |
| GNG4 | -595.5 |
| MUC6 | -599.5 |
| VNN1 | -605.5 |
| PIGG | -608.5 |
| RNF139 | -616.5 |
| PSMA3 | -754.5 |
| FAM20A | -774.5 |
| NUP88 | -800.5 |
| DCTN4 | -814.5 |
| B3GNT8 | -834.5 |
| CCDC22 | -868.5 |
| LMAN1L | -882.5 |
| AGBL5 | -897.5 |
| CPM | -899.5 |
| KCTD7 | -902.5 |
| UBE2I | -909.5 |
| TGFBI | -935.5 |
| INHBB | -949.5 |
| POM121 | -968.0 |
| POM121C | -968.0 |
| AURKA | -982.5 |
| ASXL2 | -989.5 |
| NR3C2 | -1003.5 |
| SHC1 | -1008.5 |
| ALG6 | -1014.5 |
| TRIM25 | -1015.5 |
| TRIM13 | -1027.5 |
| TXN | -1082.5 |
| UCN | -1083.5 |
| EXOC8 | -1084.5 |
| FCSK | -1086.5 |
| TUBA3E | -1087.5 |
| MMP2 | -1091.5 |
| ANO8 | -1094.5 |
| FFAR4 | -1114.5 |
| GCNT4 | -1123.5 |
| ALG10 | -1129.0 |
| ALG10B | -1129.0 |
| ST8SIA5 | -1153.5 |
| DPH7 | -1164.5 |
| MRPL43 | -1166.5 |
| PROC | -1175.5 |
| PSMB10 | -1181.5 |
| ACTL6A | -1190.5 |
| IGFBP7 | -1193.5 |
| USP28 | -1197.5 |
| FBXW11 | -1203.5 |
| EEF1B2 | -1217.5 |
| PIGF | -1220.5 |
| ARSG | -1228.5 |
| RAB24 | -1272.5 |
| YARS2 | -1276.5 |
| LTBP1 | -1317.5 |
| NAT8 | -1347.0 |
| NAT8B | -1347.0 |
| ARRB2 | -1362.5 |
| FBXL18 | -1363.5 |
| SCG2 | -1375.5 |
| CISH | -1377.5 |
| GNAT1 | -1378.5 |
| NUP160 | -1394.5 |
| GOLGB1 | -1400.5 |
| PIGY | -1411.5 |
| SEC13 | -1413.5 |
| MRPS16 | -1420.5 |
| PSMF1 | -1438.5 |
| MBD6 | -1439.5 |
| KLF4 | -1440.5 |
| BCL10 | -1468.5 |
| RCN1 | -1485.0 |
| ERO1B | -1490.5 |
| TGFB1 | -1494.5 |
| PIGU | -1506.5 |
| B4GALT2 | -1507.5 |
| CAPZA3 | -1550.5 |
| GNAZ | -1587.5 |
| STAM | -1589.5 |
| TBCC | -1597.5 |
| DCAF10 | -1610.5 |
| CDC25A | -1611.5 |
| OTOA | -1614.5 |
| NR1H2 | -1637.5 |
| RAB3D | -1641.5 |
| HDAC4 | -1650.5 |
| POMT2 | -1668.5 |
| RPL36 | -1676.5 |
| AMTN | -1679.5 |
| RAD18 | -1683.5 |
| ASB7 | -1685.5 |
| GNG12 | -1688.5 |
| NOP56 | -1690.5 |
| RPL31 | -1702.5 |
| ZBTB16 | -1703.5 |
| NUP210 | -1705.5 |
| RIPK2 | -1709.5 |
| MRPL27 | -1728.5 |
| SCFD1 | -1743.5 |
| ALG14 | -1762.5 |
| DCAF7 | -1767.5 |
| ARSK | -1772.5 |
| RAB7A | -1781.5 |
| UHRF2 | -1794.5 |
| KLHL5 | -1802.5 |
| USP44 | -1803.5 |
| PDIA3 | -1811.5 |
| MRPS28 | -1815.5 |
| MSRB3 | -1828.5 |
| STAM2 | -1842.5 |
| BTRC | -1843.5 |
| GNAI2 | -1866.5 |
| NUP188 | -1868.5 |
| TMED9 | -1874.5 |
| SRP54 | -1887.5 |
| RNF152 | -1891.5 |
| CCT6B | -1900.5 |
| CD52 | -1904.5 |
| USP33 | -1939.5 |
| ACTR5 | -1944.5 |
| AR | -1955.5 |
| STX5 | -1984.5 |
| DARS1 | -1997.5 |
| EXOC6 | -2014.5 |
| GALNT6 | -2027.5 |
| USP22 | -2034.5 |
| PLET1 | -2044.5 |
| GNGT1 | -2049.5 |
| FUT8 | -2055.5 |
| RAB3B | -2066.5 |
| DPM3 | -2068.5 |
| DAD1 | -2086.5 |
| GFPT2 | -2096.5 |
| ANKRD28 | -2102.5 |
| LEP | -2110.5 |
| PCGF2 | -2133.5 |
| UBE2Q2 | -2148.5 |
| GNG11 | -2149.5 |
| EIF4A1 | -2162.5 |
| MOGS | -2164.5 |
| PIGO | -2167.5 |
| LMO7 | -2173.5 |
| CHGB | -2180.5 |
| USP18 | -2198.0 |
| EXOSC4 | -2203.5 |
| TPST2 | -2228.5 |
| SLC34A1 | -2251.0 |
| TTR | -2281.5 |
| EVA1A | -2285.5 |
| ARF4 | -2289.5 |
| RAB29 | -2295.5 |
| UBE2K | -2298.5 |
| TUBB1 | -2306.5 |
| GALNT1 | -2316.5 |
| TULP4 | -2320.5 |
| RAB23 | -2336.5 |
| DDX5 | -2353.5 |
| EIF2B3 | -2357.5 |
| RPL7A | -2363.5 |
| DYNC1LI2 | -2368.5 |
| BRCC3 | -2379.5 |
| PRKDC | -2381.5 |
| RGS9 | -2392.5 |
| PIAS3 | -2404.5 |
| FBXO2 | -2409.5 |
| UBE2H | -2410.5 |
| SEC61A1 | -2411.5 |
| DOLPP1 | -2413.5 |
| USP3 | -2439.5 |
| THBS1 | -2452.5 |
| MDM4 | -2459.5 |
| CSF2RB | -2462.5 |
| SEC22A | -2470.5 |
| AGBL4 | -2525.5 |
| SFTPA1 | -2527.0 |
| SFTPA2 | -2527.0 |
| ASGR1 | -2535.5 |
| TNKS2 | -2539.5 |
| USP34 | -2548.5 |
| NTM | -2549.5 |
| FBXL5 | -2550.5 |
| F7 | -2554.5 |
| MRPS35 | -2568.5 |
| ST6GALNAC5 | -2592.5 |
| PGM3 | -2617.5 |
| MSLN | -2626.5 |
| CLTRN | -2630.0 |
| GNG10 | -2665.5 |
| ATF6 | -2670.5 |
| PSENEN | -2678.5 |
| TIMP1 | -2680.5 |
| HSPG2 | -2698.5 |
| ERN1 | -2704.5 |
| ACE2 | -2706.5 |
| PIGW | -2715.5 |
| FEM1B | -2716.5 |
| PEX13 | -2723.5 |
| EXOSC9 | -2726.5 |
| DCUN1D1 | -2732.5 |
| DPM2 | -2752.5 |
| PSMD9 | -2755.0 |
| B4GAT1 | -2761.5 |
| USP9X | -2762.5 |
| PSMD13 | -2775.5 |
| ST3GAL2 | -2776.5 |
| TRAPPC3 | -2779.5 |
| ACHE | -2783.5 |
| RPS23 | -2786.5 |
| TPGS2 | -2790.5 |
| RAB31 | -2791.5 |
| LYPD8 | -2797.0 |
| INS | -2798.5 |
| STAMBPL1 | -2799.5 |
| INO80D | -2837.5 |
| TCF7L2 | -2848.5 |
| KDELR1 | -2857.5 |
| CPB2 | -2868.5 |
| BST1 | -2872.5 |
| AFP | -2884.5 |
| IFIH1 | -2885.5 |
| MRPS36 | -2886.5 |
| CREBBP | -2899.5 |
| RFT1 | -2901.0 |
| RAB38 | -2906.5 |
| NR5A1 | -2913.5 |
| ST8SIA1 | -2915.5 |
| UBE2W | -2941.0 |
| EIF3F | -2965.5 |
| TTLL11 | -2971.5 |
| WDR61 | -2988.5 |
| KIF5C | -2998.5 |
| THY1 | -3012.5 |
| SEC11A | -3017.5 |
| KIF5B | -3021.5 |
| MUC16 | -3039.5 |
| INCENP | -3046.5 |
| FN3KRP | -3059.5 |
| B3GLCT | -3087.5 |
| SERP1 | -3120.5 |
| RAB27B | -3126.5 |
| PPP6C | -3128.5 |
| SUZ12 | -3134.5 |
| RORA | -3141.5 |
| LARGE2 | -3146.5 |
| GALNT16 | -3148.5 |
| NUP85 | -3156.5 |
| UCHL1 | -3161.5 |
| XPNPEP2 | -3162.5 |
| PCNA | -3165.5 |
| RGS7 | -3177.5 |
| MUC20 | -3184.5 |
| TOPORS | -3191.5 |
| ADRB2 | -3195.5 |
| WARS2 | -3221.5 |
| NRIP1 | -3232.5 |
| NUP43 | -3243.5 |
| RPL7 | -3262.5 |
| PPARG | -3265.5 |
| HCFC1 | -3268.5 |
| CHST8 | -3284.5 |
| PSCA | -3285.5 |
| NOD2 | -3286.5 |
| GPLD1 | -3296.5 |
| FAM20C | -3301.5 |
| SPCS3 | -3307.5 |
| RPS3 | -3309.5 |
| ETFBKMT | -3317.5 |
| NCOA1 | -3368.5 |
| EDEM3 | -3377.5 |
| FBXL7 | -3388.5 |
| TTLL10 | -3395.5 |
| ALG2 | -3421.5 |
| CMA1 | -3445.5 |
| TMED3 | -3454.5 |
| TAF9B | -3457.5 |
| CASP8AP2 | -3463.5 |
| PCSK2 | -3470.5 |
| FBXW4 | -3486.5 |
| GCG | -3500.5 |
| COPB1 | -3511.5 |
| UBE2B | -3529.5 |
| POMK | -3530.5 |
| SMAD3 | -3534.5 |
| OTUD7A | -3546.5 |
| DCSTAMP | -3549.0 |
| CHST10 | -3554.5 |
| SP100 | -3563.5 |
| RPS2 | -3580.5 |
| RAB2B | -3586.5 |
| TUBB6 | -3594.5 |
| NAE1 | -3606.5 |
| PLA2G4B | -3614.0 |
| FBXW7 | -3647.5 |
| EEF1A1 | -3659.5 |
| CDH2 | -3669.5 |
| AREG | -3687.5 |
| MAP3K7 | -3694.5 |
| GPC3 | -3706.5 |
| STX17 | -3717.5 |
| DCAF17 | -3740.5 |
| BCHE | -3751.5 |
| TGOLN2 | -3765.5 |
| TCP1 | -3778.5 |
| ADAMTS3 | -3789.5 |
| GALNT12 | -3791.5 |
| SEC24B | -3799.5 |
| VCPIP1 | -3803.5 |
| SIAH2 | -3808.5 |
| MYSM1 | -3819.5 |
| APOA4 | -3825.5 |
| GALNT5 | -3833.5 |
| RAB19 | -3864.5 |
| IL6 | -3914.5 |
| RNF128 | -3922.5 |
| UBE2Z | -3933.5 |
| CREB3L1 | -3946.5 |
| NGLY1 | -3967.5 |
| MAN1B1 | -4029.5 |
| ARFGAP1 | -4032.5 |
| PIGV | -4034.5 |
| WRN | -4072.5 |
| COMMD6 | -4074.5 |
| PDCL | -4136.5 |
| UCHL3 | -4145.5 |
| LYZ | -4146.5 |
| EXOSC7 | -4155.5 |
| FBXO15 | -4156.5 |
| NAGK | -4160.5 |
| EIF2S1 | -4178.5 |
| CDC73 | -4185.5 |
| ASXL1 | -4189.5 |
| KCTD6 | -4195.5 |
| FBXO7 | -4204.5 |
| RPL5 | -4208.5 |
| FOXK2 | -4210.5 |
| CKAP4 | -4212.5 |
| MGAT3 | -4218.5 |
| RNF168 | -4223.5 |
| SEMA5B | -4239.5 |
| ADAMTS13 | -4240.5 |
| SKP2 | -4252.5 |
| TUBB4A | -4256.5 |
| IGFBP4 | -4257.5 |
| RNF144A | -4282.5 |
| BMP15 | -4299.5 |
| LY6G6D | -4304.5 |
| RPS15A | -4306.5 |
| EIF5 | -4315.5 |
| SMAD1 | -4336.5 |
| RTN4RL2 | -4356.5 |
| INHA | -4369.5 |
| NANP | -4418.5 |
| NSMCE4A | -4422.5 |
| ST6GALNAC1 | -4426.5 |
| RPS25 | -4440.5 |
| YKT6 | -4449.5 |
| NSF | -4467.5 |
| ALG8 | -4469.5 |
| NUP98 | -4473.5 |
| CAND1 | -4498.5 |
| PIGL | -4510.5 |
| RAB33B | -4533.5 |
| SPTBN4 | -4538.5 |
| RAB8A | -4539.5 |
| GGA1 | -4549.5 |
| UBD | -4558.5 |
| L3MBTL2 | -4584.5 |
| ALG1 | -4606.5 |
| CSNK2A2 | -4612.5 |
| CDCA8 | -4631.5 |
| VHL | -4639.5 |
| SEC31A | -4647.5 |
| ARCN1 | -4656.5 |
| ARSB | -4665.5 |
| CHST4 | -4701.5 |
| PIAS2 | -4718.5 |
| PIGP | -4723.5 |
| RPL10L | -4738.5 |
| B4GALT1 | -4742.5 |
| HDAC1 | -4797.5 |
| TRMT112 | -4815.5 |
| SPARCL1 | -4833.5 |
| EIF3M | -4836.5 |
| KLHL20 | -4856.5 |
| COPZ2 | -4860.5 |
| RPL38 | -4919.5 |
| FBXO41 | -4920.5 |
| ACE | -4922.5 |
| UBA6 | -4924.5 |
| NR2C1 | -4930.5 |
| RPL35A | -4964.5 |
| NUP93 | -4965.5 |
| COG6 | -4981.5 |
| GPR119 | -5023.5 |
| KLHL11 | -5032.5 |
| GALNT10 | -5046.5 |
| GNG2 | -5056.5 |
| CREB3L4 | -5057.5 |
| ELOB | -5059.5 |
| F8 | -5061.5 |
| PTRH2 | -5069.5 |
| CPB1 | -5071.5 |
| FGF23 | -5072.5 |
| PHC3 | -5074.5 |
| RNF20 | -5077.5 |
| B3GNT9 | -5091.5 |
| NUP107 | -5093.5 |
| FBXL8 | -5096.0 |
| RAB39A | -5101.5 |
| ICMT | -5125.5 |
| CPA3 | -5129.5 |
| USP7 | -5134.5 |
| SMAD4 | -5135.5 |
| SSR2 | -5139.5 |
| SPRN | -5143.5 |
| POMGNT1 | -5150.5 |
| RAB1A | -5165.5 |
| APOA2 | -5197.5 |
| P2RY2 | -5215.5 |
| ALPL | -5259.5 |
| ALG11 | -5260.5 |
| AGBL3 | -5288.5 |
| TFG | -5293.5 |
| B3GNT7 | -5294.5 |
| RAB37 | -5302.5 |
| UBA2 | -5311.5 |
| GALNTL6 | -5323.5 |
| NUP133 | -5325.5 |
| NOTUM | -5332.5 |
| SEC61B | -5336.5 |
| RAB7B | -5352.5 |
| MUC19 | -5359.5 |
| TSPAN14 | -5364.5 |
| ARSI | -5379.5 |
| CSF1 | -5418.5 |
| RAB26 | -5424.5 |
| XRN2 | -5434.5 |
| UBE2L6 | -5445.5 |
| CTSH | -5458.5 |
| PROS1 | -5462.5 |
| UBE2V2 | -5483.5 |
| UBE2E1 | -5485.5 |
| CHD3 | -5496.5 |
| LAMB1 | -5500.5 |
| HLA-A | -5511.0 |
| HLA-B | -5511.0 |
| FBN1 | -5514.5 |
| RAB15 | -5537.5 |
| SUMO2 | -5548.5 |
| ADAMTS18 | -5549.5 |
| LRR1 | -5573.5 |
| USP42 | -5582.5 |
| F10 | -5595.5 |
| RAB27A | -5601.5 |
| ADAMTS6 | -5605.5 |
| MGAT4B | -5613.5 |
| EEF2KMT | -5623.5 |
| LYPD2 | -5649.5 |
| GPIHBP1 | -5652.5 |
| RAB17 | -5670.5 |
| RAB43 | -5678.5 |
| SRPRB | -5708.5 |
| SEC61A2 | -5711.5 |
| FUCA2 | -5728.5 |
| MTFMT | -5744.5 |
| GOSR1 | -5774.5 |
| SERPINA10 | -5777.5 |
| RPL27 | -5778.5 |
| GALNT13 | -5791.5 |
| PPA2 | -5799.5 |
| CSNK1D | -5844.5 |
| EXOSC8 | -5869.5 |
| RAE1 | -5897.5 |
| TNC | -5911.5 |
| GNG13 | -5917.5 |
| H2BC3 | -5930.5 |
| AGT | -5931.5 |
| RIPK1 | -5961.5 |
| AMBN | -5988.5 |
| TBCA | -5992.5 |
| BMP4 | -6003.5 |
| LYPD1 | -6021.5 |
| RAB9A | -6033.5 |
| SIN3A | -6055.5 |
| NUP155 | -6056.5 |
| SEC23IP | -6087.5 |
| PFDN4 | -6092.5 |
| TNKS | -6095.5 |
| USP37 | -6101.5 |
| DTL | -6103.5 |
| RECK | -6124.5 |
| MGAT5 | -6125.5 |
| CCNE2 | -6133.5 |
| ADAMTS19 | -6164.5 |
| FN1 | -6177.5 |
| H2BU1 | -6178.5 |
| TMED7 | -6180.5 |
| FKBP9 | -6182.5 |
| BRCA1 | -6186.5 |
| HNRNPK | -6187.5 |
| FBXL13 | -6212.5 |
| RAB34 | -6217.5 |
| ST8SIA6 | -6219.5 |
| RELA | -6220.5 |
| KLHL2 | -6254.5 |
| IGFBP3 | -6259.5 |
| EEF1E1 | -6270.0 |
| ZNF131 | -6276.5 |
| ADAMTS5 | -6278.5 |
| SHPRH | -6283.5 |
| FGG | -6286.5 |
| ADAMTS12 | -6289.5 |
| APOE | -6290.5 |
| KDM1B | -6307.5 |
| GNAT2 | -6310.5 |
| TGFBR1 | -6311.5 |
| ST8SIA3 | -6329.5 |
| CNTN4 | -6335.5 |
| UBE2A | -6339.5 |
| THSD7A | -6351.5 |
| RAB6B | -6359.5 |
| STT3A | -6362.5 |
| PRND | -6374.5 |
| FGA | -6382.5 |
| RPS18 | -6410.5 |
| MGAT4C | -6415.5 |
| B4GALT4 | -6422.5 |
| THBS2 | -6443.5 |
| SPACA4 | -6448.5 |
| DDX11 | -6454.5 |
| F5 | -6460.5 |
| RAD21 | -6461.5 |
| RPS19 | -6473.5 |
| TTLL1 | -6483.5 |
| NTNG2 | -6485.5 |
| KLHL13 | -6491.5 |
| MXRA8 | -6502.5 |
| GCNT3 | -6517.5 |
| PLG | -6522.5 |
| FSTL1 | -6540.5 |
| ALB | -6541.5 |
| NPM1 | -6547.5 |
| VWA1 | -6552.5 |
| NR1I2 | -6566.5 |
| TRAM1 | -6569.5 |
| ENAM | -6615.5 |
| RAB3C | -6620.5 |
| RAB8B | -6622.5 |
| EIF4H | -6631.5 |
| GNB5 | -6634.5 |
| RPL30 | -6652.5 |
| SNCAIP | -6658.5 |
| LTF | -6660.5 |
| RPS21 | -6677.5 |
| RWDD3 | -6691.5 |
| RPLP1 | -6712.5 |
| B3GNT2 | -6719.5 |
| GSPT2 | -6727.5 |
| COMMD10 | -6733.5 |
| THRA | -6740.5 |
| IGFBP1 | -6742.5 |
| SDC2 | -6795.5 |
| GNB1 | -6797.5 |
| FAU | -6841.5 |
| HIF1A | -6851.5 |
| MGAT4A | -6859.5 |
| UBXN7 | -6860.5 |
| ADAMTS4 | -6871.5 |
| EXOSC3 | -6877.5 |
| DDB2 | -6883.5 |
| CCNF | -6884.5 |
| PUM2 | -6908.5 |
| KDELR2 | -6922.5 |
| GNG7 | -6928.5 |
| RARA | -6942.5 |
| RAB42 | -6944.5 |
| MAN2A1 | -6966.5 |
| H2BC12 | -7021.5 |
| BIRC5 | -7024.5 |
| EIF2AK3 | -7029.5 |
| TUBA1A | -7062.5 |
| SEC22C | -7089.5 |
| SCG3 | -7093.5 |
| NEGR1 | -7118.5 |
| CCNA1 | -7120.5 |
| CP | -7124.5 |
| SPSB1 | -7140.5 |
| HLTF | -7165.5 |
| GNAI3 | -7185.5 |
| AURKB | -7193.5 |
| RPS17 | -7220.5 |
| ADAMTS17 | -7223.5 |
| SLC30A7 | -7224.5 |
| NR1H4 | -7229.5 |
| INO80 | -7269.5 |
| MANEA | -7273.5 |
| KHSRP | -7285.5 |
| STX1A | -7287.5 |
| MSRA | -7292.5 |
| NOP58 | -7294.5 |
| TTLL5 | -7327.5 |
| EDEM1 | -7348.5 |
| RPL3 | -7355.5 |
| ALG9 | -7371.0 |
| PIGN | -7372.5 |
| MRTFA | -7387.5 |
| STAG2 | -7408.5 |
| PRSS23 | -7410.5 |
| ASB4 | -7412.5 |
| SPTBN2 | -7414.5 |
| LAMC1 | -7420.5 |
| CALCA | -7427.5 |
| SIAH1 | -7434.5 |
| GNB2 | -7445.5 |
| FBXL16 | -7460.5 |
| ADAMTS2 | -7475.5 |
| RPS16 | -7482.5 |
| TGFA | -7488.5 |
| WSB1 | -7494.5 |
| CCNA2 | -7508.5 |
| TBCE | -7521.0 |
| BECN1 | -7524.5 |
| UBE2C | -7543.5 |
| LSAMP | -7559.5 |
| UBE2T | -7584.5 |
| EXOC2 | -7589.5 |
| MBTPS2 | -7595.5 |
| DIS3 | -7602.5 |
| MME | -7616.5 |
| LY6G6C | -7624.5 |
| ASB3 | -7631.5 |
| ST6GAL1 | -7635.5 |
| VNN3 | -7642.5 |
| ST6GALNAC3 | -7651.5 |
| MAGT1 | -7656.5 |
| SRP72 | -7684.5 |
| PDIA5 | -7694.5 |
| KDELR3 | -7698.5 |
| BIRC3 | -7702.5 |
| MUC13 | -7711.5 |
| SEC22B | -7731.5 |
| CD109 | -7756.5 |
| B4GALT6 | -7779.5 |
| RPL6 | -7781.5 |
| TUBB2A | -7796.5 |
| BLM | -7824.5 |
| GALNT7 | -7835.5 |
| RNF2 | -7887.5 |
| H3-3A | -7895.5 |
| KBTBD6 | -7935.0 |
| KBTBD7 | -7935.0 |
| OGT | -7946.5 |
| SENP1 | -7954.5 |
| GNB4 | -7962.5 |
| PIAS1 | -7967.5 |
| TDG | -7977.5 |
| DNMT1 | -7997.5 |
| MBTPS1 | -8002.5 |
| NTNG1 | -8006.5 |
| GNPNAT1 | -8010.5 |
| SPON2 | -8013.5 |
| OPCML | -8017.5 |
| CAMKMT | -8018.5 |
| VCAN | -8054.5 |
| RPL23A | -8061.5 |
| NLRP3 | -8069.5 |
| ACTB | -8079.5 |
| SSR1 | -8085.5 |
| CYLD | -8088.5 |
| FBXO10 | -8091.5 |
| DCUN1D4 | -8092.5 |
| EXOSC1 | -8113.5 |
| ANPEP | -8118.5 |
| MUC15 | -8136.5 |
| ASB16 | -8155.5 |
| CEACAM5 | -8171.0 |
| CEACAM7 | -8171.0 |
| SEC24A | -8183.5 |
| FBXW9 | -8190.5 |
| TUSC3 | -8204.5 |
| SERPIND1 | -8205.5 |
| NUP37 | -8222.5 |
| ALPG | -8227.5 |
| ALPI | -8227.5 |
| ASGR2 | -8230.5 |
| GRIA1 | -8233.5 |
| EXOSC2 | -8248.5 |
| NR5A2 | -8252.5 |
| PAF1 | -8255.5 |
| NSMCE2 | -8258.5 |
| FBXL4 | -8265.5 |
| MDC1 | -8298.5 |
| GNE | -8301.5 |
| TUBB2B | -8309.5 |
| C3 | -8310.5 |
| STAG1 | -8335.5 |
| SLC35A1 | -8338.5 |
| DPP4 | -8343.5 |
| SPHK1 | -8349.5 |
| C1GALT1 | -8351.5 |
| CDC20 | -8352.5 |
| APOB | -8370.5 |
| CLSPN | -8372.5 |
| GALNT17 | -8392.5 |
| FBXL3 | -8399.5 |
| AHSG | -8405.5 |
| GGCX | -8408.5 |
| MAN1A1 | -8412.5 |
| SMAD2 | -8431.5 |
| PRL | -8438.5 |
| NUP214 | -8440.5 |
| H4C1 | -8450.0 |
| RPS13 | -8475.5 |
| TOP2A | -8480.5 |
| TSPYL2 | -8481.5 |
| MYO5A | -8482.5 |
| PAPPA | -8549.5 |
| IGF1 | -8567.5 |
| ADAMTS14 | -8568.5 |
| ERCC8 | -8584.5 |
| CDK1 | -8596.5 |
| APH1B | -8609.5 |
| SERPINC1 | -8610.5 |
| DPH1 | -8637.5 |
| TPST1 | -8639.5 |
| DDX17 | -8649.5 |
| KNG1 | -8666.5 |
| PARN | -8669.5 |
| AMELX | -8682.5 |
Defective CFTR causes cystic fibrosis
| 272 | |
|---|---|
| set | Defective CFTR causes cystic fibrosis |
| setSize | 58 |
| pANOVA | 2.33e-09 |
| s.dist | 0.453 |
| p.adjustANOVA | 3.06e-07 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| PSMB8 | 8750.5 |
| PSMD1 | 8707.5 |
| RNF5 | 8489.5 |
| PSMC1 | 7622.5 |
| UBA52 | 7357.5 |
| PSMA6 | 7345.5 |
| DERL3 | 7165.5 |
| PSMD4 | 7024.5 |
| PSMB5 | 6910.5 |
| PSMB9 | 6825.5 |
| RNF185 | 6684.5 |
| VCP | 6599.5 |
| PSMA8 | 6529.5 |
| PSME1 | 6431.5 |
| PSMD14 | 6156.5 |
| PSMB6 | 6079.5 |
| PSMB7 | 5988.5 |
| PSMD7 | 5955.5 |
| PSMD11 | 5787.5 |
| PSMD8 | 5682.5 |
| GeneID | Gene Rank |
|---|---|
| PSMB8 | 8750.5 |
| PSMD1 | 8707.5 |
| RNF5 | 8489.5 |
| PSMC1 | 7622.5 |
| UBA52 | 7357.5 |
| PSMA6 | 7345.5 |
| DERL3 | 7165.5 |
| PSMD4 | 7024.5 |
| PSMB5 | 6910.5 |
| PSMB9 | 6825.5 |
| RNF185 | 6684.5 |
| VCP | 6599.5 |
| PSMA8 | 6529.5 |
| PSME1 | 6431.5 |
| PSMD14 | 6156.5 |
| PSMB6 | 6079.5 |
| PSMB7 | 5988.5 |
| PSMD7 | 5955.5 |
| PSMD11 | 5787.5 |
| PSMD8 | 5682.5 |
| PSMA4 | 5533.5 |
| PSMD3 | 5512.5 |
| PSMC2 | 5421.5 |
| PSME4 | 5222.5 |
| PSMB1 | 5207.5 |
| PSMD10 | 5093.5 |
| PSMC3 | 4982.5 |
| PSMA2 | 4823.0 |
| OS9 | 4799.5 |
| PSMC4 | 4751.5 |
| PSMD2 | 4685.5 |
| PSMD5 | 4655.5 |
| SEL1L | 4548.5 |
| PSMD6 | 4428.5 |
| PSMC5 | 4349.5 |
| PSMA7 | 3962.5 |
| ERLIN1 | 3915.5 |
| DERL1 | 3559.5 |
| DERL2 | 3262.5 |
| PSMD12 | 3211.5 |
| ERLIN2 | 3026.5 |
| PSMB2 | 2944.5 |
| PSME2 | 2547.5 |
| ERLEC1 | 2361.5 |
| RPS27A | 2261.5 |
| PSMA1 | 1867.5 |
| PSMB4 | 1567.5 |
| PSMC6 | 1488.5 |
| PSME3 | 1442.5 |
| PSMB3 | 391.5 |
| CFTR | 341.5 |
| UBC | 100.5 |
| PSMA5 | 5.5 |
| PSMA3 | -754.5 |
| PSMB10 | -1181.5 |
| PSMF1 | -1438.5 |
| PSMD9 | -2755.0 |
| PSMD13 | -2775.5 |
ABC transporter disorders
| 2 | |
|---|---|
| set | ABC transporter disorders |
| setSize | 74 |
| pANOVA | 3.62e-09 |
| s.dist | 0.397 |
| p.adjustANOVA | 4.36e-07 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| ABCB4 | 8969.5 |
| ABCB6 | 8912.5 |
| PSMB8 | 8750.5 |
| PSMD1 | 8707.5 |
| RNF5 | 8489.5 |
| PSMC1 | 7622.5 |
| UBA52 | 7357.5 |
| PSMA6 | 7345.5 |
| DERL3 | 7165.5 |
| ABCD1 | 7028.5 |
| PSMD4 | 7024.5 |
| PSMB5 | 6910.5 |
| PSMB9 | 6825.5 |
| RNF185 | 6684.5 |
| VCP | 6599.5 |
| PSMA8 | 6529.5 |
| ABCC8 | 6498.5 |
| PSME1 | 6431.5 |
| KCNJ11 | 6359.5 |
| PSMD14 | 6156.5 |
| GeneID | Gene Rank |
|---|---|
| ABCB4 | 8969.5 |
| ABCB6 | 8912.5 |
| PSMB8 | 8750.5 |
| PSMD1 | 8707.5 |
| RNF5 | 8489.5 |
| PSMC1 | 7622.5 |
| UBA52 | 7357.5 |
| PSMA6 | 7345.5 |
| DERL3 | 7165.5 |
| ABCD1 | 7028.5 |
| PSMD4 | 7024.5 |
| PSMB5 | 6910.5 |
| PSMB9 | 6825.5 |
| RNF185 | 6684.5 |
| VCP | 6599.5 |
| PSMA8 | 6529.5 |
| ABCC8 | 6498.5 |
| PSME1 | 6431.5 |
| KCNJ11 | 6359.5 |
| PSMD14 | 6156.5 |
| PSMB6 | 6079.5 |
| PSMB7 | 5988.5 |
| PSMD7 | 5955.5 |
| PSMD11 | 5787.5 |
| PSMD8 | 5682.5 |
| PSMA4 | 5533.5 |
| PSMD3 | 5512.5 |
| PSMC2 | 5421.5 |
| PSME4 | 5222.5 |
| PSMB1 | 5207.5 |
| PSMD10 | 5093.5 |
| PSMC3 | 4982.5 |
| PSMA2 | 4823.0 |
| OS9 | 4799.5 |
| PSMC4 | 4751.5 |
| PSMD2 | 4685.5 |
| PSMD5 | 4655.5 |
| SEL1L | 4548.5 |
| PSMD6 | 4428.5 |
| PSMC5 | 4349.5 |
| ABCC2 | 4308.5 |
| PSMA7 | 3962.5 |
| ERLIN1 | 3915.5 |
| APOA1 | 3608.5 |
| DERL1 | 3559.5 |
| DERL2 | 3262.5 |
| PSMD12 | 3211.5 |
| ERLIN2 | 3026.5 |
| PSMB2 | 2944.5 |
| PSME2 | 2547.5 |
| ERLEC1 | 2361.5 |
| RPS27A | 2261.5 |
| ABCA3 | 2242.5 |
| ABCA12 | 2188.5 |
| PSMA1 | 1867.5 |
| ABCG5 | 1736.5 |
| PSMB4 | 1567.5 |
| PSMC6 | 1488.5 |
| PSME3 | 1442.5 |
| ABCD4 | 1103.5 |
| PSMB3 | 391.5 |
| CFTR | 341.5 |
| UBC | 100.5 |
| PSMA5 | 5.5 |
| PSMA3 | -754.5 |
| PSMB10 | -1181.5 |
| PSMF1 | -1438.5 |
| ABCB11 | -1502.5 |
| PSMD9 | -2755.0 |
| PSMD13 | -2775.5 |
| ABCC9 | -3974.5 |
| ABCA1 | -5132.5 |
| ABCG8 | -5691.5 |
| ABCC6 | -7281.5 |
Metabolism
| 673 | |
|---|---|
| set | Metabolism |
| setSize | 1943 |
| pANOVA | 4.82e-09 |
| s.dist | 0.0812 |
| p.adjustANOVA | 5.36e-07 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| RXRB | 9009.5 |
| SLC37A2 | 8998.5 |
| PPIP5K1 | 8970.5 |
| ABCB4 | 8969.5 |
| SGMS1 | 8963.5 |
| PPT2 | 8959.0 |
| ELOVL1 | 8947.5 |
| GPX4 | 8944.5 |
| CSNK2B | 8941.5 |
| PFKFB3 | 8932.5 |
| PRKAB2 | 8910.5 |
| RPL13A | 8886.5 |
| MED16 | 8883.5 |
| TPMT | 8880.5 |
| COQ7 | 8860.5 |
| DGUOK | 8859.5 |
| SLC25A44 | 8858.5 |
| PLCB4 | 8855.5 |
| ALAS1 | 8847.5 |
| PPIP5K2 | 8843.5 |
| GeneID | Gene Rank |
|---|---|
| RXRB | 9009.5 |
| SLC37A2 | 8998.5 |
| PPIP5K1 | 8970.5 |
| ABCB4 | 8969.5 |
| SGMS1 | 8963.5 |
| PPT2 | 8959.0 |
| ELOVL1 | 8947.5 |
| GPX4 | 8944.5 |
| CSNK2B | 8941.5 |
| PFKFB3 | 8932.5 |
| PRKAB2 | 8910.5 |
| RPL13A | 8886.5 |
| MED16 | 8883.5 |
| TPMT | 8880.5 |
| COQ7 | 8860.5 |
| DGUOK | 8859.5 |
| SLC25A44 | 8858.5 |
| PLCB4 | 8855.5 |
| ALAS1 | 8847.5 |
| PPIP5K2 | 8843.5 |
| HMOX2 | 8835.5 |
| ASS1 | 8829.5 |
| ACO2 | 8817.5 |
| MED9 | 8812.5 |
| AKR1B10 | 8808.5 |
| INPP5K | 8806.5 |
| PKM | 8792.5 |
| ACSL6 | 8787.0 |
| HSD17B8 | 8783.5 |
| SERINC4 | 8782.5 |
| AK1 | 8781.5 |
| BBOX1 | 8764.5 |
| PISD | 8759.5 |
| ASAH2 | 8756.5 |
| PSMB8 | 8750.5 |
| OPLAH | 8736.5 |
| INPP4B | 8729.5 |
| NEU1 | 8725.5 |
| ECI2 | 8721.5 |
| ESRRA | 8712.5 |
| IARS1 | 8710.5 |
| PSMD1 | 8707.5 |
| GBA3 | 8704.5 |
| GSTO1 | 8682.5 |
| ACOX1 | 8680.5 |
| NDUFA12 | 8677.5 |
| UGT2A3 | 8675.5 |
| MAN2C1 | 8662.5 |
| CPNE7 | 8650.5 |
| CKMT1A | 8644.0 |
| CES2 | 8642.5 |
| ATP5F1D | 8640.5 |
| PDP1 | 8638.5 |
| SPR | 8636.5 |
| SYNJ2 | 8630.5 |
| PHKG2 | 8609.5 |
| NDUFA8 | 8607.5 |
| HK1 | 8603.5 |
| HYAL2 | 8601.5 |
| SLC19A1 | 8600.5 |
| AMACR | 8598.5 |
| CRAT | 8595.5 |
| PARP4 | 8593.5 |
| RPLP2 | 8590.5 |
| GLDC | 8582.5 |
| PDHX | 8564.5 |
| PLAAT3 | 8555.5 |
| B4GALT7 | 8547.5 |
| INPPL1 | 8545.5 |
| HIBCH | 8541.5 |
| MOCS2 | 8539.5 |
| ATP5PB | 8530.5 |
| HSD17B4 | 8517.5 |
| SCAP | 8507.5 |
| MED20 | 8506.5 |
| ALDOA | 8495.5 |
| DCXR | 8491.5 |
| PLA2G6 | 8484.5 |
| MED29 | 8477.5 |
| ADK | 8474.5 |
| PHKA1 | 8469.5 |
| DGAT2 | 8466.5 |
| GMPR | 8456.5 |
| GAMT | 8452.5 |
| CHST15 | 8448.5 |
| HSP90AB1 | 8445.5 |
| SAMHD1 | 8440.5 |
| PFKFB2 | 8437.5 |
| SELENOI | 8432.5 |
| NDUFS5 | 8426.5 |
| BCKDK | 8425.5 |
| MTMR3 | 8415.5 |
| ACP5 | 8411.5 |
| CIAO1 | 8408.5 |
| BPGM | 8406.5 |
| PECR | 8397.5 |
| ACAA2 | 8392.5 |
| ACSL1 | 8383.5 |
| GMPS | 8360.5 |
| ALAD | 8349.5 |
| FXN | 8330.5 |
| HS6ST1 | 8328.5 |
| SULT1A3 | 8318.0 |
| SULT1A4 | 8318.0 |
| STARD10 | 8309.5 |
| NHLRC1 | 8293.5 |
| ORMDL3 | 8292.5 |
| SLC25A20 | 8291.5 |
| PRKAR2A | 8262.5 |
| POR | 8261.5 |
| BPNT1 | 8259.5 |
| MAT2A | 8239.5 |
| PDHB | 8238.5 |
| NT5C3A | 8235.5 |
| PCCA | 8219.5 |
| B4GALT5 | 8216.5 |
| MCCC2 | 8214.5 |
| HMBS | 8204.5 |
| ACOXL | 8189.5 |
| BSG | 8186.5 |
| NFS1 | 8160.5 |
| ECSIT | 8154.5 |
| KYAT1 | 8136.0 |
| FLAD1 | 8131.5 |
| CSNK1G2 | 8129.5 |
| SLC5A5 | 8126.5 |
| PPP1CA | 8118.5 |
| ST3GAL1 | 8113.5 |
| GPAM | 8112.5 |
| DLST | 8106.5 |
| PTGR2 | 8102.0 |
| NUP50 | 8100.5 |
| COX11 | 8096.5 |
| ACOT8 | 8091.5 |
| MLYCD | 8087.5 |
| MAT2B | 8081.5 |
| LIPH | 8080.5 |
| NMRK2 | 8079.5 |
| ABO | 8068.5 |
| ACAD9 | 8063.5 |
| MTMR7 | 8052.5 |
| PIP5K1B | 8043.5 |
| DGAT1 | 8042.5 |
| AKR7L | 8041.5 |
| PTGES2 | 8034.5 |
| NRF1 | 8006.5 |
| ME3 | 8005.5 |
| GYG1 | 8004.5 |
| FAHD1 | 7997.5 |
| ACADS | 7996.5 |
| ENPP6 | 7991.5 |
| RPS9 | 7978.5 |
| GPD1 | 7968.5 |
| ENTPD5 | 7967.5 |
| PDSS2 | 7955.5 |
| CYP4F8 | 7954.5 |
| PGK1 | 7945.5 |
| PIAS4 | 7919.5 |
| PAPSS2 | 7904.5 |
| PLCD1 | 7891.5 |
| DBI | 7888.5 |
| HYAL1 | 7885.5 |
| COQ5 | 7884.5 |
| UCKL1 | 7880.5 |
| NDUFS7 | 7874.5 |
| LPIN1 | 7864.5 |
| PCYT2 | 7859.5 |
| NUDT9 | 7844.5 |
| STS | 7827.5 |
| NFYC | 7813.5 |
| MED31 | 7809.5 |
| GSS | 7797.5 |
| GNB3 | 7796.5 |
| COQ9 | 7787.5 |
| EPRS1 | 7782.5 |
| OSBPL1A | 7776.5 |
| HS3ST6 | 7772.5 |
| PGLS | 7765.5 |
| PLB1 | 7757.5 |
| RUFY1 | 7756.5 |
| COX10 | 7751.5 |
| HK3 | 7740.5 |
| IMPA2 | 7734.5 |
| HS3ST1 | 7726.5 |
| B4GALNT1 | 7717.5 |
| PPCDC | 7714.5 |
| PAOX | 7705.0 |
| MPST | 7683.5 |
| GCSH | 7674.5 |
| SLC25A13 | 7672.5 |
| ABHD10 | 7670.5 |
| SLC25A12 | 7665.5 |
| PPARGC1B | 7660.5 |
| ECI1 | 7640.5 |
| PITPNB | 7638.5 |
| CYP7A1 | 7634.5 |
| PSMC1 | 7622.5 |
| RIMKLA | 7610.5 |
| CIAPIN1 | 7608.5 |
| CYP27A1 | 7595.5 |
| NAMPT | 7590.5 |
| SMARCD3 | 7588.5 |
| PIP4K2C | 7587.5 |
| TXNRD1 | 7572.5 |
| CDA | 7570.5 |
| GAPDH | 7566.5 |
| GBE1 | 7557.5 |
| SLC27A1 | 7555.5 |
| PGP | 7540.5 |
| PLIN3 | 7535.5 |
| STK11 | 7504.5 |
| CPT1B | 7496.5 |
| RAB4A | 7480.5 |
| MOCS1 | 7475.5 |
| GYS1 | 7463.5 |
| MT-CO1 | 7459.5 |
| PFKM | 7448.5 |
| OAT | 7447.5 |
| ACP6 | 7444.5 |
| ACBD6 | 7437.5 |
| MMAB | 7436.5 |
| LDHB | 7435.0 |
| CARNS1 | 7433.5 |
| IDH2 | 7427.5 |
| LDHC | 7413.5 |
| MECR | 7404.5 |
| TACO1 | 7403.5 |
| NOSIP | 7380.5 |
| AIP | 7363.5 |
| UBA52 | 7357.5 |
| PSMA6 | 7345.5 |
| PLA2G4F | 7341.5 |
| ASPA | 7336.5 |
| NUDT3 | 7335.5 |
| NT5M | 7333.5 |
| MID1IP1 | 7325.5 |
| NDUFA13 | 7316.5 |
| GUK1 | 7313.5 |
| TRAP1 | 7311.5 |
| MED26 | 7297.0 |
| PLCD3 | 7285.5 |
| ETFDH | 7282.5 |
| PHYH | 7272.5 |
| PRKACA | 7262.5 |
| GDE1 | 7261.5 |
| FECH | 7256.5 |
| NUP58 | 7254.5 |
| PGM1 | 7253.5 |
| PIK3C3 | 7250.5 |
| AIMP2 | 7246.5 |
| PHKB | 7245.5 |
| DCTD | 7241.5 |
| SRM | 7229.5 |
| CA14 | 7226.5 |
| PDK2 | 7219.5 |
| UROS | 7201.5 |
| AAAS | 7196.5 |
| TIMMDC1 | 7186.5 |
| IDH3A | 7182.5 |
| INPP5J | 7166.5 |
| ECHS1 | 7149.5 |
| TNFAIP8 | 7137.5 |
| NFYA | 7132.5 |
| PLA2G12A | 7130.5 |
| VAPB | 7129.5 |
| SIN3B | 7124.5 |
| MTRR | 7118.5 |
| NDUFAF3 | 7105.5 |
| SEC24D | 7100.5 |
| GPI | 7099.5 |
| PTEN | 7076.5 |
| SLC37A4 | 7073.5 |
| MED11 | 7072.5 |
| SLC25A11 | 7070.5 |
| STXBP1 | 7068.5 |
| GPD1L | 7049.5 |
| ISCU | 7048.5 |
| HAO2 | 7043.5 |
| INMT | 7038.0 |
| ABCD1 | 7028.5 |
| PSMD4 | 7024.5 |
| CIAO3 | 7015.5 |
| MDH1 | 7013.5 |
| CKMT2 | 7012.5 |
| SCO1 | 6994.5 |
| NAPRT | 6991.5 |
| VDR | 6987.5 |
| MED4 | 6976.5 |
| NDUFS2 | 6971.5 |
| AK7 | 6958.5 |
| NDST2 | 6950.0 |
| GNA14 | 6948.5 |
| MT-CO2 | 6945.5 |
| ST6GALNAC6 | 6936.0 |
| FMO1 | 6932.5 |
| GLA | 6921.5 |
| NDUFV1 | 6920.5 |
| RDH11 | 6913.0 |
| PSMB5 | 6910.5 |
| PXMP2 | 6909.5 |
| SDHB | 6907.5 |
| ASNS | 6904.5 |
| NCAN | 6888.5 |
| RRM2B | 6885.5 |
| GAPDHS | 6874.5 |
| ENO3 | 6866.5 |
| ODC1 | 6863.5 |
| DLAT | 6848.5 |
| PPP2R1A | 6847.5 |
| CYP8B1 | 6843.5 |
| SMPD1 | 6835.5 |
| PGAM2 | 6832.5 |
| PSMB9 | 6825.5 |
| RPL28 | 6806.5 |
| CPT2 | 6802.5 |
| ACADVL | 6798.5 |
| GPT | 6797.5 |
| HAGH | 6790.5 |
| NDUFAF4 | 6785.5 |
| FMO2 | 6782.5 |
| GLRX5 | 6778.5 |
| GNPDA1 | 6777.5 |
| PYGM | 6750.5 |
| MTMR2 | 6745.5 |
| PARP6 | 6741.5 |
| AUH | 6735.5 |
| IDH3B | 6732.5 |
| PPARA | 6721.5 |
| ACADM | 6715.5 |
| PLCE1 | 6711.5 |
| KYAT3 | 6687.5 |
| SLC25A19 | 6672.5 |
| GNG8 | 6665.5 |
| DPEP1 | 6660.5 |
| GLRX | 6659.5 |
| SLC35B2 | 6657.5 |
| GSTM2 | 6652.5 |
| PNPLA6 | 6645.5 |
| PDHA1 | 6639.5 |
| CYP2F1 | 6637.5 |
| MTMR4 | 6626.5 |
| GLUL | 6620.5 |
| RPL19 | 6608.5 |
| NAXD | 6580.5 |
| FAM120B | 6573.5 |
| PLIN2 | 6558.5 |
| ENTPD6 | 6557.5 |
| NUDT19 | 6554.5 |
| SLC19A2 | 6550.5 |
| MTMR14 | 6538.5 |
| PSMA8 | 6529.5 |
| GNG5 | 6527.5 |
| TSPO | 6509.5 |
| ABCC8 | 6498.5 |
| CIAO2B | 6496.5 |
| RPL29 | 6487.5 |
| OXCT1 | 6479.5 |
| FH | 6469.5 |
| CYB5R3 | 6464.5 |
| GNAS | 6461.5 |
| APIP | 6459.5 |
| RPS10 | 6457.0 |
| IDH1 | 6455.5 |
| KARS1 | 6454.5 |
| ADHFE1 | 6444.5 |
| PSME1 | 6431.5 |
| RETSAT | 6428.5 |
| PYGB | 6421.5 |
| NDUFB10 | 6419.5 |
| COX7A2L | 6410.5 |
| LRP12 | 6409.5 |
| PHOSPHO1 | 6396.5 |
| HAO1 | 6395.5 |
| BCKDHA | 6385.0 |
| KCNJ11 | 6359.5 |
| APRT | 6350.5 |
| HADHB | 6348.5 |
| CYP11A1 | 6346.5 |
| GCDH | 6343.5 |
| SAR1B | 6335.5 |
| MIGA2 | 6333.5 |
| MVD | 6331.5 |
| ACSM4 | 6327.5 |
| UQCRC1 | 6324.5 |
| N6AMT1 | 6322.5 |
| NDUFS3 | 6318.5 |
| SLC44A4 | 6314.5 |
| GPC1 | 6312.5 |
| RPS11 | 6306.5 |
| ITPKA | 6298.5 |
| MORC2 | 6277.5 |
| ADSL | 6261.5 |
| MTM1 | 6242.5 |
| PRKAA2 | 6239.5 |
| UQCRFS1 | 6235.5 |
| NUDT13 | 6228.5 |
| AACS | 6219.5 |
| ADIPOR2 | 6204.5 |
| GAA | 6197.5 |
| CPTP | 6189.5 |
| DERA | 6188.5 |
| HMOX1 | 6170.5 |
| MCAT | 6165.5 |
| PSMD14 | 6156.5 |
| ETFB | 6145.5 |
| FABP3 | 6143.5 |
| NDUFV2 | 6127.5 |
| NUDT12 | 6124.5 |
| PDPR | 6116.5 |
| NDUFA10 | 6103.5 |
| PIP4K2B | 6099.5 |
| AKT1 | 6092.5 |
| GLUD1 | 6087.0 |
| GLUD2 | 6087.0 |
| PSMB6 | 6079.5 |
| FDFT1 | 6031.5 |
| SLC25A10 | 6026.0 |
| PPP2R5D | 6015.5 |
| TALDO1 | 6010.5 |
| AMPD2 | 6008.5 |
| PARP10 | 6005.5 |
| LIAS | 5989.5 |
| PSMB7 | 5988.5 |
| B3GAT3 | 5984.5 |
| FIG4 | 5967.5 |
| ISCA2 | 5966.5 |
| RPL35 | 5961.5 |
| HADH | 5956.5 |
| PSMD7 | 5955.5 |
| HSD17B10 | 5948.5 |
| PTGR1 | 5937.5 |
| PRKAR1A | 5935.5 |
| DMAC2L | 5929.5 |
| NUBP1 | 5920.5 |
| MTMR6 | 5917.5 |
| CYP2U1 | 5915.5 |
| COX5B | 5910.5 |
| TYMP | 5908.5 |
| STAB2 | 5904.5 |
| SRD5A3 | 5897.5 |
| CS | 5894.5 |
| GBA2 | 5889.5 |
| NDUFA6 | 5887.5 |
| MTMR1 | 5883.5 |
| RPL13 | 5882.5 |
| SHMT2 | 5866.5 |
| MARS1 | 5857.5 |
| AGK | 5849.5 |
| PPOX | 5848.5 |
| TPTE | 5843.0 |
| TPTE2 | 5843.0 |
| MPC1 | 5835.5 |
| RAPGEF3 | 5818.5 |
| PLEKHA2 | 5809.5 |
| NME2 | 5802.5 |
| ACOT11 | 5798.5 |
| PSMD11 | 5787.5 |
| GOT1 | 5784.5 |
| ATIC | 5763.5 |
| GPHN | 5762.5 |
| NQO2 | 5753.5 |
| BLVRB | 5751.5 |
| PPA1 | 5736.5 |
| PLBD1 | 5731.5 |
| NDUFA2 | 5728.5 |
| PFKL | 5725.5 |
| PDSS1 | 5718.5 |
| MED28 | 5709.5 |
| DNM2 | 5708.5 |
| CPT1A | 5701.5 |
| RPIA | 5686.5 |
| PSMD8 | 5682.5 |
| AMD1 | 5673.5 |
| ACOT7 | 5658.5 |
| ITPKC | 5656.5 |
| ETFA | 5655.5 |
| ST3GAL3 | 5647.5 |
| DBT | 5632.5 |
| ADIPOR1 | 5618.5 |
| CKM | 5616.5 |
| PNPLA3 | 5611.5 |
| RPSA | 5610.5 |
| CARNMT1 | 5601.5 |
| KDSR | 5592.5 |
| UGP2 | 5586.5 |
| HIBADH | 5578.5 |
| GALT | 5567.5 |
| TAZ | 5561.5 |
| MAPKAPK2 | 5540.5 |
| NDUFB9 | 5536.5 |
| PSMA4 | 5533.5 |
| PLA2G10 | 5530.5 |
| IL4I1 | 5522.5 |
| NDUFS8 | 5518.5 |
| GPC2 | 5513.5 |
| PSMD3 | 5512.5 |
| GPS2 | 5505.5 |
| BDH1 | 5493.5 |
| AKR1B1 | 5489.5 |
| SHMT1 | 5482.5 |
| RPS14 | 5480.5 |
| NMNAT1 | 5464.5 |
| SLC25A28 | 5456.5 |
| ARV1 | 5453.5 |
| PLA2G5 | 5452.5 |
| CYC1 | 5440.5 |
| GSTO2 | 5439.5 |
| CHAC2 | 5437.5 |
| NR1H3 | 5426.5 |
| AK2 | 5424.5 |
| GCLM | 5423.5 |
| PSMC2 | 5421.5 |
| SURF1 | 5398.5 |
| ABHD4 | 5393.5 |
| ACOT1 | 5390.0 |
| ACOT2 | 5390.0 |
| MED27 | 5382.5 |
| ACACB | 5379.5 |
| NOS3 | 5373.5 |
| COQ2 | 5364.5 |
| BCAT2 | 5358.5 |
| ACAT1 | 5356.5 |
| OSBPL2 | 5333.5 |
| PLA2G15 | 5305.5 |
| UPP1 | 5300.5 |
| PSAP | 5285.5 |
| CYP46A1 | 5277.5 |
| HADHA | 5276.5 |
| RPS7 | 5274.5 |
| PFAS | 5269.5 |
| HS3ST5 | 5240.5 |
| ARF1 | 5233.5 |
| MCEE | 5227.5 |
| PRPS1 | 5226.5 |
| PSME4 | 5222.5 |
| BCKDHB | 5209.5 |
| PSMB1 | 5207.5 |
| ACOX2 | 5204.5 |
| ANKRD1 | 5199.5 |
| IPPK | 5193.5 |
| RPL3L | 5191.5 |
| OAZ2 | 5164.5 |
| AMPD3 | 5160.5 |
| FABP6 | 5150.5 |
| GNAI1 | 5149.5 |
| B3GAT2 | 5146.5 |
| ACBD4 | 5145.5 |
| GLB1 | 5131.5 |
| AGPAT2 | 5121.5 |
| OSBP | 5117.5 |
| CTPS1 | 5112.5 |
| PSMD10 | 5093.5 |
| CSNK2A1 | 5083.0 |
| ALOXE3 | 5079.5 |
| NDUFA11 | 5077.0 |
| B3GNT4 | 5073.5 |
| ATP5F1B | 5063.5 |
| NQO1 | 5061.5 |
| HACD1 | 5037.5 |
| PPM1K | 5032.5 |
| PIK3R1 | 5011.5 |
| PANK4 | 4995.5 |
| PSMC3 | 4982.5 |
| MCCC1 | 4978.5 |
| INPP5A | 4977.5 |
| GPCPD1 | 4975.5 |
| UQCRH | 4971.0 |
| RPL18 | 4957.5 |
| ACBD7 | 4955.5 |
| RPL10A | 4938.5 |
| NEU2 | 4929.5 |
| LGMN | 4928.5 |
| HDC | 4926.5 |
| ACSS3 | 4914.5 |
| SLC25A37 | 4882.5 |
| ADCY8 | 4866.5 |
| PLCB1 | 4864.5 |
| NUDT11 | 4863.5 |
| MED24 | 4861.5 |
| PGM2L1 | 4850.5 |
| PKLR | 4848.5 |
| MGST3 | 4847.5 |
| MPC2 | 4845.5 |
| CDS1 | 4824.5 |
| PSMA2 | 4823.0 |
| SMPD2 | 4820.5 |
| BMX | 4810.5 |
| MRI1 | 4801.5 |
| ACAN | 4789.5 |
| CARM1 | 4781.5 |
| ALDOC | 4780.5 |
| ALDH7A1 | 4769.5 |
| COX18 | 4765.5 |
| PLA2G4C | 4756.5 |
| PSMC4 | 4751.5 |
| LPCAT4 | 4744.5 |
| SPTLC3 | 4741.5 |
| CYP26B1 | 4735.5 |
| PTGDS | 4723.0 |
| NMRK1 | 4712.5 |
| NUBP2 | 4703.5 |
| RNLS | 4686.5 |
| PSMD2 | 4685.5 |
| PC | 4683.5 |
| SMPD4 | 4682.5 |
| PODXL2 | 4678.5 |
| PLD3 | 4675.5 |
| RPL18A | 4656.5 |
| PSMD5 | 4655.5 |
| UQCRQ | 4627.5 |
| NDUFB8 | 4615.0 |
| CDIPT | 4612.5 |
| CIDEA | 4610.5 |
| SDHC | 4606.5 |
| GNGT2 | 4590.5 |
| NDUFB2 | 4587.5 |
| AKAP5 | 4574.5 |
| MED19 | 4573.5 |
| ADPRM | 4568.5 |
| ADRA2C | 4558.5 |
| ACAD10 | 4554.5 |
| LHPP | 4549.5 |
| RPL9 | 4522.5 |
| DCTPP1 | 4516.5 |
| SLC45A2 | 4514.5 |
| ENTPD3 | 4490.5 |
| AZIN2 | 4480.5 |
| HEXB | 4476.5 |
| OGDH | 4470.5 |
| DSE | 4463.0 |
| DDHD1 | 4461.5 |
| NUP62 | 4455.5 |
| PYCR1 | 4446.5 |
| RPS4X | 4442.5 |
| MLX | 4435.5 |
| L2HGDH | 4434.5 |
| PSMD6 | 4428.5 |
| SCLY | 4420.5 |
| SPHK2 | 4418.5 |
| HK2 | 4414.5 |
| ACADL | 4411.5 |
| MVK | 4402.5 |
| NUDT18 | 4401.5 |
| FABP12 | 4365.5 |
| UCK1 | 4364.5 |
| MTHFD1L | 4362.5 |
| NDUFAB1 | 4350.5 |
| PSMC5 | 4349.5 |
| FDX2 | 4347.0 |
| AKR1A1 | 4321.5 |
| BCAN | 4318.5 |
| ABCC2 | 4308.5 |
| GART | 4297.5 |
| ACAD11 | 4281.5 |
| MOGAT2 | 4276.5 |
| CRYM | 4267.5 |
| SULT1A1 | 4265.5 |
| SULT1A2 | 4265.5 |
| VDAC1 | 4260.5 |
| SUOX | 4249.5 |
| AK5 | 4242.5 |
| SDHA | 4232.0 |
| SERINC1 | 4220.5 |
| NEU4 | 4217.5 |
| PCYT1A | 4196.5 |
| RPL15 | 4191.5 |
| ELOVL3 | 4185.5 |
| POMC | 4179.5 |
| PDK1 | 4175.5 |
| ACER1 | 4169.5 |
| LIPT2 | 4163.5 |
| ASAH1 | 4150.5 |
| IVD | 4144.5 |
| SLC25A15 | 4142.5 |
| IP6K3 | 4126.5 |
| SRD5A2 | 4122.5 |
| B3GALT1 | 4114.5 |
| CYP1A2 | 4097.5 |
| PIP5K1C | 4096.5 |
| ACOT13 | 4095.5 |
| UCP2 | 4090.5 |
| STARD5 | 4071.5 |
| FOLR2 | 4060.5 |
| EPM2A | 4052.5 |
| NUDT15 | 4035.5 |
| PNPLA4 | 4031.5 |
| HSD17B12 | 4028.5 |
| GDPD5 | 4021.5 |
| EHHADH | 3987.5 |
| PNPO | 3977.5 |
| NDUFA7 | 3973.0 |
| PSMA7 | 3962.5 |
| HLCS | 3952.5 |
| UMPS | 3946.5 |
| SLC2A1 | 3939.5 |
| ENO2 | 3938.5 |
| GNMT | 3935.5 |
| COX4I1 | 3926.5 |
| ACSF2 | 3919.5 |
| ACSS1 | 3902.5 |
| HMGCL | 3899.5 |
| PNPLA2 | 3894.5 |
| CYP4V2 | 3891.5 |
| UGT8 | 3888.5 |
| PLCD4 | 3885.5 |
| ALAS2 | 3881.5 |
| ADRA2A | 3874.5 |
| CMBL | 3867.5 |
| CHP1 | 3866.5 |
| COQ3 | 3858.5 |
| UQCR10 | 3843.5 |
| B3GALT4 | 3841.5 |
| SGPL1 | 3836.5 |
| GALC | 3835.5 |
| MTARC2 | 3831.5 |
| BPHL | 3824.5 |
| MED6 | 3823.5 |
| GGT6 | 3811.5 |
| OTC | 3799.5 |
| ABCB7 | 3781.5 |
| SLC25A27 | 3731.5 |
| SHPK | 3721.0 |
| ADCY5 | 3713.5 |
| NDUFA9 | 3708.5 |
| SLC2A2 | 3700.5 |
| KCNG2 | 3698.5 |
| TECR | 3697.5 |
| ALOX15B | 3679.5 |
| MMUT | 3678.5 |
| CYP26C1 | 3674.5 |
| HMGCLL1 | 3627.5 |
| COQ6 | 3617.5 |
| NR1D1 | 3615.5 |
| APOA1 | 3608.5 |
| ITPK1 | 3577.5 |
| LPL | 3569.5 |
| SERPINA6 | 3567.5 |
| COX14 | 3517.5 |
| NDUFA5 | 3514.5 |
| UQCRC2 | 3503.5 |
| XDH | 3492.5 |
| NDST3 | 3487.5 |
| RAPGEF4 | 3416.5 |
| RPS26 | 3411.5 |
| ATP5PD | 3402.5 |
| HYAL3 | 3392.5 |
| DIO2 | 3389.5 |
| ERCC2 | 3386.5 |
| TPH1 | 3380.5 |
| CALM1 | 3372.5 |
| AMT | 3370.0 |
| ISCA1 | 3368.5 |
| B3GALT5 | 3354.5 |
| CA1 | 3352.5 |
| LPCAT1 | 3334.5 |
| NDUFB6 | 3329.5 |
| SUCLG1 | 3325.5 |
| CDS2 | 3311.5 |
| ALDH3A1 | 3308.5 |
| THEM5 | 3298.5 |
| NUP153 | 3291.5 |
| PLCB3 | 3290.5 |
| SAMD8 | 3287.5 |
| CYP1A1 | 3279.5 |
| SUCLA2 | 3268.5 |
| ALOX12 | 3264.5 |
| ENTPD8 | 3260.5 |
| CYP2D6 | 3254.0 |
| PPP2R1B | 3230.5 |
| NUP35 | 3225.5 |
| SLC25A17 | 3212.5 |
| PSMD12 | 3211.5 |
| CSGALNACT1 | 3209.5 |
| AGPAT4 | 3198.5 |
| ABHD5 | 3179.5 |
| NT5C | 3172.5 |
| RPS6 | 3167.5 |
| FMO3 | 3133.5 |
| CBR3 | 3116.0 |
| GK2 | 3116.0 |
| NDUFC1 | 3113.5 |
| ESD | 3111.5 |
| RPL23 | 3101.5 |
| NUP42 | 3099.5 |
| SEPSECS | 3071.5 |
| MMAA | 3070.5 |
| NDUFS1 | 3068.5 |
| PCCB | 3066.5 |
| GPT2 | 3055.5 |
| GRHL1 | 3027.5 |
| MMACHC | 3025.5 |
| SMPD3 | 3010.5 |
| DLD | 2984.5 |
| NDUFAF1 | 2966.5 |
| CD320 | 2951.5 |
| EP300 | 2949.5 |
| PSMB2 | 2944.5 |
| PANK1 | 2939.5 |
| ATP5PO | 2930.0 |
| COQ10B | 2915.5 |
| ARSA | 2907.5 |
| PTGES | 2895.5 |
| NDOR1 | 2887.5 |
| FABP7 | 2873.5 |
| DEGS2 | 2849.5 |
| IMPDH2 | 2846.5 |
| NDUFAF7 | 2842.5 |
| KCNB1 | 2840.5 |
| DHRS7B | 2814.5 |
| TMEM86B | 2808.5 |
| HMGCS2 | 2803.5 |
| ADAL | 2796.5 |
| PLA2G3 | 2764.5 |
| NUDT1 | 2759.5 |
| ST3GAL6 | 2752.5 |
| SULT2B1 | 2751.5 |
| COX7B | 2750.5 |
| CA6 | 2723.5 |
| UQCR11 | 2718.0 |
| OCRL | 2708.5 |
| AIMP1 | 2707.5 |
| MED21 | 2698.5 |
| MED25 | 2697.5 |
| GBA | 2686.5 |
| B4GALT3 | 2679.5 |
| SUMF1 | 2678.5 |
| NDUFC2 | 2669.0 |
| ACAA1 | 2649.5 |
| ATP5MF | 2647.5 |
| TPR | 2614.5 |
| IDH3G | 2586.5 |
| SLC25A32 | 2585.0 |
| DEGS1 | 2549.5 |
| PSME2 | 2547.5 |
| MT-ND1 | 2529.5 |
| PLA2G4E | 2517.5 |
| SLC27A5 | 2502.5 |
| PPARD | 2501.5 |
| AZIN1 | 2497.5 |
| CNDP2 | 2481.5 |
| HS3ST2 | 2452.5 |
| ACMSD | 2451.5 |
| NDUFB7 | 2448.5 |
| FTCD | 2441.5 |
| PLAAT1 | 2413.5 |
| NDUFS4 | 2412.5 |
| SLC37A1 | 2401.5 |
| ACOX3 | 2390.5 |
| ACSF3 | 2370.5 |
| CHKA | 2366.5 |
| G6PC3 | 2353.5 |
| RPL8 | 2340.5 |
| ARF3 | 2323.5 |
| PDP2 | 2306.5 |
| NDUFA3 | 2298.5 |
| SDHD | 2278.0 |
| ELOVL6 | 2275.5 |
| RPS27A | 2261.5 |
| GOT2 | 2260.5 |
| AGL | 2254.5 |
| GNS | 2237.5 |
| SARDH | 2232.5 |
| TSHB | 2225.5 |
| ALDOB | 2220.5 |
| PPP1CC | 2218.5 |
| PLA1A | 2198.5 |
| FBP1 | 2195.5 |
| MED30 | 2191.5 |
| FHL2 | 2190.5 |
| OAZ1 | 2182.5 |
| FMOD | 2173.5 |
| STARD7 | 2167.5 |
| PI4K2B | 2154.5 |
| MTHFD1 | 2143.5 |
| ETHE1 | 2138.5 |
| MED7 | 2133.5 |
| PI4K2A | 2128.5 |
| PPP1R3C | 2101.5 |
| MIOX | 2098.5 |
| CHKB | 2095.5 |
| LRP8 | 2094.5 |
| ACY3 | 2085.5 |
| SGPP1 | 2083.5 |
| CHST9 | 2079.5 |
| RAB5A | 2068.5 |
| RPL24 | 2057.5 |
| ADCY4 | 2051.5 |
| ACSM3 | 2050.5 |
| PRKG2 | 2039.5 |
| RPS5 | 2028.5 |
| MED13 | 2016.5 |
| NDUFAF5 | 2012.5 |
| TECRL | 2005.5 |
| BHMT2 | 2001.5 |
| TKFC | 1998.5 |
| ACSS2 | 1997.5 |
| PRODH | 1996.0 |
| NFYB | 1992.5 |
| FBP2 | 1984.5 |
| ALDH6A1 | 1978.5 |
| FITM2 | 1951.5 |
| CTSA | 1936.5 |
| SLC22A13 | 1913.5 |
| PIK3R4 | 1910.5 |
| QARS1 | 1901.5 |
| SLC19A3 | 1894.5 |
| PTGS1 | 1892.5 |
| CBR4 | 1888.5 |
| THEM4 | 1879.5 |
| PON1 | 1875.5 |
| G6PD | 1872.5 |
| PSMA1 | 1867.5 |
| MT-ND3 | 1861.5 |
| GATM | 1845.5 |
| ENTPD2 | 1838.5 |
| GPC4 | 1831.5 |
| RPL22 | 1825.5 |
| PLPP3 | 1824.0 |
| PGS1 | 1811.5 |
| ENTPD4 | 1809.5 |
| CYCS | 1802.5 |
| FABP5 | 1801.5 |
| CYP4F2 | 1790.5 |
| ISYNA1 | 1779.5 |
| HSD17B3 | 1748.5 |
| SLC35B3 | 1734.5 |
| SARS1 | 1720.5 |
| DNPH1 | 1707.5 |
| DGAT2L6 | 1698.0 |
| ACOT9 | 1689.5 |
| G0S2 | 1684.5 |
| KPNB1 | 1665.5 |
| GCK | 1664.5 |
| MTHFD2 | 1649.5 |
| MT-CO3 | 1568.5 |
| PSMB4 | 1567.5 |
| UPP2 | 1563.5 |
| LDHA | 1562.5 |
| CACNB2 | 1544.5 |
| CDK19 | 1539.5 |
| PIK3R2 | 1532.0 |
| SULT4A1 | 1525.5 |
| PRKACB | 1490.5 |
| PSMC6 | 1488.5 |
| CKB | 1483.5 |
| RARS1 | 1477.5 |
| BTD | 1449.5 |
| NT5C2 | 1446.5 |
| ST3GAL4 | 1445.5 |
| PSME3 | 1442.5 |
| HEXA | 1424.0 |
| ABHD14B | 1422.5 |
| SDC3 | 1408.5 |
| FITM1 | 1404.5 |
| MMS19 | 1397.5 |
| MT-CYB | 1377.5 |
| PCK1 | 1371.5 |
| CA13 | 1369.5 |
| RBKS | 1368.5 |
| PCK2 | 1364.5 |
| RANBP2 | 1353.5 |
| HSD17B1 | 1339.5 |
| MED1 | 1332.5 |
| MT-ND5 | 1325.5 |
| PRKAR1B | 1313.5 |
| IDO1 | 1311.5 |
| ENO1 | 1307.5 |
| GLO1 | 1280.5 |
| GNPAT | 1278.5 |
| PEMT | 1267.5 |
| NDUFA4 | 1265.5 |
| MT-ATP6 | 1243.5 |
| ENPP1 | 1224.5 |
| PFKP | 1186.5 |
| PHYKPL | 1177.5 |
| PI4KB | 1165.5 |
| RAB14 | 1158.5 |
| ASMT | 1147.5 |
| LRP10 | 1135.5 |
| RPS8 | 1133.5 |
| PAH | 1132.5 |
| MDH2 | 1129.5 |
| CYP26A1 | 1119.5 |
| PPARGC1A | 1116.5 |
| ASRGL1 | 1107.5 |
| ABCD4 | 1103.5 |
| RPS27L | 1090.5 |
| GCHFR | 1089.5 |
| PTPN13 | 1079.5 |
| HYKK | 1069.5 |
| COX6A1 | 1068.5 |
| NDUFB5 | 1061.5 |
| BDH2 | 1057.5 |
| LPGAT1 | 1010.5 |
| SC5D | 1005.5 |
| GLS | 992.5 |
| SBF1 | 979.5 |
| PPM1L | 964.5 |
| CES1 | 953.5 |
| PLD4 | 942.5 |
| CHPT1 | 936.5 |
| GGCT | 924.0 |
| GCH1 | 922.5 |
| FUT11 | 900.5 |
| CGA | 845.5 |
| HSD17B2 | 845.5 |
| PNLIP | 845.5 |
| DCN | 798.5 |
| LPCAT3 | 794.5 |
| SLC44A3 | 789.5 |
| NNT | 785.5 |
| HDAC3 | 774.5 |
| FUT2 | 749.5 |
| SPNS2 | 736.5 |
| IP6K2 | 735.5 |
| XYLT1 | 732.5 |
| CA7 | 728.5 |
| PLEKHA4 | 719.5 |
| ACACA | 711.5 |
| CA4 | 706.5 |
| CYB5A | 701.5 |
| CTH | 694.5 |
| SLC35D1 | 685.5 |
| COX20 | 681.5 |
| ARG2 | 673.5 |
| CAD | 672.5 |
| ITPA | 668.5 |
| B3GALT6 | 632.5 |
| MBOAT7 | 613.5 |
| GNA11 | 611.5 |
| HACD4 | 609.5 |
| ARSL | 606.5 |
| HACD2 | 581.5 |
| MOCS3 | 577.5 |
| FASN | 566.5 |
| ALDH1A1 | 561.5 |
| LARS1 | 552.5 |
| RPS15 | 545.5 |
| HAL | 542.5 |
| D2HGDH | 530.5 |
| HILPDA | 526.5 |
| OLAH | 522.5 |
| APOA5 | 517.5 |
| COX5A | 481.5 |
| PRPS2 | 477.5 |
| NADK2 | 422.5 |
| RXRA | 395.5 |
| PSMB3 | 391.5 |
| MT-ND4 | 390.5 |
| PNPLA7 | 377.5 |
| FOLH1 | 374.5 |
| RPL37 | 367.5 |
| PIK3R3 | 358.0 |
| FDX1 | 347.5 |
| OAZ3 | 346.5 |
| NMNAT3 | 327.5 |
| RBP2 | 325.5 |
| ATP5MC3 | 319.5 |
| PRELP | 313.5 |
| MT-ND2 | 306.5 |
| RPL37A | 302.5 |
| PNP | 301.5 |
| EPHX1 | 290.5 |
| ADCY6 | 282.5 |
| FA2H | 277.5 |
| ASPG | 274.5 |
| TSTD1 | 249.5 |
| NCOA3 | 231.5 |
| ADCY1 | 230.5 |
| LIPE | 223.5 |
| APOC2 | 211.0 |
| GALE | 207.5 |
| SLC5A6 | 204.5 |
| CYB5B | 197.5 |
| CERK | 183.5 |
| ADCY9 | 180.5 |
| SGSH | 178.5 |
| NCOA2 | 159.5 |
| MTR | 153.5 |
| FPGS | 142.5 |
| RPS3A | 133.5 |
| CYP2R1 | 132.5 |
| CBS | 128.0 |
| CBSL | 128.0 |
| LTC4S | 115.5 |
| GPAT3 | 105.5 |
| ABCC1 | 103.5 |
| UBC | 100.5 |
| AADAC | 70.5 |
| CYP2C19 | 62.0 |
| CYP2C9 | 62.0 |
| GLYATL3 | 53.0 |
| RPL21 | 45.0 |
| GPAT2 | 29.5 |
| ME2 | 9.5 |
| PSMA5 | 5.5 |
| RPL32 | 0.5 |
| SLC6A7 | -1.5 |
| OSBPL5 | -2.5 |
| SLC44A2 | -5.5 |
| SLC6A11 | -14.5 |
| UROC1 | -21.5 |
| FUT1 | -27.5 |
| SLC22A1 | -29.5 |
| SEC23A | -37.5 |
| GYS2 | -40.5 |
| INPP4A | -49.5 |
| NUP54 | -72.5 |
| SGPP2 | -76.5 |
| SERINC2 | -78.5 |
| ME1 | -80.5 |
| UBIAD1 | -83.5 |
| LPIN2 | -85.5 |
| RPS28 | -86.5 |
| GNG3 | -91.5 |
| MOCOS | -97.5 |
| PARP9 | -110.5 |
| PRXL2B | -119.5 |
| VAMP2 | -124.0 |
| NUP205 | -128.5 |
| IDUA | -148.5 |
| FUT10 | -159.5 |
| XYLT2 | -164.5 |
| HAAO | -207.5 |
| AASDHPPT | -218.5 |
| BCO1 | -227.5 |
| SUCLG2 | -231.5 |
| NCOR2 | -240.5 |
| SERINC3 | -247.5 |
| PLEKHA3 | -248.5 |
| AADAT | -279.5 |
| NEU3 | -291.5 |
| IPMK | -334.5 |
| UCP1 | -358.5 |
| SGMS2 | -360.5 |
| MED22 | -361.5 |
| NDUFB11 | -363.5 |
| SLC16A1 | -369.5 |
| SLC16A3 | -371.5 |
| PNMT | -380.5 |
| ALDH2 | -391.0 |
| ACAD8 | -392.5 |
| ATP5PF | -401.5 |
| GLIPR1 | -417.5 |
| COASY | -424.5 |
| PRKD2 | -442.5 |
| NDC1 | -444.5 |
| PITPNM1 | -459.5 |
| B3GNT3 | -475.5 |
| PAICS | -480.5 |
| PDK4 | -495.5 |
| SLCO2B1 | -527.5 |
| ACY1 | -532.0 |
| MAOA | -533.5 |
| SRD5A1 | -565.5 |
| PSTK | -576.5 |
| INPP5D | -584.5 |
| TH | -588.5 |
| GNG4 | -595.5 |
| FABP9 | -598.5 |
| VNN1 | -605.5 |
| CUBN | -609.5 |
| SACM1L | -613.5 |
| PTGS2 | -620.5 |
| LIPI | -695.0 |
| RAN | -695.0 |
| PSMA3 | -754.5 |
| GUSB | -761.5 |
| PIK3C2B | -762.5 |
| NT5C1A | -764.5 |
| OSBPL3 | -766.5 |
| PRKAG2 | -768.5 |
| KCNS3 | -779.5 |
| ESYT2 | -783.5 |
| DPEP3 | -788.5 |
| MT-ND6 | -790.5 |
| ORMDL1 | -793.5 |
| NUP88 | -800.5 |
| SULT1E1 | -803.0 |
| INPP5E | -821.5 |
| SLC52A1 | -854.0 |
| SLC52A2 | -854.0 |
| CHPF | -874.5 |
| UBE2I | -909.5 |
| AK4 | -910.5 |
| CPOX | -940.5 |
| AANAT | -943.5 |
| HS3ST3A1 | -955.5 |
| POM121 | -968.0 |
| POM121C | -968.0 |
| SLC6A8 | -974.0 |
| GPX1 | -1059.5 |
| PPP2CA | -1075.5 |
| TXN | -1082.5 |
| CYP2W1 | -1089.5 |
| DPYS | -1098.5 |
| TGS1 | -1108.5 |
| SMS | -1156.5 |
| PLA2G2D | -1167.5 |
| NUBPL | -1174.5 |
| PSMB10 | -1181.5 |
| DAO | -1182.5 |
| PPP2CB | -1185.5 |
| COX19 | -1192.5 |
| BHMT | -1201.5 |
| CA2 | -1202.5 |
| PLA2R1 | -1219.5 |
| GDPD3 | -1227.5 |
| ARSG | -1228.5 |
| ADPGK | -1273.5 |
| AHRR | -1304.5 |
| DMGDH | -1312.5 |
| SORD | -1329.5 |
| PPCS | -1330.5 |
| THRSP | -1334.5 |
| INPP1 | -1341.5 |
| TDO2 | -1342.5 |
| CHST12 | -1345.5 |
| SPTLC2 | -1355.5 |
| PPAT | -1367.5 |
| TPK1 | -1370.5 |
| EXT1 | -1387.5 |
| SLC3A2 | -1390.5 |
| NUP160 | -1394.5 |
| ATP5F1E | -1407.5 |
| SEC13 | -1413.5 |
| PARP8 | -1424.5 |
| PSMF1 | -1438.5 |
| AGXT | -1460.5 |
| AWAT1 | -1460.5 |
| G6PC2 | -1460.5 |
| SMOX | -1471.5 |
| TCN2 | -1473.5 |
| CACNA2D2 | -1500.5 |
| ABCB11 | -1502.5 |
| B4GALT2 | -1507.5 |
| CYP24A1 | -1550.5 |
| DDAH2 | -1601.5 |
| GDA | -1609.5 |
| ALOX5AP | -1617.5 |
| IP6K1 | -1631.5 |
| ACOT6 | -1635.5 |
| NR1H2 | -1637.5 |
| UCK2 | -1642.5 |
| LYVE1 | -1649.5 |
| RPL36 | -1676.5 |
| GNG12 | -1688.5 |
| SNAP25 | -1689.5 |
| THRAP3 | -1692.5 |
| RPL31 | -1702.5 |
| DECR1 | -1704.5 |
| NUP210 | -1705.5 |
| LTA4H | -1739.5 |
| ARSK | -1772.5 |
| PPP1CB | -1775.5 |
| RGL1 | -1778.5 |
| NCOR1 | -1780.5 |
| CRYL1 | -1787.5 |
| PI4KA | -1819.5 |
| TKT | -1820.5 |
| PLA2G2A | -1826.5 |
| SLC27A2 | -1841.5 |
| TYR | -1854.5 |
| CHST1 | -1862.5 |
| GNAI2 | -1866.5 |
| NUP188 | -1868.5 |
| ACER2 | -1873.5 |
| B3GALNT1 | -1890.5 |
| ACADSB | -1894.5 |
| PDXK | -1897.5 |
| CD36 | -1918.5 |
| MTHFR | -1922.5 |
| ALOX15 | -1942.5 |
| RBP4 | -1959.5 |
| DBH | -1964.5 |
| FABP2 | -1965.5 |
| ALDH1B1 | -1967.5 |
| DARS1 | -1997.5 |
| MED23 | -2037.5 |
| GNGT1 | -2049.5 |
| HPSE2 | -2064.5 |
| COMT | -2069.5 |
| MTMR9 | -2080.5 |
| PITPNM3 | -2081.5 |
| NOSTRIN | -2083.5 |
| OSBPL7 | -2104.5 |
| ACSL5 | -2111.5 |
| PHKG1 | -2112.5 |
| COQ10A | -2127.5 |
| TTPA | -2139.5 |
| GNG11 | -2149.5 |
| DHFR | -2160.0 |
| DHFR2 | -2160.0 |
| RIMKLB | -2163.5 |
| ENTPD1 | -2171.5 |
| COX7C | -2174.5 |
| PSAT1 | -2184.5 |
| MMADHC | -2185.5 |
| CYP27B1 | -2187.5 |
| IMPA1 | -2191.5 |
| CIDEC | -2192.5 |
| AHCY | -2211.5 |
| GPX2 | -2223.5 |
| TPST2 | -2228.5 |
| TTR | -2281.5 |
| CACNA1A | -2300.5 |
| DIO1 | -2326.5 |
| CH25H | -2328.5 |
| GGT7 | -2343.5 |
| TPH2 | -2348.5 |
| PLA2G1B | -2349.5 |
| CYGB | -2358.5 |
| RPL7A | -2363.5 |
| RHCE | -2367.0 |
| RHD | -2367.0 |
| CSAD | -2388.5 |
| PNPLA8 | -2389.5 |
| ESYT1 | -2394.5 |
| CA12 | -2398.5 |
| DPEP2 | -2406.5 |
| GCLC | -2430.5 |
| PLD2 | -2440.5 |
| ELOVL4 | -2448.5 |
| PIP4K2A | -2457.5 |
| NUDT4 | -2477.0 |
| INSIG2 | -2486.5 |
| KERA | -2513.5 |
| POLD1 | -2524.5 |
| VAC14 | -2537.5 |
| HPD | -2540.5 |
| TMEM126B | -2544.5 |
| PLCZ1 | -2556.5 |
| CHST2 | -2558.5 |
| CHST7 | -2569.5 |
| TNFRSF21 | -2575.5 |
| MBOAT2 | -2579.5 |
| PTDSS1 | -2612.5 |
| RFK | -2632.5 |
| PARP14 | -2642.5 |
| RAP1A | -2646.5 |
| GNG10 | -2665.5 |
| MAOB | -2668.5 |
| CERT1 | -2672.5 |
| SLC23A2 | -2686.5 |
| CYP4B1 | -2687.5 |
| ATP5MG | -2690.0 |
| GNPDA2 | -2695.5 |
| HSPG2 | -2698.5 |
| SLC26A2 | -2702.5 |
| PLA2G4A | -2714.5 |
| PPT1 | -2725.5 |
| WASL | -2730.5 |
| BPNT2 | -2733.5 |
| HPRT1 | -2737.5 |
| PSMD9 | -2755.0 |
| NDUFAF6 | -2759.5 |
| B4GAT1 | -2761.5 |
| PSMD13 | -2775.5 |
| ST3GAL2 | -2776.5 |
| ACHE | -2783.5 |
| RPS23 | -2786.5 |
| INS | -2798.5 |
| HACL1 | -2803.5 |
| HGD | -2821.5 |
| GLTP | -2828.5 |
| NDUFS6 | -2838.5 |
| PLPP2 | -2849.5 |
| UROD | -2854.5 |
| BST1 | -2872.5 |
| ORMDL2 | -2877.5 |
| ENPP3 | -2880.5 |
| ACSBG1 | -2898.5 |
| CREBBP | -2899.5 |
| HS2ST1 | -2912.0 |
| PON3 | -2920.5 |
| HPGD | -2939.5 |
| SLC9A1 | -2945.5 |
| NCOA6 | -2951.5 |
| NDST4 | -2957.5 |
| CYP39A1 | -2975.5 |
| TPO | -2993.5 |
| MED18 | -3007.5 |
| PIK3R6 | -3023.5 |
| BGN | -3040.5 |
| NME3 | -3042.5 |
| PIPOX | -3049.5 |
| CA5B | -3071.5 |
| AMPD1 | -3079.5 |
| MED17 | -3091.0 |
| PLCG1 | -3094.5 |
| RORA | -3141.5 |
| ATP5ME | -3145.5 |
| NUP85 | -3156.5 |
| SLC7A5 | -3157.5 |
| CHSY1 | -3167.5 |
| ALDH18A1 | -3171.5 |
| PLD6 | -3181.5 |
| AMDHD1 | -3197.5 |
| DHCR24 | -3198.5 |
| HELZ2 | -3208.5 |
| LUM | -3215.5 |
| NUP43 | -3243.5 |
| RPL7 | -3262.5 |
| CRLS1 | -3263.5 |
| GPC6 | -3264.5 |
| PPARG | -3265.5 |
| PRSS1 | -3277.5 |
| PRSS3 | -3277.5 |
| DDC | -3288.5 |
| RPS3 | -3309.5 |
| HSD17B7 | -3326.5 |
| DDAH1 | -3329.5 |
| TIAM2 | -3332.5 |
| HAS1 | -3350.5 |
| QDPR | -3354.5 |
| PIP5K1A | -3355.5 |
| AHCYL1 | -3359.5 |
| NCOA1 | -3368.5 |
| ACOT12 | -3398.5 |
| CA9 | -3419.5 |
| TYMS | -3433.5 |
| SLC46A1 | -3448.5 |
| CHAC1 | -3483.5 |
| GCG | -3500.5 |
| SLC25A21 | -3501.5 |
| CERS1 | -3507.5 |
| LRP1 | -3516.5 |
| DUOX1 | -3517.5 |
| TST | -3528.5 |
| MIGA1 | -3532.5 |
| NDUFB3 | -3539.5 |
| HAS2 | -3559.5 |
| SDC4 | -3567.5 |
| NAXE | -3573.5 |
| RBP1 | -3579.5 |
| RPS2 | -3580.5 |
| ITPKB | -3591.5 |
| FAAH | -3599.5 |
| ETNK1 | -3611.5 |
| PLA2G4B | -3614.0 |
| TBXAS1 | -3636.5 |
| CHPF2 | -3638.5 |
| CBLIF | -3640.5 |
| OMD | -3645.5 |
| AGPAT3 | -3651.5 |
| MAN2B2 | -3658.5 |
| GCAT | -3664.5 |
| ADCY7 | -3667.5 |
| NDUFA1 | -3668.5 |
| PHKA2 | -3683.5 |
| GPC3 | -3706.5 |
| AFMID | -3713.5 |
| BCHE | -3751.5 |
| ELOVL7 | -3762.5 |
| MTHFD2L | -3771.5 |
| SLC25A1 | -3780.5 |
| PIK3CA | -3786.5 |
| GSTM3 | -3787.5 |
| GM2A | -3790.5 |
| AK6 | -3796.5 |
| SEC24B | -3799.5 |
| RIDA | -3802.5 |
| APOA4 | -3825.5 |
| ASL | -3827.0 |
| SLC5A8 | -3828.5 |
| HSD17B11 | -3840.5 |
| NAGLU | -3869.5 |
| EXT2 | -3876.5 |
| PANK2 | -3877.5 |
| CPNE1 | -3891.5 |
| ARNT2 | -3895.5 |
| XYLB | -3905.5 |
| CPNE6 | -3918.5 |
| NDUFB4 | -3950.5 |
| SLC25A2 | -3958.5 |
| PTS | -3961.5 |
| DHCR7 | -4004.5 |
| UGCG | -4014.5 |
| PYCR2 | -4028.0 |
| CTRB1 | -4046.0 |
| CTRB2 | -4046.0 |
| CYP1B1 | -4084.5 |
| OCA2 | -4102.5 |
| ENOPH1 | -4106.5 |
| PRPS1L1 | -4113.5 |
| PTDSS2 | -4128.5 |
| MTHFS | -4150.0 |
| STAR | -4173.5 |
| PIK3CD | -4177.5 |
| PCBD1 | -4187.5 |
| ACER3 | -4196.5 |
| RPL5 | -4208.5 |
| HS6ST2 | -4211.5 |
| PLCH2 | -4255.5 |
| TNFAIP8L1 | -4263.5 |
| UST | -4264.5 |
| SCD | -4268.5 |
| PIK3CB | -4270.5 |
| PMVK | -4277.5 |
| PRKD1 | -4279.5 |
| FUT7 | -4294.5 |
| RPS15A | -4306.5 |
| ALDH3A2 | -4314.5 |
| PLEKHA8 | -4323.5 |
| CHRM3 | -4341.5 |
| NDST1 | -4351.5 |
| AS3MT | -4357.5 |
| DHODH | -4364.5 |
| ALDH1L1 | -4367.5 |
| B3GALT2 | -4377.5 |
| DUOX2 | -4399.5 |
| AOC3 | -4419.5 |
| LYPLA1 | -4435.5 |
| RPS25 | -4440.5 |
| NUP98 | -4473.5 |
| PIK3CG | -4490.5 |
| AGPS | -4511.5 |
| MED10 | -4534.5 |
| SLC26A1 | -4536.5 |
| CYP19A1 | -4541.5 |
| HPGDS | -4553.5 |
| CPNE3 | -4561.5 |
| AGMAT | -4568.5 |
| SLC25A14 | -4573.5 |
| ARG1 | -4574.5 |
| PIKFYVE | -4587.5 |
| ITPR2 | -4590.5 |
| DCK | -4603.5 |
| CSNK2A2 | -4612.5 |
| CSGALNACT2 | -4620.5 |
| AGRN | -4633.5 |
| LPIN3 | -4637.5 |
| PLPP6 | -4658.5 |
| ARSB | -4665.5 |
| FAR1 | -4667.5 |
| NADK | -4668.5 |
| SYNJ1 | -4672.5 |
| AKR7A3 | -4673.5 |
| ACSBG2 | -4675.5 |
| CEPT1 | -4693.5 |
| ITPR3 | -4707.5 |
| HSCB | -4732.5 |
| RPL10L | -4738.5 |
| ALOX5 | -4740.5 |
| B4GALT1 | -4742.5 |
| INPP5B | -4755.5 |
| PLAAT5 | -4768.5 |
| CYP2C18 | -4771.0 |
| GPAT4 | -4776.5 |
| ELOVL5 | -4787.5 |
| TRMT112 | -4815.5 |
| PTPMT1 | -4823.5 |
| PLA2G4D | -4864.5 |
| MT-ATP8 | -4868.5 |
| GPD2 | -4892.5 |
| CDO1 | -4894.5 |
| ADA | -4899.5 |
| OSBPL6 | -4900.5 |
| NAT1 | -4902.0 |
| NAT2 | -4902.0 |
| HSD3B7 | -4908.5 |
| GSTP1 | -4914.5 |
| RPL38 | -4919.5 |
| PRKCA | -4927.5 |
| PLCG2 | -4936.5 |
| RPL35A | -4964.5 |
| NUP93 | -4965.5 |
| NME1 | -4994.5 |
| ARNT | -4995.5 |
| PCTP | -5012.5 |
| INPP5F | -5022.5 |
| UCP3 | -5025.5 |
| CA3 | -5043.5 |
| COX8A | -5052.5 |
| GNG2 | -5056.5 |
| ACLY | -5064.5 |
| SPTLC1 | -5066.5 |
| NUP107 | -5093.5 |
| TK1 | -5116.5 |
| IDS | -5120.0 |
| GLYCTK | -5123.5 |
| ABCA1 | -5132.5 |
| MBOAT1 | -5133.5 |
| LIPT1 | -5144.5 |
| TSPOAP1 | -5146.5 |
| AK9 | -5151.5 |
| FUT9 | -5159.5 |
| PTGIS | -5179.5 |
| HS3ST3B1 | -5185.5 |
| CHSY3 | -5190.5 |
| APOA2 | -5197.5 |
| MANBA | -5199.5 |
| EPHX2 | -5201.5 |
| MED15 | -5227.5 |
| KYNU | -5240.5 |
| GSTK1 | -5244.5 |
| SLC16A8 | -5262.5 |
| GDPD1 | -5272.5 |
| PITPNM2 | -5276.5 |
| LPCAT2 | -5277.5 |
| GCKR | -5290.5 |
| B3GNT7 | -5294.5 |
| NUP133 | -5325.5 |
| ABHD3 | -5337.5 |
| CSPG4 | -5340.5 |
| COX6B1 | -5355.5 |
| ELOVL2 | -5358.5 |
| ARSI | -5379.5 |
| SAT1 | -5390.5 |
| TBL1XR1 | -5408.5 |
| SLC10A2 | -5409.5 |
| MGST1 | -5414.5 |
| TNFAIP8L2 | -5465.5 |
| AMN | -5484.5 |
| PGM2 | -5494.5 |
| SUMO2 | -5548.5 |
| NAGS | -5551.5 |
| ITPR1 | -5566.5 |
| ACSL3 | -5585.5 |
| CYP17A1 | -5593.5 |
| SREBF2 | -5602.5 |
| SULT1B1 | -5607.5 |
| TNFAIP8L3 | -5612.5 |
| PIK3R5 | -5631.5 |
| IQGAP1 | -5645.5 |
| GPIHBP1 | -5652.5 |
| OSBPL8 | -5658.5 |
| ENTPD7 | -5664.5 |
| BLVRA | -5672.5 |
| UPB1 | -5700.5 |
| GLB1L | -5725.5 |
| LMBRD1 | -5726.5 |
| STARD3 | -5731.5 |
| GNA15 | -5733.5 |
| CAV1 | -5750.5 |
| SLC22A3 | -5757.5 |
| CHST13 | -5766.5 |
| RPL27 | -5778.5 |
| ESYT3 | -5782.5 |
| PHGDH | -5798.5 |
| PPA2 | -5799.5 |
| OGN | -5813.5 |
| CERS2 | -5833.5 |
| ACBD5 | -5836.5 |
| GMPR2 | -5870.5 |
| IMPDH1 | -5881.5 |
| EBP | -5884.0 |
| HSD11B2 | -5896.5 |
| RAE1 | -5897.5 |
| GNG13 | -5917.5 |
| ADCY2 | -5924.5 |
| FUT4 | -5927.5 |
| AGT | -5931.5 |
| SULT6B1 | -5932.5 |
| MTARC1 | -5946.0 |
| GLS2 | -5976.5 |
| NAT8L | -5982.5 |
| SDSL | -5984.5 |
| MAN2B1 | -6007.0 |
| DDO | -6010.5 |
| HMMR | -6015.5 |
| ATP5F1A | -6042.5 |
| SIN3A | -6055.5 |
| NUP155 | -6056.5 |
| HPSE | -6059.5 |
| LRP2 | -6066.5 |
| ANGPTL4 | -6076.5 |
| CROT | -6097.5 |
| CSPG5 | -6102.5 |
| CA5A | -6114.5 |
| CHST3 | -6115.5 |
| DDHD2 | -6123.5 |
| TAT | -6128.5 |
| AK8 | -6136.5 |
| PIK3C2A | -6139.5 |
| PLIN1 | -6150.5 |
| CACNB3 | -6160.5 |
| PLPP1 | -6170.5 |
| CHDH | -6185.5 |
| SREBF1 | -6213.5 |
| FABP1 | -6232.5 |
| CYP4F22 | -6238.5 |
| SPTSSA | -6249.5 |
| EEF1E1 | -6270.0 |
| STARD4 | -6281.5 |
| CD38 | -6284.5 |
| APOE | -6290.5 |
| FADS2 | -6303.5 |
| VKORC1L1 | -6308.5 |
| MOGAT1 | -6309.5 |
| SLC27A3 | -6314.5 |
| SLCO1B1 | -6316.5 |
| SLCO1B3 | -6316.5 |
| VKORC1 | -6319.5 |
| B3GAT1 | -6322.5 |
| ACOT4 | -6347.5 |
| CCNC | -6352.5 |
| PON2 | -6353.5 |
| SLC23A1 | -6369.5 |
| ADI1 | -6383.5 |
| PLCB2 | -6389.5 |
| AGMO | -6395.5 |
| PFKFB1 | -6409.5 |
| RPS18 | -6410.5 |
| GLCE | -6414.5 |
| B4GALT4 | -6422.5 |
| PSPH | -6432.5 |
| GLP1R | -6437.5 |
| HSD17B14 | -6440.5 |
| ZDHHC21 | -6469.5 |
| HOGA1 | -6470.5 |
| RPS19 | -6473.5 |
| PAPSS1 | -6478.5 |
| OSBPL9 | -6482.5 |
| AGPAT5 | -6488.5 |
| SLC10A1 | -6507.5 |
| PYGL | -6536.5 |
| HACD3 | -6538.5 |
| ALB | -6541.5 |
| GSTM4 | -6543.5 |
| VAPA | -6554.5 |
| OSBPL10 | -6564.5 |
| SLC35D2 | -6586.0 |
| CHST14 | -6592.5 |
| QPRT | -6597.5 |
| GNB5 | -6634.5 |
| MTMR12 | -6648.5 |
| RPL30 | -6652.5 |
| SECISBP2 | -6655.5 |
| BRIP1 | -6657.5 |
| MED13L | -6673.5 |
| RPS21 | -6677.5 |
| ADH7 | -6680.5 |
| BAAT | -6684.5 |
| ALDH3B1 | -6699.5 |
| CERS4 | -6704.5 |
| HMGCR | -6711.5 |
| RPLP1 | -6712.5 |
| B3GNT2 | -6719.5 |
| SLC36A4 | -6726.5 |
| CYP2S1 | -6743.5 |
| SERINC5 | -6746.5 |
| CMPK1 | -6747.5 |
| PDK3 | -6753.5 |
| SP1 | -6760.5 |
| SYT5 | -6783.5 |
| EEFSEC | -6785.5 |
| SDC2 | -6795.5 |
| GNB1 | -6797.5 |
| MTAP | -6822.0 |
| NUDT7 | -6823.5 |
| NDUFV3 | -6831.5 |
| TK2 | -6839.5 |
| FAU | -6841.5 |
| MAT1A | -6853.5 |
| MTMR10 | -6886.5 |
| KHK | -6910.5 |
| AGXT2 | -6924.5 |
| GNG7 | -6928.5 |
| CYP4F3 | -6929.5 |
| GSR | -6931.5 |
| TM7SF2 | -6992.5 |
| PEX11A | -6997.5 |
| IDI1 | -7006.5 |
| IDO2 | -7011.5 |
| GLYAT | -7026.5 |
| ADCY3 | -7027.5 |
| NSDHL | -7119.5 |
| CTPS2 | -7123.5 |
| CYP51A1 | -7126.5 |
| RPE | -7132.0 |
| RPEL1 | -7132.0 |
| FABP4 | -7138.5 |
| MGST2 | -7153.5 |
| PFKFB4 | -7154.5 |
| NADSYN1 | -7182.5 |
| SLC52A3 | -7186.5 |
| GC | -7191.5 |
| RPS17 | -7220.5 |
| TRIB3 | -7228.5 |
| NR1H4 | -7229.5 |
| STARD3NL | -7230.5 |
| SDC1 | -7234.5 |
| MGLL | -7261.5 |
| HAS3 | -7263.5 |
| HMGCS1 | -7277.5 |
| STX1A | -7287.5 |
| PANK3 | -7289.5 |
| MTF1 | -7295.5 |
| TXN2 | -7297.5 |
| FAR2 | -7313.5 |
| ETNPPL | -7315.5 |
| RRM2 | -7343.5 |
| TBL1X | -7352.0 |
| RPL3 | -7355.5 |
| CACNA1D | -7378.5 |
| AWAT2 | -7388.5 |
| GSTA5 | -7402.5 |
| PTGES3 | -7413.5 |
| PIK3C2G | -7419.5 |
| MARCKS | -7421.5 |
| GSTM1 | -7436.5 |
| LCLAT1 | -7440.5 |
| CERS6 | -7443.5 |
| GNB2 | -7445.5 |
| FAH | -7467.5 |
| SLC44A1 | -7471.5 |
| DSEL | -7476.5 |
| RPS16 | -7482.5 |
| AHR | -7492.0 |
| FADS1 | -7500.5 |
| UGDH | -7503.5 |
| ADIPOQ | -7514.5 |
| DTYMK | -7519.5 |
| SQLE | -7540.5 |
| GALK1 | -7553.5 |
| CEMIP | -7561.5 |
| SRR | -7564.5 |
| CHST11 | -7582.5 |
| CYP7B1 | -7588.5 |
| MBTPS2 | -7595.5 |
| CYP3A4 | -7611.5 |
| CYP3A43 | -7611.5 |
| CYP3A5 | -7611.5 |
| CYP3A7 | -7611.5 |
| NPAS2 | -7617.5 |
| DHTKD1 | -7643.5 |
| GK | -7655.0 |
| GK3P | -7655.0 |
| CYP2E1 | -7664.5 |
| TMLHE | -7675.5 |
| PM20D1 | -7706.5 |
| CTRC | -7707.5 |
| NNMT | -7709.5 |
| PLEKHA1 | -7740.5 |
| NMRAL1 | -7748.5 |
| DUT | -7757.5 |
| THTPA | -7761.5 |
| NT5E | -7766.5 |
| BCO2 | -7771.5 |
| B4GALT6 | -7779.5 |
| RPL6 | -7781.5 |
| NUDT5 | -7785.5 |
| UQCRB | -7789.5 |
| PRODH2 | -7791.5 |
| MED12 | -7797.5 |
| PARP16 | -7800.5 |
| APOC3 | -7801.5 |
| ARNTL | -7817.5 |
| AGPAT1 | -7831.5 |
| CERS3 | -7832.5 |
| PLA2G2F | -7836.5 |
| AASS | -7838.5 |
| LDLR | -7842.5 |
| GSTZ1 | -7866.5 |
| MFSD2A | -7867.5 |
| MINPP1 | -7877.5 |
| LSS | -7884.5 |
| BCAT1 | -7890.5 |
| COX16 | -7904.5 |
| AKR1D1 | -7916.5 |
| ALDH1L2 | -7917.5 |
| SBF2 | -7925.5 |
| GNB4 | -7962.5 |
| HSD17B13 | -7973.5 |
| CD44 | -7979.5 |
| CYP2J2 | -7983.5 |
| ACSL4 | -7994.5 |
| MBTPS1 | -8002.5 |
| GGT1 | -8036.5 |
| ETNK2 | -8040.5 |
| AOC1 | -8042.5 |
| IYD | -8049.5 |
| VCAN | -8054.5 |
| CERS5 | -8055.5 |
| NMNAT2 | -8056.5 |
| RPL23A | -8061.5 |
| SLC6A12 | -8096.5 |
| STARD6 | -8103.5 |
| PRKD3 | -8116.5 |
| LRAT | -8126.5 |
| CACNA1C | -8127.5 |
| RRM1 | -8133.5 |
| PRKAR2B | -8138.5 |
| PCYT1B | -8157.5 |
| AOX1 | -8158.5 |
| SEC24A | -8183.5 |
| ACSM1 | -8188.5 |
| PLEKHA5 | -8201.5 |
| INSIG1 | -8208.5 |
| G6PC | -8214.5 |
| NUP37 | -8222.5 |
| FLVCR1 | -8223.5 |
| ALPI | -8227.5 |
| PLCH1 | -8229.5 |
| ENPP2 | -8236.5 |
| SLCO1A2 | -8246.5 |
| KMO | -8249.5 |
| NAALAD2 | -8305.5 |
| CHD9 | -8313.5 |
| SDS | -8322.5 |
| CPS1 | -8324.5 |
| RTEL1 | -8330.0 |
| ABCC5 | -8348.5 |
| SPHK1 | -8349.5 |
| APOB | -8370.5 |
| MSMO1 | -8374.5 |
| CYP4A11 | -8385.0 |
| CYP4A22 | -8385.0 |
| CYP4F11 | -8385.0 |
| CYP4F12 | -8385.0 |
| ADH5 | -8387.5 |
| KCNC2 | -8389.5 |
| GSTT2 | -8398.0 |
| GSTT2B | -8398.0 |
| SLC22A2 | -8417.5 |
| CYP21A2 | -8437.5 |
| NUP214 | -8440.5 |
| ACSM5 | -8442.5 |
| SLC44A5 | -8444.5 |
| ABCC3 | -8455.5 |
| DPYD | -8466.5 |
| RPS13 | -8475.5 |
| ABCG2 | -8477.5 |
| SULT1C2 | -8488.5 |
| NT5C1B | -8494.0 |
| APOM | -8495.5 |
| GGT5 | -8496.5 |
| GGPS1 | -8600.5 |
| PLD1 | -8613.5 |
| SULT2A1 | -8618.5 |
| ACAT2 | -8629.5 |
| CLOCK | -8631.5 |
| CYP2A13 | -8633.5 |
| CYP2A6 | -8633.5 |
| CYP2A7 | -8633.5 |
| GRHPR | -8636.5 |
| TPST1 | -8639.5 |
| TPI1 | -8641.5 |
| CACNA1E | -8644.5 |
| MED14 | -8670.5 |
| PDZD11 | -8676.5 |
| UGT1A1 | -8678.5 |
Respiratory electron transport
| 1070 | |
|---|---|
| set | Respiratory electron transport |
| setSize | 96 |
| pANOVA | 5.36e-09 |
| s.dist | 0.345 |
| p.adjustANOVA | 5.53e-07 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| NDUFA12 | 8677.5 |
| NDUFA8 | 8607.5 |
| NDUFS5 | 8426.5 |
| ECSIT | 8154.5 |
| COX11 | 8096.5 |
| ACAD9 | 8063.5 |
| NDUFS7 | 7874.5 |
| MT-CO1 | 7459.5 |
| TACO1 | 7403.5 |
| NDUFA13 | 7316.5 |
| TRAP1 | 7311.5 |
| ETFDH | 7282.5 |
| TIMMDC1 | 7186.5 |
| NDUFAF3 | 7105.5 |
| SCO1 | 6994.5 |
| NDUFS2 | 6971.5 |
| MT-CO2 | 6945.5 |
| NDUFV1 | 6920.5 |
| SDHB | 6907.5 |
| NDUFAF4 | 6785.5 |
| GeneID | Gene Rank |
|---|---|
| NDUFA12 | 8677.5 |
| NDUFA8 | 8607.5 |
| NDUFS5 | 8426.5 |
| ECSIT | 8154.5 |
| COX11 | 8096.5 |
| ACAD9 | 8063.5 |
| NDUFS7 | 7874.5 |
| MT-CO1 | 7459.5 |
| TACO1 | 7403.5 |
| NDUFA13 | 7316.5 |
| TRAP1 | 7311.5 |
| ETFDH | 7282.5 |
| TIMMDC1 | 7186.5 |
| NDUFAF3 | 7105.5 |
| SCO1 | 6994.5 |
| NDUFS2 | 6971.5 |
| MT-CO2 | 6945.5 |
| NDUFV1 | 6920.5 |
| SDHB | 6907.5 |
| NDUFAF4 | 6785.5 |
| NDUFB10 | 6419.5 |
| COX7A2L | 6410.5 |
| UQCRC1 | 6324.5 |
| NDUFS3 | 6318.5 |
| UQCRFS1 | 6235.5 |
| ETFB | 6145.5 |
| NDUFV2 | 6127.5 |
| NDUFA10 | 6103.5 |
| COX5B | 5910.5 |
| NDUFA6 | 5887.5 |
| NDUFA2 | 5728.5 |
| ETFA | 5655.5 |
| NDUFB9 | 5536.5 |
| NDUFS8 | 5518.5 |
| CYC1 | 5440.5 |
| SURF1 | 5398.5 |
| NDUFA11 | 5077.0 |
| UQCRH | 4971.0 |
| COX18 | 4765.5 |
| UQCRQ | 4627.5 |
| NDUFB8 | 4615.0 |
| SDHC | 4606.5 |
| NDUFB2 | 4587.5 |
| NDUFAB1 | 4350.5 |
| SDHA | 4232.0 |
| NDUFA7 | 3973.0 |
| COX4I1 | 3926.5 |
| UQCR10 | 3843.5 |
| NDUFA9 | 3708.5 |
| COX14 | 3517.5 |
| NDUFA5 | 3514.5 |
| UQCRC2 | 3503.5 |
| NDUFB6 | 3329.5 |
| NDUFC1 | 3113.5 |
| NDUFS1 | 3068.5 |
| NDUFAF1 | 2966.5 |
| COQ10B | 2915.5 |
| NDUFAF7 | 2842.5 |
| COX7B | 2750.5 |
| UQCR11 | 2718.0 |
| NDUFC2 | 2669.0 |
| MT-ND1 | 2529.5 |
| NDUFB7 | 2448.5 |
| NDUFS4 | 2412.5 |
| NDUFA3 | 2298.5 |
| SDHD | 2278.0 |
| NDUFAF5 | 2012.5 |
| MT-ND3 | 1861.5 |
| CYCS | 1802.5 |
| MT-CO3 | 1568.5 |
| MT-CYB | 1377.5 |
| MT-ND5 | 1325.5 |
| NDUFA4 | 1265.5 |
| COX6A1 | 1068.5 |
| NDUFB5 | 1061.5 |
| COX20 | 681.5 |
| COX5A | 481.5 |
| MT-ND4 | 390.5 |
| MT-ND2 | 306.5 |
| NDUFB11 | -363.5 |
| MT-ND6 | -790.5 |
| NUBPL | -1174.5 |
| COX19 | -1192.5 |
| COQ10A | -2127.5 |
| COX7C | -2174.5 |
| TMEM126B | -2544.5 |
| NDUFAF6 | -2759.5 |
| NDUFS6 | -2838.5 |
| NDUFB3 | -3539.5 |
| NDUFA1 | -3668.5 |
| NDUFB4 | -3950.5 |
| COX8A | -5052.5 |
| COX6B1 | -5355.5 |
| NDUFV3 | -6831.5 |
| UQCRB | -7789.5 |
| COX16 | -7904.5 |
Selective autophagy
| 1127 | |
|---|---|
| set | Selective autophagy |
| setSize | 56 |
| pANOVA | 1.25e-08 |
| s.dist | 0.44 |
| p.adjustANOVA | 1.2e-06 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| CSNK2B | 8941.5 |
| PARK7 | 8928.5 |
| PRKAB2 | 8910.5 |
| IFT88 | 8744.5 |
| SQSTM1 | 8697.5 |
| ARL13B | 8606.5 |
| MFN2 | 8568.5 |
| PINK1 | 8514.5 |
| TOMM40 | 8333.5 |
| MAP1LC3B | 8304.0 |
| HSPA8 | 7910.5 |
| MFN1 | 7800.5 |
| PLIN3 | 7535.5 |
| NBR1 | 7530.5 |
| UBA52 | 7357.5 |
| USP30 | 7330.5 |
| DYNC1LI1 | 7142.5 |
| DYNC1H1 | 6922.5 |
| VCP | 6599.5 |
| PLIN2 | 6558.5 |
| GeneID | Gene Rank |
|---|---|
| CSNK2B | 8941.5 |
| PARK7 | 8928.5 |
| PRKAB2 | 8910.5 |
| IFT88 | 8744.5 |
| SQSTM1 | 8697.5 |
| ARL13B | 8606.5 |
| MFN2 | 8568.5 |
| PINK1 | 8514.5 |
| TOMM40 | 8333.5 |
| MAP1LC3B | 8304.0 |
| HSPA8 | 7910.5 |
| MFN1 | 7800.5 |
| PLIN3 | 7535.5 |
| NBR1 | 7530.5 |
| UBA52 | 7357.5 |
| USP30 | 7330.5 |
| DYNC1LI1 | 7142.5 |
| DYNC1H1 | 6922.5 |
| VCP | 6599.5 |
| PLIN2 | 6558.5 |
| TOMM6 | 6247.5 |
| PRKAA2 | 6239.5 |
| DYNLL2 | 6153.5 |
| PRKAB1 | 5775.5 |
| ATG5 | 5242.5 |
| MAP1LC3A | 5210.5 |
| DYNC1I2 | 5195.5 |
| ATG12 | 5189.5 |
| CSNK2A1 | 5083.0 |
| HDAC6 | 4383.5 |
| VDAC1 | 4260.5 |
| UBE2N | 3887.0 |
| EPAS1 | 3670.5 |
| TOMM20 | 3158.5 |
| PRKAG3 | 3034.5 |
| TOMM22 | 2933.5 |
| TOMM70 | 2806.5 |
| DYNC1I1 | 2733.5 |
| PCNT | 2681.5 |
| RPS27A | 2261.5 |
| HSF1 | 1964.5 |
| FUNDC1 | 1863.5 |
| DYNLL1 | 767.5 |
| ULK1 | 458.5 |
| CFTR | 341.5 |
| PGAM5 | 146.5 |
| UBC | 100.5 |
| PEX5 | -258.5 |
| PRKAG2 | -768.5 |
| MTERF3 | -1961.5 |
| SRC | -2361.5 |
| DYNC1LI2 | -2368.5 |
| CETN1 | -2424.5 |
| CSNK2A2 | -4612.5 |
| ATM | -4881.5 |
| TOMM7 | -4954.5 |
ABC-family proteins mediated transport
| 4 | |
|---|---|
| set | ABC-family proteins mediated transport |
| setSize | 97 |
| pANOVA | 1.32e-08 |
| s.dist | 0.334 |
| p.adjustANOVA | 1.2e-06 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| ABCF1 | 8999.5 |
| ABCB4 | 8969.5 |
| ABCB6 | 8912.5 |
| PSMB8 | 8750.5 |
| PSMD1 | 8707.5 |
| ABCB8 | 8594.5 |
| RNF5 | 8489.5 |
| PEX19 | 8449.5 |
| PSMC1 | 7622.5 |
| ABCC4 | 7377.5 |
| UBA52 | 7357.5 |
| PSMA6 | 7345.5 |
| DERL3 | 7165.5 |
| ABCD1 | 7028.5 |
| PSMD4 | 7024.5 |
| PSMB5 | 6910.5 |
| PSMB9 | 6825.5 |
| RNF185 | 6684.5 |
| VCP | 6599.5 |
| PSMA8 | 6529.5 |
| GeneID | Gene Rank |
|---|---|
| ABCF1 | 8999.5 |
| ABCB4 | 8969.5 |
| ABCB6 | 8912.5 |
| PSMB8 | 8750.5 |
| PSMD1 | 8707.5 |
| ABCB8 | 8594.5 |
| RNF5 | 8489.5 |
| PEX19 | 8449.5 |
| PSMC1 | 7622.5 |
| ABCC4 | 7377.5 |
| UBA52 | 7357.5 |
| PSMA6 | 7345.5 |
| DERL3 | 7165.5 |
| ABCD1 | 7028.5 |
| PSMD4 | 7024.5 |
| PSMB5 | 6910.5 |
| PSMB9 | 6825.5 |
| RNF185 | 6684.5 |
| VCP | 6599.5 |
| PSMA8 | 6529.5 |
| ABCG4 | 6520.5 |
| PSME1 | 6431.5 |
| KCNJ11 | 6359.5 |
| ABCD3 | 6258.5 |
| PSMD14 | 6156.5 |
| PSMB6 | 6079.5 |
| PSMB7 | 5988.5 |
| PSMD7 | 5955.5 |
| PSMD11 | 5787.5 |
| PSMD8 | 5682.5 |
| PSMA4 | 5533.5 |
| PSMD3 | 5512.5 |
| PSMC2 | 5421.5 |
| PSME4 | 5222.5 |
| PSMB1 | 5207.5 |
| PSMD10 | 5093.5 |
| ABCD2 | 5081.5 |
| PSMC3 | 4982.5 |
| PSMA2 | 4823.0 |
| OS9 | 4799.5 |
| EIF2S2 | 4761.5 |
| PSMC4 | 4751.5 |
| ABCC10 | 4709.5 |
| PSMD2 | 4685.5 |
| ABCA7 | 4681.5 |
| PSMD5 | 4655.5 |
| SEL1L | 4548.5 |
| PSMD6 | 4428.5 |
| PSMC5 | 4349.5 |
| ABCC2 | 4308.5 |
| ABCA4 | 4066.5 |
| PSMA7 | 3962.5 |
| ERLIN1 | 3915.5 |
| ABCB7 | 3781.5 |
| APOA1 | 3608.5 |
| DERL1 | 3559.5 |
| DERL2 | 3262.5 |
| PSMD12 | 3211.5 |
| ERLIN2 | 3026.5 |
| EIF2S3 | 3002.0 |
| PSMB2 | 2944.5 |
| ABCG1 | 2687.5 |
| PSME2 | 2547.5 |
| ERLEC1 | 2361.5 |
| RPS27A | 2261.5 |
| ABCA3 | 2242.5 |
| ABCA12 | 2188.5 |
| PSMA1 | 1867.5 |
| ABCB10 | 1793.5 |
| ABCG5 | 1736.5 |
| PSMB4 | 1567.5 |
| PSMC6 | 1488.5 |
| PSME3 | 1442.5 |
| ABCB9 | 935.5 |
| PSMB3 | 391.5 |
| CFTR | 341.5 |
| ABCC1 | 103.5 |
| UBC | 100.5 |
| PSMA5 | 5.5 |
| ABCA2 | -465.5 |
| PSMA3 | -754.5 |
| PSMB10 | -1181.5 |
| PSMF1 | -1438.5 |
| ABCA9 | -2610.5 |
| PSMD9 | -2755.0 |
| PSMD13 | -2775.5 |
| ABCC9 | -3974.5 |
| EIF2S1 | -4178.5 |
| ABCA6 | -4286.5 |
| ABCA5 | -4648.5 |
| PEX3 | -4652.5 |
| ABCG8 | -5691.5 |
| ABCB5 | -6245.5 |
| ABCA8 | -6809.5 |
| ABCC6 | -7281.5 |
| ABCC5 | -8348.5 |
| ABCC3 | -8455.5 |
Hh mutants that don't undergo autocatalytic processing are degraded by ERAD
| 534 | |
|---|---|
| set | Hh mutants that don't undergo autocatalytic processing are degraded by ERAD |
| setSize | 53 |
| pANOVA | 2.63e-08 |
| s.dist | 0.442 |
| p.adjustANOVA | 2.24e-06 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| PSMB8 | 8750.5 |
| PSMD1 | 8707.5 |
| SYVN1 | 7703.5 |
| PSMC1 | 7622.5 |
| UBA52 | 7357.5 |
| PSMA6 | 7345.5 |
| PSMD4 | 7024.5 |
| PSMB5 | 6910.5 |
| PSMB9 | 6825.5 |
| VCP | 6599.5 |
| PSMA8 | 6529.5 |
| PSME1 | 6431.5 |
| PSMD14 | 6156.5 |
| PSMB6 | 6079.5 |
| PSMB7 | 5988.5 |
| PSMD7 | 5955.5 |
| PSMD11 | 5787.5 |
| PSMD8 | 5682.5 |
| PSMA4 | 5533.5 |
| PSMD3 | 5512.5 |
| GeneID | Gene Rank |
|---|---|
| PSMB8 | 8750.5 |
| PSMD1 | 8707.5 |
| SYVN1 | 7703.5 |
| PSMC1 | 7622.5 |
| UBA52 | 7357.5 |
| PSMA6 | 7345.5 |
| PSMD4 | 7024.5 |
| PSMB5 | 6910.5 |
| PSMB9 | 6825.5 |
| VCP | 6599.5 |
| PSMA8 | 6529.5 |
| PSME1 | 6431.5 |
| PSMD14 | 6156.5 |
| PSMB6 | 6079.5 |
| PSMB7 | 5988.5 |
| PSMD7 | 5955.5 |
| PSMD11 | 5787.5 |
| PSMD8 | 5682.5 |
| PSMA4 | 5533.5 |
| PSMD3 | 5512.5 |
| PSMC2 | 5421.5 |
| PSME4 | 5222.5 |
| PSMB1 | 5207.5 |
| PSMD10 | 5093.5 |
| PSMC3 | 4982.5 |
| PSMA2 | 4823.0 |
| OS9 | 4799.5 |
| PSMC4 | 4751.5 |
| PSMD2 | 4685.5 |
| PSMD5 | 4655.5 |
| SEL1L | 4548.5 |
| PSMD6 | 4428.5 |
| PSMC5 | 4349.5 |
| PSMA7 | 3962.5 |
| DERL2 | 3262.5 |
| PSMD12 | 3211.5 |
| PSMB2 | 2944.5 |
| PSME2 | 2547.5 |
| ERLEC1 | 2361.5 |
| RPS27A | 2261.5 |
| PSMA1 | 1867.5 |
| PSMB4 | 1567.5 |
| PSMC6 | 1488.5 |
| PSME3 | 1442.5 |
| PSMB3 | 391.5 |
| UBC | 100.5 |
| PSMA5 | 5.5 |
| SHH | -695.0 |
| PSMA3 | -754.5 |
| PSMB10 | -1181.5 |
| PSMF1 | -1438.5 |
| PSMD9 | -2755.0 |
| PSMD13 | -2775.5 |
Hh mutants abrogate ligand secretion
| 533 | |
|---|---|
| set | Hh mutants abrogate ligand secretion |
| setSize | 56 |
| pANOVA | 3.1e-08 |
| s.dist | 0.428 |
| p.adjustANOVA | 2.49e-06 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| PSMB8 | 8750.5 |
| PSMD1 | 8707.5 |
| SYVN1 | 7703.5 |
| PSMC1 | 7622.5 |
| UBA52 | 7357.5 |
| PSMA6 | 7345.5 |
| PSMD4 | 7024.5 |
| PSMB5 | 6910.5 |
| PSMB9 | 6825.5 |
| VCP | 6599.5 |
| PSMA8 | 6529.5 |
| PSME1 | 6431.5 |
| PSMD14 | 6156.5 |
| PSMB6 | 6079.5 |
| PSMB7 | 5988.5 |
| PSMD7 | 5955.5 |
| PSMD11 | 5787.5 |
| PSMD8 | 5682.5 |
| PSMA4 | 5533.5 |
| PSMD3 | 5512.5 |
| GeneID | Gene Rank |
|---|---|
| PSMB8 | 8750.5 |
| PSMD1 | 8707.5 |
| SYVN1 | 7703.5 |
| PSMC1 | 7622.5 |
| UBA52 | 7357.5 |
| PSMA6 | 7345.5 |
| PSMD4 | 7024.5 |
| PSMB5 | 6910.5 |
| PSMB9 | 6825.5 |
| VCP | 6599.5 |
| PSMA8 | 6529.5 |
| PSME1 | 6431.5 |
| PSMD14 | 6156.5 |
| PSMB6 | 6079.5 |
| PSMB7 | 5988.5 |
| PSMD7 | 5955.5 |
| PSMD11 | 5787.5 |
| PSMD8 | 5682.5 |
| PSMA4 | 5533.5 |
| PSMD3 | 5512.5 |
| PSMC2 | 5421.5 |
| PSME4 | 5222.5 |
| PSMB1 | 5207.5 |
| PSMD10 | 5093.5 |
| PSMC3 | 4982.5 |
| PSMA2 | 4823.0 |
| OS9 | 4799.5 |
| PSMC4 | 4751.5 |
| PSMD2 | 4685.5 |
| HHAT | 4670.5 |
| PSMD5 | 4655.5 |
| SEL1L | 4548.5 |
| PSMD6 | 4428.5 |
| PSMC5 | 4349.5 |
| PSMA7 | 3962.5 |
| DERL2 | 3262.5 |
| PSMD12 | 3211.5 |
| PSMB2 | 2944.5 |
| PSME2 | 2547.5 |
| ERLEC1 | 2361.5 |
| IHH | 2289.5 |
| RPS27A | 2261.5 |
| PSMA1 | 1867.5 |
| PSMB4 | 1567.5 |
| PSMC6 | 1488.5 |
| PSME3 | 1442.5 |
| PSMB3 | 391.5 |
| UBC | 100.5 |
| PSMA5 | 5.5 |
| SHH | -695.0 |
| PSMA3 | -754.5 |
| PSMB10 | -1181.5 |
| PSMF1 | -1438.5 |
| DHH | -1812.5 |
| PSMD9 | -2755.0 |
| PSMD13 | -2775.5 |
Interleukin-1 signaling
| 587 | |
|---|---|
| set | Interleukin-1 signaling |
| setSize | 94 |
| pANOVA | 4.17e-08 |
| s.dist | 0.327 |
| p.adjustANOVA | 3.18e-06 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| AGER | 8956.5 |
| PSMB8 | 8750.5 |
| PSMD1 | 8707.5 |
| SQSTM1 | 8697.5 |
| NFKBIB | 8429.5 |
| NOD1 | 8105.5 |
| NKIRAS2 | 7943.5 |
| APP | 7804.5 |
| PSMC1 | 7622.5 |
| SKP1 | 7381.5 |
| UBA52 | 7357.5 |
| NKIRAS1 | 7353.5 |
| PSMA6 | 7345.5 |
| TNIP2 | 7247.5 |
| PSMD4 | 7024.5 |
| PSMB5 | 6910.5 |
| PSMB9 | 6825.5 |
| TAB2 | 6793.5 |
| PELI3 | 6700.5 |
| IL1B | 6648.5 |
| GeneID | Gene Rank |
|---|---|
| AGER | 8956.5 |
| PSMB8 | 8750.5 |
| PSMD1 | 8707.5 |
| SQSTM1 | 8697.5 |
| NFKBIB | 8429.5 |
| NOD1 | 8105.5 |
| NKIRAS2 | 7943.5 |
| APP | 7804.5 |
| PSMC1 | 7622.5 |
| SKP1 | 7381.5 |
| UBA52 | 7357.5 |
| NKIRAS1 | 7353.5 |
| PSMA6 | 7345.5 |
| TNIP2 | 7247.5 |
| PSMD4 | 7024.5 |
| PSMB5 | 6910.5 |
| PSMB9 | 6825.5 |
| TAB2 | 6793.5 |
| PELI3 | 6700.5 |
| IL1B | 6648.5 |
| PSMA8 | 6529.5 |
| PSME1 | 6431.5 |
| MAP3K8 | 6329.5 |
| PSMD14 | 6156.5 |
| PSMB6 | 6079.5 |
| PSMB7 | 5988.5 |
| PSMD7 | 5955.5 |
| NFKB2 | 5930.5 |
| CUL1 | 5811.5 |
| PSMD11 | 5787.5 |
| IKBKG | 5786.5 |
| PSMD8 | 5682.5 |
| PSMA4 | 5533.5 |
| PSMD3 | 5512.5 |
| IL1RAP | 5449.5 |
| TAB3 | 5441.5 |
| PSMC2 | 5421.5 |
| MAP2K1 | 5275.5 |
| PSME4 | 5222.5 |
| PSMB1 | 5207.5 |
| PSMD10 | 5093.5 |
| PSMC3 | 4982.5 |
| PSMA2 | 4823.0 |
| PSMC4 | 4751.5 |
| PSMD2 | 4685.5 |
| PSMD5 | 4655.5 |
| PSMD6 | 4428.5 |
| PSMC5 | 4349.5 |
| RBX1 | 4159.5 |
| PSMA7 | 3962.5 |
| UBE2N | 3887.0 |
| MAP2K6 | 3880.5 |
| TAB1 | 3233.5 |
| PSMD12 | 3211.5 |
| PSMB2 | 2944.5 |
| IRAK2 | 2926.5 |
| PSME2 | 2547.5 |
| MAP3K3 | 2535.5 |
| NFKB1 | 2395.5 |
| RPS27A | 2261.5 |
| PSMA1 | 1867.5 |
| PSMB4 | 1567.5 |
| PSMC6 | 1488.5 |
| PSME3 | 1442.5 |
| MYD88 | 1336.5 |
| TOLLIP | 1309.5 |
| IKBKB | 1146.5 |
| IL1R2 | 1075.5 |
| IL1RN | 670.5 |
| IRAK1 | 408.5 |
| PSMB3 | 391.5 |
| UBC | 100.5 |
| PSMA5 | 5.5 |
| TRAF6 | -331.5 |
| PSMA3 | -754.5 |
| PSMB10 | -1181.5 |
| FBXW11 | -1203.5 |
| MAP2K4 | -1376.5 |
| PSMF1 | -1438.5 |
| RIPK2 | -1709.5 |
| BTRC | -1843.5 |
| CHUK | -2390.5 |
| HMGB1 | -2574.5 |
| PSMD9 | -2755.0 |
| PSMD13 | -2775.5 |
| NOD2 | -3286.5 |
| MAP3K7 | -3694.5 |
| PELI2 | -4274.5 |
| IRAK3 | -5654.5 |
| PELI1 | -6202.5 |
| RELA | -6220.5 |
| IRAK4 | -6357.5 |
| IL1R1 | -7048.5 |
| IL1A | -7386.5 |
tRNA Aminoacylation
| 1440 | |
|---|---|
| set | tRNA Aminoacylation |
| setSize | 42 |
| pANOVA | 5.94e-08 |
| s.dist | 0.483 |
| p.adjustANOVA | 4.24e-06 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| VARS1 | 8908.5 |
| VARS2 | 8870.5 |
| IARS2 | 8848.5 |
| NARS1 | 8747.5 |
| IARS1 | 8710.5 |
| FARS2 | 8703.5 |
| NARS2 | 8624.5 |
| LARS2 | 8505.5 |
| MARS2 | 7972.5 |
| AARS1 | 7920.5 |
| WARS1 | 7854.5 |
| EPRS1 | 7782.5 |
| HARS2 | 7498.5 |
| AIMP2 | 7246.5 |
| DARS2 | 7106.5 |
| EARS2 | 6792.5 |
| KARS1 | 6454.5 |
| MARS1 | 5857.5 |
| PPA1 | 5736.5 |
| AARS2 | 5661.5 |
| GeneID | Gene Rank |
|---|---|
| VARS1 | 8908.5 |
| VARS2 | 8870.5 |
| IARS2 | 8848.5 |
| NARS1 | 8747.5 |
| IARS1 | 8710.5 |
| FARS2 | 8703.5 |
| NARS2 | 8624.5 |
| LARS2 | 8505.5 |
| MARS2 | 7972.5 |
| AARS1 | 7920.5 |
| WARS1 | 7854.5 |
| EPRS1 | 7782.5 |
| HARS2 | 7498.5 |
| AIMP2 | 7246.5 |
| DARS2 | 7106.5 |
| EARS2 | 6792.5 |
| KARS1 | 6454.5 |
| MARS1 | 5857.5 |
| PPA1 | 5736.5 |
| AARS2 | 5661.5 |
| TARS2 | 5405.5 |
| GARS1 | 4498.5 |
| RARS2 | 4410.5 |
| YARS1 | 4257.5 |
| CARS1 | 4157.5 |
| HARS1 | 4044.5 |
| SARS2 | 3976.0 |
| TARS1 | 3797.5 |
| FARSA | 3117.5 |
| AIMP1 | 2707.5 |
| PARS2 | 2174.5 |
| QARS1 | 1901.5 |
| SARS1 | 1720.5 |
| FARSB | 1504.5 |
| RARS1 | 1477.5 |
| CARS2 | 1179.5 |
| LARS1 | 552.5 |
| YARS2 | -1276.5 |
| DARS1 | -1997.5 |
| WARS2 | -3221.5 |
| PPA2 | -5799.5 |
| EEF1E1 | -6270.0 |
Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.
| 1071 | |
|---|---|
| set | Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
| setSize | 117 |
| pANOVA | 6.16e-08 |
| s.dist | 0.29 |
| p.adjustANOVA | 4.24e-06 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| NDUFA12 | 8677.5 |
| ATP5F1D | 8640.5 |
| NDUFA8 | 8607.5 |
| ATP5PB | 8530.5 |
| NDUFS5 | 8426.5 |
| ECSIT | 8154.5 |
| COX11 | 8096.5 |
| ACAD9 | 8063.5 |
| NDUFS7 | 7874.5 |
| MT-CO1 | 7459.5 |
| TACO1 | 7403.5 |
| NDUFA13 | 7316.5 |
| TRAP1 | 7311.5 |
| ETFDH | 7282.5 |
| TIMMDC1 | 7186.5 |
| NDUFAF3 | 7105.5 |
| SCO1 | 6994.5 |
| NDUFS2 | 6971.5 |
| MT-CO2 | 6945.5 |
| NDUFV1 | 6920.5 |
| GeneID | Gene Rank |
|---|---|
| NDUFA12 | 8677.5 |
| ATP5F1D | 8640.5 |
| NDUFA8 | 8607.5 |
| ATP5PB | 8530.5 |
| NDUFS5 | 8426.5 |
| ECSIT | 8154.5 |
| COX11 | 8096.5 |
| ACAD9 | 8063.5 |
| NDUFS7 | 7874.5 |
| MT-CO1 | 7459.5 |
| TACO1 | 7403.5 |
| NDUFA13 | 7316.5 |
| TRAP1 | 7311.5 |
| ETFDH | 7282.5 |
| TIMMDC1 | 7186.5 |
| NDUFAF3 | 7105.5 |
| SCO1 | 6994.5 |
| NDUFS2 | 6971.5 |
| MT-CO2 | 6945.5 |
| NDUFV1 | 6920.5 |
| SDHB | 6907.5 |
| NDUFAF4 | 6785.5 |
| NDUFB10 | 6419.5 |
| COX7A2L | 6410.5 |
| UQCRC1 | 6324.5 |
| NDUFS3 | 6318.5 |
| UQCRFS1 | 6235.5 |
| ETFB | 6145.5 |
| NDUFV2 | 6127.5 |
| NDUFA10 | 6103.5 |
| DMAC2L | 5929.5 |
| COX5B | 5910.5 |
| NDUFA6 | 5887.5 |
| NDUFA2 | 5728.5 |
| ETFA | 5655.5 |
| NDUFB9 | 5536.5 |
| NDUFS8 | 5518.5 |
| CYC1 | 5440.5 |
| SURF1 | 5398.5 |
| NDUFA11 | 5077.0 |
| ATP5F1B | 5063.5 |
| UQCRH | 4971.0 |
| COX18 | 4765.5 |
| UQCRQ | 4627.5 |
| NDUFB8 | 4615.0 |
| SDHC | 4606.5 |
| NDUFB2 | 4587.5 |
| NDUFAB1 | 4350.5 |
| SDHA | 4232.0 |
| UCP2 | 4090.5 |
| NDUFA7 | 3973.0 |
| COX4I1 | 3926.5 |
| UQCR10 | 3843.5 |
| SLC25A27 | 3731.5 |
| NDUFA9 | 3708.5 |
| COX14 | 3517.5 |
| NDUFA5 | 3514.5 |
| UQCRC2 | 3503.5 |
| ATP5PD | 3402.5 |
| NDUFB6 | 3329.5 |
| NDUFC1 | 3113.5 |
| NDUFS1 | 3068.5 |
| NDUFAF1 | 2966.5 |
| ATP5PO | 2930.0 |
| COQ10B | 2915.5 |
| NDUFAF7 | 2842.5 |
| COX7B | 2750.5 |
| UQCR11 | 2718.0 |
| NDUFC2 | 2669.0 |
| ATP5MF | 2647.5 |
| MT-ND1 | 2529.5 |
| NDUFB7 | 2448.5 |
| NDUFS4 | 2412.5 |
| NDUFA3 | 2298.5 |
| SDHD | 2278.0 |
| NDUFAF5 | 2012.5 |
| MT-ND3 | 1861.5 |
| CYCS | 1802.5 |
| MT-CO3 | 1568.5 |
| MT-CYB | 1377.5 |
| MT-ND5 | 1325.5 |
| NDUFA4 | 1265.5 |
| MT-ATP6 | 1243.5 |
| COX6A1 | 1068.5 |
| NDUFB5 | 1061.5 |
| COX20 | 681.5 |
| COX5A | 481.5 |
| MT-ND4 | 390.5 |
| ATP5MC3 | 319.5 |
| MT-ND2 | 306.5 |
| UCP1 | -358.5 |
| NDUFB11 | -363.5 |
| ATP5PF | -401.5 |
| MT-ND6 | -790.5 |
| NUBPL | -1174.5 |
| COX19 | -1192.5 |
| ATP5F1E | -1407.5 |
| COQ10A | -2127.5 |
| COX7C | -2174.5 |
| TMEM126B | -2544.5 |
| ATP5MG | -2690.0 |
| NDUFAF6 | -2759.5 |
| NDUFS6 | -2838.5 |
| ATP5ME | -3145.5 |
| NDUFB3 | -3539.5 |
| NDUFA1 | -3668.5 |
| NDUFB4 | -3950.5 |
| SLC25A14 | -4573.5 |
| MT-ATP8 | -4868.5 |
| UCP3 | -5025.5 |
| COX8A | -5052.5 |
| COX6B1 | -5355.5 |
| ATP5F1A | -6042.5 |
| NDUFV3 | -6831.5 |
| PM20D1 | -7706.5 |
| UQCRB | -7789.5 |
| COX16 | -7904.5 |
AUF1 (hnRNP D0) binds and destabilizes mRNA
| 21 | |
|---|---|
| set | AUF1 (hnRNP D0) binds and destabilizes mRNA |
| setSize | 51 |
| pANOVA | 8.72e-08 |
| s.dist | 0.433 |
| p.adjustANOVA | 5.49e-06 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| PSMB8 | 8750.5 |
| PSMD1 | 8707.5 |
| EIF4G1 | 8580.5 |
| HSPA8 | 7910.5 |
| HSPA1A | 7838.0 |
| PSMC1 | 7622.5 |
| UBA52 | 7357.5 |
| PSMA6 | 7345.5 |
| PSMD4 | 7024.5 |
| PSMB5 | 6910.5 |
| PSMB9 | 6825.5 |
| PSMA8 | 6529.5 |
| PSME1 | 6431.5 |
| PSMD14 | 6156.5 |
| PSMB6 | 6079.5 |
| PSMB7 | 5988.5 |
| PSMD7 | 5955.5 |
| PSMD11 | 5787.5 |
| PSMD8 | 5682.5 |
| PSMA4 | 5533.5 |
| GeneID | Gene Rank |
|---|---|
| PSMB8 | 8750.5 |
| PSMD1 | 8707.5 |
| EIF4G1 | 8580.5 |
| HSPA8 | 7910.5 |
| HSPA1A | 7838.0 |
| PSMC1 | 7622.5 |
| UBA52 | 7357.5 |
| PSMA6 | 7345.5 |
| PSMD4 | 7024.5 |
| PSMB5 | 6910.5 |
| PSMB9 | 6825.5 |
| PSMA8 | 6529.5 |
| PSME1 | 6431.5 |
| PSMD14 | 6156.5 |
| PSMB6 | 6079.5 |
| PSMB7 | 5988.5 |
| PSMD7 | 5955.5 |
| PSMD11 | 5787.5 |
| PSMD8 | 5682.5 |
| PSMA4 | 5533.5 |
| PSMD3 | 5512.5 |
| PSMC2 | 5421.5 |
| PSME4 | 5222.5 |
| PSMB1 | 5207.5 |
| PSMD10 | 5093.5 |
| PSMC3 | 4982.5 |
| PSMA2 | 4823.0 |
| PSMC4 | 4751.5 |
| PSMD2 | 4685.5 |
| PSMD5 | 4655.5 |
| PSMD6 | 4428.5 |
| PSMC5 | 4349.5 |
| PSMA7 | 3962.5 |
| PSMD12 | 3211.5 |
| PSMB2 | 2944.5 |
| PSME2 | 2547.5 |
| RPS27A | 2261.5 |
| PSMA1 | 1867.5 |
| PSMB4 | 1567.5 |
| PSMC6 | 1488.5 |
| PSME3 | 1442.5 |
| HSPB1 | 682.5 |
| PSMB3 | 391.5 |
| UBC | 100.5 |
| PSMA5 | 5.5 |
| PSMA3 | -754.5 |
| PSMB10 | -1181.5 |
| PSMF1 | -1438.5 |
| PSMD9 | -2755.0 |
| PSMD13 | -2775.5 |
| HNRNPD | -8425.5 |
Regulation of ornithine decarboxylase (ODC)
| 1054 | |
|---|---|
| set | Regulation of ornithine decarboxylase (ODC) |
| setSize | 49 |
| pANOVA | 8.74e-08 |
| s.dist | 0.442 |
| p.adjustANOVA | 5.49e-06 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| PSMB8 | 8750.5 |
| PSMD1 | 8707.5 |
| PSMC1 | 7622.5 |
| PSMA6 | 7345.5 |
| PSMD4 | 7024.5 |
| PSMB5 | 6910.5 |
| ODC1 | 6863.5 |
| PSMB9 | 6825.5 |
| PSMA8 | 6529.5 |
| PSME1 | 6431.5 |
| PSMD14 | 6156.5 |
| PSMB6 | 6079.5 |
| PSMB7 | 5988.5 |
| PSMD7 | 5955.5 |
| PSMD11 | 5787.5 |
| PSMD8 | 5682.5 |
| PSMA4 | 5533.5 |
| PSMD3 | 5512.5 |
| PSMC2 | 5421.5 |
| PSME4 | 5222.5 |
| GeneID | Gene Rank |
|---|---|
| PSMB8 | 8750.5 |
| PSMD1 | 8707.5 |
| PSMC1 | 7622.5 |
| PSMA6 | 7345.5 |
| PSMD4 | 7024.5 |
| PSMB5 | 6910.5 |
| ODC1 | 6863.5 |
| PSMB9 | 6825.5 |
| PSMA8 | 6529.5 |
| PSME1 | 6431.5 |
| PSMD14 | 6156.5 |
| PSMB6 | 6079.5 |
| PSMB7 | 5988.5 |
| PSMD7 | 5955.5 |
| PSMD11 | 5787.5 |
| PSMD8 | 5682.5 |
| PSMA4 | 5533.5 |
| PSMD3 | 5512.5 |
| PSMC2 | 5421.5 |
| PSME4 | 5222.5 |
| PSMB1 | 5207.5 |
| OAZ2 | 5164.5 |
| PSMD10 | 5093.5 |
| NQO1 | 5061.5 |
| PSMC3 | 4982.5 |
| PSMA2 | 4823.0 |
| PSMC4 | 4751.5 |
| PSMD2 | 4685.5 |
| PSMD5 | 4655.5 |
| PSMD6 | 4428.5 |
| PSMC5 | 4349.5 |
| PSMA7 | 3962.5 |
| PSMD12 | 3211.5 |
| PSMB2 | 2944.5 |
| PSME2 | 2547.5 |
| AZIN1 | 2497.5 |
| OAZ1 | 2182.5 |
| PSMA1 | 1867.5 |
| PSMB4 | 1567.5 |
| PSMC6 | 1488.5 |
| PSME3 | 1442.5 |
| PSMB3 | 391.5 |
| OAZ3 | 346.5 |
| PSMA5 | 5.5 |
| PSMA3 | -754.5 |
| PSMB10 | -1181.5 |
| PSMF1 | -1438.5 |
| PSMD9 | -2755.0 |
| PSMD13 | -2775.5 |
NIK-->noncanonical NF-kB signaling
| 739 | |
|---|---|
| set | NIK-->noncanonical NF-kB signaling |
| setSize | 56 |
| pANOVA | 9.53e-08 |
| s.dist | 0.412 |
| p.adjustANOVA | 5.74e-06 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| PSMB8 | 8750.5 |
| PSMD1 | 8707.5 |
| PSMC1 | 7622.5 |
| SKP1 | 7381.5 |
| UBE2M | 7376.5 |
| UBA52 | 7357.5 |
| PSMA6 | 7345.5 |
| PSMD4 | 7024.5 |
| PSMB5 | 6910.5 |
| PSMB9 | 6825.5 |
| PSMA8 | 6529.5 |
| PSME1 | 6431.5 |
| PSMD14 | 6156.5 |
| PSMB6 | 6079.5 |
| PSMB7 | 5988.5 |
| PSMD7 | 5955.5 |
| NFKB2 | 5930.5 |
| CUL1 | 5811.5 |
| PSMD11 | 5787.5 |
| PSMD8 | 5682.5 |
| GeneID | Gene Rank |
|---|---|
| PSMB8 | 8750.5 |
| PSMD1 | 8707.5 |
| PSMC1 | 7622.5 |
| SKP1 | 7381.5 |
| UBE2M | 7376.5 |
| UBA52 | 7357.5 |
| PSMA6 | 7345.5 |
| PSMD4 | 7024.5 |
| PSMB5 | 6910.5 |
| PSMB9 | 6825.5 |
| PSMA8 | 6529.5 |
| PSME1 | 6431.5 |
| PSMD14 | 6156.5 |
| PSMB6 | 6079.5 |
| PSMB7 | 5988.5 |
| PSMD7 | 5955.5 |
| NFKB2 | 5930.5 |
| CUL1 | 5811.5 |
| PSMD11 | 5787.5 |
| PSMD8 | 5682.5 |
| PSMA4 | 5533.5 |
| PSMD3 | 5512.5 |
| PSMC2 | 5421.5 |
| PSME4 | 5222.5 |
| PSMB1 | 5207.5 |
| PSMD10 | 5093.5 |
| PSMC3 | 4982.5 |
| PSMA2 | 4823.0 |
| PSMC4 | 4751.5 |
| PSMD2 | 4685.5 |
| PSMD5 | 4655.5 |
| PSMD6 | 4428.5 |
| PSMC5 | 4349.5 |
| PSMA7 | 3962.5 |
| PSMD12 | 3211.5 |
| PSMB2 | 2944.5 |
| PSME2 | 2547.5 |
| RPS27A | 2261.5 |
| MAP3K14 | 2011.5 |
| PSMA1 | 1867.5 |
| UBA3 | 1735.5 |
| PSMB4 | 1567.5 |
| PSMC6 | 1488.5 |
| PSME3 | 1442.5 |
| RELB | 1279.5 |
| PSMB3 | 391.5 |
| UBC | 100.5 |
| PSMA5 | 5.5 |
| PSMA3 | -754.5 |
| PSMB10 | -1181.5 |
| FBXW11 | -1203.5 |
| PSMF1 | -1438.5 |
| BTRC | -1843.5 |
| CHUK | -2390.5 |
| PSMD9 | -2755.0 |
| PSMD13 | -2775.5 |
Degradation of GLI2 by the proteasome
| 286 | |
|---|---|
| set | Degradation of GLI2 by the proteasome |
| setSize | 55 |
| pANOVA | 1.1e-07 |
| s.dist | 0.414 |
| p.adjustANOVA | 6.39e-06 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| PSMB8 | 8750.5 |
| PSMD1 | 8707.5 |
| PSMC1 | 7622.5 |
| SKP1 | 7381.5 |
| UBA52 | 7357.5 |
| PSMA6 | 7345.5 |
| PRKACA | 7262.5 |
| PSMD4 | 7024.5 |
| PSMB5 | 6910.5 |
| PSMB9 | 6825.5 |
| PSMA8 | 6529.5 |
| PSME1 | 6431.5 |
| PSMD14 | 6156.5 |
| PSMB6 | 6079.5 |
| PSMB7 | 5988.5 |
| PSMD7 | 5955.5 |
| CUL1 | 5811.5 |
| PSMD11 | 5787.5 |
| PSMD8 | 5682.5 |
| PSMA4 | 5533.5 |
| GeneID | Gene Rank |
|---|---|
| PSMB8 | 8750.5 |
| PSMD1 | 8707.5 |
| PSMC1 | 7622.5 |
| SKP1 | 7381.5 |
| UBA52 | 7357.5 |
| PSMA6 | 7345.5 |
| PRKACA | 7262.5 |
| PSMD4 | 7024.5 |
| PSMB5 | 6910.5 |
| PSMB9 | 6825.5 |
| PSMA8 | 6529.5 |
| PSME1 | 6431.5 |
| PSMD14 | 6156.5 |
| PSMB6 | 6079.5 |
| PSMB7 | 5988.5 |
| PSMD7 | 5955.5 |
| CUL1 | 5811.5 |
| PSMD11 | 5787.5 |
| PSMD8 | 5682.5 |
| PSMA4 | 5533.5 |
| PSMD3 | 5512.5 |
| PSMC2 | 5421.5 |
| SUFU | 5369.5 |
| PSME4 | 5222.5 |
| PSMB1 | 5207.5 |
| PSMD10 | 5093.5 |
| PSMC3 | 4982.5 |
| PSMA2 | 4823.0 |
| PSMC4 | 4751.5 |
| PSMD2 | 4685.5 |
| PSMD5 | 4655.5 |
| PSMD6 | 4428.5 |
| PSMC5 | 4349.5 |
| RBX1 | 4159.5 |
| PSMA7 | 3962.5 |
| PSMD12 | 3211.5 |
| PSMB2 | 2944.5 |
| PSME2 | 2547.5 |
| RPS27A | 2261.5 |
| PSMA1 | 1867.5 |
| PSMB4 | 1567.5 |
| PRKACB | 1490.5 |
| PSMC6 | 1488.5 |
| PSME3 | 1442.5 |
| PSMB3 | 391.5 |
| UBC | 100.5 |
| PSMA5 | 5.5 |
| PSMA3 | -754.5 |
| GSK3B | -787.5 |
| PSMB10 | -1181.5 |
| PSMF1 | -1438.5 |
| BTRC | -1843.5 |
| PSMD9 | -2755.0 |
| PSMD13 | -2775.5 |
| CSNK1A1 | -5751.5 |
Regulation of Apoptosis
| 1010 | |
|---|---|
| set | Regulation of Apoptosis |
| setSize | 50 |
| pANOVA | 1.34e-07 |
| s.dist | 0.431 |
| p.adjustANOVA | 7.2e-06 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| PSMB8 | 8750.5 |
| PSMD1 | 8707.5 |
| OPA1 | 8625.5 |
| PSMC1 | 7622.5 |
| UBA52 | 7357.5 |
| PSMA6 | 7345.5 |
| PSMD4 | 7024.5 |
| PSMB5 | 6910.5 |
| PSMB9 | 6825.5 |
| PSMA8 | 6529.5 |
| PSME1 | 6431.5 |
| PSMD14 | 6156.5 |
| PSMB6 | 6079.5 |
| PSMB7 | 5988.5 |
| PSMD7 | 5955.5 |
| PSMD11 | 5787.5 |
| PSMD8 | 5682.5 |
| OMA1 | 5608.5 |
| PSMA4 | 5533.5 |
| PSMD3 | 5512.5 |
| GeneID | Gene Rank |
|---|---|
| PSMB8 | 8750.5 |
| PSMD1 | 8707.5 |
| OPA1 | 8625.5 |
| PSMC1 | 7622.5 |
| UBA52 | 7357.5 |
| PSMA6 | 7345.5 |
| PSMD4 | 7024.5 |
| PSMB5 | 6910.5 |
| PSMB9 | 6825.5 |
| PSMA8 | 6529.5 |
| PSME1 | 6431.5 |
| PSMD14 | 6156.5 |
| PSMB6 | 6079.5 |
| PSMB7 | 5988.5 |
| PSMD7 | 5955.5 |
| PSMD11 | 5787.5 |
| PSMD8 | 5682.5 |
| OMA1 | 5608.5 |
| PSMA4 | 5533.5 |
| PSMD3 | 5512.5 |
| PSMC2 | 5421.5 |
| PSME4 | 5222.5 |
| PSMB1 | 5207.5 |
| PSMD10 | 5093.5 |
| PSMC3 | 4982.5 |
| PSMA2 | 4823.0 |
| PSMC4 | 4751.5 |
| PSMD2 | 4685.5 |
| PSMD5 | 4655.5 |
| PSMD6 | 4428.5 |
| PSMC5 | 4349.5 |
| PSMA7 | 3962.5 |
| PSMD12 | 3211.5 |
| PSMB2 | 2944.5 |
| PSME2 | 2547.5 |
| RPS27A | 2261.5 |
| PSMA1 | 1867.5 |
| PSMB4 | 1567.5 |
| PSMC6 | 1488.5 |
| PSME3 | 1442.5 |
| PAK2 | 449.5 |
| PSMB3 | 391.5 |
| UBC | 100.5 |
| PSMA5 | 5.5 |
| PSMA3 | -754.5 |
| PSMB10 | -1181.5 |
| PSMF1 | -1438.5 |
| PSMD9 | -2755.0 |
| PSMD13 | -2775.5 |
| ARHGAP10 | -2997.5 |
Pyruvate metabolism and Citric Acid (TCA) cycle
| 936 | |
|---|---|
| set | Pyruvate metabolism and Citric Acid (TCA) cycle |
| setSize | 52 |
| pANOVA | 1.34e-07 |
| s.dist | 0.423 |
| p.adjustANOVA | 7.2e-06 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| ACO2 | 8817.5 |
| PDP1 | 8638.5 |
| PDHX | 8564.5 |
| PDHB | 8238.5 |
| BSG | 8186.5 |
| DLST | 8106.5 |
| ME3 | 8005.5 |
| FAHD1 | 7997.5 |
| LDHB | 7435.0 |
| IDH2 | 7427.5 |
| LDHC | 7413.5 |
| PDK2 | 7219.5 |
| IDH3A | 7182.5 |
| SDHB | 6907.5 |
| DLAT | 6848.5 |
| HAGH | 6790.5 |
| IDH3B | 6732.5 |
| PDHA1 | 6639.5 |
| FH | 6469.5 |
| ADHFE1 | 6444.5 |
| GeneID | Gene Rank |
|---|---|
| ACO2 | 8817.5 |
| PDP1 | 8638.5 |
| PDHX | 8564.5 |
| PDHB | 8238.5 |
| BSG | 8186.5 |
| DLST | 8106.5 |
| ME3 | 8005.5 |
| FAHD1 | 7997.5 |
| LDHB | 7435.0 |
| IDH2 | 7427.5 |
| LDHC | 7413.5 |
| PDK2 | 7219.5 |
| IDH3A | 7182.5 |
| SDHB | 6907.5 |
| DLAT | 6848.5 |
| HAGH | 6790.5 |
| IDH3B | 6732.5 |
| PDHA1 | 6639.5 |
| FH | 6469.5 |
| ADHFE1 | 6444.5 |
| PDPR | 6116.5 |
| CS | 5894.5 |
| MPC1 | 5835.5 |
| MPC2 | 4845.5 |
| SDHC | 4606.5 |
| OGDH | 4470.5 |
| L2HGDH | 4434.5 |
| VDAC1 | 4260.5 |
| SDHA | 4232.0 |
| PDK1 | 4175.5 |
| SUCLG1 | 3325.5 |
| SUCLA2 | 3268.5 |
| DLD | 2984.5 |
| IDH3G | 2586.5 |
| PPARD | 2501.5 |
| PDP2 | 2306.5 |
| SDHD | 2278.0 |
| LDHA | 1562.5 |
| GLO1 | 1280.5 |
| MDH2 | 1129.5 |
| NNT | 785.5 |
| D2HGDH | 530.5 |
| RXRA | 395.5 |
| ME2 | 9.5 |
| ME1 | -80.5 |
| SUCLG2 | -231.5 |
| SLC16A1 | -369.5 |
| SLC16A3 | -371.5 |
| PDK4 | -495.5 |
| SLC16A8 | -5262.5 |
| PDK3 | -6753.5 |
| GSTZ1 | -7866.5 |
Metabolism of polyamines
| 686 | |
|---|---|
| set | Metabolism of polyamines |
| setSize | 57 |
| pANOVA | 1.49e-07 |
| s.dist | 0.402 |
| p.adjustANOVA | 7.71e-06 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| PSMB8 | 8750.5 |
| PSMD1 | 8707.5 |
| PAOX | 7705.0 |
| PSMC1 | 7622.5 |
| PSMA6 | 7345.5 |
| SRM | 7229.5 |
| PSMD4 | 7024.5 |
| PSMB5 | 6910.5 |
| ODC1 | 6863.5 |
| PSMB9 | 6825.5 |
| PSMA8 | 6529.5 |
| PSME1 | 6431.5 |
| PSMD14 | 6156.5 |
| PSMB6 | 6079.5 |
| PSMB7 | 5988.5 |
| PSMD7 | 5955.5 |
| PSMD11 | 5787.5 |
| PSMD8 | 5682.5 |
| AMD1 | 5673.5 |
| PSMA4 | 5533.5 |
| GeneID | Gene Rank |
|---|---|
| PSMB8 | 8750.5 |
| PSMD1 | 8707.5 |
| PAOX | 7705.0 |
| PSMC1 | 7622.5 |
| PSMA6 | 7345.5 |
| SRM | 7229.5 |
| PSMD4 | 7024.5 |
| PSMB5 | 6910.5 |
| ODC1 | 6863.5 |
| PSMB9 | 6825.5 |
| PSMA8 | 6529.5 |
| PSME1 | 6431.5 |
| PSMD14 | 6156.5 |
| PSMB6 | 6079.5 |
| PSMB7 | 5988.5 |
| PSMD7 | 5955.5 |
| PSMD11 | 5787.5 |
| PSMD8 | 5682.5 |
| AMD1 | 5673.5 |
| PSMA4 | 5533.5 |
| PSMD3 | 5512.5 |
| PSMC2 | 5421.5 |
| PSME4 | 5222.5 |
| PSMB1 | 5207.5 |
| OAZ2 | 5164.5 |
| PSMD10 | 5093.5 |
| NQO1 | 5061.5 |
| PSMC3 | 4982.5 |
| PSMA2 | 4823.0 |
| PSMC4 | 4751.5 |
| PSMD2 | 4685.5 |
| PSMD5 | 4655.5 |
| AZIN2 | 4480.5 |
| PSMD6 | 4428.5 |
| PSMC5 | 4349.5 |
| PSMA7 | 3962.5 |
| PSMD12 | 3211.5 |
| PSMB2 | 2944.5 |
| PSME2 | 2547.5 |
| AZIN1 | 2497.5 |
| OAZ1 | 2182.5 |
| PSMA1 | 1867.5 |
| PSMB4 | 1567.5 |
| PSMC6 | 1488.5 |
| PSME3 | 1442.5 |
| PSMB3 | 391.5 |
| OAZ3 | 346.5 |
| PSMA5 | 5.5 |
| PSMA3 | -754.5 |
| SMS | -1156.5 |
| PSMB10 | -1181.5 |
| PSMF1 | -1438.5 |
| SMOX | -1471.5 |
| PSMD9 | -2755.0 |
| PSMD13 | -2775.5 |
| AGMAT | -4568.5 |
| SAT1 | -5390.5 |
Cross-presentation of soluble exogenous antigens (endosomes)
| 231 | |
|---|---|
| set | Cross-presentation of soluble exogenous antigens (endosomes) |
| setSize | 48 |
| pANOVA | 1.56e-07 |
| s.dist | 0.438 |
| p.adjustANOVA | 7.8e-06 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| PSMB8 | 8750.5 |
| PSMD1 | 8707.5 |
| FCGR1A | 7708.0 |
| FCGR1B | 7708.0 |
| PSMC1 | 7622.5 |
| PSMA6 | 7345.5 |
| PSMD4 | 7024.5 |
| PSMB5 | 6910.5 |
| PSMB9 | 6825.5 |
| PSMA8 | 6529.5 |
| PSME1 | 6431.5 |
| PSMD14 | 6156.5 |
| PSMB6 | 6079.5 |
| PSMB7 | 5988.5 |
| PSMD7 | 5955.5 |
| PSMD11 | 5787.5 |
| PSMD8 | 5682.5 |
| PSMA4 | 5533.5 |
| PSMD3 | 5512.5 |
| PSMC2 | 5421.5 |
| GeneID | Gene Rank |
|---|---|
| PSMB8 | 8750.5 |
| PSMD1 | 8707.5 |
| FCGR1A | 7708.0 |
| FCGR1B | 7708.0 |
| PSMC1 | 7622.5 |
| PSMA6 | 7345.5 |
| PSMD4 | 7024.5 |
| PSMB5 | 6910.5 |
| PSMB9 | 6825.5 |
| PSMA8 | 6529.5 |
| PSME1 | 6431.5 |
| PSMD14 | 6156.5 |
| PSMB6 | 6079.5 |
| PSMB7 | 5988.5 |
| PSMD7 | 5955.5 |
| PSMD11 | 5787.5 |
| PSMD8 | 5682.5 |
| PSMA4 | 5533.5 |
| PSMD3 | 5512.5 |
| PSMC2 | 5421.5 |
| PSME4 | 5222.5 |
| PSMB1 | 5207.5 |
| PSMD10 | 5093.5 |
| PSMC3 | 4982.5 |
| PSMA2 | 4823.0 |
| PSMC4 | 4751.5 |
| PSMD2 | 4685.5 |
| PSMD5 | 4655.5 |
| PSMD6 | 4428.5 |
| PSMC5 | 4349.5 |
| CD207 | 4077.5 |
| PSMA7 | 3962.5 |
| PSMD12 | 3211.5 |
| PSMB2 | 2944.5 |
| PSME2 | 2547.5 |
| PSMA1 | 1867.5 |
| PSMB4 | 1567.5 |
| PSMC6 | 1488.5 |
| PSME3 | 1442.5 |
| PSMB3 | 391.5 |
| PSMA5 | 5.5 |
| MRC1 | -413.5 |
| PSMA3 | -754.5 |
| PSMB10 | -1181.5 |
| PSMF1 | -1438.5 |
| PSMD9 | -2755.0 |
| PSMD13 | -2775.5 |
| MRC2 | -2840.5 |
Mitochondrial Fatty Acid Beta-Oxidation
| 703 | |
|---|---|
| set | Mitochondrial Fatty Acid Beta-Oxidation |
| setSize | 36 |
| pANOVA | 1.69e-07 |
| s.dist | 0.504 |
| p.adjustANOVA | 8.09e-06 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| ACAA2 | 8392.5 |
| PCCA | 8219.5 |
| ACADS | 7996.5 |
| DBI | 7888.5 |
| ECI1 | 7640.5 |
| ACBD6 | 7437.5 |
| MECR | 7404.5 |
| ECHS1 | 7149.5 |
| ACADVL | 6798.5 |
| ACADM | 6715.5 |
| HADHB | 6348.5 |
| MCAT | 6165.5 |
| HADH | 5956.5 |
| ACOT11 | 5798.5 |
| ACOT7 | 5658.5 |
| ACOT1 | 5390.0 |
| ACOT2 | 5390.0 |
| HADHA | 5276.5 |
| MCEE | 5227.5 |
| ACBD7 | 4955.5 |
| GeneID | Gene Rank |
|---|---|
| ACAA2 | 8392.5 |
| PCCA | 8219.5 |
| ACADS | 7996.5 |
| DBI | 7888.5 |
| ECI1 | 7640.5 |
| ACBD6 | 7437.5 |
| MECR | 7404.5 |
| ECHS1 | 7149.5 |
| ACADVL | 6798.5 |
| ACADM | 6715.5 |
| HADHB | 6348.5 |
| MCAT | 6165.5 |
| HADH | 5956.5 |
| ACOT11 | 5798.5 |
| ACOT7 | 5658.5 |
| ACOT1 | 5390.0 |
| ACOT2 | 5390.0 |
| HADHA | 5276.5 |
| MCEE | 5227.5 |
| ACBD7 | 4955.5 |
| ACAD10 | 4554.5 |
| ACADL | 4411.5 |
| NDUFAB1 | 4350.5 |
| ACAD11 | 4281.5 |
| ACOT13 | 4095.5 |
| ACSF2 | 3919.5 |
| MMUT | 3678.5 |
| THEM5 | 3298.5 |
| MMAA | 3070.5 |
| PCCB | 3066.5 |
| ACSM3 | 2050.5 |
| THEM4 | 1879.5 |
| ACOT9 | 1689.5 |
| DECR1 | -1704.5 |
| ACOT12 | -3398.5 |
| PCTP | -5012.5 |
Vif-mediated degradation of APOBEC3G
| 1391 | |
|---|---|
| set | Vif-mediated degradation of APOBEC3G |
| setSize | 50 |
| pANOVA | 1.8e-07 |
| s.dist | 0.427 |
| p.adjustANOVA | 8.09e-06 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| PSMB8 | 8750.5 |
| PSMD1 | 8707.5 |
| PSMC1 | 7622.5 |
| UBA52 | 7357.5 |
| PSMA6 | 7345.5 |
| PSMD4 | 7024.5 |
| PSMB5 | 6910.5 |
| PSMB9 | 6825.5 |
| PSMA8 | 6529.5 |
| PSME1 | 6431.5 |
| PSMD14 | 6156.5 |
| PSMB6 | 6079.5 |
| PSMB7 | 5988.5 |
| PSMD7 | 5955.5 |
| ELOC | 5925.5 |
| PSMD11 | 5787.5 |
| PSMD8 | 5682.5 |
| PSMA4 | 5533.5 |
| PSMD3 | 5512.5 |
| PSMC2 | 5421.5 |
| GeneID | Gene Rank |
|---|---|
| PSMB8 | 8750.5 |
| PSMD1 | 8707.5 |
| PSMC1 | 7622.5 |
| UBA52 | 7357.5 |
| PSMA6 | 7345.5 |
| PSMD4 | 7024.5 |
| PSMB5 | 6910.5 |
| PSMB9 | 6825.5 |
| PSMA8 | 6529.5 |
| PSME1 | 6431.5 |
| PSMD14 | 6156.5 |
| PSMB6 | 6079.5 |
| PSMB7 | 5988.5 |
| PSMD7 | 5955.5 |
| ELOC | 5925.5 |
| PSMD11 | 5787.5 |
| PSMD8 | 5682.5 |
| PSMA4 | 5533.5 |
| PSMD3 | 5512.5 |
| PSMC2 | 5421.5 |
| PSME4 | 5222.5 |
| PSMB1 | 5207.5 |
| PSMD10 | 5093.5 |
| PSMC3 | 4982.5 |
| PSMA2 | 4823.0 |
| PSMC4 | 4751.5 |
| CUL5 | 4698.5 |
| PSMD2 | 4685.5 |
| PSMD5 | 4655.5 |
| PSMD6 | 4428.5 |
| PSMC5 | 4349.5 |
| RBX1 | 4159.5 |
| PSMA7 | 3962.5 |
| PSMD12 | 3211.5 |
| PSMB2 | 2944.5 |
| PSME2 | 2547.5 |
| RPS27A | 2261.5 |
| PSMA1 | 1867.5 |
| PSMB4 | 1567.5 |
| PSMC6 | 1488.5 |
| PSME3 | 1442.5 |
| PSMB3 | 391.5 |
| UBC | 100.5 |
| PSMA5 | 5.5 |
| PSMA3 | -754.5 |
| PSMB10 | -1181.5 |
| PSMF1 | -1438.5 |
| PSMD9 | -2755.0 |
| PSMD13 | -2775.5 |
| ELOB | -5059.5 |
Degradation of GLI1 by the proteasome
| 285 | |
|---|---|
| set | Degradation of GLI1 by the proteasome |
| setSize | 56 |
| pANOVA | 1.8e-07 |
| s.dist | 0.403 |
| p.adjustANOVA | 8.09e-06 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| PSMB8 | 8750.5 |
| PSMD1 | 8707.5 |
| PSMC1 | 7622.5 |
| SKP1 | 7381.5 |
| UBA52 | 7357.5 |
| PSMA6 | 7345.5 |
| PRKACA | 7262.5 |
| PSMD4 | 7024.5 |
| PSMB5 | 6910.5 |
| PSMB9 | 6825.5 |
| PSMA8 | 6529.5 |
| PSME1 | 6431.5 |
| PSMD14 | 6156.5 |
| PSMB6 | 6079.5 |
| PSMB7 | 5988.5 |
| PSMD7 | 5955.5 |
| CUL1 | 5811.5 |
| PSMD11 | 5787.5 |
| PSMD8 | 5682.5 |
| PSMA4 | 5533.5 |
| GeneID | Gene Rank |
|---|---|
| PSMB8 | 8750.5 |
| PSMD1 | 8707.5 |
| PSMC1 | 7622.5 |
| SKP1 | 7381.5 |
| UBA52 | 7357.5 |
| PSMA6 | 7345.5 |
| PRKACA | 7262.5 |
| PSMD4 | 7024.5 |
| PSMB5 | 6910.5 |
| PSMB9 | 6825.5 |
| PSMA8 | 6529.5 |
| PSME1 | 6431.5 |
| PSMD14 | 6156.5 |
| PSMB6 | 6079.5 |
| PSMB7 | 5988.5 |
| PSMD7 | 5955.5 |
| CUL1 | 5811.5 |
| PSMD11 | 5787.5 |
| PSMD8 | 5682.5 |
| PSMA4 | 5533.5 |
| PSMD3 | 5512.5 |
| PSMC2 | 5421.5 |
| SUFU | 5369.5 |
| PSME4 | 5222.5 |
| PSMB1 | 5207.5 |
| PSMD10 | 5093.5 |
| PSMC3 | 4982.5 |
| PSMA2 | 4823.0 |
| PSMC4 | 4751.5 |
| PSMD2 | 4685.5 |
| PSMD5 | 4655.5 |
| PSMD6 | 4428.5 |
| PSMC5 | 4349.5 |
| RBX1 | 4159.5 |
| PSMA7 | 3962.5 |
| PSMD12 | 3211.5 |
| PSMB2 | 2944.5 |
| PSME2 | 2547.5 |
| RPS27A | 2261.5 |
| PSMA1 | 1867.5 |
| PSMB4 | 1567.5 |
| PRKACB | 1490.5 |
| PSMC6 | 1488.5 |
| PSME3 | 1442.5 |
| GLI1 | 620.5 |
| PSMB3 | 391.5 |
| UBC | 100.5 |
| PSMA5 | 5.5 |
| ITCH | -558.5 |
| PSMA3 | -754.5 |
| PSMB10 | -1181.5 |
| PSMF1 | -1438.5 |
| BTRC | -1843.5 |
| PSMD9 | -2755.0 |
| PSMD13 | -2775.5 |
| NUMB | -8051.5 |
Vpu mediated degradation of CD4
| 1399 | |
|---|---|
| set | Vpu mediated degradation of CD4 |
| setSize | 49 |
| pANOVA | 1.85e-07 |
| s.dist | 0.431 |
| p.adjustANOVA | 8.09e-06 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| PSMB8 | 8750.5 |
| PSMD1 | 8707.5 |
| PSMC1 | 7622.5 |
| SKP1 | 7381.5 |
| UBA52 | 7357.5 |
| PSMA6 | 7345.5 |
| PSMD4 | 7024.5 |
| PSMB5 | 6910.5 |
| PSMB9 | 6825.5 |
| PSMA8 | 6529.5 |
| PSME1 | 6431.5 |
| PSMD14 | 6156.5 |
| PSMB6 | 6079.5 |
| PSMB7 | 5988.5 |
| PSMD7 | 5955.5 |
| PSMD11 | 5787.5 |
| PSMD8 | 5682.5 |
| PSMA4 | 5533.5 |
| PSMD3 | 5512.5 |
| PSMC2 | 5421.5 |
| GeneID | Gene Rank |
|---|---|
| PSMB8 | 8750.5 |
| PSMD1 | 8707.5 |
| PSMC1 | 7622.5 |
| SKP1 | 7381.5 |
| UBA52 | 7357.5 |
| PSMA6 | 7345.5 |
| PSMD4 | 7024.5 |
| PSMB5 | 6910.5 |
| PSMB9 | 6825.5 |
| PSMA8 | 6529.5 |
| PSME1 | 6431.5 |
| PSMD14 | 6156.5 |
| PSMB6 | 6079.5 |
| PSMB7 | 5988.5 |
| PSMD7 | 5955.5 |
| PSMD11 | 5787.5 |
| PSMD8 | 5682.5 |
| PSMA4 | 5533.5 |
| PSMD3 | 5512.5 |
| PSMC2 | 5421.5 |
| PSME4 | 5222.5 |
| PSMB1 | 5207.5 |
| PSMD10 | 5093.5 |
| PSMC3 | 4982.5 |
| PSMA2 | 4823.0 |
| PSMC4 | 4751.5 |
| PSMD2 | 4685.5 |
| PSMD5 | 4655.5 |
| PSMD6 | 4428.5 |
| PSMC5 | 4349.5 |
| PSMA7 | 3962.5 |
| PSMD12 | 3211.5 |
| PSMB2 | 2944.5 |
| PSME2 | 2547.5 |
| RPS27A | 2261.5 |
| CD4 | 1967.5 |
| PSMA1 | 1867.5 |
| PSMB4 | 1567.5 |
| PSMC6 | 1488.5 |
| PSME3 | 1442.5 |
| PSMB3 | 391.5 |
| UBC | 100.5 |
| PSMA5 | 5.5 |
| PSMA3 | -754.5 |
| PSMB10 | -1181.5 |
| PSMF1 | -1438.5 |
| BTRC | -1843.5 |
| PSMD9 | -2755.0 |
| PSMD13 | -2775.5 |
Mitochondrial protein import
| 707 | |
|---|---|
| set | Mitochondrial protein import |
| setSize | 62 |
| pANOVA | 1.99e-07 |
| s.dist | 0.382 |
| p.adjustANOVA | 8.45e-06 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| TIMM50 | 8913.5 |
| ACO2 | 8817.5 |
| LDHD | 8757.5 |
| CMC2 | 8574.5 |
| PITRM1 | 8463.5 |
| TOMM40 | 8333.5 |
| FXN | 8330.5 |
| PMPCA | 8171.5 |
| SLC25A13 | 7672.5 |
| SLC25A12 | 7665.5 |
| GRPEL1 | 7654.5 |
| CHCHD5 | 7532.5 |
| TIMM44 | 7140.5 |
| MTX1 | 6581.5 |
| TOMM6 | 6247.5 |
| TIMM23 | 6237.5 |
| PMPCB | 6193.5 |
| TIMM8A | 6184.5 |
| SAMM50 | 6128.5 |
| TIMM21 | 6056.5 |
| GeneID | Gene Rank |
|---|---|
| TIMM50 | 8913.5 |
| ACO2 | 8817.5 |
| LDHD | 8757.5 |
| CMC2 | 8574.5 |
| PITRM1 | 8463.5 |
| TOMM40 | 8333.5 |
| FXN | 8330.5 |
| PMPCA | 8171.5 |
| SLC25A13 | 7672.5 |
| SLC25A12 | 7665.5 |
| GRPEL1 | 7654.5 |
| CHCHD5 | 7532.5 |
| TIMM44 | 7140.5 |
| MTX1 | 6581.5 |
| TOMM6 | 6247.5 |
| TIMM23 | 6237.5 |
| PMPCB | 6193.5 |
| TIMM8A | 6184.5 |
| SAMM50 | 6128.5 |
| TIMM21 | 6056.5 |
| CHCHD4 | 6017.5 |
| CS | 5894.5 |
| TIMM8B | 5797.5 |
| HSPD1 | 5605.5 |
| TAZ | 5561.5 |
| CYC1 | 5440.5 |
| COQ2 | 5364.5 |
| TIMM10 | 5314.5 |
| SLC25A4 | 5264.5 |
| HSPA9 | 5108.5 |
| TIMM10B | 5095.0 |
| ATP5F1B | 5063.5 |
| CHCHD3 | 5047.5 |
| NDUFB8 | 4615.0 |
| VDAC1 | 4260.5 |
| TIMM17A | 3995.5 |
| TIMM22 | 3837.5 |
| OTC | 3799.5 |
| BCS1L | 3714.5 |
| TOMM20 | 3158.5 |
| COA4 | 3056.5 |
| TOMM22 | 2933.5 |
| TOMM70 | 2806.5 |
| IDH3G | 2586.5 |
| PAM16 | 1923.5 |
| CHCHD7 | 1405.5 |
| TIMM9 | 1333.5 |
| COA6 | 1213.5 |
| CMC4 | 1002.5 |
| MTX2 | 965.5 |
| COX17 | 646.5 |
| TIMM13 | 27.5 |
| DNAJC19 | -270.5 |
| COX19 | -1192.5 |
| GRPEL2 | -4259.5 |
| GFER | -4610.5 |
| HSCB | -4732.5 |
| TOMM7 | -4954.5 |
| ATP5F1A | -6042.5 |
| TIMM17B | -6725.5 |
| CHCHD10 | -7851.5 |
| CHCHD2 | -7918.5 |
FBXL7 down-regulates AURKA during mitotic entry and in early mitosis
| 381 | |
|---|---|
| set | FBXL7 down-regulates AURKA during mitotic entry and in early mitosis |
| setSize | 52 |
| pANOVA | 2.46e-07 |
| s.dist | 0.414 |
| p.adjustANOVA | 1.02e-05 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| PSMB8 | 8750.5 |
| PSMD1 | 8707.5 |
| PSMC1 | 7622.5 |
| SKP1 | 7381.5 |
| UBA52 | 7357.5 |
| PSMA6 | 7345.5 |
| PSMD4 | 7024.5 |
| PSMB5 | 6910.5 |
| PSMB9 | 6825.5 |
| PSMA8 | 6529.5 |
| PSME1 | 6431.5 |
| PSMD14 | 6156.5 |
| PSMB6 | 6079.5 |
| PSMB7 | 5988.5 |
| PSMD7 | 5955.5 |
| CUL1 | 5811.5 |
| PSMD11 | 5787.5 |
| PSMD8 | 5682.5 |
| PSMA4 | 5533.5 |
| PSMD3 | 5512.5 |
| GeneID | Gene Rank |
|---|---|
| PSMB8 | 8750.5 |
| PSMD1 | 8707.5 |
| PSMC1 | 7622.5 |
| SKP1 | 7381.5 |
| UBA52 | 7357.5 |
| PSMA6 | 7345.5 |
| PSMD4 | 7024.5 |
| PSMB5 | 6910.5 |
| PSMB9 | 6825.5 |
| PSMA8 | 6529.5 |
| PSME1 | 6431.5 |
| PSMD14 | 6156.5 |
| PSMB6 | 6079.5 |
| PSMB7 | 5988.5 |
| PSMD7 | 5955.5 |
| CUL1 | 5811.5 |
| PSMD11 | 5787.5 |
| PSMD8 | 5682.5 |
| PSMA4 | 5533.5 |
| PSMD3 | 5512.5 |
| PSMC2 | 5421.5 |
| PSME4 | 5222.5 |
| PSMB1 | 5207.5 |
| PSMD10 | 5093.5 |
| PSMC3 | 4982.5 |
| PSMA2 | 4823.0 |
| PSMC4 | 4751.5 |
| PSMD2 | 4685.5 |
| PSMD5 | 4655.5 |
| PSMD6 | 4428.5 |
| PSMC5 | 4349.5 |
| RBX1 | 4159.5 |
| PSMA7 | 3962.5 |
| PSMD12 | 3211.5 |
| PSMB2 | 2944.5 |
| PSME2 | 2547.5 |
| RPS27A | 2261.5 |
| PSMA1 | 1867.5 |
| PSMB4 | 1567.5 |
| PSMC6 | 1488.5 |
| PSME3 | 1442.5 |
| PSMB3 | 391.5 |
| UBC | 100.5 |
| PSMA5 | 5.5 |
| PSMA3 | -754.5 |
| AURKA | -982.5 |
| PSMB10 | -1181.5 |
| FBXL18 | -1363.5 |
| PSMF1 | -1438.5 |
| PSMD9 | -2755.0 |
| PSMD13 | -2775.5 |
| FBXL7 | -3388.5 |
Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha
| 819 | |
|---|---|
| set | Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha |
| setSize | 63 |
| pANOVA | 2.79e-07 |
| s.dist | 0.374 |
| p.adjustANOVA | 1.12e-05 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| PSMB8 | 8750.5 |
| PSMD1 | 8707.5 |
| EGLN1 | 8386.0 |
| PSMC1 | 7622.5 |
| EGLN2 | 7426.5 |
| UBA52 | 7357.5 |
| PSMA6 | 7345.5 |
| CUL2 | 7195.5 |
| UBE2D3 | 7189.5 |
| PSMD4 | 7024.5 |
| PSMB5 | 6910.5 |
| PSMB9 | 6825.5 |
| PSMA8 | 6529.5 |
| PSME1 | 6431.5 |
| PSMD14 | 6156.5 |
| PSMB6 | 6079.5 |
| PSMB7 | 5988.5 |
| PSMD7 | 5955.5 |
| ELOC | 5925.5 |
| PSMD11 | 5787.5 |
| GeneID | Gene Rank |
|---|---|
| PSMB8 | 8750.5 |
| PSMD1 | 8707.5 |
| EGLN1 | 8386.0 |
| PSMC1 | 7622.5 |
| EGLN2 | 7426.5 |
| UBA52 | 7357.5 |
| PSMA6 | 7345.5 |
| CUL2 | 7195.5 |
| UBE2D3 | 7189.5 |
| PSMD4 | 7024.5 |
| PSMB5 | 6910.5 |
| PSMB9 | 6825.5 |
| PSMA8 | 6529.5 |
| PSME1 | 6431.5 |
| PSMD14 | 6156.5 |
| PSMB6 | 6079.5 |
| PSMB7 | 5988.5 |
| PSMD7 | 5955.5 |
| ELOC | 5925.5 |
| PSMD11 | 5787.5 |
| PSMD8 | 5682.5 |
| PSMA4 | 5533.5 |
| PSMD3 | 5512.5 |
| PSMC2 | 5421.5 |
| PSME4 | 5222.5 |
| PSMB1 | 5207.5 |
| PSMD10 | 5093.5 |
| PSMC3 | 4982.5 |
| PSMA2 | 4823.0 |
| PSMC4 | 4751.5 |
| EGLN3 | 4702.5 |
| PSMD2 | 4685.5 |
| PSMD5 | 4655.5 |
| PSMD6 | 4428.5 |
| PSMC5 | 4349.5 |
| RBX1 | 4159.5 |
| PSMA7 | 3962.5 |
| HIF3A | 3792.5 |
| EPAS1 | 3670.5 |
| PSMD12 | 3211.5 |
| UBE2D1 | 3169.5 |
| PSMB2 | 2944.5 |
| PSME2 | 2547.5 |
| RPS27A | 2261.5 |
| PSMA1 | 1867.5 |
| PSMB4 | 1567.5 |
| PSMC6 | 1488.5 |
| PSME3 | 1442.5 |
| PSMB3 | 391.5 |
| UBE2D2 | 126.5 |
| UBC | 100.5 |
| PSMA5 | 5.5 |
| LIMD1 | -224.5 |
| PSMA3 | -754.5 |
| PSMB10 | -1181.5 |
| PSMF1 | -1438.5 |
| WTIP | -2033.5 |
| PSMD9 | -2755.0 |
| PSMD13 | -2775.5 |
| VHL | -4639.5 |
| ELOB | -5059.5 |
| AJUBA | -5412.5 |
| HIF1A | -6851.5 |
Regulation of activated PAK-2p34 by proteasome mediated degradation
| 1038 | |
|---|---|
| set | Regulation of activated PAK-2p34 by proteasome mediated degradation |
| setSize | 47 |
| pANOVA | 2.88e-07 |
| s.dist | 0.433 |
| p.adjustANOVA | 1.13e-05 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| PSMB8 | 8750.5 |
| PSMD1 | 8707.5 |
| PSMC1 | 7622.5 |
| UBA52 | 7357.5 |
| PSMA6 | 7345.5 |
| PSMD4 | 7024.5 |
| PSMB5 | 6910.5 |
| PSMB9 | 6825.5 |
| PSMA8 | 6529.5 |
| PSME1 | 6431.5 |
| PSMD14 | 6156.5 |
| PSMB6 | 6079.5 |
| PSMB7 | 5988.5 |
| PSMD7 | 5955.5 |
| PSMD11 | 5787.5 |
| PSMD8 | 5682.5 |
| PSMA4 | 5533.5 |
| PSMD3 | 5512.5 |
| PSMC2 | 5421.5 |
| PSME4 | 5222.5 |
| GeneID | Gene Rank |
|---|---|
| PSMB8 | 8750.5 |
| PSMD1 | 8707.5 |
| PSMC1 | 7622.5 |
| UBA52 | 7357.5 |
| PSMA6 | 7345.5 |
| PSMD4 | 7024.5 |
| PSMB5 | 6910.5 |
| PSMB9 | 6825.5 |
| PSMA8 | 6529.5 |
| PSME1 | 6431.5 |
| PSMD14 | 6156.5 |
| PSMB6 | 6079.5 |
| PSMB7 | 5988.5 |
| PSMD7 | 5955.5 |
| PSMD11 | 5787.5 |
| PSMD8 | 5682.5 |
| PSMA4 | 5533.5 |
| PSMD3 | 5512.5 |
| PSMC2 | 5421.5 |
| PSME4 | 5222.5 |
| PSMB1 | 5207.5 |
| PSMD10 | 5093.5 |
| PSMC3 | 4982.5 |
| PSMA2 | 4823.0 |
| PSMC4 | 4751.5 |
| PSMD2 | 4685.5 |
| PSMD5 | 4655.5 |
| PSMD6 | 4428.5 |
| PSMC5 | 4349.5 |
| PSMA7 | 3962.5 |
| PSMD12 | 3211.5 |
| PSMB2 | 2944.5 |
| PSME2 | 2547.5 |
| RPS27A | 2261.5 |
| PSMA1 | 1867.5 |
| PSMB4 | 1567.5 |
| PSMC6 | 1488.5 |
| PSME3 | 1442.5 |
| PAK2 | 449.5 |
| PSMB3 | 391.5 |
| UBC | 100.5 |
| PSMA5 | 5.5 |
| PSMA3 | -754.5 |
| PSMB10 | -1181.5 |
| PSMF1 | -1438.5 |
| PSMD9 | -2755.0 |
| PSMD13 | -2775.5 |
Deubiquitination
| 297 | |
|---|---|
| set | Deubiquitination |
| setSize | 231 |
| pANOVA | 2.98e-07 |
| s.dist | 0.196 |
| p.adjustANOVA | 1.13e-05 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| USP2 | 8778.5 |
| USP20 | 8761.5 |
| PSMB8 | 8750.5 |
| PSMD1 | 8707.5 |
| FOXO4 | 8664.5 |
| RAD23A | 8618.5 |
| TNIP1 | 8492.5 |
| USP25 | 8470.5 |
| RHOT1 | 8433.5 |
| USP4 | 8388.5 |
| RUVBL1 | 8255.5 |
| MAVS | 8242.5 |
| USP15 | 8228.5 |
| NFRKB | 8144.5 |
| NOD1 | 8105.5 |
| MAT2B | 8081.5 |
| ACTR8 | 8001.5 |
| HGS | 7865.5 |
| FKBP8 | 7818.5 |
| NEDD8 | 7736.5 |
| GeneID | Gene Rank |
|---|---|
| USP2 | 8778.5 |
| USP20 | 8761.5 |
| PSMB8 | 8750.5 |
| PSMD1 | 8707.5 |
| FOXO4 | 8664.5 |
| RAD23A | 8618.5 |
| TNIP1 | 8492.5 |
| USP25 | 8470.5 |
| RHOT1 | 8433.5 |
| USP4 | 8388.5 |
| RUVBL1 | 8255.5 |
| MAVS | 8242.5 |
| USP15 | 8228.5 |
| NFRKB | 8144.5 |
| NOD1 | 8105.5 |
| MAT2B | 8081.5 |
| ACTR8 | 8001.5 |
| HGS | 7865.5 |
| FKBP8 | 7818.5 |
| NEDD8 | 7736.5 |
| USP48 | 7686.5 |
| PSMC1 | 7622.5 |
| USP19 | 7579.5 |
| USP5 | 7503.5 |
| UBA52 | 7357.5 |
| UIMC1 | 7349.5 |
| PSMA6 | 7345.5 |
| INO80E | 7337.5 |
| USP30 | 7330.5 |
| TNIP2 | 7247.5 |
| PTEN | 7076.5 |
| PSMD4 | 7024.5 |
| USP13 | 7000.5 |
| TAF10 | 6985.5 |
| PSMB5 | 6910.5 |
| PSMB9 | 6825.5 |
| ESR1 | 6813.5 |
| INO80B | 6726.0 |
| MDM2 | 6693.5 |
| OTUD3 | 6668.5 |
| TRAF2 | 6628.5 |
| TNFAIP3 | 6624.5 |
| VCP | 6599.5 |
| BAP1 | 6571.5 |
| PSMA8 | 6529.5 |
| KEAP1 | 6518.5 |
| USP21 | 6463.5 |
| PSME1 | 6431.5 |
| VDAC2 | 6210.5 |
| PSMD14 | 6156.5 |
| INO80C | 6134.5 |
| MBD5 | 6111.5 |
| PSMB6 | 6079.5 |
| KAT2B | 6027.5 |
| USP47 | 6014.5 |
| PSMB7 | 5988.5 |
| OTUB1 | 5970.5 |
| ATXN3 | 5958.0 |
| ATXN3L | 5958.0 |
| PSMD7 | 5955.5 |
| TGFBR2 | 5914.5 |
| MUL1 | 5864.5 |
| MYC | 5828.5 |
| PSMD11 | 5787.5 |
| IKBKG | 5786.5 |
| PSMD8 | 5682.5 |
| RAD23B | 5659.5 |
| PSMA4 | 5533.5 |
| PSMD3 | 5512.5 |
| TADA3 | 5438.5 |
| USP12 | 5428.5 |
| PSMC2 | 5421.5 |
| KAT2A | 5284.5 |
| SMAD7 | 5247.5 |
| PSME4 | 5222.5 |
| PSMB1 | 5207.5 |
| TRAF3 | 5171.5 |
| RNF123 | 5138.5 |
| USP14 | 5122.5 |
| PSMD10 | 5093.5 |
| PSMC3 | 4982.5 |
| ADRM1 | 4905.5 |
| PSMA2 | 4823.0 |
| PSMC4 | 4751.5 |
| PSMD2 | 4685.5 |
| PSMD5 | 4655.5 |
| OTUD5 | 4643.5 |
| USP24 | 4607.5 |
| H2AC1 | 4603.5 |
| GATA3 | 4430.5 |
| PSMD6 | 4428.5 |
| PSMC5 | 4349.5 |
| APC | 4290.5 |
| H2AC21 | 4285.5 |
| VDAC1 | 4260.5 |
| USP11 | 4212.5 |
| AXIN2 | 4074.5 |
| WDR48 | 4040.5 |
| DDX58 | 4015.5 |
| PSMA7 | 3962.5 |
| JOSD1 | 3957.5 |
| STAMBP | 3927.5 |
| USP10 | 3877.5 |
| SUDS3 | 3848.5 |
| OTUB2 | 3739.5 |
| TNIP3 | 3734.5 |
| TADA2B | 3675.5 |
| USP49 | 3646.5 |
| BABAM1 | 3557.5 |
| JOSD2 | 3490.5 |
| USP16 | 3451.5 |
| OTUD7B | 3367.5 |
| TAB1 | 3233.5 |
| PSMD12 | 3211.5 |
| UBE2D1 | 3169.5 |
| TOMM20 | 3158.5 |
| IL33 | 3098.5 |
| RNF146 | 3078.5 |
| EP300 | 2949.5 |
| PSMB2 | 2944.5 |
| VDAC3 | 2927.5 |
| TOMM70 | 2806.5 |
| RCE1 | 2747.5 |
| SMURF2 | 2597.5 |
| POLB | 2550.5 |
| PSME2 | 2547.5 |
| H2BC1 | 2483.5 |
| FOXK1 | 2423.5 |
| YY1 | 2391.5 |
| ZRANB1 | 2308.5 |
| RPS27A | 2261.5 |
| YOD1 | 2244.5 |
| RHOA | 2014.5 |
| TFPT | 1969.5 |
| PSMA1 | 1867.5 |
| UCHL5 | 1761.5 |
| PSMB4 | 1567.5 |
| PSMC6 | 1488.5 |
| PSME3 | 1442.5 |
| H2BC11 | 1257.5 |
| USP8 | 1256.5 |
| MCRS1 | 1074.5 |
| ARRB1 | 770.5 |
| WDR20 | 500.5 |
| SENP8 | 470.5 |
| PSMB3 | 391.5 |
| BARD1 | 384.5 |
| CFTR | 341.5 |
| BIRC2 | 238.5 |
| UBC | 100.5 |
| PSMA5 | 5.5 |
| ATXN7 | -150.5 |
| CCP110 | -194.5 |
| IDE | -266.5 |
| TRAF6 | -331.5 |
| PSMA3 | -754.5 |
| ASXL2 | -989.5 |
| TRIM25 | -1015.5 |
| PSMB10 | -1181.5 |
| ACTL6A | -1190.5 |
| USP28 | -1197.5 |
| ARRB2 | -1362.5 |
| PSMF1 | -1438.5 |
| MBD6 | -1439.5 |
| TGFB1 | -1494.5 |
| STAM | -1589.5 |
| CDC25A | -1611.5 |
| RIPK2 | -1709.5 |
| USP44 | -1803.5 |
| STAM2 | -1842.5 |
| USP33 | -1939.5 |
| ACTR5 | -1944.5 |
| AR | -1955.5 |
| USP22 | -2034.5 |
| USP18 | -2198.0 |
| BRCC3 | -2379.5 |
| USP3 | -2439.5 |
| MDM4 | -2459.5 |
| TNKS2 | -2539.5 |
| USP34 | -2548.5 |
| PSMD9 | -2755.0 |
| USP9X | -2762.5 |
| PSMD13 | -2775.5 |
| STAMBPL1 | -2799.5 |
| INO80D | -2837.5 |
| IFIH1 | -2885.5 |
| UCHL1 | -3161.5 |
| ADRB2 | -3195.5 |
| HCFC1 | -3268.5 |
| NOD2 | -3286.5 |
| TAF9B | -3457.5 |
| SMAD3 | -3534.5 |
| OTUD7A | -3546.5 |
| MAP3K7 | -3694.5 |
| VCPIP1 | -3803.5 |
| SIAH2 | -3808.5 |
| MYSM1 | -3819.5 |
| RNF128 | -3922.5 |
| UCHL3 | -4145.5 |
| ASXL1 | -4189.5 |
| FOXK2 | -4210.5 |
| SKP2 | -4252.5 |
| SMAD1 | -4336.5 |
| PTRH2 | -5069.5 |
| USP7 | -5134.5 |
| SMAD4 | -5135.5 |
| USP42 | -5582.5 |
| H2BC3 | -5930.5 |
| RIPK1 | -5961.5 |
| TNKS | -6095.5 |
| USP37 | -6101.5 |
| H2BU1 | -6178.5 |
| BRCA1 | -6186.5 |
| KDM1B | -6307.5 |
| TGFBR1 | -6311.5 |
| HIF1A | -6851.5 |
| DDB2 | -6883.5 |
| H2BC12 | -7021.5 |
| CCNA1 | -7120.5 |
| INO80 | -7269.5 |
| CCNA2 | -7508.5 |
| BECN1 | -7524.5 |
| BIRC3 | -7702.5 |
| OGT | -7946.5 |
| NLRP3 | -8069.5 |
| ACTB | -8079.5 |
| CYLD | -8088.5 |
| CDC20 | -8352.5 |
| CLSPN | -8372.5 |
| SMAD2 | -8431.5 |
| CDK1 | -8596.5 |
Interleukin-1 family signaling
| 586 | |
|---|---|
| set | Interleukin-1 family signaling |
| setSize | 127 |
| pANOVA | 3.64e-07 |
| s.dist | 0.261 |
| p.adjustANOVA | 1.35e-05 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| AGER | 8956.5 |
| PSMB8 | 8750.5 |
| PSMD1 | 8707.5 |
| SQSTM1 | 8697.5 |
| NFKBIB | 8429.5 |
| IL4 | 8331.5 |
| PTPN6 | 8246.5 |
| NOD1 | 8105.5 |
| NKIRAS2 | 7943.5 |
| PTPN11 | 7913.5 |
| APP | 7804.5 |
| IL18BP | 7738.5 |
| PSMC1 | 7622.5 |
| SKP1 | 7381.5 |
| UBA52 | 7357.5 |
| NKIRAS1 | 7353.5 |
| PSMA6 | 7345.5 |
| TNIP2 | 7247.5 |
| PSMD4 | 7024.5 |
| PSMB5 | 6910.5 |
| GeneID | Gene Rank |
|---|---|
| AGER | 8956.5 |
| PSMB8 | 8750.5 |
| PSMD1 | 8707.5 |
| SQSTM1 | 8697.5 |
| NFKBIB | 8429.5 |
| IL4 | 8331.5 |
| PTPN6 | 8246.5 |
| NOD1 | 8105.5 |
| NKIRAS2 | 7943.5 |
| PTPN11 | 7913.5 |
| APP | 7804.5 |
| IL18BP | 7738.5 |
| PSMC1 | 7622.5 |
| SKP1 | 7381.5 |
| UBA52 | 7357.5 |
| NKIRAS1 | 7353.5 |
| PSMA6 | 7345.5 |
| TNIP2 | 7247.5 |
| PSMD4 | 7024.5 |
| PSMB5 | 6910.5 |
| PSMB9 | 6825.5 |
| TAB2 | 6793.5 |
| PELI3 | 6700.5 |
| IL1B | 6648.5 |
| IL36RN | 6617.5 |
| PSMA8 | 6529.5 |
| PSME1 | 6431.5 |
| MAP3K8 | 6329.5 |
| TBK1 | 6213.5 |
| PTPN14 | 6203.5 |
| PSMD14 | 6156.5 |
| PSMB6 | 6079.5 |
| STAT3 | 6074.5 |
| PSMB7 | 5988.5 |
| PTPN18 | 5965.5 |
| PSMD7 | 5955.5 |
| NFKB2 | 5930.5 |
| CUL1 | 5811.5 |
| PSMD11 | 5787.5 |
| IKBKG | 5786.5 |
| PSMD8 | 5682.5 |
| PSMA4 | 5533.5 |
| PSMD3 | 5512.5 |
| IL1RAP | 5449.5 |
| TAB3 | 5441.5 |
| PSMC2 | 5421.5 |
| MAP2K1 | 5275.5 |
| PSME4 | 5222.5 |
| PSMB1 | 5207.5 |
| PSMD10 | 5093.5 |
| PTPN5 | 5043.5 |
| PSMC3 | 4982.5 |
| PSMA2 | 4823.0 |
| PSMC4 | 4751.5 |
| PSMD2 | 4685.5 |
| PSMD5 | 4655.5 |
| IL13 | 4648.5 |
| CASP1 | 4564.5 |
| PSMD6 | 4428.5 |
| PSMC5 | 4349.5 |
| RBX1 | 4159.5 |
| PSMA7 | 3962.5 |
| IL18R1 | 3945.5 |
| UBE2N | 3887.0 |
| MAP2K6 | 3880.5 |
| TAB1 | 3233.5 |
| PSMD12 | 3211.5 |
| IL33 | 3098.5 |
| PSMB2 | 2944.5 |
| IRAK2 | 2926.5 |
| PSME2 | 2547.5 |
| MAP3K3 | 2535.5 |
| NFKB1 | 2395.5 |
| RPS27A | 2261.5 |
| PSMA1 | 1867.5 |
| IL1F10 | 1737.5 |
| PSMB4 | 1567.5 |
| PSMC6 | 1488.5 |
| PSME3 | 1442.5 |
| MYD88 | 1336.5 |
| TOLLIP | 1309.5 |
| IKBKB | 1146.5 |
| PTPN13 | 1079.5 |
| IL1R2 | 1075.5 |
| IL1RN | 670.5 |
| IL18RAP | 586.5 |
| IRAK1 | 408.5 |
| PSMB3 | 391.5 |
| UBC | 100.5 |
| PSMA5 | 5.5 |
| TRAF6 | -331.5 |
| MAPK8 | -572.5 |
| PSMA3 | -754.5 |
| PTPN2 | -1057.5 |
| PSMB10 | -1181.5 |
| FBXW11 | -1203.5 |
| MAP2K4 | -1376.5 |
| PSMF1 | -1438.5 |
| IL36A | -1550.5 |
| RIPK2 | -1709.5 |
| PTPN23 | -1727.5 |
| PTPN9 | -1763.5 |
| BTRC | -1843.5 |
| IL1RL2 | -2384.5 |
| CHUK | -2390.5 |
| SIGIRR | -2397.5 |
| HMGB1 | -2574.5 |
| PSMD9 | -2755.0 |
| PSMD13 | -2775.5 |
| NOD2 | -3286.5 |
| SMAD3 | -3534.5 |
| MAP3K7 | -3694.5 |
| IL36B | -3940.5 |
| PELI2 | -4274.5 |
| IL1RAPL1 | -4448.5 |
| ALOX5 | -4740.5 |
| PTPN7 | -5621.5 |
| IRAK3 | -5654.5 |
| IL18 | -5965.5 |
| PELI1 | -6202.5 |
| RELA | -6220.5 |
| IRAK4 | -6357.5 |
| PTPN4 | -6358.5 |
| IL1R1 | -7048.5 |
| IL1A | -7386.5 |
| PTPN12 | -7680.5 |
| IL1RL1 | -7942.5 |
GLI3 is processed to GLI3R by the proteasome
| 459 | |
|---|---|
| set | GLI3 is processed to GLI3R by the proteasome |
| setSize | 56 |
| pANOVA | 3.98e-07 |
| s.dist | 0.392 |
| p.adjustANOVA | 1.44e-05 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| PSMB8 | 8750.5 |
| PSMD1 | 8707.5 |
| PSMC1 | 7622.5 |
| SKP1 | 7381.5 |
| UBA52 | 7357.5 |
| PSMA6 | 7345.5 |
| PRKACA | 7262.5 |
| PSMD4 | 7024.5 |
| PSMB5 | 6910.5 |
| PSMB9 | 6825.5 |
| PSMA8 | 6529.5 |
| PSME1 | 6431.5 |
| PSMD14 | 6156.5 |
| PSMB6 | 6079.5 |
| PSMB7 | 5988.5 |
| PSMD7 | 5955.5 |
| CUL1 | 5811.5 |
| PSMD11 | 5787.5 |
| PSMD8 | 5682.5 |
| PSMA4 | 5533.5 |
| GeneID | Gene Rank |
|---|---|
| PSMB8 | 8750.5 |
| PSMD1 | 8707.5 |
| PSMC1 | 7622.5 |
| SKP1 | 7381.5 |
| UBA52 | 7357.5 |
| PSMA6 | 7345.5 |
| PRKACA | 7262.5 |
| PSMD4 | 7024.5 |
| PSMB5 | 6910.5 |
| PSMB9 | 6825.5 |
| PSMA8 | 6529.5 |
| PSME1 | 6431.5 |
| PSMD14 | 6156.5 |
| PSMB6 | 6079.5 |
| PSMB7 | 5988.5 |
| PSMD7 | 5955.5 |
| CUL1 | 5811.5 |
| PSMD11 | 5787.5 |
| PSMD8 | 5682.5 |
| PSMA4 | 5533.5 |
| PSMD3 | 5512.5 |
| PSMC2 | 5421.5 |
| SUFU | 5369.5 |
| PSME4 | 5222.5 |
| PSMB1 | 5207.5 |
| PSMD10 | 5093.5 |
| PSMC3 | 4982.5 |
| PSMA2 | 4823.0 |
| PSMC4 | 4751.5 |
| PSMD2 | 4685.5 |
| PSMD5 | 4655.5 |
| PSMD6 | 4428.5 |
| PSMC5 | 4349.5 |
| RBX1 | 4159.5 |
| PSMA7 | 3962.5 |
| PSMD12 | 3211.5 |
| PSMB2 | 2944.5 |
| PSME2 | 2547.5 |
| RPS27A | 2261.5 |
| PSMA1 | 1867.5 |
| PSMB4 | 1567.5 |
| PRKACB | 1490.5 |
| PSMC6 | 1488.5 |
| PSME3 | 1442.5 |
| PSMB3 | 391.5 |
| UBC | 100.5 |
| PSMA5 | 5.5 |
| PSMA3 | -754.5 |
| GSK3B | -787.5 |
| PSMB10 | -1181.5 |
| PSMF1 | -1438.5 |
| BTRC | -1843.5 |
| PSMD9 | -2755.0 |
| PSMD13 | -2775.5 |
| CSNK1A1 | -5751.5 |
| GLI3 | -7127.5 |
SCF-beta-TrCP mediated degradation of Emi1
| 1095 | |
|---|---|
| set | SCF-beta-TrCP mediated degradation of Emi1 |
| setSize | 52 |
| pANOVA | 4.35e-07 |
| s.dist | 0.405 |
| p.adjustANOVA | 1.53e-05 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| PSMB8 | 8750.5 |
| PSMD1 | 8707.5 |
| PSMC1 | 7622.5 |
| SKP1 | 7381.5 |
| UBA52 | 7357.5 |
| PSMA6 | 7345.5 |
| PSMD4 | 7024.5 |
| PSMB5 | 6910.5 |
| PSMB9 | 6825.5 |
| PSMA8 | 6529.5 |
| PSME1 | 6431.5 |
| PSMD14 | 6156.5 |
| PSMB6 | 6079.5 |
| PSMB7 | 5988.5 |
| PSMD7 | 5955.5 |
| CUL1 | 5811.5 |
| PSMD11 | 5787.5 |
| PSMD8 | 5682.5 |
| PSMA4 | 5533.5 |
| PSMD3 | 5512.5 |
| GeneID | Gene Rank |
|---|---|
| PSMB8 | 8750.5 |
| PSMD1 | 8707.5 |
| PSMC1 | 7622.5 |
| SKP1 | 7381.5 |
| UBA52 | 7357.5 |
| PSMA6 | 7345.5 |
| PSMD4 | 7024.5 |
| PSMB5 | 6910.5 |
| PSMB9 | 6825.5 |
| PSMA8 | 6529.5 |
| PSME1 | 6431.5 |
| PSMD14 | 6156.5 |
| PSMB6 | 6079.5 |
| PSMB7 | 5988.5 |
| PSMD7 | 5955.5 |
| CUL1 | 5811.5 |
| PSMD11 | 5787.5 |
| PSMD8 | 5682.5 |
| PSMA4 | 5533.5 |
| PSMD3 | 5512.5 |
| PSMC2 | 5421.5 |
| PSME4 | 5222.5 |
| PSMB1 | 5207.5 |
| PSMD10 | 5093.5 |
| PSMC3 | 4982.5 |
| PSMA2 | 4823.0 |
| PSMC4 | 4751.5 |
| PSMD2 | 4685.5 |
| PSMD5 | 4655.5 |
| PSMD6 | 4428.5 |
| PSMC5 | 4349.5 |
| PSMA7 | 3962.5 |
| PSMD12 | 3211.5 |
| PSMB2 | 2944.5 |
| FBXO5 | 2702.5 |
| PSME2 | 2547.5 |
| RPS27A | 2261.5 |
| FZR1 | 1968.5 |
| PSMA1 | 1867.5 |
| PSMB4 | 1567.5 |
| PSMC6 | 1488.5 |
| PSME3 | 1442.5 |
| PSMB3 | 391.5 |
| UBC | 100.5 |
| PSMA5 | 5.5 |
| PSMA3 | -754.5 |
| PSMB10 | -1181.5 |
| PSMF1 | -1438.5 |
| BTRC | -1843.5 |
| PSMD9 | -2755.0 |
| PSMD13 | -2775.5 |
| CDC20 | -8352.5 |
Cell surface interactions at the vascular wall
| 170 | |
|---|---|
| set | Cell surface interactions at the vascular wall |
| setSize | 155 |
| pANOVA | 4.47e-07 |
| s.dist | -0.235 |
| p.adjustANOVA | 1.54e-05 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| CD244 | -8468.5 |
| APOB | -8370.5 |
| PPIA | -8361.0 |
| L1CAM | -8213.5 |
| CEACAM1 | -8171.0 |
| CEACAM3 | -8171.0 |
| CEACAM5 | -8171.0 |
| CEACAM6 | -8171.0 |
| CEACAM8 | -8171.0 |
| PSG1 | -8171.0 |
| PSG11 | -8171.0 |
| PSG2 | -8171.0 |
| PSG3 | -8171.0 |
| PSG4 | -8171.0 |
| PSG5 | -8171.0 |
| PSG6 | -8171.0 |
| PSG7 | -8171.0 |
| PSG8 | -8171.0 |
| PSG9 | -8171.0 |
| VPREB3 | -8135.5 |
| GeneID | Gene Rank |
|---|---|
| CD244 | -8468.5 |
| APOB | -8370.5 |
| PPIA | -8361.0 |
| L1CAM | -8213.5 |
| CEACAM1 | -8171.0 |
| CEACAM3 | -8171.0 |
| CEACAM5 | -8171.0 |
| CEACAM6 | -8171.0 |
| CEACAM8 | -8171.0 |
| PSG1 | -8171.0 |
| PSG11 | -8171.0 |
| PSG2 | -8171.0 |
| PSG3 | -8171.0 |
| PSG4 | -8171.0 |
| PSG5 | -8171.0 |
| PSG6 | -8171.0 |
| PSG7 | -8171.0 |
| PSG8 | -8171.0 |
| PSG9 | -8171.0 |
| VPREB3 | -8135.5 |
| CD99L2 | -8057.5 |
| CD44 | -7979.5 |
| YES1 | -7705.5 |
| CD47 | -7660.5 |
| NRAS | -7625.5 |
| ITGAM | -7426.5 |
| MAG | -7389.5 |
| SDC1 | -7234.5 |
| IGKV1-12 | -7039.0 |
| IGKV1-16 | -7039.0 |
| IGKV1-17 | -7039.0 |
| IGKV1-39 | -7039.0 |
| IGKV1-5 | -7039.0 |
| IGKV1D-12 | -7039.0 |
| IGKV1D-16 | -7039.0 |
| IGKV1D-39 | -7039.0 |
| SLC7A7 | -6965.5 |
| SDC2 | -6795.5 |
| KRAS | -6786.5 |
| ATP1B2 | -6306.5 |
| FN1 | -6177.5 |
| CXADR | -6141.5 |
| CAV1 | -5750.5 |
| IGLV3-16 | -5675.5 |
| IGLV3-22 | -5675.5 |
| IGLV3-25 | -5675.5 |
| IGLV3-27 | -5675.5 |
| GRB7 | -5611.5 |
| PROS1 | -5462.5 |
| CD2 | -5386.5 |
| SLC16A8 | -5262.5 |
| SPN | -5108.5 |
| IGLC1 | -4828.0 |
| IGLC2 | -4828.0 |
| IGLC3 | -4828.0 |
| IGLC7 | -4828.0 |
| IGLL1 | -4828.0 |
| TREM1 | -4405.5 |
| IGHV4-34 | -4385.0 |
| IGHV4-39 | -4385.0 |
| IGHV4-59 | -4385.0 |
| CD48 | -4366.5 |
| JCHAIN | -4348.5 |
| PIK3CB | -4270.5 |
| ITGAX | -4225.5 |
| PROCR | -4108.5 |
| ITGB3 | -3942.0 |
| FCAMR | -3865.5 |
| PIK3CA | -3786.5 |
| VPREB1 | -3776.5 |
| MERTK | -3750.5 |
| SDC4 | -3567.5 |
| LYN | -3527.5 |
| DOK2 | -3469.5 |
| ANGPT2 | -3298.5 |
| SLC7A5 | -3157.5 |
| SLC7A11 | -3154.5 |
| PLCG1 | -3094.5 |
| ATP1B3 | -3029.5 |
| ITGA6 | -2918.5 |
| IGHV2-5 | -2844.5 |
| IGHV2-70 | -2844.5 |
| GYPC | -2758.5 |
| LCK | -2739.5 |
| GLG1 | -2576.5 |
| TEK | -2432.5 |
| SRC | -2361.5 |
| MIF | -2210.5 |
| SLC7A8 | -1980.5 |
| ITGA4 | -1928.5 |
| SELP | -1681.5 |
| TGFB1 | -1494.5 |
| SLC3A2 | -1390.5 |
| PROC | -1175.5 |
| PICK1 | -1117.5 |
| SHC1 | -1008.5 |
| EPCAM | -887.5 |
| IGHV7-81 | -695.0 |
| CD177 | -611.5 |
| INPP5D | -584.5 |
| IGKV2-28 | -517.5 |
| IGKV2D-28 | -517.5 |
| IGKV2D-40 | -517.5 |
| F11R | -514.5 |
| SLC16A3 | -371.5 |
| SLC16A1 | -369.5 |
| FYN | -339.5 |
| ITGB2 | 145.5 |
| SELE | 342.5 |
| IGKV4-1 | 362.5 |
| SLC7A6 | 369.5 |
| F2 | 644.5 |
| GP6 | 928.5 |
| SOS1 | 1229.5 |
| JAM3 | 1395.5 |
| SDC3 | 1408.5 |
| PIK3R2 | 1532.0 |
| FCER1G | 1820.5 |
| SELPLG | 1885.5 |
| ANGPT4 | 2123.5 |
| CD84 | 2345.5 |
| SLC7A9 | 2794.5 |
| ANGPT1 | 3009.5 |
| OLR1 | 3343.5 |
| CD99 | 4293.5 |
| JAM2 | 4714.5 |
| SELL | 4757.5 |
| ITGA5 | 4984.5 |
| PIK3R1 | 5011.5 |
| TSPAN7 | 5291.0 |
| ITGAL | 5399.5 |
| GRB2 | 5591.5 |
| ESAM | 5603.5 |
| ITGB1 | 5760.5 |
| PPIL2 | 5869.5 |
| SLC7A10 | 5949.5 |
| THBD | 6089.5 |
| ITGAV | 6100.5 |
| IGKV2-30 | 6283.0 |
| IGKV2D-30 | 6283.0 |
| GPC1 | 6312.5 |
| GRB14 | 6551.5 |
| SIRPA | 6690.0 |
| SIRPG | 6690.0 |
| IGLV6-57 | 6930.5 |
| IGHM | 7883.5 |
| PTPN11 | 7913.5 |
| ITGA3 | 8156.5 |
| BSG | 8186.5 |
| PTPN6 | 8246.5 |
| HRAS | 8620.5 |
| CD74 | 8687.5 |
| ATP1B1 | 8849.5 |
| IGKC | 8857.5 |
| GAS6 | 9006.5 |
Hedgehog ligand biogenesis
| 528 | |
|---|---|
| set | Hedgehog ligand biogenesis |
| setSize | 61 |
| pANOVA | 5.34e-07 |
| s.dist | 0.371 |
| p.adjustANOVA | 1.8e-05 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| PSMB8 | 8750.5 |
| PSMD1 | 8707.5 |
| SYVN1 | 7703.5 |
| PSMC1 | 7622.5 |
| UBA52 | 7357.5 |
| PSMA6 | 7345.5 |
| PSMD4 | 7024.5 |
| PSMB5 | 6910.5 |
| PSMB9 | 6825.5 |
| VCP | 6599.5 |
| PSMA8 | 6529.5 |
| PSME1 | 6431.5 |
| P4HB | 6271.5 |
| PSMD14 | 6156.5 |
| PSMB6 | 6079.5 |
| PSMB7 | 5988.5 |
| PSMD7 | 5955.5 |
| PSMD11 | 5787.5 |
| PSMD8 | 5682.5 |
| PSMA4 | 5533.5 |
| GeneID | Gene Rank |
|---|---|
| PSMB8 | 8750.5 |
| PSMD1 | 8707.5 |
| SYVN1 | 7703.5 |
| PSMC1 | 7622.5 |
| UBA52 | 7357.5 |
| PSMA6 | 7345.5 |
| PSMD4 | 7024.5 |
| PSMB5 | 6910.5 |
| PSMB9 | 6825.5 |
| VCP | 6599.5 |
| PSMA8 | 6529.5 |
| PSME1 | 6431.5 |
| P4HB | 6271.5 |
| PSMD14 | 6156.5 |
| PSMB6 | 6079.5 |
| PSMB7 | 5988.5 |
| PSMD7 | 5955.5 |
| PSMD11 | 5787.5 |
| PSMD8 | 5682.5 |
| PSMA4 | 5533.5 |
| PSMD3 | 5512.5 |
| PSMC2 | 5421.5 |
| PSME4 | 5222.5 |
| PSMB1 | 5207.5 |
| PSMD10 | 5093.5 |
| PSMC3 | 4982.5 |
| PSMA2 | 4823.0 |
| OS9 | 4799.5 |
| PSMC4 | 4751.5 |
| PSMD2 | 4685.5 |
| HHAT | 4670.5 |
| PSMD5 | 4655.5 |
| SEL1L | 4548.5 |
| PSMD6 | 4428.5 |
| PSMC5 | 4349.5 |
| PSMA7 | 3962.5 |
| DERL2 | 3262.5 |
| PSMD12 | 3211.5 |
| PSMB2 | 2944.5 |
| PSME2 | 2547.5 |
| ERLEC1 | 2361.5 |
| IHH | 2289.5 |
| RPS27A | 2261.5 |
| PSMA1 | 1867.5 |
| PSMB4 | 1567.5 |
| PSMC6 | 1488.5 |
| PSME3 | 1442.5 |
| PSMB3 | 391.5 |
| UBC | 100.5 |
| PSMA5 | 5.5 |
| ADAM17 | -478.5 |
| SHH | -695.0 |
| PSMA3 | -754.5 |
| PSMB10 | -1181.5 |
| PSMF1 | -1438.5 |
| DHH | -1812.5 |
| PSMD9 | -2755.0 |
| PSMD13 | -2775.5 |
| DISP2 | -5005.5 |
| NOTUM | -5332.5 |
| SCUBE2 | -6218.5 |
Degradation of DVL
| 284 | |
|---|---|
| set | Degradation of DVL |
| setSize | 54 |
| pANOVA | 5.86e-07 |
| s.dist | 0.393 |
| p.adjustANOVA | 1.9e-05 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| PSMB8 | 8750.5 |
| PSMD1 | 8707.5 |
| PSMC1 | 7622.5 |
| UBA52 | 7357.5 |
| PSMA6 | 7345.5 |
| PSMD4 | 7024.5 |
| PSMB5 | 6910.5 |
| PSMB9 | 6825.5 |
| PSMA8 | 6529.5 |
| PSME1 | 6431.5 |
| PSMD14 | 6156.5 |
| PSMB6 | 6079.5 |
| PSMB7 | 5988.5 |
| PSMD7 | 5955.5 |
| PSMD11 | 5787.5 |
| PSMD8 | 5682.5 |
| PSMA4 | 5533.5 |
| PSMD3 | 5512.5 |
| PSMC2 | 5421.5 |
| PSME4 | 5222.5 |
| GeneID | Gene Rank |
|---|---|
| PSMB8 | 8750.5 |
| PSMD1 | 8707.5 |
| PSMC1 | 7622.5 |
| UBA52 | 7357.5 |
| PSMA6 | 7345.5 |
| PSMD4 | 7024.5 |
| PSMB5 | 6910.5 |
| PSMB9 | 6825.5 |
| PSMA8 | 6529.5 |
| PSME1 | 6431.5 |
| PSMD14 | 6156.5 |
| PSMB6 | 6079.5 |
| PSMB7 | 5988.5 |
| PSMD7 | 5955.5 |
| PSMD11 | 5787.5 |
| PSMD8 | 5682.5 |
| PSMA4 | 5533.5 |
| PSMD3 | 5512.5 |
| PSMC2 | 5421.5 |
| PSME4 | 5222.5 |
| PSMB1 | 5207.5 |
| PSMD10 | 5093.5 |
| PSMC3 | 4982.5 |
| PSMA2 | 4823.0 |
| PSMC4 | 4751.5 |
| PSMD2 | 4685.5 |
| PSMD5 | 4655.5 |
| PSMD6 | 4428.5 |
| PSMC5 | 4349.5 |
| RBX1 | 4159.5 |
| PSMA7 | 3962.5 |
| HECW1 | 3566.5 |
| PSMD12 | 3211.5 |
| PSMB2 | 2944.5 |
| DVL3 | 2855.5 |
| PSME2 | 2547.5 |
| RPS27A | 2261.5 |
| DVL2 | 2062.5 |
| PSMA1 | 1867.5 |
| PSMB4 | 1567.5 |
| PSMC6 | 1488.5 |
| DVL1 | 1473.5 |
| PSME3 | 1442.5 |
| CUL3 | 572.5 |
| PSMB3 | 391.5 |
| UBC | 100.5 |
| PSMA5 | 5.5 |
| PSMA3 | -754.5 |
| PSMB10 | -1181.5 |
| PSMF1 | -1438.5 |
| KLHL12 | -1721.5 |
| PSMD9 | -2755.0 |
| PSMD13 | -2775.5 |
| DACT1 | -3592.5 |
Regulation of RUNX2 expression and activity
| 1026 | |
|---|---|
| set | Regulation of RUNX2 expression and activity |
| setSize | 69 |
| pANOVA | 6.03e-07 |
| s.dist | 0.347 |
| p.adjustANOVA | 1.9e-05 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| STAT1 | 8891.5 |
| PSMB8 | 8750.5 |
| ESRRA | 8712.5 |
| PSMD1 | 8707.5 |
| PPARGC1B | 7660.5 |
| PSMC1 | 7622.5 |
| SKP1 | 7381.5 |
| UBA52 | 7357.5 |
| PSMA6 | 7345.5 |
| PSMD4 | 7024.5 |
| PSMB5 | 6910.5 |
| PSMB9 | 6825.5 |
| ESR1 | 6813.5 |
| PSMA8 | 6529.5 |
| PSME1 | 6431.5 |
| PSMD14 | 6156.5 |
| PSMB6 | 6079.5 |
| PSMB7 | 5988.5 |
| PSMD7 | 5955.5 |
| CUL1 | 5811.5 |
| GeneID | Gene Rank |
|---|---|
| STAT1 | 8891.5 |
| PSMB8 | 8750.5 |
| ESRRA | 8712.5 |
| PSMD1 | 8707.5 |
| PPARGC1B | 7660.5 |
| PSMC1 | 7622.5 |
| SKP1 | 7381.5 |
| UBA52 | 7357.5 |
| PSMA6 | 7345.5 |
| PSMD4 | 7024.5 |
| PSMB5 | 6910.5 |
| PSMB9 | 6825.5 |
| ESR1 | 6813.5 |
| PSMA8 | 6529.5 |
| PSME1 | 6431.5 |
| PSMD14 | 6156.5 |
| PSMB6 | 6079.5 |
| PSMB7 | 5988.5 |
| PSMD7 | 5955.5 |
| CUL1 | 5811.5 |
| PSMD11 | 5787.5 |
| PSMD8 | 5682.5 |
| PSMA4 | 5533.5 |
| PSMD3 | 5512.5 |
| PSMC2 | 5421.5 |
| NR3C1 | 5325.5 |
| PSME4 | 5222.5 |
| PSMB1 | 5207.5 |
| PSMD10 | 5093.5 |
| STUB1 | 5004.5 |
| PSMC3 | 4982.5 |
| PSMA2 | 4823.0 |
| PSMC4 | 4751.5 |
| PSMD2 | 4685.5 |
| PSMD5 | 4655.5 |
| PSMD6 | 4428.5 |
| PSMC5 | 4349.5 |
| RBX1 | 4159.5 |
| TWIST1 | 4084.5 |
| PSMA7 | 3962.5 |
| PSMD12 | 3211.5 |
| PSMB2 | 2944.5 |
| DLX6 | 2658.5 |
| PSME2 | 2547.5 |
| BMP2 | 2527.5 |
| RPS27A | 2261.5 |
| PSMA1 | 1867.5 |
| PSMB4 | 1567.5 |
| PSMC6 | 1488.5 |
| PSME3 | 1442.5 |
| PPARGC1A | 1116.5 |
| PSMB3 | 391.5 |
| UBC | 100.5 |
| PSMA5 | 5.5 |
| DLX5 | -96.5 |
| PSMA3 | -754.5 |
| GSK3B | -787.5 |
| PSMB10 | -1181.5 |
| PSMF1 | -1438.5 |
| MSX2 | -1752.5 |
| WWP1 | -2403.5 |
| PSMD9 | -2755.0 |
| PSMD13 | -2775.5 |
| FBXW7 | -3647.5 |
| SMURF1 | -3855.5 |
| SKP2 | -4252.5 |
| CBFB | -4500.5 |
| RUNX2 | -5866.5 |
| HIVEP3 | -7071.5 |
Dectin-1 mediated noncanonical NF-kB signaling
| 265 | |
|---|---|
| set | Dectin-1 mediated noncanonical NF-kB signaling |
| setSize | 59 |
| pANOVA | 6.05e-07 |
| s.dist | 0.376 |
| p.adjustANOVA | 1.9e-05 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| PSMB8 | 8750.5 |
| PSMD1 | 8707.5 |
| PSMC1 | 7622.5 |
| SKP1 | 7381.5 |
| UBE2M | 7376.5 |
| UBA52 | 7357.5 |
| PSMA6 | 7345.5 |
| PSMD4 | 7024.5 |
| PSMB5 | 6910.5 |
| PSMB9 | 6825.5 |
| PSMA8 | 6529.5 |
| PSME1 | 6431.5 |
| CCL17 | 6273.5 |
| PSMD14 | 6156.5 |
| PSMB6 | 6079.5 |
| PSMB7 | 5988.5 |
| PSMD7 | 5955.5 |
| NFKB2 | 5930.5 |
| CUL1 | 5811.5 |
| PSMD11 | 5787.5 |
| GeneID | Gene Rank |
|---|---|
| PSMB8 | 8750.5 |
| PSMD1 | 8707.5 |
| PSMC1 | 7622.5 |
| SKP1 | 7381.5 |
| UBE2M | 7376.5 |
| UBA52 | 7357.5 |
| PSMA6 | 7345.5 |
| PSMD4 | 7024.5 |
| PSMB5 | 6910.5 |
| PSMB9 | 6825.5 |
| PSMA8 | 6529.5 |
| PSME1 | 6431.5 |
| CCL17 | 6273.5 |
| PSMD14 | 6156.5 |
| PSMB6 | 6079.5 |
| PSMB7 | 5988.5 |
| PSMD7 | 5955.5 |
| NFKB2 | 5930.5 |
| CUL1 | 5811.5 |
| PSMD11 | 5787.5 |
| PSMD8 | 5682.5 |
| PSMA4 | 5533.5 |
| PSMD3 | 5512.5 |
| PSMC2 | 5421.5 |
| PSME4 | 5222.5 |
| PSMB1 | 5207.5 |
| PSMD10 | 5093.5 |
| PSMC3 | 4982.5 |
| PSMA2 | 4823.0 |
| PSMC4 | 4751.5 |
| PSMD2 | 4685.5 |
| PSMD5 | 4655.5 |
| PSMD6 | 4428.5 |
| PSMC5 | 4349.5 |
| PSMA7 | 3962.5 |
| PSMD12 | 3211.5 |
| PSMB2 | 2944.5 |
| PSME2 | 2547.5 |
| RPS27A | 2261.5 |
| MAP3K14 | 2011.5 |
| PSMA1 | 1867.5 |
| UBA3 | 1735.5 |
| PSMB4 | 1567.5 |
| PSMC6 | 1488.5 |
| PSME3 | 1442.5 |
| RELB | 1279.5 |
| PSMB3 | 391.5 |
| UBC | 100.5 |
| PSMA5 | 5.5 |
| PSMA3 | -754.5 |
| PSMB10 | -1181.5 |
| FBXW11 | -1203.5 |
| PSMF1 | -1438.5 |
| BTRC | -1843.5 |
| CHUK | -2390.5 |
| PSMD9 | -2755.0 |
| PSMD13 | -2775.5 |
| RELA | -6220.5 |
| CCL22 | -7744.5 |
Cellular response to hypoxia
| 177 | |
|---|---|
| set | Cellular response to hypoxia |
| setSize | 72 |
| pANOVA | 6.2e-07 |
| s.dist | 0.34 |
| p.adjustANOVA | 1.91e-05 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| VEGFA | 8964.5 |
| PSMB8 | 8750.5 |
| PSMD1 | 8707.5 |
| EGLN1 | 8386.0 |
| PSMC1 | 7622.5 |
| EGLN2 | 7426.5 |
| UBA52 | 7357.5 |
| PSMA6 | 7345.5 |
| CUL2 | 7195.5 |
| UBE2D3 | 7189.5 |
| PSMD4 | 7024.5 |
| PSMB5 | 6910.5 |
| PSMB9 | 6825.5 |
| PSMA8 | 6529.5 |
| PSME1 | 6431.5 |
| PSMD14 | 6156.5 |
| PSMB6 | 6079.5 |
| PSMB7 | 5988.5 |
| PSMD7 | 5955.5 |
| ELOC | 5925.5 |
| GeneID | Gene Rank |
|---|---|
| VEGFA | 8964.5 |
| PSMB8 | 8750.5 |
| PSMD1 | 8707.5 |
| EGLN1 | 8386.0 |
| PSMC1 | 7622.5 |
| EGLN2 | 7426.5 |
| UBA52 | 7357.5 |
| PSMA6 | 7345.5 |
| CUL2 | 7195.5 |
| UBE2D3 | 7189.5 |
| PSMD4 | 7024.5 |
| PSMB5 | 6910.5 |
| PSMB9 | 6825.5 |
| PSMA8 | 6529.5 |
| PSME1 | 6431.5 |
| PSMD14 | 6156.5 |
| PSMB6 | 6079.5 |
| PSMB7 | 5988.5 |
| PSMD7 | 5955.5 |
| ELOC | 5925.5 |
| PSMD11 | 5787.5 |
| PSMD8 | 5682.5 |
| PSMA4 | 5533.5 |
| PSMD3 | 5512.5 |
| PSMC2 | 5421.5 |
| HIGD1A | 5350.5 |
| PSME4 | 5222.5 |
| PSMB1 | 5207.5 |
| PSMD10 | 5093.5 |
| PSMC3 | 4982.5 |
| PSMA2 | 4823.0 |
| PSMC4 | 4751.5 |
| EGLN3 | 4702.5 |
| CITED2 | 4699.5 |
| PSMD2 | 4685.5 |
| PSMD5 | 4655.5 |
| PSMD6 | 4428.5 |
| PSMC5 | 4349.5 |
| RBX1 | 4159.5 |
| PSMA7 | 3962.5 |
| HIF3A | 3792.5 |
| HIF1AN | 3788.5 |
| EPAS1 | 3670.5 |
| PSMD12 | 3211.5 |
| UBE2D1 | 3169.5 |
| EP300 | 2949.5 |
| PSMB2 | 2944.5 |
| PSME2 | 2547.5 |
| RPS27A | 2261.5 |
| PSMA1 | 1867.5 |
| PSMB4 | 1567.5 |
| PSMC6 | 1488.5 |
| PSME3 | 1442.5 |
| PSMB3 | 391.5 |
| UBE2D2 | 126.5 |
| UBC | 100.5 |
| PSMA5 | 5.5 |
| LIMD1 | -224.5 |
| PSMA3 | -754.5 |
| PSMB10 | -1181.5 |
| PSMF1 | -1438.5 |
| WTIP | -2033.5 |
| PSMD9 | -2755.0 |
| PSMD13 | -2775.5 |
| CREBBP | -2899.5 |
| CA9 | -3419.5 |
| VHL | -4639.5 |
| ARNT | -4995.5 |
| ELOB | -5059.5 |
| EPO | -5264.5 |
| AJUBA | -5412.5 |
| HIF1A | -6851.5 |
Autodegradation of the E3 ubiquitin ligase COP1
| 102 | |
|---|---|
| set | Autodegradation of the E3 ubiquitin ligase COP1 |
| setSize | 47 |
| pANOVA | 6.4e-07 |
| s.dist | 0.42 |
| p.adjustANOVA | 1.93e-05 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| PSMB8 | 8750.5 |
| PSMD1 | 8707.5 |
| PSMC1 | 7622.5 |
| UBA52 | 7357.5 |
| PSMA6 | 7345.5 |
| PSMD4 | 7024.5 |
| PSMB5 | 6910.5 |
| PSMB9 | 6825.5 |
| PSMA8 | 6529.5 |
| PSME1 | 6431.5 |
| PSMD14 | 6156.5 |
| PSMB6 | 6079.5 |
| PSMB7 | 5988.5 |
| PSMD7 | 5955.5 |
| PSMD11 | 5787.5 |
| PSMD8 | 5682.5 |
| PSMA4 | 5533.5 |
| PSMD3 | 5512.5 |
| PSMC2 | 5421.5 |
| PSME4 | 5222.5 |
| GeneID | Gene Rank |
|---|---|
| PSMB8 | 8750.5 |
| PSMD1 | 8707.5 |
| PSMC1 | 7622.5 |
| UBA52 | 7357.5 |
| PSMA6 | 7345.5 |
| PSMD4 | 7024.5 |
| PSMB5 | 6910.5 |
| PSMB9 | 6825.5 |
| PSMA8 | 6529.5 |
| PSME1 | 6431.5 |
| PSMD14 | 6156.5 |
| PSMB6 | 6079.5 |
| PSMB7 | 5988.5 |
| PSMD7 | 5955.5 |
| PSMD11 | 5787.5 |
| PSMD8 | 5682.5 |
| PSMA4 | 5533.5 |
| PSMD3 | 5512.5 |
| PSMC2 | 5421.5 |
| PSME4 | 5222.5 |
| PSMB1 | 5207.5 |
| PSMD10 | 5093.5 |
| PSMC3 | 4982.5 |
| PSMA2 | 4823.0 |
| PSMC4 | 4751.5 |
| PSMD2 | 4685.5 |
| PSMD5 | 4655.5 |
| PSMD6 | 4428.5 |
| PSMC5 | 4349.5 |
| PSMA7 | 3962.5 |
| PSMD12 | 3211.5 |
| PSMB2 | 2944.5 |
| PSME2 | 2547.5 |
| RPS27A | 2261.5 |
| PSMA1 | 1867.5 |
| PSMB4 | 1567.5 |
| PSMC6 | 1488.5 |
| PSME3 | 1442.5 |
| PSMB3 | 391.5 |
| UBC | 100.5 |
| PSMA5 | 5.5 |
| PSMA3 | -754.5 |
| PSMB10 | -1181.5 |
| PSMF1 | -1438.5 |
| PSMD9 | -2755.0 |
| PSMD13 | -2775.5 |
| ATM | -4881.5 |
FCGR3A-mediated phagocytosis
| 387 | |
|---|---|
| set | FCGR3A-mediated phagocytosis |
| setSize | 87 |
| pANOVA | 7.68e-07 |
| s.dist | -0.307 |
| p.adjustANOVA | 2.18e-05 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| ARPC2 | -8638.5 |
| ARPC5 | -8617.5 |
| CYFIP2 | -8558.5 |
| MYO5A | -8482.5 |
| MYO9B | -8423.5 |
| WASF2 | -8403.5 |
| ACTB | -8079.5 |
| CD247 | -8071.5 |
| ACTR3 | -7923.5 |
| RAC1 | -7765.5 |
| YES1 | -7705.5 |
| SYK | -7580.5 |
| BTK | -7424.5 |
| VAV1 | -7406.5 |
| ELMO2 | -7347.5 |
| VAV3 | -7293.5 |
| ELMO1 | -7076.5 |
| IGKV1-12 | -7039.0 |
| IGKV1-16 | -7039.0 |
| IGKV1-17 | -7039.0 |
| GeneID | Gene Rank |
|---|---|
| ARPC2 | -8638.5 |
| ARPC5 | -8617.5 |
| CYFIP2 | -8558.5 |
| MYO5A | -8482.5 |
| MYO9B | -8423.5 |
| WASF2 | -8403.5 |
| ACTB | -8079.5 |
| CD247 | -8071.5 |
| ACTR3 | -7923.5 |
| RAC1 | -7765.5 |
| YES1 | -7705.5 |
| SYK | -7580.5 |
| BTK | -7424.5 |
| VAV1 | -7406.5 |
| ELMO2 | -7347.5 |
| VAV3 | -7293.5 |
| ELMO1 | -7076.5 |
| IGKV1-12 | -7039.0 |
| IGKV1-16 | -7039.0 |
| IGKV1-17 | -7039.0 |
| IGKV1-39 | -7039.0 |
| IGKV1-5 | -7039.0 |
| IGKV1D-12 | -7039.0 |
| IGKV1D-16 | -7039.0 |
| IGKV1D-39 | -7039.0 |
| ACTR2 | -6872.5 |
| MYO10 | -6643.5 |
| WAS | -6573.5 |
| CYFIP1 | -6275.5 |
| NCKAP1L | -5905.5 |
| DOCK1 | -5681.5 |
| IGLV3-16 | -5675.5 |
| IGLV3-22 | -5675.5 |
| IGLV3-25 | -5675.5 |
| IGLV3-27 | -5675.5 |
| PTK2 | -5506.5 |
| ARPC1B | -5078.5 |
| WIPF1 | -5015.5 |
| IGLC1 | -4828.0 |
| IGLC2 | -4828.0 |
| IGLC3 | -4828.0 |
| IGLC7 | -4828.0 |
| ABI1 | -4717.5 |
| ABI2 | -4575.5 |
| NCKIPSD | -4420.5 |
| IGHV4-34 | -4385.0 |
| IGHV4-39 | -4385.0 |
| IGHV4-59 | -4385.0 |
| WIPF2 | -4347.5 |
| LYN | -3527.5 |
| IGHV2-5 | -2844.5 |
| IGHV2-70 | -2844.5 |
| CDC42 | -2813.5 |
| WASL | -2730.5 |
| SRC | -2361.5 |
| NCKAP1 | -1488.5 |
| MYH9 | -1301.5 |
| CD3G | -891.5 |
| IGHV7-81 | -695.0 |
| MAPK1 | -523.5 |
| IGKV2-28 | -517.5 |
| IGKV2D-28 | -517.5 |
| IGKV2D-40 | -517.5 |
| FYN | -339.5 |
| ARPC3 | 305.5 |
| IGKV4-1 | 362.5 |
| HCK | 1919.5 |
| WASF1 | 2249.5 |
| MAPK3 | 2999.5 |
| ARPC4 | 3107.5 |
| ACTG1 | 3383.5 |
| BRK1 | 4083.5 |
| FCGR3A | 4854.0 |
| ABL1 | 5165.5 |
| NCK1 | 5332.5 |
| CRK | 5404.5 |
| GRB2 | 5591.5 |
| WIPF3 | 5919.5 |
| IGKV2-30 | 6283.0 |
| IGKV2D-30 | 6283.0 |
| IGLV6-57 | 6930.5 |
| BAIAP2 | 8026.5 |
| FGR | 8128.5 |
| VAV2 | 8325.5 |
| MYO1C | 8565.5 |
| WASF3 | 8828.5 |
| IGKC | 8857.5 |
Leishmania phagocytosis
| 636 | |
|---|---|
| set | Leishmania phagocytosis |
| setSize | 87 |
| pANOVA | 7.68e-07 |
| s.dist | -0.307 |
| p.adjustANOVA | 2.18e-05 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| ARPC2 | -8638.5 |
| ARPC5 | -8617.5 |
| CYFIP2 | -8558.5 |
| MYO5A | -8482.5 |
| MYO9B | -8423.5 |
| WASF2 | -8403.5 |
| ACTB | -8079.5 |
| CD247 | -8071.5 |
| ACTR3 | -7923.5 |
| RAC1 | -7765.5 |
| YES1 | -7705.5 |
| SYK | -7580.5 |
| BTK | -7424.5 |
| VAV1 | -7406.5 |
| ELMO2 | -7347.5 |
| VAV3 | -7293.5 |
| ELMO1 | -7076.5 |
| IGKV1-12 | -7039.0 |
| IGKV1-16 | -7039.0 |
| IGKV1-17 | -7039.0 |
| GeneID | Gene Rank |
|---|---|
| ARPC2 | -8638.5 |
| ARPC5 | -8617.5 |
| CYFIP2 | -8558.5 |
| MYO5A | -8482.5 |
| MYO9B | -8423.5 |
| WASF2 | -8403.5 |
| ACTB | -8079.5 |
| CD247 | -8071.5 |
| ACTR3 | -7923.5 |
| RAC1 | -7765.5 |
| YES1 | -7705.5 |
| SYK | -7580.5 |
| BTK | -7424.5 |
| VAV1 | -7406.5 |
| ELMO2 | -7347.5 |
| VAV3 | -7293.5 |
| ELMO1 | -7076.5 |
| IGKV1-12 | -7039.0 |
| IGKV1-16 | -7039.0 |
| IGKV1-17 | -7039.0 |
| IGKV1-39 | -7039.0 |
| IGKV1-5 | -7039.0 |
| IGKV1D-12 | -7039.0 |
| IGKV1D-16 | -7039.0 |
| IGKV1D-39 | -7039.0 |
| ACTR2 | -6872.5 |
| MYO10 | -6643.5 |
| WAS | -6573.5 |
| CYFIP1 | -6275.5 |
| NCKAP1L | -5905.5 |
| DOCK1 | -5681.5 |
| IGLV3-16 | -5675.5 |
| IGLV3-22 | -5675.5 |
| IGLV3-25 | -5675.5 |
| IGLV3-27 | -5675.5 |
| PTK2 | -5506.5 |
| ARPC1B | -5078.5 |
| WIPF1 | -5015.5 |
| IGLC1 | -4828.0 |
| IGLC2 | -4828.0 |
| IGLC3 | -4828.0 |
| IGLC7 | -4828.0 |
| ABI1 | -4717.5 |
| ABI2 | -4575.5 |
| NCKIPSD | -4420.5 |
| IGHV4-34 | -4385.0 |
| IGHV4-39 | -4385.0 |
| IGHV4-59 | -4385.0 |
| WIPF2 | -4347.5 |
| LYN | -3527.5 |
| IGHV2-5 | -2844.5 |
| IGHV2-70 | -2844.5 |
| CDC42 | -2813.5 |
| WASL | -2730.5 |
| SRC | -2361.5 |
| NCKAP1 | -1488.5 |
| MYH9 | -1301.5 |
| CD3G | -891.5 |
| IGHV7-81 | -695.0 |
| MAPK1 | -523.5 |
| IGKV2-28 | -517.5 |
| IGKV2D-28 | -517.5 |
| IGKV2D-40 | -517.5 |
| FYN | -339.5 |
| ARPC3 | 305.5 |
| IGKV4-1 | 362.5 |
| HCK | 1919.5 |
| WASF1 | 2249.5 |
| MAPK3 | 2999.5 |
| ARPC4 | 3107.5 |
| ACTG1 | 3383.5 |
| BRK1 | 4083.5 |
| FCGR3A | 4854.0 |
| ABL1 | 5165.5 |
| NCK1 | 5332.5 |
| CRK | 5404.5 |
| GRB2 | 5591.5 |
| WIPF3 | 5919.5 |
| IGKV2-30 | 6283.0 |
| IGKV2D-30 | 6283.0 |
| IGLV6-57 | 6930.5 |
| BAIAP2 | 8026.5 |
| FGR | 8128.5 |
| VAV2 | 8325.5 |
| MYO1C | 8565.5 |
| WASF3 | 8828.5 |
| IGKC | 8857.5 |
Here is the session info with all the versions of packages used.
sessionInfo()
## R version 4.0.3 (2020-10-10)
## Platform: x86_64-pc-linux-gnu (64-bit)
## Running under: Ubuntu 18.04.5 LTS
##
## Matrix products: default
## BLAS: /usr/lib/x86_64-linux-gnu/blas/libblas.so.3.7.1
## LAPACK: /usr/lib/x86_64-linux-gnu/lapack/liblapack.so.3.7.1
##
## locale:
## [1] LC_CTYPE=en_US.UTF-8 LC_NUMERIC=C
## [3] LC_TIME=en_US.UTF-8 LC_COLLATE=en_US.UTF-8
## [5] LC_MONETARY=en_US.UTF-8 LC_MESSAGES=en_US.UTF-8
## [7] LC_PAPER=en_US.UTF-8 LC_NAME=C
## [9] LC_ADDRESS=C LC_TELEPHONE=C
## [11] LC_MEASUREMENT=en_US.UTF-8 LC_IDENTIFICATION=C
##
## attached base packages:
## [1] parallel stats4 stats graphics grDevices utils datasets
## [8] methods base
##
## other attached packages:
## [1] pkgload_1.1.0 GGally_2.0.0
## [3] ggplot2_3.3.2 beeswarm_0.2.3
## [5] gtools_3.8.2 tibble_3.0.4
## [7] dplyr_1.0.2 echarts4r_0.3.3
## [9] gplots_3.1.0 mitch_1.2.2
## [11] DESeq2_1.30.0 SummarizedExperiment_1.20.0
## [13] Biobase_2.50.0 MatrixGenerics_1.2.0
## [15] matrixStats_0.57.0 GenomicRanges_1.42.0
## [17] GenomeInfoDb_1.26.0 IRanges_2.24.0
## [19] S4Vectors_0.28.0 BiocGenerics_0.36.0
## [21] reshape2_1.4.4
##
## loaded via a namespace (and not attached):
## [1] httr_1.4.2 jsonlite_1.7.1 bit64_4.0.5
## [4] splines_4.0.3 assertthat_0.2.1 shiny_1.5.0
## [7] highr_0.8 blob_1.2.1 GenomeInfoDbData_1.2.4
## [10] yaml_2.2.1 backports_1.2.0 pillar_1.4.6
## [13] RSQLite_2.2.1 lattice_0.20-41 glue_1.4.2
## [16] digest_0.6.27 RColorBrewer_1.1-2 promises_1.1.1
## [19] XVector_0.30.0 colorspace_2.0-0 htmltools_0.5.0
## [22] httpuv_1.5.4 Matrix_1.2-18 plyr_1.8.6
## [25] XML_3.99-0.5 pkgconfig_2.0.3 genefilter_1.72.0
## [28] zlibbioc_1.36.0 purrr_0.3.4 xtable_1.8-4
## [31] scales_1.1.1 later_1.1.0.1 BiocParallel_1.24.1
## [34] annotate_1.68.0 generics_0.1.0 ellipsis_0.3.1
## [37] withr_2.3.0 survival_3.2-7 magrittr_1.5
## [40] crayon_1.3.4 mime_0.9 evaluate_0.14
## [43] memoise_1.1.0 MASS_7.3-53 tools_4.0.3
## [46] lifecycle_0.2.0 stringr_1.4.0 munsell_0.5.0
## [49] locfit_1.5-9.4 DelayedArray_0.16.0 AnnotationDbi_1.52.0
## [52] compiler_4.0.3 caTools_1.18.0 rlang_0.4.8
## [55] grid_4.0.3 RCurl_1.98-1.2 htmlwidgets_1.5.2
## [58] rmarkdown_2.5 bitops_1.0-6 testthat_3.0.0
## [61] gtable_0.3.0 DBI_1.1.0 reshape_0.8.8
## [64] R6_2.5.0 gridExtra_2.3 knitr_1.30
## [67] fastmap_1.0.1 bit_4.0.4 rprojroot_1.3-2
## [70] desc_1.2.0 KernSmooth_2.23-18 stringi_1.5.3
## [73] Rcpp_1.0.5 vctrs_0.3.4 geneplotter_1.68.0
## [76] tidyselect_1.1.0 xfun_0.19
END of report